*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 86 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 250 ALA A 61 ALA.? 20.04 ZN ZN A 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -30.68 49.76 89.87 -30.90 49.96 91.37 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 250 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 250 ALA A 71 ALA.? 18.90 ZN ZN A 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -10.85 57.79 70.32 -10.50 59.22 69.90 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 86 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 250 ALA B 61 ALA.? 20.38 ZN ZN B 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -21.56 56.20 16.28 -21.70 56.37 14.76 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 250 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 250 ALA B 71 ALA.? 18.94 ZN ZN B 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -34.70 39.55 36.03 -36.14 39.66 36.51 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 8.18 57.58 47.56 10.27 57.39 47.78 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 11.45 52.92 44.80 10.43 52.05 43.19 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 250 ALA C 61 ALA.? 19.20 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 8.18 57.58 47.56 10.27 57.39 47.78 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 11.45 52.92 44.80 10.43 52.05 43.19 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 14.70 52.81 52.57 16.23 52.88 52.61 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 A 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 250 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 A 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 250 ALA C 71 ALA.? 19.01 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -5.38 44.92 71.40 -5.39 43.57 72.14 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 A 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 A 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 250 ALA D 61 ALA.? 19.60 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -37.19 13.11 53.70 -37.94 11.80 53.61 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 A 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 250 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 A 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 250 ALA D 71 ALA.? 18.99 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -23.67 30.79 35.16 -22.42 30.44 34.35 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 14 hits 2wwt_o00 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 13 SER^? 14.04 ZN ZN A 128 A 524 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 556 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER B 13 SER^? 13.94 ZN ZN B 128 A 524 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 556 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER C 13 SER^? 14.25 ZN ZN C 128 A 524 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 556 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER D 13 SER^? 14.41 ZN ZN D 128 A 524 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 556 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -18.46 42.11 47.13 -20.09 43.42 47.28 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o00 naa= 3 ULMN 5 1a8s_c02 CHLOROPEROXIDASE F user 1 5 # 1 28 TRP A 17 TRP.? 10.56 ZN ZN A 128 94 SER A 13 SER^? 14.04 ZN ZN A 128 95 THR A 14 THR.? 9.34 ZN ZN A 128 224 ASP C 97 ASP^? 13.06 ZN ZN C 128 253 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 24.59 83.97 61.05 23.40 86.69 63.64 -25.41 56.81 62.93 -26.41 53.27 64.33 coo 16.00 80.13 58.60 16.16 82.12 59.96 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 19.36 80.73 56.97 21.18 81.74 57.48 -23.51 50.82 61.06 -23.73 50.87 63.22 coo 8.47 84.84 62.27 10.52 84.40 62.08 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 13.14 83.03 63.68 14.37 82.62 62.02 -17.83 49.51 56.44 -17.15 47.54 56.54 1a8s_c02 source 1a8s CHLOROPEROXIDASE F : 1 hits 1a8s_c02 naa= 5 ULMN 5 1apy_c01 ASPARTYLGLUCOSAMINIDASE user 1 5 # 1 C 49 SER B 13 SER^? 13.94 ZN ZN B 128 D 183 THR B 11 THR^? 14.42 ZN ZN C 128 D 201 THR C 11 THR^? 14.35 ZN ZN C 128 D 234 THR C 35 THR.? 11.32 ZN ZN B 128 D 235 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 28.33 56.67 -3.82 29.16 57.00 -1.57 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 26.22 55.99 1.14 25.12 54.28 1.92 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 22.71 56.04 -1.66 22.97 53.95 -1.20 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 27.28 52.33 6.04 28.76 53.82 5.51 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 29.38 49.78 4.20 28.58 49.83 3.90 -10.25 50.55 45.92 -9.76 50.87 45.25 1apy_c01 source 1apy ASPARTYLGLUCOSAMINIDASE : 1 hits 1apy_c01 naa= 5 ULMN 5 1zoi_c06 ESTERASE user 1 5 # 1 A 31 TRP A 17 TRP.? 10.56 ZN ZN A 128 A 97 SER A 13 SER^? 14.04 ZN ZN A 128 A 98 THR A 14 THR.? 9.34 ZN ZN A 128 A 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 256 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 63.06 21.33 50.87 66.70 20.53 49.57 -25.41 56.81 62.93 -26.41 53.27 64.33 coo 64.84 24.93 59.62 66.28 24.42 57.72 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 62.03 25.05 57.04 61.71 24.37 55.01 -23.51 50.82 61.06 -23.73 50.87 63.22 coo 73.80 27.56 60.96 72.24 26.45 60.08 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 70.86 23.63 59.28 68.91 24.23 58.80 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 5 1zoi_c06 ESTERASE user 2 5 # 2 A 31 TRP B 17 TRP.? 10.25 ZN ZN B 128 A 97 SER B 13 SER^? 13.94 ZN ZN B 128 A 98 THR B 14 THR.? 9.29 ZN ZN B 128 A 227 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 256 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 63.06 21.33 50.87 66.70 20.53 49.57 -29.66 53.19 43.28 -26.01 53.30 41.81 coo 64.84 24.93 59.62 66.28 24.42 57.72 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 62.03 25.05 57.04 61.71 24.37 55.01 -24.73 49.75 45.33 -24.61 49.96 43.21 coo 73.80 27.56 60.96 72.24 26.45 60.08 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 70.86 23.63 59.28 68.91 24.23 58.80 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 5 1zoi_c06 ESTERASE user 3 5 # 3 A 31 TRP D 17 TRP.? 10.91 ZN ZN D 128 A 97 SER D 13 SER^? 14.41 ZN ZN D 128 A 98 THR D 14 THR.? 9.56 ZN ZN D 128 A 227 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 256 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 63.06 21.33 50.87 66.70 20.53 49.57 -15.81 30.38 49.44 -18.93 31.08 51.75 coo 64.84 24.93 59.62 66.28 24.42 57.72 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 62.03 25.05 57.04 61.71 24.37 55.01 -18.99 35.81 50.60 -20.41 34.18 50.44 coo 73.80 27.56 60.96 72.24 26.45 60.08 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 70.86 23.63 59.28 68.91 24.23 58.80 -18.46 42.11 47.13 -20.09 43.42 47.28 1zoi_c06 source 1zoi ESTERASE : 3 hits 1zoi_c06 naa= 5 ULMN 5 1zoi_c07 ESTERASE user 1 5 # 1 B 31 TRP A 17 TRP.? 10.56 ZN ZN A 128 B 97 SER A 13 SER^? 14.04 ZN ZN A 128 B 98 THR A 14 THR.? 9.34 ZN ZN A 128 B 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 256 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 63.21 -7.40 37.39 66.89 -8.01 38.64 -25.41 56.81 62.93 -26.41 53.27 64.33 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 62.00 -3.96 31.04 61.72 -5.41 32.64 -23.51 50.82 61.06 -23.73 50.87 63.22 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 5 1zoi_c07 ESTERASE user 2 5 # 2 B 31 TRP B 17 TRP.? 10.25 ZN ZN B 128 B 97 SER B 13 SER^? 13.94 ZN ZN B 128 B 98 THR B 14 THR.? 9.29 ZN ZN B 128 B 227 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 256 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 63.21 -7.40 37.39 66.89 -8.01 38.64 -29.66 53.19 43.28 -26.01 53.30 41.81 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 62.00 -3.96 31.04 61.72 -5.41 32.64 -24.73 49.75 45.33 -24.61 49.96 43.21 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 5 1zoi_c07 ESTERASE user 3 5 # 3 B 31 TRP D 17 TRP.? 10.91 ZN ZN D 128 B 97 SER D 13 SER^? 14.41 ZN ZN D 128 B 98 THR D 14 THR.? 9.56 ZN ZN D 128 B 227 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 256 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 63.21 -7.40 37.39 66.89 -8.01 38.64 -15.81 30.38 49.44 -18.93 31.08 51.75 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 62.00 -3.96 31.04 61.72 -5.41 32.64 -18.99 35.81 50.60 -20.41 34.18 50.44 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -18.46 42.11 47.13 -20.09 43.42 47.28 1zoi_c07 source 1zoi ESTERASE : 3 hits 1zoi_c07 naa= 5 ULMN 5 1zoi_c08 ESTERASE user 1 5 # 1 C 31 TRP A 17 TRP.? 10.56 ZN ZN A 128 C 97 SER A 13 SER^? 14.04 ZN ZN A 128 C 98 THR A 14 THR.? 9.34 ZN ZN A 128 C 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 256 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 63.83 -4.59 68.93 67.47 -3.09 68.79 -25.41 56.81 62.93 -26.41 53.27 64.33 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 63.04 -11.90 69.14 62.71 -9.81 69.61 -23.51 50.82 61.06 -23.73 50.87 63.22 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 5 1zoi_c08 ESTERASE user 2 5 # 2 C 31 TRP B 17 TRP.? 10.25 ZN ZN B 128 C 97 SER B 13 SER^? 13.94 ZN ZN B 128 C 98 THR B 14 THR.? 9.29 ZN ZN B 128 C 227 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 256 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 63.83 -4.59 68.93 67.47 -3.09 68.79 -29.66 53.19 43.28 -26.01 53.30 41.81 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 63.04 -11.90 69.14 62.71 -9.81 69.61 -24.73 49.75 45.33 -24.61 49.96 43.21 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 5 1zoi_c08 ESTERASE user 3 5 # 3 C 31 TRP D 17 TRP.? 10.91 ZN ZN D 128 C 97 SER D 13 SER^? 14.41 ZN ZN D 128 C 98 THR D 14 THR.? 9.56 ZN ZN D 128 C 227 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 256 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 63.83 -4.59 68.93 67.47 -3.09 68.79 -15.81 30.38 49.44 -18.93 31.08 51.75 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 63.04 -11.90 69.14 62.71 -9.81 69.61 -18.99 35.81 50.60 -20.41 34.18 50.44 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -18.46 42.11 47.13 -20.09 43.42 47.28 1zoi_c08 source 1zoi ESTERASE : 3 hits 1zoi_c08 naa= 5 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 B 39 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 219 LYS C 81 LYS.? 11.89 ZN ZN C 128 B 376 GLY C 34 GLY.? 11.55 ZN ZN C 128 B 399 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo -2.66 39.94 47.71 -4.08 39.67 44.99 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -12.62 42.34 36.27 -8.73 43.54 40.31 0.65 56.08 51.29 4.22 57.96 54.91 coo -6.85 37.45 46.42 -7.20 36.92 45.92 -10.25 50.55 45.92 -9.76 50.87 45.25 coo -4.26 38.64 36.66 -3.61 38.69 37.17 -8.85 58.20 48.91 -9.08 57.49 48.72 13pk_c01 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c01 naa= 4 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 1 4 # 1 A 140 ALA A 22 ALA.? 9.97 ZN ZN A 128 A 141 PRO A 23 PRO~? 9.74 ZN ZN A 128 A 228 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 257 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -27.72 57.67 66.22 -26.73 57.38 67.36 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -30.33 54.20 65.69 -30.37 56.11 66.84 coo 2.03 38.95 28.44 3.60 38.60 29.83 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 6.85 37.62 29.99 7.50 38.47 31.78 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 2 4 # 2 A 140 ALA B 22 ALA.? 9.88 ZN ZN B 128 A 141 PRO B 23 PRO~? 9.12 ZN ZN B 128 A 228 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 257 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -30.03 55.57 39.93 -30.02 54.67 38.71 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -25.80 56.52 39.81 -27.73 57.65 39.62 coo 2.03 38.95 28.44 3.60 38.60 29.83 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 6.85 37.62 29.99 7.50 38.47 31.78 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 3 4 # 3 A 140 ALA C 22 ALA.? 10.24 ZN ZN C 128 A 141 PRO C 23 PRO~? 9.67 ZN ZN C 128 A 228 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 257 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -3.42 37.06 56.15 -2.84 38.26 56.86 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -3.79 39.45 52.56 -2.76 37.57 53.15 coo 2.03 38.95 28.44 3.60 38.60 29.83 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 6.85 37.62 29.99 7.50 38.47 31.78 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 4 4 # 4 A 140 ALA D 22 ALA.? 10.37 ZN ZN D 128 A 141 PRO D 23 PRO~? 9.97 ZN ZN D 128 A 228 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 257 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -16.97 26.63 50.50 -18.20 26.22 49.69 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -18.42 28.32 54.20 -17.85 26.29 53.48 coo 2.03 38.95 28.44 3.60 38.60 29.83 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 6.85 37.62 29.99 7.50 38.47 31.78 -17.20 28.58 35.23 -16.55 27.59 33.50 1a7u_c04 source 1a7u CHLOROPEROXIDASE T : 4 hits 1a7u_c04 naa= 4 ULMN 4 1a7u_c05 CHLOROPEROXIDASE T user 1 4 # 1 B 140 ALA A 22 ALA.? 9.97 ZN ZN A 128 B 141 PRO A 23 PRO~? 9.74 ZN ZN A 128 B 228 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 257 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo 25.73 54.94 3.35 27.07 55.54 3.80 -27.72 57.67 66.22 -26.73 57.38 67.36 coo 25.81 51.10 5.29 24.88 53.11 5.69 -30.33 54.20 65.69 -30.37 56.11 66.84 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 32.76 68.02 0.70 31.21 68.44 2.05 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 4 1a7u_c05 CHLOROPEROXIDASE T user 2 4 # 2 B 140 ALA B 22 ALA.? 9.88 ZN ZN B 128 B 141 PRO B 23 PRO~? 9.12 ZN ZN B 128 B 228 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 257 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo 25.73 54.94 3.35 27.07 55.54 3.80 -30.03 55.57 39.93 -30.02 54.67 38.71 coo 25.81 51.10 5.29 24.88 53.11 5.69 -25.80 56.52 39.81 -27.73 57.65 39.62 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 32.76 68.02 0.70 31.21 68.44 2.05 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 4 1a7u_c05 CHLOROPEROXIDASE T user 3 4 # 3 B 140 ALA C 22 ALA.? 10.24 ZN ZN C 128 B 141 PRO C 23 PRO~? 9.67 ZN ZN C 128 B 228 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 257 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo 25.73 54.94 3.35 27.07 55.54 3.80 -3.42 37.06 56.15 -2.84 38.26 56.86 coo 25.81 51.10 5.29 24.88 53.11 5.69 -3.79 39.45 52.56 -2.76 37.57 53.15 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 32.76 68.02 0.70 31.21 68.44 2.05 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 4 1a7u_c05 CHLOROPEROXIDASE T user 4 4 # 4 B 140 ALA D 22 ALA.? 10.37 ZN ZN D 128 B 141 PRO D 23 PRO~? 9.97 ZN ZN D 128 B 228 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 257 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 25.73 54.94 3.35 27.07 55.54 3.80 -16.97 26.63 50.50 -18.20 26.22 49.69 coo 25.81 51.10 5.29 24.88 53.11 5.69 -18.42 28.32 54.20 -17.85 26.29 53.48 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 32.76 68.02 0.70 31.21 68.44 2.05 -17.20 28.58 35.23 -16.55 27.59 33.50 1a7u_c05 source 1a7u CHLOROPEROXIDASE T : 4 hits 1a7u_c05 naa= 4 ULMN 4 1akm_c03 ORNITHINE TRANSCARBAMYLASE user 1 4 # 1 A 57 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 58 THR A 11 THR^? 14.69 ZN ZN D 128 A 106 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 37.17 69.43 16.95 39.61 69.29 18.96 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 31.76 68.35 14.99 32.00 68.70 12.89 -21.95 40.72 59.07 -22.88 39.66 60.69 coo 33.87 66.22 9.96 35.73 68.37 10.99 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 35.28 73.60 8.07 35.11 72.84 9.96 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 4 1akm_c03 ORNITHINE TRANSCARBAMYLASE user 2 4 # 2 A 57 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 58 THR D 11 THR^? 14.18 ZN ZN D 128 A 106 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 133 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 37.17 69.43 16.95 39.61 69.29 18.96 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 31.76 68.35 14.99 32.00 68.70 12.89 -25.16 43.60 54.40 -26.66 42.42 55.40 coo 33.87 66.22 9.96 35.73 68.37 10.99 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 35.28 73.60 8.07 35.11 72.84 9.96 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 4 1akm_c03 ORNITHINE TRANSCARBAMYLASE user 3 4 # 3 A 57 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 58 THR B 11 THR^? 14.42 ZN ZN C 128 A 106 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 133 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 37.17 69.43 16.95 39.61 69.29 18.96 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 31.76 68.35 14.99 32.00 68.70 12.89 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 33.87 66.22 9.96 35.73 68.37 10.99 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 35.28 73.60 8.07 35.11 72.84 9.96 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 4 1akm_c03 ORNITHINE TRANSCARBAMYLASE user 4 4 # 4 A 57 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 58 THR C 11 THR^? 14.35 ZN ZN C 128 A 106 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 133 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 37.17 69.43 16.95 39.61 69.29 18.96 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 31.76 68.35 14.99 32.00 68.70 12.89 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 33.87 66.22 9.96 35.73 68.37 10.99 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 35.28 73.60 8.07 35.11 72.84 9.96 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 4 1akm_c03 ORNITHINE TRANSCARBAMYLASE user 5 4 # 5 A 57 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 58 THR B 11 THR^? 14.42 ZN ZN C 128 A 106 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 37.17 69.43 16.95 39.61 69.29 18.96 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 31.76 68.35 14.99 32.00 68.70 12.89 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 33.87 66.22 9.96 35.73 68.37 10.99 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 35.28 73.60 8.07 35.11 72.84 9.96 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 4 1akm_c03 ORNITHINE TRANSCARBAMYLASE user 6 4 # 6 A 57 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 58 THR C 11 THR^? 14.35 ZN ZN C 128 A 106 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 37.17 69.43 16.95 39.61 69.29 18.96 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 31.76 68.35 14.99 32.00 68.70 12.89 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 33.87 66.22 9.96 35.73 68.37 10.99 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 35.28 73.60 8.07 35.11 72.84 9.96 -24.77 44.27 50.01 -22.89 43.34 50.12 1akm_c03 source 1akm ORNITHINE TRANSCARBAMYLASE : 6 hits 1akm_c03 naa= 4 ULMN 4 1akm_c04 ORNITHINE TRANSCARBAMYLASE user 1 4 # 1 B 57 ARG A 12 ARG^? 10.24 ZN ZN A 128 B 58 THR A 11 THR^? 14.69 ZN ZN D 128 B 106 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 31.47 45.08 32.03 31.41 42.08 31.00 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 30.01 50.73 32.15 31.74 51.62 33.16 -21.95 40.72 59.07 -22.88 39.66 60.69 coo 35.62 52.37 31.71 35.46 49.72 33.20 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 36.28 50.33 39.07 34.91 49.66 37.71 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 4 1akm_c04 ORNITHINE TRANSCARBAMYLASE user 2 4 # 2 B 57 ARG A 12 ARG^? 10.24 ZN ZN A 128 B 58 THR D 11 THR^? 14.18 ZN ZN D 128 B 106 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 133 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 31.47 45.08 32.03 31.41 42.08 31.00 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 30.01 50.73 32.15 31.74 51.62 33.16 -25.16 43.60 54.40 -26.66 42.42 55.40 coo 35.62 52.37 31.71 35.46 49.72 33.20 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 36.28 50.33 39.07 34.91 49.66 37.71 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 4 1akm_c04 ORNITHINE TRANSCARBAMYLASE user 3 4 # 3 B 57 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 58 THR B 11 THR^? 14.42 ZN ZN C 128 B 106 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 133 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 31.47 45.08 32.03 31.41 42.08 31.00 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 30.01 50.73 32.15 31.74 51.62 33.16 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 35.62 52.37 31.71 35.46 49.72 33.20 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 36.28 50.33 39.07 34.91 49.66 37.71 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 4 1akm_c04 ORNITHINE TRANSCARBAMYLASE user 4 4 # 4 B 57 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 58 THR C 11 THR^? 14.35 ZN ZN C 128 B 106 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 133 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 31.47 45.08 32.03 31.41 42.08 31.00 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 30.01 50.73 32.15 31.74 51.62 33.16 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 35.62 52.37 31.71 35.46 49.72 33.20 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 36.28 50.33 39.07 34.91 49.66 37.71 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 4 1akm_c04 ORNITHINE TRANSCARBAMYLASE user 5 4 # 5 B 57 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 58 THR B 11 THR^? 14.42 ZN ZN C 128 B 106 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 31.47 45.08 32.03 31.41 42.08 31.00 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 30.01 50.73 32.15 31.74 51.62 33.16 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 35.62 52.37 31.71 35.46 49.72 33.20 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 36.28 50.33 39.07 34.91 49.66 37.71 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 4 1akm_c04 ORNITHINE TRANSCARBAMYLASE user 6 4 # 6 B 57 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 58 THR C 11 THR^? 14.35 ZN ZN C 128 B 106 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 31.47 45.08 32.03 31.41 42.08 31.00 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 30.01 50.73 32.15 31.74 51.62 33.16 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 35.62 52.37 31.71 35.46 49.72 33.20 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 36.28 50.33 39.07 34.91 49.66 37.71 -24.77 44.27 50.01 -22.89 43.34 50.12 1akm_c04 source 1akm ORNITHINE TRANSCARBAMYLASE : 6 hits 1akm_c04 naa= 4 ULMN 4 1akm_c05 ORNITHINE TRANSCARBAMYLASE user 1 4 # 1 C 57 ARG A 12 ARG^? 10.24 ZN ZN A 128 C 58 THR A 11 THR^? 14.69 ZN ZN D 128 C 106 ARG D 12 ARG^? 9.28 ZN ZN D 128 C 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 22.08 47.45 4.33 23.58 48.95 2.06 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 19.99 47.16 9.87 19.96 45.01 10.26 -21.95 40.72 59.07 -22.88 39.66 60.69 coo 23.22 42.51 11.24 22.66 42.44 8.27 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 18.34 38.49 6.81 18.75 40.50 6.70 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 4 1akm_c05 ORNITHINE TRANSCARBAMYLASE user 2 4 # 2 C 57 ARG A 12 ARG^? 10.24 ZN ZN A 128 C 58 THR D 11 THR^? 14.18 ZN ZN D 128 C 106 ARG D 12 ARG^? 9.28 ZN ZN D 128 C 133 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 22.08 47.45 4.33 23.58 48.95 2.06 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 19.99 47.16 9.87 19.96 45.01 10.26 -25.16 43.60 54.40 -26.66 42.42 55.40 coo 23.22 42.51 11.24 22.66 42.44 8.27 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 18.34 38.49 6.81 18.75 40.50 6.70 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 4 1akm_c05 ORNITHINE TRANSCARBAMYLASE user 3 4 # 3 C 57 ARG B 12 ARG^? 9.84 ZN ZN B 128 C 58 THR B 11 THR^? 14.42 ZN ZN C 128 C 106 ARG C 12 ARG^? 8.72 ZN ZN C 128 C 133 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 22.08 47.45 4.33 23.58 48.95 2.06 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 19.99 47.16 9.87 19.96 45.01 10.26 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 23.22 42.51 11.24 22.66 42.44 8.27 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 18.34 38.49 6.81 18.75 40.50 6.70 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 4 1akm_c05 ORNITHINE TRANSCARBAMYLASE user 4 4 # 4 C 57 ARG B 12 ARG^? 9.84 ZN ZN B 128 C 58 THR C 11 THR^? 14.35 ZN ZN C 128 C 106 ARG C 12 ARG^? 8.72 ZN ZN C 128 C 133 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 22.08 47.45 4.33 23.58 48.95 2.06 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 19.99 47.16 9.87 19.96 45.01 10.26 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 23.22 42.51 11.24 22.66 42.44 8.27 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 18.34 38.49 6.81 18.75 40.50 6.70 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 4 1akm_c05 ORNITHINE TRANSCARBAMYLASE user 5 4 # 5 C 57 ARG C 12 ARG^? 8.72 ZN ZN C 128 C 58 THR B 11 THR^? 14.42 ZN ZN C 128 C 106 ARG B 12 ARG^? 9.84 ZN ZN B 128 C 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 22.08 47.45 4.33 23.58 48.95 2.06 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 19.99 47.16 9.87 19.96 45.01 10.26 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 23.22 42.51 11.24 22.66 42.44 8.27 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 18.34 38.49 6.81 18.75 40.50 6.70 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 4 1akm_c05 ORNITHINE TRANSCARBAMYLASE user 6 4 # 6 C 57 ARG C 12 ARG^? 8.72 ZN ZN C 128 C 58 THR C 11 THR^? 14.35 ZN ZN C 128 C 106 ARG B 12 ARG^? 9.84 ZN ZN B 128 C 133 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 22.08 47.45 4.33 23.58 48.95 2.06 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 19.99 47.16 9.87 19.96 45.01 10.26 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 23.22 42.51 11.24 22.66 42.44 8.27 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 18.34 38.49 6.81 18.75 40.50 6.70 -24.77 44.27 50.01 -22.89 43.34 50.12 1akm_c05 source 1akm ORNITHINE TRANSCARBAMYLASE : 6 hits 1akm_c05 naa= 4 ULMN 4 1at1_c00 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 1 4 # 1 A 54 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 55 THR C 11 THR^? 14.35 ZN ZN C 128 A 105 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 134 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 45.01 25.56 13.42 46.87 24.72 15.81 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 46.66 31.81 11.47 45.07 33.00 12.28 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 45.90 36.70 17.09 45.44 33.84 15.97 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 39.84 34.19 14.29 41.49 33.14 13.80 -18.46 42.11 47.13 -20.09 43.42 47.28 1at1_c00 source 1at1 ASPARTATE CARBAMOYLTRANSFERASE (ASPARTATE TRAN: 1 hits 1at1_c00 naa= 4 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 1 4 # 1 C 54 ARG A 12 ARG^? 10.24 ZN ZN A 128 C 55 THR D 11 THR^? 14.18 ZN ZN D 128 C 105 ARG D 12 ARG^? 9.28 ZN ZN D 128 C 134 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 72.21 50.46 66.89 73.19 48.88 64.48 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 66.13 49.41 68.53 64.87 51.09 67.81 -25.16 43.60 54.40 -26.66 42.42 55.40 coo 61.54 50.76 63.40 64.63 51.00 63.85 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 64.44 56.54 65.92 65.14 54.67 66.30 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 4 1at1_c01 ASPARTATE CARBAMOYLTRANSFERASE (ASPAuser 2 4 # 2 C 54 ARG B 12 ARG^? 9.84 ZN ZN B 128 C 55 THR C 11 THR^? 14.35 ZN ZN C 128 C 105 ARG C 12 ARG^? 8.72 ZN ZN C 128 C 134 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 72.21 50.46 66.89 73.19 48.88 64.48 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 66.13 49.41 68.53 64.87 51.09 67.81 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 61.54 50.76 63.40 64.63 51.00 63.85 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 64.44 56.54 65.92 65.14 54.67 66.30 -18.46 42.11 47.13 -20.09 43.42 47.28 1at1_c01 source 1at1 ASPARTATE CARBAMOYLTRANSFERASE (ASPARTATE TRAN: 2 hits 1at1_c01 naa= 4 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 1 4 # 1 A 142 ALA C 49 ALA^? 16.41 ZN ZN C 128 A 144 GLY C 48 GLY.? 18.12 ZN ZN C 128 A 280 TYR D 52 TYR^? 7.54 ZN ZN D 128 A 414 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -0.09 43.99 68.78 1.05 44.60 69.61 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -1.53 40.99 70.60 -2.12 41.62 70.55 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 2 4 # 2 A 142 ALA C 71 ALA.? 19.01 ZN ZN C 128 A 144 GLY C 72 GLY.? 17.57 ZN ZN A 128 A 280 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 414 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -8.50 47.01 71.89 -7.91 47.25 71.32 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 3 4 # 3 A 142 ALA D 71 ALA.? 18.99 ZN ZN D 128 A 144 GLY D 72 GLY.? 17.67 ZN ZN B 128 A 280 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 414 GLU D 70 GLU^? 19.86 ZN ZN D 128 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -25.01 34.28 34.53 -25.35 33.80 35.13 coo -3.84 22.59 11.63 -6.55 23.25 11.72 8.07 52.98 53.71 8.63 50.62 55.11 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -27.83 26.66 34.57 -27.72 25.48 32.82 1b8f_c00 source 1b8f HISTIDINE AMMONIA-LYASE : 3 hits 1b8f_c00 naa= 4 ULMN 4 1c2t_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 A 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 135 SER A 13 SER^? 14.04 ZN ZN A 128 A 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 16.88 2.43 18.09 16.20 3.65 19.72 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 16.00 9.54 19.61 16.53 10.80 21.20 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 13.58 9.16 13.93 14.63 11.33 13.80 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 20.15 8.89 19.42 18.82 8.12 20.82 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1c2t_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 4 # 2 A 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 135 SER C 13 SER^? 14.25 ZN ZN C 128 A 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 16.88 2.43 18.09 16.20 3.65 19.72 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 16.00 9.54 19.61 16.53 10.80 21.20 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 13.58 9.16 13.93 14.63 11.33 13.80 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 20.15 8.89 19.42 18.82 8.12 20.82 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1c2t_c00 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 4 # 3 A 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 135 SER D 13 SER^? 14.41 ZN ZN D 128 A 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 16.88 2.43 18.09 16.20 3.65 19.72 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 16.00 9.54 19.61 16.53 10.80 21.20 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 13.58 9.16 13.93 14.63 11.33 13.80 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 20.15 8.89 19.42 18.82 8.12 20.82 -21.74 43.31 43.14 -23.53 43.14 44.28 1c2t_c00 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 3 hits 1c2t_c00 naa= 4 ULMN 4 1c2t_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 B 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 135 SER A 13 SER^? 14.04 ZN ZN A 128 B 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 32.78 15.84 -5.64 32.35 13.64 -4.67 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 35.12 16.22 2.69 37.05 17.04 2.40 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1c2t_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 4 # 2 B 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 135 SER C 13 SER^? 14.25 ZN ZN C 128 B 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 32.78 15.84 -5.64 32.35 13.64 -4.67 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 35.12 16.22 2.69 37.05 17.04 2.40 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1c2t_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 4 # 3 B 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 B 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 135 SER D 13 SER^? 14.41 ZN ZN D 128 B 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 32.78 15.84 -5.64 32.35 13.64 -4.67 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 35.12 16.22 2.69 37.05 17.04 2.40 -21.74 43.31 43.14 -23.53 43.14 44.28 1c2t_c01 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 3 hits 1c2t_c01 naa= 4 ULMN 4 1cde_c00 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 4 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 135 SER A 13 SER^? 14.04 ZN ZN A 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1cde_c00 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 4 # 2 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 135 SER C 13 SER^? 14.25 ZN ZN C 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1cde_c00 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 4 # 3 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 135 SER D 13 SER^? 14.41 ZN ZN D 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c00 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 3 hits 1cde_c00 naa= 4 ULMN 4 1cde_c01 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 4 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 135 SER A 13 SER^? 14.04 ZN ZN A 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1cde_c01 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 4 # 2 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 135 SER C 13 SER^? 14.25 ZN ZN C 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1cde_c01 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 4 # 3 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 135 SER D 13 SER^? 14.41 ZN ZN D 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c01 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 3 hits 1cde_c01 naa= 4 ULMN 4 1cde_c02 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 4 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 135 SER A 13 SER^? 14.04 ZN ZN A 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1cde_c02 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 4 # 2 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 135 SER C 13 SER^? 14.25 ZN ZN C 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1cde_c02 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 4 # 3 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 135 SER D 13 SER^? 14.41 ZN ZN D 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c02 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 3 hits 1cde_c02 naa= 4 ULMN 4 1cde_c03 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 4 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 135 SER A 13 SER^? 14.04 ZN ZN A 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1cde_c03 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 4 # 2 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 135 SER C 13 SER^? 14.25 ZN ZN C 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1cde_c03 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 4 # 3 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 135 SER D 13 SER^? 14.41 ZN ZN D 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 6.72 -8.38 -2.91 7.04 -10.66 -3.42 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c03 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 3 hits 1cde_c03 naa= 4 ULMN 4 1dbt_c02 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 A 33 LYS A 33 LYS.? 11.45 ZN ZN A 128 A 60 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 62 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 65 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 71.59 57.86 25.98 66.66 59.50 26.53 -32.13 43.51 68.59 -35.31 47.47 65.43 coo 66.44 58.31 23.16 64.45 58.00 23.81 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 61.71 58.67 18.68 62.06 59.06 24.07 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 57.96 61.59 10.16 57.54 63.39 9.12 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 4 1dbt_c02 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 A 33 LYS B 33 LYS.? 11.38 ZN ZN B 128 A 60 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 62 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 65 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 71.59 57.86 25.98 66.66 59.50 26.53 -14.69 55.97 38.01 -16.66 60.81 39.16 coo 66.44 58.31 23.16 64.45 58.00 23.81 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 61.71 58.67 18.68 62.06 59.06 24.07 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 57.96 61.59 10.16 57.54 63.39 9.12 -18.76 47.29 19.05 -17.56 47.54 20.78 1dbt_c02 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c02 naa= 4 ULMN 4 1dbt_c03 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 B 33 LYS A 33 LYS.? 11.45 ZN ZN A 128 B 60 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 62 LYS A 81 LYS.? 12.55 ZN ZN A 128 B 65 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 60.66 73.37 6.16 58.97 68.44 6.56 -32.13 43.51 68.59 -35.31 47.47 65.43 coo 58.78 69.55 10.14 57.19 68.14 10.07 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 57.51 66.37 15.65 56.43 65.69 10.35 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 59.76 62.84 24.35 61.26 61.55 25.03 -22.76 44.44 87.32 -23.27 43.38 85.56 1dbt_c03 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 1 hits 1dbt_c03 naa= 4 ULMN 4 1dbt_c04 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 C 33 LYS A 33 LYS.? 11.45 ZN ZN A 128 C 60 ASP A 32 ASP.? -2.97 ZN ZN A 128s C 62 LYS A 81 LYS.? 12.55 ZN ZN A 128 C 65 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 48.78 54.73 53.49 45.16 54.73 57.01 -32.13 43.51 68.59 -35.31 47.47 65.43 coo 46.15 51.25 57.34 45.59 51.66 59.34 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 43.68 46.22 60.72 43.55 51.70 60.99 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 39.24 37.68 61.54 37.35 37.05 60.87 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 4 1dbt_c04 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 C 33 LYS B 33 LYS.? 11.38 ZN ZN B 128 C 60 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 62 LYS B 81 LYS.? 12.71 ZN ZN B 128 C 65 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 48.78 54.73 53.49 45.16 54.73 57.01 -14.69 55.97 38.01 -16.66 60.81 39.16 coo 46.15 51.25 57.34 45.59 51.66 59.34 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 43.68 46.22 60.72 43.55 51.70 60.99 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 39.24 37.68 61.54 37.35 37.05 60.87 -18.76 47.29 19.05 -17.56 47.54 20.78 1dbt_c04 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c04 naa= 4 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 1 4 # 1 A 92 TYR A 93 TYR^? 17.82 ZN ZN A 128 A 112 PHE C 99 PHE^? 14.04 ZN ZN C 128 A 178 PHE C 74 PHE^? 15.05 ZN ZN C 128 A 333 TRP A 17 TRP.? 10.56 ZN ZN A 128 coo 36.26 31.30 22.39 35.67 33.02 24.49 -17.49 60.90 64.70 -15.26 61.56 63.14 coo 45.52 35.08 26.96 42.72 35.07 26.70 -14.56 53.53 56.74 -15.34 51.98 58.97 coo 43.67 42.67 22.02 43.98 41.21 24.38 -9.43 52.07 65.61 -10.77 54.53 65.79 coo 37.80 27.73 29.78 38.27 31.62 30.15 -25.41 56.81 62.93 -26.41 53.27 64.33 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 2 4 # 2 A 92 TYR B 93 TYR^? 18.00 ZN ZN B 128 A 112 PHE D 99 PHE^? 14.35 ZN ZN D 128 A 178 PHE D 74 PHE^? 14.94 ZN ZN D 128 A 333 TRP B 17 TRP.? 10.25 ZN ZN B 128 coo 36.26 31.30 22.39 35.67 33.02 24.49 -35.98 46.77 41.76 -37.33 44.77 43.20 coo 45.52 35.08 26.96 42.72 35.07 26.70 -29.67 42.10 49.53 -27.93 42.65 47.39 coo 43.67 42.67 22.02 43.98 41.21 24.38 -29.53 36.49 40.87 -31.48 38.47 40.51 coo 37.80 27.73 29.78 38.27 31.62 30.15 -29.66 53.19 43.28 -26.01 53.30 41.81 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 3 4 # 3 A 92 TYR C 93 TYR^? 17.98 ZN ZN C 128 A 112 PHE A 99 PHE^? 14.45 ZN ZN A 128 A 178 PHE A 74 PHE^? 15.18 ZN ZN A 128 A 333 TRP C 17 TRP.? 10.94 ZN ZN C 128 coo 36.26 31.30 22.39 35.67 33.02 24.49 -6.81 37.29 66.15 -8.85 36.99 68.07 coo 45.52 35.08 26.96 42.72 35.07 26.70 -17.21 40.83 64.08 -15.57 42.86 63.04 coo 43.67 42.67 22.02 43.98 41.21 24.38 -11.97 47.81 69.31 -10.39 45.49 69.36 coo 37.80 27.73 29.78 38.27 31.62 30.15 -7.22 36.96 57.26 -7.10 40.02 54.79 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 4 4 # 4 A 92 TYR D 93 TYR^? 18.01 ZN ZN D 128 A 112 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 178 PHE B 74 PHE^? 15.25 ZN ZN B 128 A 333 TRP D 17 TRP.? 10.91 ZN ZN D 128 coo 36.26 31.30 22.39 35.67 33.02 24.49 -16.06 30.04 40.46 -15.16 31.88 38.54 coo 45.52 35.08 26.96 42.72 35.07 26.70 -16.73 40.99 42.20 -19.09 40.00 43.35 coo 43.67 42.67 22.02 43.98 41.21 24.38 -24.88 37.89 37.15 -23.16 35.68 37.15 coo 37.80 27.73 29.78 38.27 31.62 30.15 -15.81 30.38 49.44 -18.93 31.08 51.75 1di1_c00 source 1di1 ARISTOLOCHENE SYNTHASE : 4 hits 1di1_c00 naa= 4 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 1 4 # 1 B 92 TYR A 93 TYR^? 17.82 ZN ZN A 128 B 112 PHE C 99 PHE^? 14.04 ZN ZN C 128 B 178 PHE C 74 PHE^? 15.05 ZN ZN C 128 B 333 TRP A 17 TRP.? 10.56 ZN ZN A 128 coo 99.56 54.98 23.15 101.17 54.32 25.32 -17.49 60.90 64.70 -15.26 61.56 63.14 coo 95.53 46.26 28.54 97.54 48.18 28.09 -14.56 53.53 56.74 -15.34 51.98 58.97 coo 102.10 41.65 23.98 100.86 42.71 26.26 -9.43 52.07 65.61 -10.77 54.53 65.79 coo 96.01 57.16 30.39 98.35 54.06 31.01 -25.41 56.81 62.93 -26.41 53.27 64.33 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 2 4 # 2 B 92 TYR B 93 TYR^? 18.00 ZN ZN B 128 B 112 PHE D 99 PHE^? 14.35 ZN ZN D 128 B 178 PHE D 74 PHE^? 14.94 ZN ZN D 128 B 333 TRP B 17 TRP.? 10.25 ZN ZN B 128 coo 99.56 54.98 23.15 101.17 54.32 25.32 -35.98 46.77 41.76 -37.33 44.77 43.20 coo 95.53 46.26 28.54 97.54 48.18 28.09 -29.67 42.10 49.53 -27.93 42.65 47.39 coo 102.10 41.65 23.98 100.86 42.71 26.26 -29.53 36.49 40.87 -31.48 38.47 40.51 coo 96.01 57.16 30.39 98.35 54.06 31.01 -29.66 53.19 43.28 -26.01 53.30 41.81 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 3 4 # 3 B 92 TYR C 93 TYR^? 17.98 ZN ZN C 128 B 112 PHE A 99 PHE^? 14.45 ZN ZN A 128 B 178 PHE A 74 PHE^? 15.18 ZN ZN A 128 B 333 TRP C 17 TRP.? 10.94 ZN ZN C 128 coo 99.56 54.98 23.15 101.17 54.32 25.32 -6.81 37.29 66.15 -8.85 36.99 68.07 coo 95.53 46.26 28.54 97.54 48.18 28.09 -17.21 40.83 64.08 -15.57 42.86 63.04 coo 102.10 41.65 23.98 100.86 42.71 26.26 -11.97 47.81 69.31 -10.39 45.49 69.36 coo 96.01 57.16 30.39 98.35 54.06 31.01 -7.22 36.96 57.26 -7.10 40.02 54.79 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 4 4 # 4 B 92 TYR D 93 TYR^? 18.01 ZN ZN D 128 B 112 PHE B 99 PHE^? 14.30 ZN ZN B 128 B 178 PHE B 74 PHE^? 15.25 ZN ZN B 128 B 333 TRP D 17 TRP.? 10.91 ZN ZN D 128 coo 99.56 54.98 23.15 101.17 54.32 25.32 -16.06 30.04 40.46 -15.16 31.88 38.54 coo 95.53 46.26 28.54 97.54 48.18 28.09 -16.73 40.99 42.20 -19.09 40.00 43.35 coo 102.10 41.65 23.98 100.86 42.71 26.26 -24.88 37.89 37.15 -23.16 35.68 37.15 coo 96.01 57.16 30.39 98.35 54.06 31.01 -15.81 30.38 49.44 -18.93 31.08 51.75 1di1_c01 source 1di1 ARISTOLOCHENE SYNTHASE : 4 hits 1di1_c01 naa= 4 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 D 44 LYS C 33 LYS.? 11.91 ZN ZN C 128 D 71 ASP C 32 ASP^? -2.40 ZN ZN C 128s D 73 LYS C 81 LYS.? 11.89 ZN ZN C 128 D 76 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 59.78 36.42 71.82 59.95 40.97 70.58 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 56.16 40.71 72.48 56.48 42.77 72.42 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 51.52 44.76 73.92 56.76 45.26 72.14 0.65 56.08 51.29 4.22 57.96 54.91 coo 42.33 47.14 73.59 41.23 47.55 71.88 8.74 58.91 56.74 6.81 58.81 55.87 1eix_c07 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 1 hits 1eix_c07 naa= 4 ULMN 4 1exp_c00 BETA-1,4-D-GLYCANASE CEX-CD user 1 4 # 1 127 GLU C 58 GLU.? 14.59 ZN ZN C 128 205 HIS C 30 HIS^? -3.56 ZN ZN C 128s 233 GLU B 107 GLU.? 12.06 ZN ZN C 128 235 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 21.30 74.05 33.80 19.79 72.64 33.96 7.13 51.72 45.00 6.65 51.50 42.95 coo 23.08 64.94 33.21 22.54 65.31 35.19 0.61 46.90 50.78 -0.23 46.71 52.70 coo 25.12 67.63 37.99 23.29 68.70 37.64 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 24.30 59.55 35.21 23.07 61.13 34.61 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 4 1exp_c00 BETA-1,4-D-GLYCANASE CEX-CD user 2 4 # 2 127 GLU D 58 GLU.? 14.54 ZN ZN D 128 205 HIS D 30 HIS^? -3.68 ZN ZN D 128s 233 GLU A 107 GLU.? 11.70 ZN ZN D 128 235 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 21.30 74.05 33.80 19.79 72.64 33.96 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 23.08 64.94 33.21 22.54 65.31 35.19 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 25.12 67.63 37.99 23.29 68.70 37.64 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 24.30 59.55 35.21 23.07 61.13 34.61 -29.32 31.61 55.53 -28.20 30.46 54.16 1exp_c00 source 1exp BETA-1,4-D-GLYCANASE CEX-CD : 2 hits 1exp_c00 naa= 4 ULMN 4 1fcb_c02 FLAVOCYTOCHROME B2 user 1 4 # 1 A 254 TYR A 8 TYR.? 17.33 ZN ZN A 128 A 282 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 373 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 376 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 75.40 55.97 6.36 72.75 56.58 5.83 -17.14 34.95 65.78 -18.35 33.52 67.89 coo 69.74 64.20 6.45 69.59 62.69 4.89 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 67.21 59.97 4.31 68.52 58.30 4.63 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 63.22 56.92 3.19 62.12 53.88 3.77 -21.38 38.31 55.98 -23.17 35.84 55.80 1fcb_c02 source 1fcb FLAVOCYTOCHROME B2 : 1 hits 1fcb_c02 naa= 4 ULMN 4 1fcb_c03 FLAVOCYTOCHROME B2 user 1 4 # 1 B 254 TYR A 8 TYR.? 17.33 ZN ZN A 128 B 282 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 373 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 376 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 48.67 71.34 -37.35 47.72 70.91 -34.78 -17.14 34.95 65.78 -18.35 33.52 67.89 coo 50.76 75.22 -28.50 48.72 74.60 -29.10 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 46.58 71.90 -28.50 46.40 71.30 -30.47 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 43.42 68.27 -26.39 42.27 65.53 -27.02 -21.38 38.31 55.98 -23.17 35.84 55.80 1fcb_c03 source 1fcb FLAVOCYTOCHROME B2 : 1 hits 1fcb_c03 naa= 4 ULMN 4 1fy2_c00 ASPARTYL DIPEPTIDASE user 1 4 # 1 A 120 SER A 60 SER.? 16.46 ZN ZN A 128 A 121 ALA A 61 ALA.? 20.04 ZN ZN A 128 A 157 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 192 GLU A 58 GLU.? 14.95 ZN ZN A 128 coo 8.85 20.26 10.46 6.48 19.62 10.40 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 7.28 23.73 9.88 5.99 24.23 10.47 -30.68 49.76 89.87 -30.90 49.96 91.37 coo 6.91 15.88 7.40 6.70 16.82 9.27 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 8.84 12.00 8.47 7.02 11.60 9.46 -35.58 45.32 81.43 -37.46 44.65 80.73 ULMN 4 1fy2_c00 ASPARTYL DIPEPTIDASE user 2 4 # 2 A 120 SER B 60 SER.? 16.61 ZN ZN B 128 A 121 ALA B 61 ALA.? 20.38 ZN ZN B 128 A 157 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 192 GLU B 58 GLU.? 14.99 ZN ZN B 128 coo 8.85 20.26 10.46 6.48 19.62 10.40 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 7.28 23.73 9.88 5.99 24.23 10.47 -21.56 56.20 16.28 -21.70 56.37 14.76 coo 6.91 15.88 7.40 6.70 16.82 9.27 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 8.84 12.00 8.47 7.02 11.60 9.46 -16.19 59.88 24.88 -15.11 61.60 25.47 ULMN 4 1fy2_c00 ASPARTYL DIPEPTIDASE user 3 4 # 3 A 120 SER C 60 SER.? 15.14 ZN ZN C 128 A 121 ALA C 61 ALA.? 19.20 ZN ZN C 128 A 157 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 192 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 8.85 20.26 10.46 6.48 19.62 10.40 12.55 55.11 50.39 10.44 55.82 51.40 coo 7.28 23.73 9.88 5.99 24.23 10.47 14.70 52.81 52.57 16.23 52.88 52.61 coo 6.91 15.88 7.40 6.70 16.82 9.27 11.45 52.92 44.80 10.43 52.05 43.19 coo 8.84 12.00 8.47 7.02 11.60 9.46 7.13 51.72 45.00 6.65 51.50 42.95 ULMN 4 1fy2_c00 ASPARTYL DIPEPTIDASE user 4 4 # 4 A 120 SER D 60 SER.? 15.90 ZN ZN D 128 A 121 ALA D 61 ALA.? 19.60 ZN ZN D 128 A 157 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 192 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 8.85 20.26 10.46 6.48 19.62 10.40 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 7.28 23.73 9.88 5.99 24.23 10.47 -37.19 13.11 53.70 -37.94 11.80 53.61 coo 6.91 15.88 7.40 6.70 16.82 9.27 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 8.84 12.00 8.47 7.02 11.60 9.46 -34.12 20.46 61.00 -33.75 20.62 63.08 1fy2_c00 source 1fy2 ASPARTYL DIPEPTIDASE : 4 hits 1fy2_c00 naa= 4 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 1 4 # 1 129 TYR B 8 TYR.? 17.28 ZN ZN B 128 157 ASP B 97 ASP^? 13.03 ZN ZN B 128 254 HIS B 10 HIS^? 15.59 ZN ZN B 128 257 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 42.78 52.38 24.86 44.83 53.69 23.54 -11.11 39.23 40.67 -9.41 39.91 38.53 coo 49.25 58.21 29.45 50.12 57.23 27.75 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 50.92 56.96 24.04 49.24 56.15 23.09 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 53.31 58.10 18.81 51.90 57.61 16.26 -12.88 45.85 50.29 -9.95 45.19 50.84 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 2 4 # 2 129 TYR C 52 TYR^? 7.59 ZN ZN C 128 157 ASP C 32 ASP^? -2.40 ZN ZN C 128s 254 HIS C 30 HIS^? -3.56 ZN ZN C 128s 257 ARG C 29 ARG.? 13.36 ZN ZN C 128 coo 42.78 52.38 24.86 44.83 53.69 23.54 1.13 52.00 59.76 1.13 53.77 57.61 coo 49.25 58.21 29.45 50.12 57.23 27.75 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 50.92 56.96 24.04 49.24 56.15 23.09 0.61 46.90 50.78 -0.23 46.71 52.70 coo 53.31 58.10 18.81 51.90 57.61 16.26 7.46 50.67 50.27 10.29 51.53 51.14 1gox_c01 source 1gox GLYCOLATE OXIDASE : 2 hits 1gox_c01 naa= 4 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 1 4 # 1 A 25 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 26 THR C 89 THR.? 19.23 ZN ZN C 128 B 25 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 26 THR C 92 THR.? 15.22 ZN ZN C 128 coo 1.46 1.38 19.19 2.92 0.53 17.93 2.93 33.32 67.19 5.03 33.43 67.23 coo 4.01 5.49 19.73 5.03 5.84 21.56 3.40 37.97 68.34 2.23 38.61 70.05 coo 8.70 2.26 18.89 7.00 1.20 18.15 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 6.29 1.66 22.97 5.06 3.28 23.79 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 2 4 # 2 A 25 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 26 THR C 92 THR.? 15.22 ZN ZN C 128 B 25 ASP C 90 ASP.? 21.10 ZN ZN C 128 B 26 THR C 89 THR.? 19.23 ZN ZN C 128 coo 1.46 1.38 19.19 2.92 0.53 17.93 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 4.01 5.49 19.73 5.03 5.84 21.56 -1.81 38.46 67.24 -0.75 40.31 66.94 coo 8.70 2.26 18.89 7.00 1.20 18.15 2.93 33.32 67.19 5.03 33.43 67.23 coo 6.29 1.66 22.97 5.06 3.28 23.79 3.40 37.97 68.34 2.23 38.61 70.05 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 3 4 # 3 A 25 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 26 THR D 89 THR.? 18.97 ZN ZN D 128 B 25 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 26 THR D 92 THR.? 15.38 ZN ZN D 128 coo 1.46 1.38 19.19 2.92 0.53 17.93 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 4.01 5.49 19.73 5.03 5.84 21.56 -19.13 20.42 38.63 -19.24 21.85 36.98 coo 8.70 2.26 18.89 7.00 1.20 18.15 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 6.29 1.66 22.97 5.06 3.28 23.79 -18.23 25.46 39.42 -20.30 24.86 39.60 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 4 4 # 4 A 25 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 26 THR D 92 THR.? 15.38 ZN ZN D 128 B 25 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 26 THR D 89 THR.? 18.97 ZN ZN D 128 coo 1.46 1.38 19.19 2.92 0.53 17.93 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 4.01 5.49 19.73 5.03 5.84 21.56 -18.23 25.46 39.42 -20.30 24.86 39.60 coo 8.70 2.26 18.89 7.00 1.20 18.15 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 6.29 1.66 22.97 5.06 3.28 23.79 -19.13 20.42 38.63 -19.24 21.85 36.98 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 5 4 # 5 A 25 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 26 THR D 89 THR.? 18.97 ZN ZN D 128 B 25 ASP D 90 ASP.? 20.62 ZN ZN D 128 B 26 THR D 92 THR.? 15.38 ZN ZN D 128 coo 1.46 1.38 19.19 2.92 0.53 17.93 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 4.01 5.49 19.73 5.03 5.84 21.56 -19.13 20.42 38.63 -19.24 21.85 36.98 coo 8.70 2.26 18.89 7.00 1.20 18.15 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 6.29 1.66 22.97 5.06 3.28 23.79 -18.23 25.46 39.42 -20.30 24.86 39.60 ULMN 4 1hiv_c00 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WIuser 6 4 # 6 A 25 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 26 THR D 92 THR.? 15.38 ZN ZN D 128 B 25 ASP D 90 ASP.? 20.62 ZN ZN D 128 B 26 THR D 89 THR.? 18.97 ZN ZN D 128 coo 1.46 1.38 19.19 2.92 0.53 17.93 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 4.01 5.49 19.73 5.03 5.84 21.56 -18.23 25.46 39.42 -20.30 24.86 39.60 coo 8.70 2.26 18.89 7.00 1.20 18.15 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 6.29 1.66 22.97 5.06 3.28 23.79 -19.13 20.42 38.63 -19.24 21.85 36.98 1hiv_c00 source 1hiv HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 : 6 hits 1hiv_c00 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 278 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 298 GLU C 103 GLU.? 13.37 ZN ZN B 128 A 348 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -20.07 59.92 44.69 -19.74 61.53 43.36 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -4.92 50.07 51.06 -4.02 48.65 52.36 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 1 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 278 ARG C 36 ARG.? 10.67 ZN ZN B 128 B 298 GLU C 103 GLU.? 13.37 ZN ZN B 128 B 348 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo -8.10 23.98 3.08 -8.58 21.04 2.27 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -20.07 59.92 44.69 -19.74 61.53 43.36 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -4.92 50.07 51.06 -4.02 48.65 52.36 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 1 hits 1i8t_c03 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU D 70 GLU^? 19.86 ZN ZN D 128 A 485 LYS D 51 LYS^? 16.00 ZN ZN D 128 A 488 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 603 LYS D 19 LYS.? 15.46 ZN ZN D 128 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -27.83 26.66 34.57 -27.72 25.48 32.82 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -28.66 23.49 42.59 -29.87 18.31 40.35 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -25.28 18.69 44.67 -26.61 17.28 43.81 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -16.96 22.44 46.27 -19.09 18.04 45.40 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 1 hits 1jxa_c01 naa= 4 ULMN 4 1kez_c00 ERYTHRONOLIDE SYNTHASE user 1 4 # 1 A 142 SER A 60 SER.? 16.46 ZN ZN A 128 A 143 ALA A 61 ALA.? 20.04 ZN ZN A 128 A 169 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 259 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo -68.77 27.83 15.56 -68.04 29.55 13.99 -31.07 46.42 88.10 -29.75 44.46 87.48 coo -65.05 26.97 15.95 -63.87 27.94 15.88 -30.68 49.76 89.87 -30.90 49.96 91.37 coo -73.45 29.40 14.56 -74.14 30.54 12.92 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -70.77 33.71 13.10 -69.61 32.04 13.63 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 4 1kez_c00 ERYTHRONOLIDE SYNTHASE user 2 4 # 2 A 142 SER B 60 SER.? 16.61 ZN ZN B 128 A 143 ALA B 61 ALA.? 20.38 ZN ZN B 128 A 169 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 259 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo -68.77 27.83 15.56 -68.04 29.55 13.99 -18.29 55.80 18.16 -16.70 54.11 18.90 coo -65.05 26.97 15.95 -63.87 27.94 15.88 -21.56 56.20 16.28 -21.70 56.37 14.76 coo -73.45 29.40 14.56 -74.14 30.54 12.92 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -70.77 33.71 13.10 -69.61 32.04 13.63 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 4 1kez_c00 ERYTHRONOLIDE SYNTHASE user 3 4 # 3 A 142 SER C 60 SER.? 15.14 ZN ZN C 128 A 143 ALA C 61 ALA.? 19.20 ZN ZN C 128 A 169 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 259 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo -68.77 27.83 15.56 -68.04 29.55 13.99 12.55 55.11 50.39 10.44 55.82 51.40 coo -65.05 26.97 15.95 -63.87 27.94 15.88 14.70 52.81 52.57 16.23 52.88 52.61 coo -73.45 29.40 14.56 -74.14 30.54 12.92 8.18 57.58 47.56 10.27 57.39 47.78 coo -70.77 33.71 13.10 -69.61 32.04 13.63 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 4 1kez_c00 ERYTHRONOLIDE SYNTHASE user 4 4 # 4 A 142 SER D 60 SER.? 15.90 ZN ZN D 128 A 143 ALA D 61 ALA.? 19.60 ZN ZN D 128 A 169 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 259 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo -68.77 27.83 15.56 -68.04 29.55 13.99 -38.49 16.22 55.46 -39.72 18.27 55.05 coo -65.05 26.97 15.95 -63.87 27.94 15.88 -37.19 13.11 53.70 -37.94 11.80 53.61 coo -73.45 29.40 14.56 -74.14 30.54 12.92 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -70.77 33.71 13.10 -69.61 32.04 13.63 -36.37 16.36 61.26 -35.21 16.95 62.91 1kez_c00 source 1kez ERYTHRONOLIDE SYNTHASE : 4 hits 1kez_c00 naa= 4 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 1 4 # 1 B 142 SER A 60 SER.? 16.46 ZN ZN A 128 B 143 ALA A 61 ALA.? 20.04 ZN ZN A 128 B 169 ASP A 57 ASP.? 17.22 ZN ZN A 128 B 259 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo -22.50 44.77 16.45 -24.28 43.38 17.37 -31.07 46.42 88.10 -29.75 44.46 87.48 coo -24.61 43.93 13.40 -25.95 43.19 13.46 -30.68 49.76 89.87 -30.90 49.96 91.37 coo -16.98 43.09 16.07 -15.37 42.66 17.38 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -20.12 38.81 19.97 -21.75 39.57 18.89 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 2 4 # 2 B 142 SER B 60 SER.? 16.61 ZN ZN B 128 B 143 ALA B 61 ALA.? 20.38 ZN ZN B 128 B 169 ASP B 57 ASP.? 17.37 ZN ZN B 128 B 259 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo -22.50 44.77 16.45 -24.28 43.38 17.37 -18.29 55.80 18.16 -16.70 54.11 18.90 coo -24.61 43.93 13.40 -25.95 43.19 13.46 -21.56 56.20 16.28 -21.70 56.37 14.76 coo -16.98 43.09 16.07 -15.37 42.66 17.38 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -20.12 38.81 19.97 -21.75 39.57 18.89 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 3 4 # 3 B 142 SER C 60 SER.? 15.14 ZN ZN C 128 B 143 ALA C 61 ALA.? 19.20 ZN ZN C 128 B 169 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 259 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo -22.50 44.77 16.45 -24.28 43.38 17.37 12.55 55.11 50.39 10.44 55.82 51.40 coo -24.61 43.93 13.40 -25.95 43.19 13.46 14.70 52.81 52.57 16.23 52.88 52.61 coo -16.98 43.09 16.07 -15.37 42.66 17.38 8.18 57.58 47.56 10.27 57.39 47.78 coo -20.12 38.81 19.97 -21.75 39.57 18.89 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 4 1kez_c01 ERYTHRONOLIDE SYNTHASE user 4 4 # 4 B 142 SER D 60 SER.? 15.90 ZN ZN D 128 B 143 ALA D 61 ALA.? 19.60 ZN ZN D 128 B 169 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 259 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo -22.50 44.77 16.45 -24.28 43.38 17.37 -38.49 16.22 55.46 -39.72 18.27 55.05 coo -24.61 43.93 13.40 -25.95 43.19 13.46 -37.19 13.11 53.70 -37.94 11.80 53.61 coo -16.98 43.09 16.07 -15.37 42.66 17.38 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -20.12 38.81 19.97 -21.75 39.57 18.89 -36.37 16.36 61.26 -35.21 16.95 62.91 1kez_c01 source 1kez ERYTHRONOLIDE SYNTHASE : 4 hits 1kez_c01 naa= 4 ULMN 4 1kez_c02 ERYTHRONOLIDE SYNTHASE user 1 4 # 1 C 142 SER A 60 SER.? 16.46 ZN ZN A 128 C 143 ALA A 61 ALA.? 20.04 ZN ZN A 128 C 169 ASP A 57 ASP.? 17.22 ZN ZN A 128 C 259 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 19.62 40.65 24.72 17.81 40.69 23.10 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 21.15 38.93 21.68 20.96 39.38 20.25 -30.68 49.76 89.87 -30.90 49.96 91.37 coo 16.48 43.18 27.83 14.54 42.95 26.97 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 14.66 45.47 23.52 15.89 43.80 23.19 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 4 1kez_c02 ERYTHRONOLIDE SYNTHASE user 2 4 # 2 C 142 SER B 60 SER.? 16.61 ZN ZN B 128 C 143 ALA B 61 ALA.? 20.38 ZN ZN B 128 C 169 ASP B 57 ASP.? 17.37 ZN ZN B 128 C 259 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 19.62 40.65 24.72 17.81 40.69 23.10 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 21.15 38.93 21.68 20.96 39.38 20.25 -21.56 56.20 16.28 -21.70 56.37 14.76 coo 16.48 43.18 27.83 14.54 42.95 26.97 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 14.66 45.47 23.52 15.89 43.80 23.19 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 4 1kez_c02 ERYTHRONOLIDE SYNTHASE user 3 4 # 3 C 142 SER C 60 SER.? 15.14 ZN ZN C 128 C 143 ALA C 61 ALA.? 19.20 ZN ZN C 128 C 169 ASP C 57 ASP.? 16.82 ZN ZN C 128 C 259 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 19.62 40.65 24.72 17.81 40.69 23.10 12.55 55.11 50.39 10.44 55.82 51.40 coo 21.15 38.93 21.68 20.96 39.38 20.25 14.70 52.81 52.57 16.23 52.88 52.61 coo 16.48 43.18 27.83 14.54 42.95 26.97 8.18 57.58 47.56 10.27 57.39 47.78 coo 14.66 45.47 23.52 15.89 43.80 23.19 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 4 1kez_c02 ERYTHRONOLIDE SYNTHASE user 4 4 # 4 C 142 SER D 60 SER.? 15.90 ZN ZN D 128 C 143 ALA D 61 ALA.? 19.60 ZN ZN D 128 C 169 ASP D 57 ASP.? 16.88 ZN ZN D 128 C 259 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 19.62 40.65 24.72 17.81 40.69 23.10 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 21.15 38.93 21.68 20.96 39.38 20.25 -37.19 13.11 53.70 -37.94 11.80 53.61 coo 16.48 43.18 27.83 14.54 42.95 26.97 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 14.66 45.47 23.52 15.89 43.80 23.19 -36.37 16.36 61.26 -35.21 16.95 62.91 1kez_c02 source 1kez ERYTHRONOLIDE SYNTHASE : 4 hits 1kez_c02 naa= 4 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 4 # 1 A 50 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 55 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 84 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 117 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 4.60 40.33 20.42 7.25 39.50 20.05 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 9.71 44.83 15.47 10.13 41.43 19.93 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 9.34 39.83 14.67 8.39 39.19 16.43 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 4 # 2 A 50 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 55 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 84 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 117 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 4.60 40.33 20.42 7.25 39.50 20.05 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 9.71 44.83 15.47 10.13 41.43 19.93 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 9.34 39.83 14.67 8.39 39.19 16.43 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 4 # 3 A 50 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 55 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 84 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 117 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 4.60 40.33 20.42 7.25 39.50 20.05 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 9.34 39.83 14.67 8.39 39.19 16.43 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 4 # 4 A 50 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 55 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 84 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 117 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 4.60 40.33 20.42 7.25 39.50 20.05 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 9.34 39.83 14.67 8.39 39.19 16.43 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 4 # 5 A 50 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 55 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 84 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 117 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 8.18 57.58 47.56 10.27 57.39 47.78 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.07 52.98 53.71 8.63 50.62 55.11 coo 9.71 44.83 15.47 10.13 41.43 19.93 0.65 56.08 51.29 4.22 57.96 54.91 coo 9.34 39.83 14.67 8.39 39.19 16.43 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 4 # 6 A 50 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 55 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 84 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 117 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 8.74 58.91 56.74 6.81 58.81 55.87 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.07 52.98 53.71 8.63 50.62 55.11 coo 9.71 44.83 15.47 10.13 41.43 19.93 0.65 56.08 51.29 4.22 57.96 54.91 coo 9.34 39.83 14.67 8.39 39.19 16.43 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 4 # 7 A 50 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 55 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 84 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 117 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 4.60 40.33 20.42 7.25 39.50 20.05 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 9.71 44.83 15.47 10.13 41.43 19.93 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 9.34 39.83 14.67 8.39 39.19 16.43 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 4 1mrq_c00 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 4 # 8 A 50 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 55 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 84 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 117 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 11.09 42.89 24.44 11.32 42.06 22.49 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 4.60 40.33 20.42 7.25 39.50 20.05 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 9.71 44.83 15.47 10.13 41.43 19.93 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 9.34 39.83 14.67 8.39 39.19 16.43 -31.62 26.29 51.88 -30.63 27.88 52.82 1mrq_c00 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 8 hits 1mrq_c00 naa= 4 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 C 181 ALA A 71 ALA.? 18.90 ZN ZN A 128 C 182 GLN A 73 GLN.? 17.59 ZN ZN A 128 C 269 ASP A 91 ASP.? 21.24 ZN ZN A 128 C 298 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo 19.41 78.76 44.53 18.61 79.22 45.75 -10.85 57.79 70.32 -10.50 59.22 69.90 coo 24.64 81.35 46.97 24.99 82.28 48.83 -9.15 53.35 73.23 -9.40 53.35 75.36 coo 10.40 79.73 42.00 12.16 80.19 43.16 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 13.42 79.87 46.31 15.44 80.29 45.93 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 2 4 # 2 C 181 ALA B 71 ALA.? 18.94 ZN ZN B 128 C 182 GLN B 73 GLN^? 18.31 ZN ZN B 128 C 269 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 298 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo 19.41 78.76 44.53 18.61 79.22 45.75 -34.70 39.55 36.03 -36.14 39.66 36.51 coo 24.64 81.35 46.97 24.99 82.28 48.83 -31.04 36.35 33.62 -31.34 36.44 31.51 coo 10.40 79.73 42.00 12.16 80.19 43.16 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 13.42 79.87 46.31 15.44 80.29 45.93 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 3 4 # 3 C 181 ALA C 71 ALA.? 19.01 ZN ZN C 128 C 182 GLN C 73 GLN^? 18.24 ZN ZN C 128 C 269 ASP C 91 ASP.? 22.72 ZN ZN C 128 C 298 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo 19.41 78.76 44.53 18.61 79.22 45.75 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 24.64 81.35 46.97 24.99 82.28 48.83 -5.47 50.48 71.48 -3.53 51.28 71.85 coo 10.40 79.73 42.00 12.16 80.19 43.16 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 13.42 79.87 46.31 15.44 80.29 45.93 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 4 1odt_c00 CEPHALOSPORIN C DEACETYLASE user 4 4 # 4 C 181 ALA D 71 ALA.? 18.99 ZN ZN D 128 C 182 GLN D 73 GLN^? 18.12 ZN ZN D 128 C 269 ASP D 91 ASP.? 22.90 ZN ZN D 128 C 298 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 19.41 78.76 44.53 18.61 79.22 45.75 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 24.64 81.35 46.97 24.99 82.28 48.83 -28.90 32.15 35.00 -30.16 30.48 34.54 coo 10.40 79.73 42.00 12.16 80.19 43.16 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 13.42 79.87 46.31 15.44 80.29 45.93 -17.20 28.58 35.23 -16.55 27.59 33.50 1odt_c00 source 1odt CEPHALOSPORIN C DEACETYLASE : 4 hits 1odt_c00 naa= 4 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 1 4 # 1 H 181 ALA A 71 ALA.? 18.90 ZN ZN A 128 H 182 GLN A 73 GLN.? 17.59 ZN ZN A 128 H 269 ASP A 91 ASP.? 21.24 ZN ZN A 128 H 298 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo 17.71 105.28 65.69 16.95 104.75 64.54 -10.85 57.79 70.32 -10.50 59.22 69.90 coo 23.16 103.35 63.17 23.71 102.54 61.29 -9.15 53.35 73.23 -9.40 53.35 75.36 coo 8.91 102.95 68.35 10.66 102.77 67.10 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 11.89 103.25 63.94 13.96 103.24 64.24 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 2 4 # 2 H 181 ALA B 71 ALA.? 18.94 ZN ZN B 128 H 182 GLN B 73 GLN^? 18.31 ZN ZN B 128 H 269 ASP B 91 ASP.? 21.34 ZN ZN B 128 H 298 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo 17.71 105.28 65.69 16.95 104.75 64.54 -34.70 39.55 36.03 -36.14 39.66 36.51 coo 23.16 103.35 63.17 23.71 102.54 61.29 -31.04 36.35 33.62 -31.34 36.44 31.51 coo 8.91 102.95 68.35 10.66 102.77 67.10 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 11.89 103.25 63.94 13.96 103.24 64.24 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 3 4 # 3 H 181 ALA C 71 ALA.? 19.01 ZN ZN C 128 H 182 GLN C 73 GLN^? 18.24 ZN ZN C 128 H 269 ASP C 91 ASP.? 22.72 ZN ZN C 128 H 298 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo 17.71 105.28 65.69 16.95 104.75 64.54 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 23.16 103.35 63.17 23.71 102.54 61.29 -5.47 50.48 71.48 -3.53 51.28 71.85 coo 8.91 102.95 68.35 10.66 102.77 67.10 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 11.89 103.25 63.94 13.96 103.24 64.24 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 4 1odt_c01 CEPHALOSPORIN C DEACETYLASE user 4 4 # 4 H 181 ALA D 71 ALA.? 18.99 ZN ZN D 128 H 182 GLN D 73 GLN^? 18.12 ZN ZN D 128 H 269 ASP D 91 ASP.? 22.90 ZN ZN D 128 H 298 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 17.71 105.28 65.69 16.95 104.75 64.54 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 23.16 103.35 63.17 23.71 102.54 61.29 -28.90 32.15 35.00 -30.16 30.48 34.54 coo 8.91 102.95 68.35 10.66 102.77 67.10 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 11.89 103.25 63.94 13.96 103.24 64.24 -17.20 28.58 35.23 -16.55 27.59 33.50 1odt_c01 source 1odt CEPHALOSPORIN C DEACETYLASE : 4 hits 1odt_c01 naa= 4 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 1 4 # 1 A 8 LYS C 33 LYS.? 11.91 ZN ZN C 128 A 11 GLY B 108 GLY.? 9.90 ZN ZN C 128 A 45 GLY C 25 GLY~? 8.98 ZN ZN C 128 A 217 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 23.95 20.41 42.64 25.99 15.22 44.13 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 21.78 10.35 42.81 21.85 10.58 42.04 2.73 45.52 45.80 2.60 46.11 45.24 coo 27.49 8.11 39.28 26.75 8.17 38.90 1.59 40.69 50.63 1.30 40.60 51.34 coo 29.45 15.15 50.79 25.80 14.13 47.92 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 2 4 # 2 A 8 LYS D 33 LYS.? 12.24 ZN ZN D 128 A 11 GLY A 108 GLY.? 9.79 ZN ZN D 128 A 45 GLY D 25 GLY~? 8.97 ZN ZN D 128 A 217 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 23.95 20.41 42.64 25.99 15.22 44.13 -30.11 33.22 59.92 -32.56 30.92 63.52 coo 21.78 10.35 42.81 21.85 10.58 42.04 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 27.49 8.11 39.28 26.75 8.17 38.90 -22.04 22.93 56.13 -21.85 23.17 55.42 coo 29.45 15.15 50.79 25.80 14.13 47.92 -36.76 27.60 54.86 -39.44 24.48 51.40 1oh9_c00 source 1oh9 ACETYLGLUTAMATE KINASE : 2 hits 1oh9_c00 naa= 4 ULMN 4 1qq5_c03 L-2-HALOACID DEHALOGENASE user 1 4 # 1 B 8 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 39 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 114 SER A 13 SER^? 14.04 ZN ZN A 128 B 176 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -12.56 -11.18 35.50 -11.97 -9.35 34.62 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -10.21 -2.50 28.59 -10.64 -4.26 31.07 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -15.18 -6.47 39.05 -16.09 -5.31 37.09 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -7.57 -10.16 36.43 -9.20 -10.33 37.73 -13.22 48.33 58.62 -13.88 46.78 59.86 1qq5_c03 source 1qq5 L-2-HALOACID DEHALOGENASE : 1 hits 1qq5_c03 naa= 4 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP A 90 ASP.? 20.22 ZN ZN A 128 33 THR A 89 THR.? 18.72 ZN ZN A 128 215 ASP A 91 ASP.? 21.24 ZN ZN A 128 216 THR A 92 THR.? 14.81 ZN ZN A 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 8.33 16.80 75.95 6.64 18.11 76.07 -19.06 65.09 74.03 -16.96 64.91 73.52 coo 5.22 15.03 71.43 7.19 14.88 70.83 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 6.39 19.66 71.72 6.69 20.58 73.70 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 4 # 2 32 ASP A 91 ASP.? 21.24 ZN ZN A 128 33 THR A 92 THR.? 14.81 ZN ZN A 128 215 ASP A 90 ASP.? 20.22 ZN ZN A 128 216 THR A 89 THR.? 18.72 ZN ZN A 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 8.33 16.80 75.95 6.64 18.11 76.07 -18.17 62.44 69.62 -18.23 61.18 71.41 coo 5.22 15.03 71.43 7.19 14.88 70.83 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 6.39 19.66 71.72 6.69 20.58 73.70 -19.06 65.09 74.03 -16.96 64.91 73.52 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 4 # 3 32 ASP B 90 ASP.? 20.48 ZN ZN B 128 33 THR B 89 THR.? 18.91 ZN ZN B 128 215 ASP B 91 ASP.? 21.34 ZN ZN B 128 216 THR B 92 THR.? 15.12 ZN ZN B 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 8.33 16.80 75.95 6.64 18.11 76.07 -39.38 49.52 32.40 -39.94 47.46 32.72 coo 5.22 15.03 71.43 7.19 14.88 70.83 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 6.39 19.66 71.72 6.69 20.58 73.70 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 4 # 4 32 ASP B 91 ASP.? 21.34 ZN ZN B 128 33 THR B 89 THR.? 18.91 ZN ZN B 128 215 ASP B 90 ASP.? 20.48 ZN ZN B 128 216 THR B 92 THR.? 15.12 ZN ZN B 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 8.33 16.80 75.95 6.64 18.11 76.07 -39.38 49.52 32.40 -39.94 47.46 32.72 coo 5.22 15.03 71.43 7.19 14.88 70.83 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 6.39 19.66 71.72 6.69 20.58 73.70 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 5 4 # 5 32 ASP B 91 ASP.? 21.34 ZN ZN B 128 33 THR B 92 THR.? 15.12 ZN ZN B 128 215 ASP B 90 ASP.? 20.48 ZN ZN B 128 216 THR B 89 THR.? 18.91 ZN ZN B 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 8.33 16.80 75.95 6.64 18.11 76.07 -37.24 47.79 36.87 -36.06 47.31 35.09 coo 5.22 15.03 71.43 7.19 14.88 70.83 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 6.39 19.66 71.72 6.69 20.58 73.70 -39.38 49.52 32.40 -39.94 47.46 32.72 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 6 4 # 6 32 ASP C 90 ASP.? 21.10 ZN ZN C 128 33 THR C 89 THR.? 19.23 ZN ZN C 128 215 ASP C 91 ASP.? 22.72 ZN ZN C 128 216 THR C 92 THR.? 15.22 ZN ZN C 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 2.93 33.32 67.19 5.03 33.43 67.23 coo 8.33 16.80 75.95 6.64 18.11 76.07 3.40 37.97 68.34 2.23 38.61 70.05 coo 5.22 15.03 71.43 7.19 14.88 70.83 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 6.39 19.66 71.72 6.69 20.58 73.70 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 7 4 # 7 32 ASP C 91 ASP.? 22.72 ZN ZN C 128 33 THR C 92 THR.? 15.22 ZN ZN C 128 215 ASP C 90 ASP.? 21.10 ZN ZN C 128 216 THR C 89 THR.? 19.23 ZN ZN C 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 8.33 16.80 75.95 6.64 18.11 76.07 -1.81 38.46 67.24 -0.75 40.31 66.94 coo 5.22 15.03 71.43 7.19 14.88 70.83 2.93 33.32 67.19 5.03 33.43 67.23 coo 6.39 19.66 71.72 6.69 20.58 73.70 3.40 37.97 68.34 2.23 38.61 70.05 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 8 4 # 8 32 ASP D 90 ASP.? 20.62 ZN ZN D 128 33 THR D 89 THR.? 18.97 ZN ZN D 128 215 ASP D 91 ASP.? 22.90 ZN ZN D 128 216 THR D 92 THR.? 15.38 ZN ZN D 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 8.33 16.80 75.95 6.64 18.11 76.07 -19.13 20.42 38.63 -19.24 21.85 36.98 coo 5.22 15.03 71.43 7.19 14.88 70.83 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 6.39 19.66 71.72 6.69 20.58 73.70 -18.23 25.46 39.42 -20.30 24.86 39.60 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 9 4 # 9 32 ASP D 91 ASP.? 22.90 ZN ZN D 128 33 THR D 89 THR.? 18.97 ZN ZN D 128 215 ASP D 90 ASP.? 20.62 ZN ZN D 128 216 THR D 92 THR.? 15.38 ZN ZN D 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 8.33 16.80 75.95 6.64 18.11 76.07 -19.13 20.42 38.63 -19.24 21.85 36.98 coo 5.22 15.03 71.43 7.19 14.88 70.83 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 6.39 19.66 71.72 6.69 20.58 73.70 -18.23 25.46 39.42 -20.30 24.86 39.60 ULMN 4 1rne_c03 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 10 4 # 10 32 ASP D 91 ASP.? 22.90 ZN ZN D 128 33 THR D 92 THR.? 15.38 ZN ZN D 128 215 ASP D 90 ASP.? 20.62 ZN ZN D 128 216 THR D 89 THR.? 18.97 ZN ZN D 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 8.33 16.80 75.95 6.64 18.11 76.07 -18.23 25.46 39.42 -20.30 24.86 39.60 coo 5.22 15.03 71.43 7.19 14.88 70.83 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 6.39 19.66 71.72 6.69 20.58 73.70 -19.13 20.42 38.63 -19.24 21.85 36.98 1rne_c03 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 10 hits 1rne_c03 naa= 4 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 1 4 # 1 A 41 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 43 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 74 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 185 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 31.38 70.47 18.87 29.95 71.93 19.26 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 26.06 68.61 17.65 25.72 69.17 15.65 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 24.70 75.42 18.17 26.81 75.34 18.23 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 2 4 # 2 A 41 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 43 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 74 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 185 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 31.38 70.47 18.87 29.95 71.93 19.26 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 26.06 68.61 17.65 25.72 69.17 15.65 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 24.70 75.42 18.17 26.81 75.34 18.23 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 3 4 # 3 A 41 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 43 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 74 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 185 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 31.38 70.47 18.87 29.95 71.93 19.26 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 26.06 68.61 17.65 25.72 69.17 15.65 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 24.70 75.42 18.17 26.81 75.34 18.23 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 4 4 # 4 A 41 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 43 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 74 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 185 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 31.38 70.47 18.87 29.95 71.93 19.26 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 26.06 68.61 17.65 25.72 69.17 15.65 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 24.70 75.42 18.17 26.81 75.34 18.23 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 5 4 # 5 A 41 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 43 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 74 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 185 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 31.38 70.47 18.87 29.95 71.93 19.26 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 26.06 68.61 17.65 25.72 69.17 15.65 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 24.70 75.42 18.17 26.81 75.34 18.23 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 6 4 # 6 A 41 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 43 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 74 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 185 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 31.38 70.47 18.87 29.95 71.93 19.26 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 26.06 68.61 17.65 25.72 69.17 15.65 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 24.70 75.42 18.17 26.81 75.34 18.23 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 7 4 # 7 A 41 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 43 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 74 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 185 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 31.38 70.47 18.87 29.95 71.93 19.26 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 26.06 68.61 17.65 25.72 69.17 15.65 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 24.70 75.42 18.17 26.81 75.34 18.23 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 8 4 # 8 A 41 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 43 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 74 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 185 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 27.18 71.98 22.91 26.19 71.28 21.20 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 31.38 70.47 18.87 29.95 71.93 19.26 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 26.06 68.61 17.65 25.72 69.17 15.65 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 24.70 75.42 18.17 26.81 75.34 18.23 -21.74 43.31 43.14 -23.53 43.14 44.28 1rpx_c03 source 1rpx RIBULOSE-PHOSPHATE 3-EPIMERASE : 8 hits 1rpx_c03 naa= 4 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 1 4 # 1 B 41 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 43 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 74 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 185 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 2 4 # 2 B 41 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 43 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 74 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 185 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 3 4 # 3 B 41 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 43 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 74 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 185 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 4 4 # 4 B 41 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 43 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 74 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 185 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 5 4 # 5 B 41 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 43 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 74 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 185 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 6 4 # 6 B 41 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 43 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 74 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 185 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 7 4 # 7 B 41 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 43 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 74 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 185 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 8 4 # 8 B 41 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 43 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 74 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 185 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -21.74 43.31 43.14 -23.53 43.14 44.28 1rpx_c04 source 1rpx RIBULOSE-PHOSPHATE 3-EPIMERASE : 8 hits 1rpx_c04 naa= 4 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 1 4 # 1 C 41 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 43 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 74 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 185 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 12.91 41.40 2.63 11.01 42.07 3.21 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 11.42 46.38 0.05 11.97 47.90 1.39 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 6.41 46.06 4.90 7.75 44.49 5.43 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 2 4 # 2 C 41 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 43 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 74 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 185 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 12.91 41.40 2.63 11.01 42.07 3.21 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 11.42 46.38 0.05 11.97 47.90 1.39 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 6.41 46.06 4.90 7.75 44.49 5.43 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 3 4 # 3 C 41 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 43 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 74 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 185 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 12.91 41.40 2.63 11.01 42.07 3.21 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 11.42 46.38 0.05 11.97 47.90 1.39 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 6.41 46.06 4.90 7.75 44.49 5.43 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 4 4 # 4 C 41 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 43 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 74 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 185 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 12.91 41.40 2.63 11.01 42.07 3.21 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 11.42 46.38 0.05 11.97 47.90 1.39 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 6.41 46.06 4.90 7.75 44.49 5.43 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 5 4 # 5 C 41 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 43 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 74 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 185 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 12.91 41.40 2.63 11.01 42.07 3.21 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 11.42 46.38 0.05 11.97 47.90 1.39 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 6.41 46.06 4.90 7.75 44.49 5.43 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 6 4 # 6 C 41 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 43 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 74 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 185 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 12.91 41.40 2.63 11.01 42.07 3.21 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 11.42 46.38 0.05 11.97 47.90 1.39 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 6.41 46.06 4.90 7.75 44.49 5.43 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 7 4 # 7 C 41 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 43 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 74 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 185 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 12.91 41.40 2.63 11.01 42.07 3.21 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 11.42 46.38 0.05 11.97 47.90 1.39 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 6.41 46.06 4.90 7.75 44.49 5.43 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 8 4 # 8 C 41 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 43 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 74 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 185 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 7.25 41.55 0.57 8.02 43.50 0.47 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 12.91 41.40 2.63 11.01 42.07 3.21 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 11.42 46.38 0.05 11.97 47.90 1.39 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 6.41 46.06 4.90 7.75 44.49 5.43 -21.74 43.31 43.14 -23.53 43.14 44.28 1rpx_c05 source 1rpx RIBULOSE-PHOSPHATE 3-EPIMERASE : 8 hits 1rpx_c05 naa= 4 ULMN 4 1u5u_c00 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 1 4 # 1 A 66 THR A 11 THR^? 14.69 ZN ZN D 128 A 67 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 137 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 193 TYR C 93 TYR^? 17.98 ZN ZN C 128 coo 28.20 41.82 42.62 29.28 42.14 44.50 -21.95 40.72 59.07 -22.88 39.66 60.69 coo 32.41 40.51 41.21 33.66 41.50 42.57 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 38.92 43.24 43.12 36.92 42.57 43.31 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 46.54 43.05 44.30 48.87 44.11 43.18 -6.81 37.29 66.15 -8.85 36.99 68.07 ULMN 4 1u5u_c00 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 2 4 # 2 A 66 THR B 11 THR^? 14.42 ZN ZN C 128 A 67 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 137 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 193 TYR D 93 TYR^? 18.01 ZN ZN D 128 coo 28.20 41.82 42.62 29.28 42.14 44.50 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 32.41 40.51 41.21 33.66 41.50 42.57 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 38.92 43.24 43.12 36.92 42.57 43.31 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 46.54 43.05 44.30 48.87 44.11 43.18 -16.06 30.04 40.46 -15.16 31.88 38.54 ULMN 4 1u5u_c00 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 3 4 # 3 A 66 THR C 11 THR^? 14.35 ZN ZN C 128 A 67 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 137 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 193 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo 28.20 41.82 42.62 29.28 42.14 44.50 -17.36 49.55 51.91 -16.04 50.82 50.77 coo 32.41 40.51 41.21 33.66 41.50 42.57 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 38.92 43.24 43.12 36.92 42.57 43.31 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 46.54 43.05 44.30 48.87 44.11 43.18 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 4 1u5u_c00 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 4 4 # 4 A 66 THR D 11 THR^? 14.18 ZN ZN D 128 A 67 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 137 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 193 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo 28.20 41.82 42.62 29.28 42.14 44.50 -25.16 43.60 54.40 -26.66 42.42 55.40 coo 32.41 40.51 41.21 33.66 41.50 42.57 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 38.92 43.24 43.12 36.92 42.57 43.31 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 46.54 43.05 44.30 48.87 44.11 43.18 -35.98 46.77 41.76 -37.33 44.77 43.20 1u5u_c00 source 1u5u ALLENE OXIDE SYNTHASE-LIPOXYGENASE PROTEIN : 4 hits 1u5u_c00 naa= 4 ULMN 4 1u5u_c01 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 1 4 # 1 B 66 THR A 11 THR^? 14.69 ZN ZN D 128 B 67 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 137 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 193 TYR C 93 TYR^? 17.98 ZN ZN C 128 coo 3.71 33.92 55.88 4.29 34.65 57.86 -21.95 40.72 59.07 -22.88 39.66 60.69 coo -0.56 34.99 57.51 -0.33 34.72 59.58 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -3.36 33.91 64.21 -1.95 34.36 62.68 -10.59 42.26 61.06 -11.87 43.93 61.32 coo -7.94 35.44 70.24 -10.15 34.30 71.53 -6.81 37.29 66.15 -8.85 36.99 68.07 ULMN 4 1u5u_c01 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 2 4 # 2 B 66 THR B 11 THR^? 14.42 ZN ZN C 128 B 67 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 137 ASN D 95 ASN^? 12.80 ZN ZN D 128 B 193 TYR D 93 TYR^? 18.01 ZN ZN D 128 coo 3.71 33.92 55.88 4.29 34.65 57.86 -15.35 45.63 47.22 -13.97 46.20 45.66 coo -0.56 34.99 57.51 -0.33 34.72 59.58 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -3.36 33.91 64.21 -1.95 34.36 62.68 -19.89 34.86 45.47 -21.06 36.60 45.16 coo -7.94 35.44 70.24 -10.15 34.30 71.53 -16.06 30.04 40.46 -15.16 31.88 38.54 ULMN 4 1u5u_c01 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 3 4 # 3 B 66 THR C 11 THR^? 14.35 ZN ZN C 128 B 67 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 137 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 193 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo 3.71 33.92 55.88 4.29 34.65 57.86 -17.36 49.55 51.91 -16.04 50.82 50.77 coo -0.56 34.99 57.51 -0.33 34.72 59.58 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -3.36 33.91 64.21 -1.95 34.36 62.68 -19.15 53.27 63.15 -17.72 51.74 62.89 coo -7.94 35.44 70.24 -10.15 34.30 71.53 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 4 1u5u_c01 ALLENE OXIDE SYNTHASE-LIPOXYGENASE Puser 4 4 # 4 B 66 THR D 11 THR^? 14.18 ZN ZN D 128 B 67 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 137 ASN B 95 ASN^? 12.67 ZN ZN B 128 B 193 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo 3.71 33.92 55.88 4.29 34.65 57.86 -25.16 43.60 54.40 -26.66 42.42 55.40 coo -0.56 34.99 57.51 -0.33 34.72 59.58 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -3.36 33.91 64.21 -1.95 34.36 62.68 -28.02 46.30 43.15 -27.06 44.43 43.46 coo -7.94 35.44 70.24 -10.15 34.30 71.53 -35.98 46.77 41.76 -37.33 44.77 43.20 1u5u_c01 source 1u5u ALLENE OXIDE SYNTHASE-LIPOXYGENASE PROTEIN : 4 hits 1u5u_c01 naa= 4 ULMN 4 1xyz_c00 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 1 4 # 1 A 645 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 723 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 754 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 756 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 8.52 14.29 34.54 9.38 13.03 33.07 7.13 51.72 45.00 6.65 51.50 42.95 coo 14.75 17.66 28.95 15.62 16.26 30.25 0.61 46.90 50.78 -0.23 46.71 52.70 coo 16.72 16.24 34.49 15.11 14.90 34.21 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 20.22 18.04 27.00 18.34 17.09 27.29 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 4 1xyz_c00 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 2 4 # 2 A 645 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 723 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 754 GLU A 107 GLU.? 11.70 ZN ZN D 128 A 756 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 8.52 14.29 34.54 9.38 13.03 33.07 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 14.75 17.66 28.95 15.62 16.26 30.25 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 16.72 16.24 34.49 15.11 14.90 34.21 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 20.22 18.04 27.00 18.34 17.09 27.29 -29.32 31.61 55.53 -28.20 30.46 54.16 1xyz_c00 source 1xyz 1,4-BETA-D-XYLAN-XYLANOHYDROLASE : 2 hits 1xyz_c00 naa= 4 ULMN 4 1xyz_c01 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 1 4 # 1 B 645 GLU C 58 GLU.? 14.59 ZN ZN C 128 B 723 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 754 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 756 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 15.60 30.64 69.31 14.72 29.15 68.11 7.13 51.72 45.00 6.65 51.50 42.95 coo 9.08 25.15 72.84 8.18 26.43 71.44 0.61 46.90 50.78 -0.23 46.71 52.70 coo 7.29 30.67 71.38 8.86 30.34 70.00 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 3.67 23.22 73.36 5.48 23.51 72.37 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 4 1xyz_c01 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 2 4 # 2 B 645 GLU D 58 GLU.? 14.54 ZN ZN D 128 B 723 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 754 GLU A 107 GLU.? 11.70 ZN ZN D 128 B 756 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 15.60 30.64 69.31 14.72 29.15 68.11 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 9.08 25.15 72.84 8.18 26.43 71.44 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 7.29 30.67 71.38 8.86 30.34 70.00 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 3.67 23.22 73.36 5.48 23.51 72.37 -29.32 31.61 55.53 -28.20 30.46 54.16 1xyz_c01 source 1xyz 1,4-BETA-D-XYLAN-XYLANOHYDROLASE : 2 hits 1xyz_c01 naa= 4 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 1 4 # 1 44 ASP A 57 ASP.? 17.22 ZN ZN A 128 49 TYR A 55 TYR^? 11.76 ZN ZN A 128 79 LYS A 81 LYS.? 12.55 ZN ZN A 128 112 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 2 4 # 2 44 ASP A 64 ASP.? 14.79 ZN ZN A 128 49 TYR A 55 TYR^? 11.76 ZN ZN A 128 79 LYS A 81 LYS.? 12.55 ZN ZN A 128 112 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 3 4 # 3 44 ASP B 57 ASP.? 17.37 ZN ZN B 128 49 TYR B 55 TYR.? 11.96 ZN ZN B 128 79 LYS B 81 LYS.? 12.71 ZN ZN B 128 112 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 4 4 # 4 44 ASP B 64 ASP.? 14.94 ZN ZN B 128 49 TYR B 55 TYR.? 11.96 ZN ZN B 128 79 LYS B 81 LYS.? 12.71 ZN ZN B 128 112 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 5 4 # 5 44 ASP C 57 ASP.? 16.82 ZN ZN C 128 49 TYR C 55 TYR.? 11.30 ZN ZN C 128 79 LYS C 81 LYS.? 11.89 ZN ZN C 128 112 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 8.18 57.58 47.56 10.27 57.39 47.78 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 8.07 52.98 53.71 8.63 50.62 55.11 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 0.65 56.08 51.29 4.22 57.96 54.91 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 6 4 # 6 44 ASP C 64 ASP.? 14.22 ZN ZN C 128 49 TYR C 55 TYR.? 11.30 ZN ZN C 128 79 LYS C 81 LYS.? 11.89 ZN ZN C 128 112 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 8.74 58.91 56.74 6.81 58.81 55.87 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 8.07 52.98 53.71 8.63 50.62 55.11 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 0.65 56.08 51.29 4.22 57.96 54.91 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 7 4 # 7 44 ASP D 57 ASP.? 16.88 ZN ZN D 128 49 TYR D 55 TYR.? 11.30 ZN ZN D 128 79 LYS D 81 LYS.? 12.28 ZN ZN D 128 112 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 4 2alr_c00 ALDEHYDE REDUCTASE user 8 4 # 8 44 ASP D 64 ASP.? 14.34 ZN ZN D 128 49 TYR D 55 TYR.? 11.30 ZN ZN D 128 79 LYS D 81 LYS.? 12.28 ZN ZN D 128 112 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 6.17 -0.98 36.99 6.36 -2.08 35.21 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 6.57 -8.25 29.17 8.05 -8.05 30.63 -31.62 26.29 51.88 -30.63 27.88 52.82 2alr_c00 source 2alr ALDEHYDE REDUCTASE : 8 hits 2alr_c00 naa= 4 ULMN 4 2bhg_c00 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 4 # 1 A 46 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 84 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 163 ALA A 61 ALA.? 20.04 ZN ZN A 128 A 182 SER A 60 SER.? 16.46 ZN ZN A 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 24.63 14.27 7.52 24.60 15.43 5.75 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 19.14 20.17 3.93 20.33 19.60 3.15 -30.68 49.76 89.87 -30.90 49.96 91.37 coo 19.93 15.70 5.43 21.32 14.86 7.23 -31.07 46.42 88.10 -29.75 44.46 87.48 ULMN 4 2bhg_c00 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 4 # 2 A 46 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 84 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 163 ALA B 61 ALA.? 20.38 ZN ZN B 128 A 182 SER B 60 SER.? 16.61 ZN ZN B 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 24.63 14.27 7.52 24.60 15.43 5.75 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 19.14 20.17 3.93 20.33 19.60 3.15 -21.56 56.20 16.28 -21.70 56.37 14.76 coo 19.93 15.70 5.43 21.32 14.86 7.23 -18.29 55.80 18.16 -16.70 54.11 18.90 ULMN 4 2bhg_c00 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 4 # 3 A 46 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 84 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 163 ALA C 61 ALA.? 19.20 ZN ZN C 128 A 182 SER C 60 SER.? 15.14 ZN ZN C 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 11.45 52.92 44.80 10.43 52.05 43.19 coo 24.63 14.27 7.52 24.60 15.43 5.75 8.18 57.58 47.56 10.27 57.39 47.78 coo 19.14 20.17 3.93 20.33 19.60 3.15 14.70 52.81 52.57 16.23 52.88 52.61 coo 19.93 15.70 5.43 21.32 14.86 7.23 12.55 55.11 50.39 10.44 55.82 51.40 ULMN 4 2bhg_c00 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 4 # 4 A 46 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 84 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 163 ALA D 61 ALA.? 19.60 ZN ZN D 128 A 182 SER D 60 SER.? 15.90 ZN ZN D 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 24.63 14.27 7.52 24.60 15.43 5.75 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 19.14 20.17 3.93 20.33 19.60 3.15 -37.19 13.11 53.70 -37.94 11.80 53.61 coo 19.93 15.70 5.43 21.32 14.86 7.23 -38.49 16.22 55.46 -39.72 18.27 55.05 2bhg_c00 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 4 hits 2bhg_c00 naa= 4 ULMN 4 2bhg_c01 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 4 # 1 A 46 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 84 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 163 ALA A 61 ALA.? 20.04 ZN ZN A 128 A 182 SER A 60 SER.? 16.46 ZN ZN A 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 24.63 14.27 7.52 24.60 15.43 5.75 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 19.14 20.17 3.93 20.33 19.60 3.15 -30.68 49.76 89.87 -30.90 49.96 91.37 coo 19.93 15.70 5.43 21.32 14.86 7.23 -31.07 46.42 88.10 -29.75 44.46 87.48 ULMN 4 2bhg_c01 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 4 # 2 A 46 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 84 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 163 ALA B 61 ALA.? 20.38 ZN ZN B 128 A 182 SER B 60 SER.? 16.61 ZN ZN B 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 24.63 14.27 7.52 24.60 15.43 5.75 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 19.14 20.17 3.93 20.33 19.60 3.15 -21.56 56.20 16.28 -21.70 56.37 14.76 coo 19.93 15.70 5.43 21.32 14.86 7.23 -18.29 55.80 18.16 -16.70 54.11 18.90 ULMN 4 2bhg_c01 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 4 # 3 A 46 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 84 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 163 ALA C 61 ALA.? 19.20 ZN ZN C 128 A 182 SER C 60 SER.? 15.14 ZN ZN C 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 11.45 52.92 44.80 10.43 52.05 43.19 coo 24.63 14.27 7.52 24.60 15.43 5.75 8.18 57.58 47.56 10.27 57.39 47.78 coo 19.14 20.17 3.93 20.33 19.60 3.15 14.70 52.81 52.57 16.23 52.88 52.61 coo 19.93 15.70 5.43 21.32 14.86 7.23 12.55 55.11 50.39 10.44 55.82 51.40 ULMN 4 2bhg_c01 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 4 # 4 A 46 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 84 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 163 ALA D 61 ALA.? 19.60 ZN ZN D 128 A 182 SER D 60 SER.? 15.90 ZN ZN D 128 coo 25.58 16.35 2.18 23.68 17.21 1.97 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 24.63 14.27 7.52 24.60 15.43 5.75 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 19.14 20.17 3.93 20.33 19.60 3.15 -37.19 13.11 53.70 -37.94 11.80 53.61 coo 19.93 15.70 5.43 21.32 14.86 7.23 -38.49 16.22 55.46 -39.72 18.27 55.05 2bhg_c01 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 4 hits 2bhg_c01 naa= 4 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 1 4 # 1 A 71 TYR A 40 TYR^? 13.15 ZN ZN A 128 A 123 PHE B 98 PHE^? 7.32 ZN ZN B 128 A 214 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 381 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -19.24 38.51 70.38 -18.99 36.30 72.07 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -18.19 48.06 41.51 -19.79 50.06 40.34 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -7.28 49.73 38.22 -8.28 50.76 40.96 2tpl_c02 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c02 naa= 4 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 1 4 # 1 B 71 TYR A 40 TYR^? 13.15 ZN ZN A 128 B 123 PHE B 98 PHE^? 7.32 ZN ZN B 128 B 214 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 381 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -19.24 38.51 70.38 -18.99 36.30 72.07 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -18.19 48.06 41.51 -19.79 50.06 40.34 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -7.28 49.73 38.22 -8.28 50.76 40.96 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 2 4 # 2 B 71 TYR C 55 TYR.? 11.30 ZN ZN C 128 B 123 PHE B 98 PHE^? 7.32 ZN ZN B 128 B 214 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 381 ARG B 42 ARG^? 15.17 ZN ZN B 128 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 8.07 52.98 53.71 8.63 50.62 55.11 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -18.19 48.06 41.51 -19.79 50.06 40.34 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -22.13 39.38 39.45 -22.11 38.65 42.43 2tpl_c03 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c03 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 100 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 116 GLN B 111 GLN.? 17.39 ZN ZN C 128 coo 32.24 20.09 5.34 30.38 19.04 5.27 8.18 57.58 47.56 10.27 57.39 47.78 coo 26.40 25.34 6.28 26.15 22.33 7.25 7.46 50.67 50.27 10.29 51.53 51.14 coo 26.74 21.94 13.78 27.57 20.97 12.08 12.24 47.63 44.81 13.39 47.10 46.52 12as_c00 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 100 ARG C 29 ARG.? 13.36 ZN ZN C 128 B 116 GLN B 111 GLN.? 17.39 ZN ZN C 128 coo 32.18 48.37 12.48 33.96 49.46 12.97 8.18 57.58 47.56 10.27 57.39 47.78 coo 39.04 43.25 11.37 38.30 45.35 13.56 7.46 50.67 50.27 10.29 51.53 51.14 coo 37.43 42.63 19.41 36.76 44.08 17.97 12.24 47.63 44.81 13.39 47.10 46.52 12as_c01 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 52 TYR^? 7.20 ZN ZN A 128 B 190 LYS A 81 LYS.? 12.55 ZN ZN A 128 B 222 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 7.17 16.59 41.26 8.01 19.20 40.73 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 13.38 20.00 35.06 11.43 22.49 39.53 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 9.76 26.58 38.10 11.63 25.78 38.76 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 93 TYR^? 17.82 ZN ZN A 128 B 190 LYS A 19 LYS.? 16.70 ZN ZN A 128 B 222 ASP A 90 ASP.? 20.22 ZN ZN A 128 coo 7.17 16.59 41.26 8.01 19.20 40.73 -17.49 60.90 64.70 -15.26 61.56 63.14 coo 13.38 20.00 35.06 11.43 22.49 39.53 -25.66 62.13 69.69 -25.48 65.02 74.91 coo 9.76 26.58 38.10 11.63 25.78 38.76 -21.48 68.18 71.21 -23.15 68.60 72.44 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 52 TYR^? 7.51 ZN ZN B 128 B 190 LYS B 81 LYS.? 12.71 ZN ZN B 128 B 222 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 7.17 16.59 41.26 8.01 19.20 40.73 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 13.38 20.00 35.06 11.43 22.49 39.53 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 9.76 26.58 38.10 11.63 25.78 38.76 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR B 93 TYR^? 18.00 ZN ZN B 128 B 190 LYS B 19 LYS.? 16.80 ZN ZN B 128 B 222 ASP B 90 ASP.? 20.48 ZN ZN B 128 coo 7.17 16.59 41.26 8.01 19.20 40.73 -35.98 46.77 41.76 -37.33 44.77 43.20 coo 13.38 20.00 35.06 11.43 22.49 39.53 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 9.76 26.58 38.10 11.63 25.78 38.76 -41.70 52.65 35.26 -41.90 54.02 33.70 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR C 40 TYR^? 12.78 ZN ZN C 128 B 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 B 222 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 7.17 16.59 41.26 8.01 19.20 40.73 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 13.38 20.00 35.06 11.43 22.49 39.53 0.65 56.08 51.29 4.22 57.96 54.91 coo 9.76 26.58 38.10 11.63 25.78 38.76 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR C 52 TYR^? 7.59 ZN ZN C 128 B 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 B 222 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 7.17 16.59 41.26 8.01 19.20 40.73 1.13 52.00 59.76 1.13 53.77 57.61 coo 13.38 20.00 35.06 11.43 22.49 39.53 0.65 56.08 51.29 4.22 57.96 54.91 coo 9.76 26.58 38.10 11.63 25.78 38.76 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 140 TYR C 93 TYR^? 17.98 ZN ZN C 128 B 190 LYS C 19 LYS.? 17.60 ZN ZN C 128 B 222 ASP C 90 ASP.? 21.10 ZN ZN C 128 coo 7.17 16.59 41.26 8.01 19.20 40.73 -6.81 37.29 66.15 -8.85 36.99 68.07 coo 13.38 20.00 35.06 11.43 22.49 39.53 0.64 35.92 60.53 5.63 36.47 64.53 coo 9.76 26.58 38.10 11.63 25.78 38.76 2.93 33.32 67.19 5.03 33.43 67.23 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 140 TYR D 40 TYR^? 12.58 ZN ZN D 128 B 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 B 222 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 7.17 16.59 41.26 8.01 19.20 40.73 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 13.38 20.00 35.06 11.43 22.49 39.53 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 9.76 26.58 38.10 11.63 25.78 38.76 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 9 3 # 9 A 140 TYR D 52 TYR^? 7.54 ZN ZN D 128 B 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 B 222 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 7.17 16.59 41.26 8.01 19.20 40.73 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 13.38 20.00 35.06 11.43 22.49 39.53 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 9.76 26.58 38.10 11.63 25.78 38.76 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 10 3 # 10 A 140 TYR D 93 TYR^? 18.01 ZN ZN D 128 B 190 LYS D 19 LYS.? 15.46 ZN ZN D 128 B 222 ASP D 90 ASP.? 20.62 ZN ZN D 128 coo 7.17 16.59 41.26 8.01 19.20 40.73 -16.06 30.04 40.46 -15.16 31.88 38.54 coo 13.38 20.00 35.06 11.43 22.49 39.53 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 9.76 26.58 38.10 11.63 25.78 38.76 -14.45 19.85 39.76 -14.81 17.95 40.62 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 10 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 222 ASP A 90 ASP.? 20.22 ZN ZN A 128 B 140 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -25.66 62.13 69.69 -25.48 65.02 74.91 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 1.51 16.60 24.17 0.82 19.23 24.79 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 222 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 140 TYR A 52 TYR^? 7.20 ZN ZN A 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -27.08 41.78 78.19 -22.69 42.64 82.54 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 1.51 16.60 24.17 0.82 19.23 24.79 -20.95 49.22 77.42 -22.18 46.73 77.85 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 222 ASP B 90 ASP.? 20.48 ZN ZN B 128 B 140 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -34.93 54.65 36.44 -38.00 53.50 31.57 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 1.51 16.60 24.17 0.82 19.23 24.79 -35.98 46.77 41.76 -37.33 44.77 43.20 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 222 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 140 TYR B 52 TYR^? 7.51 ZN ZN B 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -14.88 50.71 28.23 -16.26 47.48 23.80 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 1.51 16.60 24.17 0.82 19.23 24.79 -23.54 46.80 28.87 -20.82 47.32 28.41 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 222 ASP C 90 ASP.? 21.10 ZN ZN C 128 B 140 TYR C 93 TYR^? 17.98 ZN ZN C 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 0.64 35.92 60.53 5.63 36.47 64.53 coo -1.04 26.60 27.37 -2.94 25.93 26.69 2.93 33.32 67.19 5.03 33.43 67.23 coo 1.51 16.60 24.17 0.82 19.23 24.79 -6.81 37.29 66.15 -8.85 36.99 68.07 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 222 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 140 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 0.65 56.08 51.29 4.22 57.96 54.91 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 1.51 16.60 24.17 0.82 19.23 24.79 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 222 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 140 TYR C 52 TYR^? 7.59 ZN ZN C 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 0.65 56.08 51.29 4.22 57.96 54.91 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 1.51 16.60 24.17 0.82 19.23 24.79 1.13 52.00 59.76 1.13 53.77 57.61 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 190 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 222 ASP D 90 ASP.? 20.62 ZN ZN D 128 B 140 TYR D 93 TYR^? 18.01 ZN ZN D 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -16.96 22.44 46.27 -19.09 18.04 45.40 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 1.51 16.60 24.17 0.82 19.23 24.79 -16.06 30.04 40.46 -15.16 31.88 38.54 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 9 3 # 9 A 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 222 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 140 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -36.76 27.60 54.86 -39.44 24.48 51.40 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 1.51 16.60 24.17 0.82 19.23 24.79 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 10 3 # 10 A 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 222 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 140 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -36.76 27.60 54.86 -39.44 24.48 51.40 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 1.51 16.60 24.17 0.82 19.23 24.79 -32.42 26.30 46.60 -34.28 26.82 48.63 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 10 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 22.33 45.48 59.73 23.35 43.67 60.06 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 20.90 36.72 61.65 22.18 37.53 63.52 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 22.33 45.48 59.73 23.35 43.67 60.06 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 20.90 36.72 61.65 22.18 37.53 63.52 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 22.33 45.48 59.73 23.35 43.67 60.06 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 20.90 36.72 61.65 22.18 37.53 63.52 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 22.33 45.48 59.73 23.35 43.67 60.06 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 20.90 36.72 61.65 22.18 37.53 63.52 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1a0j_c00 TRYPSIN user 5 3 # 5 A 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 22.33 45.48 59.73 23.35 43.67 60.06 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 20.90 36.72 61.65 22.18 37.53 63.52 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c00 TRYPSIN user 6 3 # 6 A 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 22.33 45.48 59.73 23.35 43.67 60.06 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 20.90 36.72 61.65 22.18 37.53 63.52 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c00 TRYPSIN user 7 3 # 7 A 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 22.33 45.48 59.73 23.35 43.67 60.06 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 20.90 36.72 61.65 22.18 37.53 63.52 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c00 TRYPSIN user 8 3 # 8 A 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 22.33 45.48 59.73 23.35 43.67 60.06 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 20.90 36.72 61.65 22.18 37.53 63.52 -22.32 47.02 46.39 -24.11 45.44 46.82 1a0j_c00 source 1a0j TRYPSIN : 8 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 43.04 44.75 47.18 43.31 45.51 49.13 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 48.11 50.52 52.24 48.62 48.46 53.13 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 43.04 44.75 47.18 43.31 45.51 49.13 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 48.11 50.52 52.24 48.62 48.46 53.13 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 43.04 44.75 47.18 43.31 45.51 49.13 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 48.11 50.52 52.24 48.62 48.46 53.13 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 43.04 44.75 47.18 43.31 45.51 49.13 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 48.11 50.52 52.24 48.62 48.46 53.13 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1a0j_c01 TRYPSIN user 5 3 # 5 B 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 43.04 44.75 47.18 43.31 45.51 49.13 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 48.11 50.52 52.24 48.62 48.46 53.13 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c01 TRYPSIN user 6 3 # 6 B 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 43.04 44.75 47.18 43.31 45.51 49.13 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 48.11 50.52 52.24 48.62 48.46 53.13 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c01 TRYPSIN user 7 3 # 7 B 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 43.04 44.75 47.18 43.31 45.51 49.13 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 48.11 50.52 52.24 48.62 48.46 53.13 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c01 TRYPSIN user 8 3 # 8 B 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 43.04 44.75 47.18 43.31 45.51 49.13 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 48.11 50.52 52.24 48.62 48.46 53.13 -22.32 47.02 46.39 -24.11 45.44 46.82 1a0j_c01 source 1a0j TRYPSIN : 8 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 34.89 38.34 78.12 35.11 39.59 76.42 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 36.16 46.87 75.66 34.01 46.43 74.59 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 34.89 38.34 78.12 35.11 39.59 76.42 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 36.16 46.87 75.66 34.01 46.43 74.59 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 34.89 38.34 78.12 35.11 39.59 76.42 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 36.16 46.87 75.66 34.01 46.43 74.59 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 34.89 38.34 78.12 35.11 39.59 76.42 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 36.16 46.87 75.66 34.01 46.43 74.59 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1a0j_c02 TRYPSIN user 5 3 # 5 C 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 34.89 38.34 78.12 35.11 39.59 76.42 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 36.16 46.87 75.66 34.01 46.43 74.59 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c02 TRYPSIN user 6 3 # 6 C 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 34.89 38.34 78.12 35.11 39.59 76.42 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 36.16 46.87 75.66 34.01 46.43 74.59 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c02 TRYPSIN user 7 3 # 7 C 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 34.89 38.34 78.12 35.11 39.59 76.42 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 36.16 46.87 75.66 34.01 46.43 74.59 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c02 TRYPSIN user 8 3 # 8 C 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 34.89 38.34 78.12 35.11 39.59 76.42 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 36.16 46.87 75.66 34.01 46.43 74.59 -22.32 47.02 46.39 -24.11 45.44 46.82 1a0j_c02 source 1a0j TRYPSIN : 8 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 D 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 D 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 13.53 16.28 93.98 11.45 16.21 94.40 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 6.63 21.03 97.42 6.71 19.20 98.95 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 D 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 13.53 16.28 93.98 11.45 16.21 94.40 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 6.63 21.03 97.42 6.71 19.20 98.95 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 D 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 D 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 13.53 16.28 93.98 11.45 16.21 94.40 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 6.63 21.03 97.42 6.71 19.20 98.95 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 D 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 13.53 16.28 93.98 11.45 16.21 94.40 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 6.63 21.03 97.42 6.71 19.20 98.95 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1a0j_c03 TRYPSIN user 5 3 # 5 D 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 D 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 D 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 13.53 16.28 93.98 11.45 16.21 94.40 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 6.63 21.03 97.42 6.71 19.20 98.95 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1a0j_c03 TRYPSIN user 6 3 # 6 D 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 D 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 13.53 16.28 93.98 11.45 16.21 94.40 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 6.63 21.03 97.42 6.71 19.20 98.95 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1a0j_c03 TRYPSIN user 7 3 # 7 D 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 D 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 D 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 13.53 16.28 93.98 11.45 16.21 94.40 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 6.63 21.03 97.42 6.71 19.20 98.95 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1a0j_c03 TRYPSIN user 8 3 # 8 D 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 D 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 13.53 16.28 93.98 11.45 16.21 94.40 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 6.63 21.03 97.42 6.71 19.20 98.95 -22.32 47.02 46.39 -24.11 45.44 46.82 1a0j_c03 source 1a0j TRYPSIN : 8 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 22.33 45.48 59.73 23.35 43.67 60.06 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 22.57 32.23 64.13 21.98 32.82 64.22 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 102 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 193 GLY B 54 GLY^? 9.98 ZN ZN B 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 22.33 45.48 59.73 23.35 43.67 60.06 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 22.57 32.23 64.13 21.98 32.82 64.22 -20.73 49.16 24.95 -21.20 49.33 24.28 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 22.33 45.48 59.73 23.35 43.67 60.06 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 22.57 32.23 64.13 21.98 32.82 64.22 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 22.33 45.48 59.73 23.35 43.67 60.06 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 22.57 32.23 64.13 21.98 32.82 64.22 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 102 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 193 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 11.45 52.92 44.80 10.43 52.05 43.19 coo 22.33 45.48 59.73 23.35 43.67 60.06 8.18 57.58 47.56 10.27 57.39 47.78 coo 22.57 32.23 64.13 21.98 32.82 64.22 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1a0j_c12 TRYPSIN user 6 3 # 6 A 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 22.33 45.48 59.73 23.35 43.67 60.06 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 22.57 32.23 64.13 21.98 32.82 64.22 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1a0j_c12 TRYPSIN user 7 3 # 7 A 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 25.57 41.22 61.68 24.18 39.98 62.50 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 22.57 32.23 64.13 21.98 32.82 64.22 -27.38 22.98 60.43 -27.77 23.26 61.11 1a0j_c12 source 1a0j TRYPSIN : 7 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 43.04 44.75 47.18 43.31 45.51 49.13 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 50.46 51.91 56.90 50.65 51.62 56.14 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 193 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 43.04 44.75 47.18 43.31 45.51 49.13 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 50.46 51.91 56.90 50.65 51.62 56.14 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 43.04 44.75 47.18 43.31 45.51 49.13 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 50.46 51.91 56.90 50.65 51.62 56.14 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 43.04 44.75 47.18 43.31 45.51 49.13 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 50.46 51.91 56.90 50.65 51.62 56.14 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1a0j_c13 TRYPSIN user 5 3 # 5 B 57 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 102 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 193 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 11.45 52.92 44.80 10.43 52.05 43.19 coo 43.04 44.75 47.18 43.31 45.51 49.13 8.18 57.58 47.56 10.27 57.39 47.78 coo 50.46 51.91 56.90 50.65 51.62 56.14 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1a0j_c13 TRYPSIN user 6 3 # 6 B 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 B 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 43.04 44.75 47.18 43.31 45.51 49.13 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 50.46 51.91 56.90 50.65 51.62 56.14 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1a0j_c13 TRYPSIN user 7 3 # 7 B 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 44.08 45.58 52.81 45.86 46.55 52.85 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 50.46 51.91 56.90 50.65 51.62 56.14 -27.38 22.98 60.43 -27.77 23.26 61.11 1a0j_c13 source 1a0j TRYPSIN : 7 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 C 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 C 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 34.89 38.34 78.12 35.11 39.59 76.42 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 35.43 51.03 72.12 35.20 50.72 72.87 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 193 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 34.89 38.34 78.12 35.11 39.59 76.42 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 35.43 51.03 72.12 35.20 50.72 72.87 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS B 30 HIS.? -4.20 ZN ZN B 128s C 102 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 193 GLY B 54 GLY^? 9.98 ZN ZN B 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 34.89 38.34 78.12 35.11 39.59 76.42 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 35.43 51.03 72.12 35.20 50.72 72.87 -20.73 49.16 24.95 -21.20 49.33 24.28 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 C 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 34.89 38.34 78.12 35.11 39.59 76.42 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 35.43 51.03 72.12 35.20 50.72 72.87 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 C 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 C 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 34.89 38.34 78.12 35.11 39.59 76.42 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 35.43 51.03 72.12 35.20 50.72 72.87 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 102 ASP C 57 ASP.? 16.82 ZN ZN C 128 C 193 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 11.45 52.92 44.80 10.43 52.05 43.19 coo 34.89 38.34 78.12 35.11 39.59 76.42 8.18 57.58 47.56 10.27 57.39 47.78 coo 35.43 51.03 72.12 35.20 50.72 72.87 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1a0j_c14 TRYPSIN user 7 3 # 7 C 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 C 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 C 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 34.89 38.34 78.12 35.11 39.59 76.42 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 35.43 51.03 72.12 35.20 50.72 72.87 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1a0j_c14 TRYPSIN user 8 3 # 8 C 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 C 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 C 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 34.37 41.18 73.21 34.04 43.09 73.87 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 35.43 51.03 72.12 35.20 50.72 72.87 -27.38 22.98 60.43 -27.77 23.26 61.11 1a0j_c14 source 1a0j TRYPSIN : 8 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 D 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 D 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 13.53 16.28 93.98 11.45 16.21 94.40 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 1.80 21.25 100.04 2.61 21.42 100.18 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 D 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 D 193 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 13.53 16.28 93.98 11.45 16.21 94.40 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 1.80 21.25 100.04 2.61 21.42 100.18 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 D 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 D 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 13.53 16.28 93.98 11.45 16.21 94.40 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 1.80 21.25 100.04 2.61 21.42 100.18 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 D 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 D 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 13.53 16.28 93.98 11.45 16.21 94.40 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 1.80 21.25 100.04 2.61 21.42 100.18 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS C 59 HIS.? 17.15 ZN ZN C 128 D 102 ASP C 57 ASP.? 16.82 ZN ZN C 128 D 193 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 11.45 52.92 44.80 10.43 52.05 43.19 coo 13.53 16.28 93.98 11.45 16.21 94.40 8.18 57.58 47.56 10.27 57.39 47.78 coo 1.80 21.25 100.04 2.61 21.42 100.18 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1a0j_c15 TRYPSIN user 6 3 # 6 D 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 D 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 D 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 13.53 16.28 93.98 11.45 16.21 94.40 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 1.80 21.25 100.04 2.61 21.42 100.18 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1a0j_c15 TRYPSIN user 7 3 # 7 D 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 D 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 D 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 8.19 15.01 95.72 7.78 16.53 97.01 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 1.80 21.25 100.04 2.61 21.42 100.18 -27.38 22.98 60.43 -27.77 23.26 61.11 1a0j_c15 source 1a0j TRYPSIN : 7 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 12 ARG^? 10.24 ZN ZN A 128 265 HIS C 10 HIS^? 15.40 ZN ZN C 128 274 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -26.71 45.35 59.66 -27.06 47.43 61.87 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 12 ARG^? 10.24 ZN ZN A 128 265 HIS C 10 HIS^? 15.40 ZN ZN C 128 274 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -26.71 45.35 59.66 -27.06 47.43 61.87 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 42 ARG^? 15.09 ZN ZN A 128 265 HIS A 10 HIS^? 15.73 ZN ZN A 128 274 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 0.94 52.26 9.16 1.95 54.78 9.91 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG A 42 ARG^? 15.09 ZN ZN A 128 265 HIS A 10 HIS^? 15.73 ZN ZN A 128 274 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 0.94 52.26 9.16 1.95 54.78 9.91 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG A 42 ARG^? 15.09 ZN ZN A 128 265 HIS A 10 HIS^? 15.73 ZN ZN A 128 274 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 0.94 52.26 9.16 1.95 54.78 9.91 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG B 12 ARG^? 9.84 ZN ZN B 128 265 HIS B 10 HIS^? 15.59 ZN ZN B 128 274 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 0.94 52.26 9.16 1.95 54.78 9.91 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG B 12 ARG^? 9.84 ZN ZN B 128 265 HIS C 10 HIS^? 15.40 ZN ZN C 128 274 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG B 12 ARG^? 9.84 ZN ZN B 128 265 HIS D 10 HIS^? 15.91 ZN ZN D 128 274 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 0.94 52.26 9.16 1.95 54.78 9.91 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1a41_c01 TOPOISOMERASE I user 9 3 # 9 223 ARG B 42 ARG^? 15.17 ZN ZN B 128 265 HIS B 10 HIS^? 15.59 ZN ZN B 128 274 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 0.94 52.26 9.16 1.95 54.78 9.91 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1a41_c01 TOPOISOMERASE I user 10 3 # 10 223 ARG B 42 ARG^? 15.17 ZN ZN B 128 265 HIS B 10 HIS^? 15.59 ZN ZN B 128 274 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 0.94 52.26 9.16 1.95 54.78 9.91 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1a41_c01 TOPOISOMERASE I user 11 3 # 11 223 ARG C 12 ARG^? 8.72 ZN ZN C 128 265 HIS D 10 HIS^? 15.91 ZN ZN D 128 274 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 0.94 52.26 9.16 1.95 54.78 9.91 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1a41_c01 TOPOISOMERASE I user 12 3 # 12 223 ARG C 42 ARG^? 15.11 ZN ZN C 128 265 HIS C 10 HIS^? 15.40 ZN ZN C 128 274 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1a41_c01 TOPOISOMERASE I user 13 3 # 13 223 ARG C 42 ARG^? 15.11 ZN ZN C 128 265 HIS C 10 HIS^? 15.40 ZN ZN C 128 274 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 14 3 # 14 223 ARG D 12 ARG^? 9.28 ZN ZN D 128 265 HIS B 10 HIS^? 15.59 ZN ZN B 128 274 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 0.94 52.26 9.16 1.95 54.78 9.91 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1a41_c01 TOPOISOMERASE I user 15 3 # 15 223 ARG D 12 ARG^? 9.28 ZN ZN D 128 265 HIS C 10 HIS^? 15.40 ZN ZN C 128 274 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1a41_c01 TOPOISOMERASE I user 16 3 # 16 223 ARG D 12 ARG^? 9.28 ZN ZN D 128 265 HIS C 10 HIS^? 15.40 ZN ZN C 128 274 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.94 52.26 9.16 1.95 54.78 9.91 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1a41_c01 TOPOISOMERASE I user 17 3 # 17 223 ARG D 42 ARG^? 14.89 ZN ZN D 128 265 HIS D 10 HIS^? 15.91 ZN ZN D 128 274 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -29.08 38.55 44.25 -27.07 40.84 43.98 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 0.94 52.26 9.16 1.95 54.78 9.91 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1a41_c01 TOPOISOMERASE I user 18 3 # 18 223 ARG D 42 ARG^? 14.89 ZN ZN D 128 265 HIS D 10 HIS^? 15.91 ZN ZN D 128 274 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -29.08 38.55 44.25 -27.07 40.84 43.98 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 0.94 52.26 9.16 1.95 54.78 9.91 -13.98 42.26 35.98 -11.85 41.33 34.40 1a41_c01 source 1a41 TOPOISOMERASE I : 18 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 60 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 175 TYR A 55 TYR^? 11.76 ZN ZN A 128 coo 46.10 28.27 19.27 45.48 26.99 20.84 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 56.42 28.06 12.93 55.01 27.92 14.50 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 45.02 22.04 15.38 46.16 24.00 13.76 -27.79 47.98 83.72 -27.46 50.77 83.49 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 60 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 175 TYR B 55 TYR.? 11.96 ZN ZN B 128 coo 46.10 28.27 19.27 45.48 26.99 20.84 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 56.42 28.06 12.93 55.01 27.92 14.50 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 45.02 22.04 15.38 46.16 24.00 13.76 -20.53 53.10 22.67 -23.31 53.51 22.82 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 60 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 175 TYR C 55 TYR.? 11.30 ZN ZN C 128 coo 46.10 28.27 19.27 45.48 26.99 20.84 7.13 51.72 45.00 6.65 51.50 42.95 coo 56.42 28.06 12.93 55.01 27.92 14.50 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 45.02 22.04 15.38 46.16 24.00 13.76 8.07 52.98 53.71 8.63 50.62 55.11 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 60 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 175 TYR D 55 TYR.? 11.30 ZN ZN D 128 coo 46.10 28.27 19.27 45.48 26.99 20.84 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 56.42 28.06 12.93 55.01 27.92 14.50 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 45.02 22.04 15.38 46.16 24.00 13.76 -35.27 19.83 52.49 -33.13 18.64 51.13 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 4 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 125 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 156 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 125 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 156 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 125 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 156 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 8.07 52.98 53.71 8.63 50.62 55.11 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 0.88 50.97 54.56 -1.00 50.36 53.86 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 125 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 156 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -28.66 23.49 42.59 -29.87 18.31 40.35 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 55 TYR^? 11.76 ZN ZN A 128 B 125 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 156 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 55 TYR.? 11.96 ZN ZN B 128 B 125 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 156 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR C 55 TYR.? 11.30 ZN ZN C 128 B 125 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 156 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 8.07 52.98 53.71 8.63 50.62 55.11 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 0.88 50.97 54.56 -1.00 50.36 53.86 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR D 55 TYR.? 11.30 ZN ZN D 128 B 125 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 156 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -28.66 23.49 42.59 -29.87 18.31 40.35 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 55 TYR^? 11.76 ZN ZN A 128 C 125 HIS A 83 HIS^? -3.82 ZN ZN A 128s C 156 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 55 TYR.? 11.96 ZN ZN B 128 C 125 HIS B 83 HIS^? -3.82 ZN ZN B 128s C 156 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR C 55 TYR.? 11.30 ZN ZN C 128 C 125 HIS C 83 HIS^? -3.45 ZN ZN C 128s C 156 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 8.07 52.98 53.71 8.63 50.62 55.11 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 0.88 50.97 54.56 -1.00 50.36 53.86 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 4 3 # 4 C 115 TYR D 55 TYR.? 11.30 ZN ZN D 128 C 125 HIS D 83 HIS^? -3.55 ZN ZN D 128s C 156 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -28.66 23.49 42.59 -29.87 18.31 40.35 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 55 TYR^? 11.76 ZN ZN A 128 D 125 HIS A 83 HIS^? -3.82 ZN ZN A 128s D 156 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 54.10 1.42 85.16 54.14 4.17 85.62 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 61.27 5.43 85.32 62.73 6.38 86.49 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 60.28 4.62 76.00 58.35 6.41 80.65 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR B 55 TYR.? 11.96 ZN ZN B 128 D 125 HIS B 83 HIS^? -3.82 ZN ZN B 128s D 156 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 54.10 1.42 85.16 54.14 4.17 85.62 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 61.27 5.43 85.32 62.73 6.38 86.49 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 60.28 4.62 76.00 58.35 6.41 80.65 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR C 55 TYR.? 11.30 ZN ZN C 128 D 125 HIS C 83 HIS^? -3.45 ZN ZN C 128s D 156 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 54.10 1.42 85.16 54.14 4.17 85.62 8.07 52.98 53.71 8.63 50.62 55.11 coo 61.27 5.43 85.32 62.73 6.38 86.49 0.88 50.97 54.56 -1.00 50.36 53.86 coo 60.28 4.62 76.00 58.35 6.41 80.65 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR D 55 TYR.? 11.30 ZN ZN D 128 D 125 HIS D 83 HIS^? -3.55 ZN ZN D 128s D 156 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 54.10 1.42 85.16 54.14 4.17 85.62 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 61.27 5.43 85.32 62.73 6.38 86.49 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 60.28 4.62 76.00 58.35 6.41 80.65 -28.66 23.49 42.59 -29.87 18.31 40.35 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 13 SER^? 14.04 ZN ZN A 128 A 228 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 257 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 9.47 41.64 34.15 9.10 39.28 33.93 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 2.03 38.95 28.44 3.60 38.60 29.83 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 6.85 37.62 29.99 7.50 38.47 31.78 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER A 13 SER^? 14.04 ZN ZN A 128 A 228 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 257 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 9.47 41.64 34.15 9.10 39.28 33.93 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 2.03 38.95 28.44 3.60 38.60 29.83 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 6.85 37.62 29.99 7.50 38.47 31.78 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 3 3 # 3 A 98 SER B 13 SER^? 13.94 ZN ZN B 128 A 228 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 257 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 9.47 41.64 34.15 9.10 39.28 33.93 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 2.03 38.95 28.44 3.60 38.60 29.83 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 6.85 37.62 29.99 7.50 38.47 31.78 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 4 3 # 4 A 98 SER C 13 SER^? 14.25 ZN ZN C 128 A 228 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 257 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 9.47 41.64 34.15 9.10 39.28 33.93 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 2.03 38.95 28.44 3.60 38.60 29.83 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 6.85 37.62 29.99 7.50 38.47 31.78 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 5 3 # 5 A 98 SER D 13 SER^? 14.41 ZN ZN D 128 A 228 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 257 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 9.47 41.64 34.15 9.10 39.28 33.93 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 2.03 38.95 28.44 3.60 38.60 29.83 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 6.85 37.62 29.99 7.50 38.47 31.78 -18.46 42.11 47.13 -20.09 43.42 47.28 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 5 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 13 SER^? 14.04 ZN ZN A 128 B 228 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 257 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 28.35 71.07 3.94 30.08 69.46 4.49 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 32.76 68.02 0.70 31.21 68.44 2.05 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER A 13 SER^? 14.04 ZN ZN A 128 B 228 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 257 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 28.35 71.07 3.94 30.08 69.46 4.49 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 32.76 68.02 0.70 31.21 68.44 2.05 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 3 3 # 3 B 98 SER B 13 SER^? 13.94 ZN ZN B 128 B 228 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 257 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 28.35 71.07 3.94 30.08 69.46 4.49 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 32.76 68.02 0.70 31.21 68.44 2.05 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 4 3 # 4 B 98 SER B 13 SER^? 13.94 ZN ZN B 128 B 228 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 257 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 28.35 71.07 3.94 30.08 69.46 4.49 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 32.76 68.02 0.70 31.21 68.44 2.05 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 5 3 # 5 B 98 SER C 13 SER^? 14.25 ZN ZN C 128 B 228 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 257 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 28.35 71.07 3.94 30.08 69.46 4.49 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 32.76 68.02 0.70 31.21 68.44 2.05 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 6 3 # 6 B 98 SER D 13 SER^? 14.41 ZN ZN D 128 B 228 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 257 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 28.35 71.07 3.94 30.08 69.46 4.49 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 32.76 68.02 0.70 31.21 68.44 2.05 -18.46 42.11 47.13 -20.09 43.42 47.28 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 6 hits 1a7u_c03 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 13 SER^? 14.04 ZN ZN A 128 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 252 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 40.95 0.07 3.20 39.54 1.39 4.66 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 41.54 1.64 9.09 40.82 1.05 7.19 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER A 13 SER^? 14.04 ZN ZN A 128 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 252 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 40.95 0.07 3.20 39.54 1.39 4.66 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 41.54 1.64 9.09 40.82 1.05 7.19 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER B 13 SER^? 13.94 ZN ZN B 128 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 252 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 40.95 0.07 3.20 39.54 1.39 4.66 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 41.54 1.64 9.09 40.82 1.05 7.19 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 4 3 # 4 94 SER B 13 SER^? 13.94 ZN ZN B 128 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 252 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 40.95 0.07 3.20 39.54 1.39 4.66 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 41.54 1.64 9.09 40.82 1.05 7.19 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 5 3 # 5 94 SER C 13 SER^? 14.25 ZN ZN C 128 223 ASP A 97 ASP^? 13.17 ZN ZN A 128 252 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 40.95 0.07 3.20 39.54 1.39 4.66 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 41.54 1.64 9.09 40.82 1.05 7.19 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 6 3 # 6 94 SER D 13 SER^? 14.41 ZN ZN D 128 223 ASP B 97 ASP^? 13.03 ZN ZN B 128 252 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 40.95 0.07 3.20 39.54 1.39 4.66 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 41.54 1.64 9.09 40.82 1.05 7.19 -18.46 42.11 47.13 -20.09 43.42 47.28 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 6 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 13 SER^? 14.04 ZN ZN A 128 224 ASP C 97 ASP^? 13.06 ZN ZN C 128 253 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 16.00 80.13 58.60 16.16 82.12 59.96 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 8.47 84.84 62.27 10.52 84.40 62.08 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 13.14 83.03 63.68 14.37 82.62 62.02 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER A 13 SER^? 14.04 ZN ZN A 128 224 ASP C 97 ASP^? 13.06 ZN ZN C 128 253 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 16.00 80.13 58.60 16.16 82.12 59.96 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 8.47 84.84 62.27 10.52 84.40 62.08 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 13.14 83.03 63.68 14.37 82.62 62.02 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 3 3 # 3 94 SER B 13 SER^? 13.94 ZN ZN B 128 224 ASP D 97 ASP^? 13.24 ZN ZN D 128 253 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 16.00 80.13 58.60 16.16 82.12 59.96 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 8.47 84.84 62.27 10.52 84.40 62.08 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 13.14 83.03 63.68 14.37 82.62 62.02 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 4 3 # 4 94 SER C 13 SER^? 14.25 ZN ZN C 128 224 ASP A 97 ASP^? 13.17 ZN ZN A 128 253 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 16.00 80.13 58.60 16.16 82.12 59.96 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 8.47 84.84 62.27 10.52 84.40 62.08 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 13.14 83.03 63.68 14.37 82.62 62.02 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 5 3 # 5 94 SER D 13 SER^? 14.41 ZN ZN D 128 224 ASP B 97 ASP^? 13.03 ZN ZN B 128 253 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 16.00 80.13 58.60 16.16 82.12 59.96 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 8.47 84.84 62.27 10.52 84.40 62.08 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 13.14 83.03 63.68 14.37 82.62 62.02 -18.46 42.11 47.13 -20.09 43.42 47.28 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 5 hits 1a8s_c00 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 12 ARG^? 10.24 ZN ZN A 128 78 HIS A 10 HIS^? 15.73 ZN ZN A 128 122 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 53.63 68.24 34.99 53.08 69.10 33.16 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 75.01 61.87 32.93 75.34 59.26 31.96 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG A 12 ARG^? 10.24 ZN ZN A 128 78 HIS A 10 HIS^? 15.73 ZN ZN A 128 122 TYR C 52 TYR^? 7.59 ZN ZN C 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 53.63 68.24 34.99 53.08 69.10 33.16 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 75.01 61.87 32.93 75.34 59.26 31.96 1.13 52.00 59.76 1.13 53.77 57.61 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG A 12 ARG^? 10.24 ZN ZN A 128 78 HIS A 10 HIS^? 15.73 ZN ZN A 128 122 TYR D 93 TYR^? 18.01 ZN ZN D 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 53.63 68.24 34.99 53.08 69.10 33.16 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 75.01 61.87 32.93 75.34 59.26 31.96 -16.06 30.04 40.46 -15.16 31.88 38.54 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG A 29 ARG.? 13.64 ZN ZN A 128 78 HIS A 30 HIS.? -4.18 ZN ZN A 128s 122 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 53.63 68.24 34.99 53.08 69.10 33.16 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 75.01 61.87 32.93 75.34 59.26 31.96 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1ab4_c00 GYRASE A user 5 3 # 5 32 ARG B 12 ARG^? 9.84 ZN ZN B 128 78 HIS B 10 HIS^? 15.59 ZN ZN B 128 122 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 53.63 68.24 34.99 53.08 69.10 33.16 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 75.01 61.87 32.93 75.34 59.26 31.96 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1ab4_c00 GYRASE A user 6 3 # 6 32 ARG B 12 ARG^? 9.84 ZN ZN B 128 78 HIS B 10 HIS^? 15.59 ZN ZN B 128 122 TYR C 93 TYR^? 17.98 ZN ZN C 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 53.63 68.24 34.99 53.08 69.10 33.16 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 75.01 61.87 32.93 75.34 59.26 31.96 -6.81 37.29 66.15 -8.85 36.99 68.07 ULMN 3 1ab4_c00 GYRASE A user 7 3 # 7 32 ARG B 12 ARG^? 9.84 ZN ZN B 128 78 HIS B 10 HIS^? 15.59 ZN ZN B 128 122 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 53.63 68.24 34.99 53.08 69.10 33.16 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 75.01 61.87 32.93 75.34 59.26 31.96 -32.42 26.30 46.60 -34.28 26.82 48.63 ULMN 3 1ab4_c00 GYRASE A user 8 3 # 8 32 ARG B 12 ARG^? 9.84 ZN ZN B 128 78 HIS D 10 HIS^? 15.91 ZN ZN D 128 122 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 53.63 68.24 34.99 53.08 69.10 33.16 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 75.01 61.87 32.93 75.34 59.26 31.96 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1ab4_c00 GYRASE A user 9 3 # 9 32 ARG B 29 ARG.? 13.89 ZN ZN B 128 78 HIS B 30 HIS.? -4.20 ZN ZN B 128s 122 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 53.63 68.24 34.99 53.08 69.10 33.16 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 75.01 61.87 32.93 75.34 59.26 31.96 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1ab4_c00 GYRASE A user 10 3 # 10 32 ARG C 12 ARG^? 8.72 ZN ZN C 128 78 HIS B 10 HIS^? 15.59 ZN ZN B 128 122 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 53.63 68.24 34.99 53.08 69.10 33.16 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 75.01 61.87 32.93 75.34 59.26 31.96 -32.42 26.30 46.60 -34.28 26.82 48.63 ULMN 3 1ab4_c00 GYRASE A user 11 3 # 11 32 ARG C 12 ARG^? 8.72 ZN ZN C 128 78 HIS C 10 HIS^? 15.40 ZN ZN C 128 122 TYR A 52 TYR^? 7.20 ZN ZN A 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 53.63 68.24 34.99 53.08 69.10 33.16 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 75.01 61.87 32.93 75.34 59.26 31.96 -20.95 49.22 77.42 -22.18 46.73 77.85 ULMN 3 1ab4_c00 GYRASE A user 12 3 # 12 32 ARG C 29 ARG.? 13.36 ZN ZN C 128 78 HIS C 30 HIS^? -3.56 ZN ZN C 128s 122 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 7.46 50.67 50.27 10.29 51.53 51.14 coo 53.63 68.24 34.99 53.08 69.10 33.16 0.61 46.90 50.78 -0.23 46.71 52.70 coo 75.01 61.87 32.93 75.34 59.26 31.96 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1ab4_c00 GYRASE A user 13 3 # 13 32 ARG C 29 ARG.? 13.36 ZN ZN C 128 78 HIS C 83 HIS^? -3.45 ZN ZN C 128s 122 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 7.46 50.67 50.27 10.29 51.53 51.14 coo 53.63 68.24 34.99 53.08 69.10 33.16 0.88 50.97 54.56 -1.00 50.36 53.86 coo 75.01 61.87 32.93 75.34 59.26 31.96 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 3 1ab4_c00 GYRASE A user 14 3 # 14 32 ARG C 42 ARG^? 15.11 ZN ZN C 128 78 HIS C 10 HIS^? 15.40 ZN ZN C 128 122 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 53.63 68.24 34.99 53.08 69.10 33.16 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 75.01 61.87 32.93 75.34 59.26 31.96 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1ab4_c00 GYRASE A user 15 3 # 15 32 ARG C 42 ARG^? 15.11 ZN ZN C 128 78 HIS C 10 HIS^? 15.40 ZN ZN C 128 122 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 53.63 68.24 34.99 53.08 69.10 33.16 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 75.01 61.87 32.93 75.34 59.26 31.96 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1ab4_c00 GYRASE A user 16 3 # 16 32 ARG D 12 ARG^? 9.28 ZN ZN D 128 78 HIS D 10 HIS^? 15.91 ZN ZN D 128 122 TYR B 52 TYR^? 7.51 ZN ZN B 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 53.63 68.24 34.99 53.08 69.10 33.16 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 75.01 61.87 32.93 75.34 59.26 31.96 -23.54 46.80 28.87 -20.82 47.32 28.41 ULMN 3 1ab4_c00 GYRASE A user 17 3 # 17 32 ARG D 29 ARG.? 13.42 ZN ZN D 128 78 HIS D 30 HIS^? -3.68 ZN ZN D 128s 122 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 53.63 68.24 34.99 53.08 69.10 33.16 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 75.01 61.87 32.93 75.34 59.26 31.96 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1ab4_c00 GYRASE A user 18 3 # 18 32 ARG D 42 ARG^? 14.89 ZN ZN D 128 78 HIS D 10 HIS^? 15.91 ZN ZN D 128 122 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 53.63 68.24 34.99 53.08 69.10 33.16 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 75.01 61.87 32.93 75.34 59.26 31.96 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1ab4_c00 GYRASE A user 19 3 # 19 32 ARG D 42 ARG^? 14.89 ZN ZN D 128 78 HIS D 10 HIS^? 15.91 ZN ZN D 128 122 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 48.32 72.26 30.89 48.69 69.28 31.53 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 53.63 68.24 34.99 53.08 69.10 33.16 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 75.01 61.87 32.93 75.34 59.26 31.96 -9.42 57.42 55.22 -8.85 60.18 55.10 1ab4_c00 source 1ab4 GYRASE A : 19 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN B 95 ASN^? 12.67 ZN ZN B 128 63 ARG B 12 ARG^? 9.84 ZN ZN B 128 255 ARG B 42 ARG^? 15.17 ZN ZN B 128 coo 42.10 13.02 11.14 41.85 11.12 10.23 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 44.36 11.24 3.39 41.81 12.78 4.00 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 38.40 3.83 10.26 40.02 6.30 9.25 -22.13 39.38 39.45 -22.11 38.65 42.43 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN B 95 ASN^? 12.67 ZN ZN B 128 63 ARG B 42 ARG^? 15.17 ZN ZN B 128 255 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 42.10 13.02 11.14 41.85 11.12 10.23 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 44.36 11.24 3.39 41.81 12.78 4.00 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 38.40 3.83 10.26 40.02 6.30 9.25 -19.64 50.95 45.34 -21.61 53.09 44.31 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN C 95 ASN^? 12.77 ZN ZN C 128 63 ARG C 42 ARG^? 15.11 ZN ZN C 128 255 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 42.10 13.02 11.14 41.85 11.12 10.23 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 44.36 11.24 3.39 41.81 12.78 4.00 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 38.40 3.83 10.26 40.02 6.30 9.25 -12.88 45.85 50.29 -9.95 45.19 50.84 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 3 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 90 ASP.? 20.22 ZN ZN A 128 187 GLU A 86 GLU^? 14.11 ZN ZN A 128 229 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -23.80 59.27 78.25 -23.36 59.70 80.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP B 90 ASP.? 20.48 ZN ZN B 128 187 GLU B 86 GLU^? 14.21 ZN ZN B 128 229 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -32.66 52.13 28.08 -32.88 52.09 25.98 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP C 90 ASP.? 21.10 ZN ZN C 128 187 GLU C 86 GLU^? 14.08 ZN ZN C 128 229 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo -52.57 56.60 47.75 -51.52 54.87 46.95 2.93 33.32 67.19 5.03 33.43 67.23 coo -45.08 48.37 46.81 -46.53 49.74 45.96 6.41 43.35 62.15 8.10 44.52 62.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP D 90 ASP.? 20.62 ZN ZN D 128 187 GLU D 86 GLU^? 14.30 ZN ZN D 128 229 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -25.28 18.69 44.67 -26.61 17.28 43.81 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -28.66 23.49 42.59 -29.87 18.31 40.35 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 57 ASP.? 17.22 ZN ZN A 128 35 SER A 60 SER.? 16.46 ZN ZN A 128 215 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -31.07 46.42 88.10 -29.75 44.46 87.48 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 35 SER A 13 SER^? 14.04 ZN ZN A 128 215 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP B 57 ASP.? 17.37 ZN ZN B 128 35 SER B 60 SER.? 16.61 ZN ZN B 128 215 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -18.29 55.80 18.16 -16.70 54.11 18.90 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 35 SER B 13 SER^? 13.94 ZN ZN B 128 215 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1am5_c04 PEPSIN user 5 3 # 5 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 35 SER C 60 SER.? 15.14 ZN ZN C 128 215 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 8.18 57.58 47.56 10.27 57.39 47.78 coo -12.30 10.35 145.24 -10.75 8.55 145.88 12.55 55.11 50.39 10.44 55.82 51.40 coo -8.20 12.64 138.30 -8.86 10.97 139.38 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1am5_c04 PEPSIN user 6 3 # 6 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 35 SER C 13 SER^? 14.25 ZN ZN C 128 215 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1am5_c04 PEPSIN user 7 3 # 7 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 35 SER D 60 SER.? 15.90 ZN ZN D 128 215 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -38.49 16.22 55.46 -39.72 18.27 55.05 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1am5_c04 PEPSIN user 8 3 # 8 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 35 SER D 13 SER^? 14.41 ZN ZN D 128 215 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -21.74 43.31 43.14 -23.53 43.14 44.28 1am5_c04 source 1am5 PEPSIN : 8 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP C 32 ASP^? -2.40 ZN ZN C 128s 214 ASP A 90 ASP.? 20.22 ZN ZN A 128 289 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 26.86 59.76 46.36 25.42 58.23 45.92 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP C 32 ASP^? -2.40 ZN ZN C 128s 214 ASP D 32 ASP^? -2.55 ZN ZN D 128s 289 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 26.86 59.76 46.36 25.42 58.23 45.92 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP D 32 ASP^? -2.55 ZN ZN D 128s 214 ASP B 90 ASP.? 20.48 ZN ZN B 128 289 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP D 32 ASP^? -2.55 ZN ZN D 128s 214 ASP C 32 ASP^? -2.40 ZN ZN C 128s 289 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.08 39.18 47.70 -23.31 39.57 46.61 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 57 ASP.? 17.22 ZN ZN A 128 227 GLU A 28 GLU~? 12.19 ZN ZN A 128 289 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 3.96 55.76 41.24 4.83 57.69 41.17 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 57 ASP.? 17.37 ZN ZN B 128 227 GLU B 28 GLU~? 11.81 ZN ZN B 128 289 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 3.96 55.76 41.24 4.83 57.69 41.17 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP C 57 ASP.? 16.82 ZN ZN C 128 227 GLU C 28 GLU~? 12.07 ZN ZN C 128 289 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 8.18 57.58 47.56 10.27 57.39 47.78 coo 3.96 55.76 41.24 4.83 57.69 41.17 5.96 41.55 51.41 5.95 40.38 49.65 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP D 57 ASP.? 16.88 ZN ZN D 128 227 GLU D 28 GLU.? 12.56 ZN ZN D 128 289 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 9.42 68.07 30.27 7.35 68.27 30.10 -41.38 20.76 48.99 -40.62 22.36 50.18 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 4 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 97 ASP^? 13.17 ZN ZN A 128 E 36 SER A 13 SER^? 14.04 ZN ZN A 128 E 213 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 26.30 12.96 16.78 25.46 12.99 18.72 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 28.33 15.15 21.27 28.70 13.12 19.97 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 20.15 16.04 19.79 21.65 14.49 19.86 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP B 97 ASP^? 13.03 ZN ZN B 128 E 36 SER B 13 SER^? 13.94 ZN ZN B 128 E 213 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 26.30 12.96 16.78 25.46 12.99 18.72 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 28.33 15.15 21.27 28.70 13.12 19.97 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 20.15 16.04 19.79 21.65 14.49 19.86 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP C 57 ASP.? 16.82 ZN ZN C 128 E 36 SER C 60 SER.? 15.14 ZN ZN C 128 E 213 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 26.30 12.96 16.78 25.46 12.99 18.72 8.18 57.58 47.56 10.27 57.39 47.78 coo 28.33 15.15 21.27 28.70 13.12 19.97 12.55 55.11 50.39 10.44 55.82 51.40 coo 20.15 16.04 19.79 21.65 14.49 19.86 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP C 97 ASP^? 13.06 ZN ZN C 128 E 36 SER C 13 SER^? 14.25 ZN ZN C 128 E 213 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 26.30 12.96 16.78 25.46 12.99 18.72 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 28.33 15.15 21.27 28.70 13.12 19.97 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 20.15 16.04 19.79 21.65 14.49 19.86 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 5 3 # 5 E 33 ASP D 57 ASP.? 16.88 ZN ZN D 128 E 36 SER D 60 SER.? 15.90 ZN ZN D 128 E 213 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 26.30 12.96 16.78 25.46 12.99 18.72 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 28.33 15.15 21.27 28.70 13.12 19.97 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 20.15 16.04 19.79 21.65 14.49 19.86 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 6 3 # 6 E 33 ASP D 97 ASP^? 13.24 ZN ZN D 128 E 36 SER D 13 SER^? 14.41 ZN ZN D 128 E 213 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 26.30 12.96 16.78 25.46 12.99 18.72 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 28.33 15.15 21.27 28.70 13.12 19.97 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 20.15 16.04 19.79 21.65 14.49 19.86 -21.74 43.31 43.14 -23.53 43.14 44.28 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 6 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS B 30 HIS.? -4.20 ZN ZN B 128s 254 LYS B 33 LYS.? 11.38 ZN ZN B 128 333 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 26.09 4.87 14.60 27.89 3.33 10.26 -14.69 55.97 38.01 -16.66 60.81 39.16 coo 37.35 7.47 11.84 34.90 6.11 10.60 -19.64 50.95 45.34 -21.61 53.09 44.31 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS D 30 HIS^? -3.68 ZN ZN D 128s 254 LYS D 33 LYS.? 12.24 ZN ZN D 128 333 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 26.09 4.87 14.60 27.89 3.33 10.26 -30.11 33.22 59.92 -32.56 30.92 63.52 coo 37.35 7.47 11.84 34.90 6.11 10.60 -21.38 38.31 55.98 -23.17 35.84 55.80 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 2 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 13 SER^? 14.04 ZN ZN A 128 A 292 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 322 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 36.34 32.23 39.60 36.43 34.62 39.93 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 19.73 19.18 41.39 21.50 18.65 40.34 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 41.69 45.14 46.60 41.78 47.19 46.18 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 44 SER^? 13.08 ZN ZN A 128 A 292 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 322 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -15.06 51.94 67.95 -14.23 50.17 66.49 coo 19.73 19.18 41.39 21.50 18.65 40.34 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 41.69 45.14 46.60 41.78 47.19 46.18 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 44 SER^? 13.08 ZN ZN A 128 A 292 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 322 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -15.06 51.94 67.95 -14.23 50.17 66.49 coo 19.73 19.18 41.39 21.50 18.65 40.34 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 41.69 45.14 46.60 41.78 47.19 46.18 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 44 SER^? 13.08 ZN ZN A 128 A 292 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 322 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -15.06 51.94 67.95 -14.23 50.17 66.49 coo 19.73 19.18 41.39 21.50 18.65 40.34 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 41.69 45.14 46.60 41.78 47.19 46.18 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 13 SER^? 13.94 ZN ZN B 128 A 292 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 322 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 36.34 32.23 39.60 36.43 34.62 39.93 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 19.73 19.18 41.39 21.50 18.65 40.34 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 41.69 45.14 46.60 41.78 47.19 46.18 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER B 13 SER^? 13.94 ZN ZN B 128 A 292 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 322 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 36.34 32.23 39.60 36.43 34.62 39.93 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 19.73 19.18 41.39 21.50 18.65 40.34 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 41.69 45.14 46.60 41.78 47.19 46.18 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 13 SER^? 13.94 ZN ZN B 128 A 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 322 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER B 13 SER^? 13.94 ZN ZN B 128 A 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 322 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER B 44 SER^? 13.00 ZN ZN B 128 A 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 322 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -27.80 41.88 38.27 -27.32 41.64 40.63 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER B 44 SER^? 13.00 ZN ZN B 128 A 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 322 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -27.80 41.88 38.27 -27.32 41.64 40.63 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER B 44 SER^? 13.00 ZN ZN B 128 A 292 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 322 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -27.80 41.88 38.27 -27.32 41.64 40.63 coo 19.73 19.18 41.39 21.50 18.65 40.34 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 A 194 SER C 13 SER^? 14.25 ZN ZN C 128 A 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 322 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 19.73 19.18 41.39 21.50 18.65 40.34 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 A 194 SER C 13 SER^? 14.25 ZN ZN C 128 A 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 322 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 19.73 19.18 41.39 21.50 18.65 40.34 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 A 194 SER C 13 SER^? 14.25 ZN ZN C 128 A 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 322 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 A 194 SER C 13 SER^? 14.25 ZN ZN C 128 A 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 322 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 A 194 SER C 44 SER^? 13.15 ZN ZN C 128 A 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 322 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -8.23 46.92 64.43 -10.34 48.09 64.36 coo 19.73 19.18 41.39 21.50 18.65 40.34 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 A 194 SER C 44 SER^? 13.15 ZN ZN C 128 A 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 322 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -8.23 46.92 64.43 -10.34 48.09 64.36 coo 19.73 19.18 41.39 21.50 18.65 40.34 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 41.69 45.14 46.60 41.78 47.19 46.18 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 A 194 SER D 13 SER^? 14.41 ZN ZN D 128 A 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 322 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 41.69 45.14 46.60 41.78 47.19 46.18 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 A 194 SER D 13 SER^? 14.41 ZN ZN D 128 A 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 322 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 41.69 45.14 46.60 41.78 47.19 46.18 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 A 194 SER D 13 SER^? 14.41 ZN ZN D 128 A 292 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 322 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 19.73 19.18 41.39 21.50 18.65 40.34 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 41.69 45.14 46.60 41.78 47.19 46.18 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 A 194 SER D 13 SER^? 14.41 ZN ZN D 128 A 292 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 322 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 19.73 19.18 41.39 21.50 18.65 40.34 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 41.69 45.14 46.60 41.78 47.19 46.18 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 A 194 SER D 44 SER^? 13.11 ZN ZN D 128 A 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 322 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.20 33.87 41.85 -23.76 35.78 42.26 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 41.69 45.14 46.60 41.78 47.19 46.18 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 23 3 # 23 A 194 SER D 44 SER^? 13.11 ZN ZN D 128 A 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 322 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.20 33.87 41.85 -23.76 35.78 42.26 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 41.69 45.14 46.60 41.78 47.19 46.18 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 24 3 # 24 A 194 SER D 44 SER^? 13.11 ZN ZN D 128 A 292 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 322 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 36.34 32.23 39.60 36.43 34.62 39.93 -25.20 33.87 41.85 -23.76 35.78 42.26 coo 19.73 19.18 41.39 21.50 18.65 40.34 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 41.69 45.14 46.60 41.78 47.19 46.18 -27.59 25.34 55.74 -27.28 26.44 53.99 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 24 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 13 SER^? 14.04 ZN ZN A 128 B 292 ASP A 90 ASP.? 20.22 ZN ZN A 128 B 322 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 35.42 71.28 22.94 36.24 69.06 22.37 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 24.74 78.07 5.59 24.32 79.03 7.46 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 48.81 64.16 26.34 49.30 62.16 26.73 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 44 SER^? 13.08 ZN ZN A 128 B 292 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 322 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -15.06 51.94 67.95 -14.23 50.17 66.49 coo 24.74 78.07 5.59 24.32 79.03 7.46 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 48.81 64.16 26.34 49.30 62.16 26.73 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 44 SER^? 13.08 ZN ZN A 128 B 292 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 322 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -15.06 51.94 67.95 -14.23 50.17 66.49 coo 24.74 78.07 5.59 24.32 79.03 7.46 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 48.81 64.16 26.34 49.30 62.16 26.73 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 44 SER^? 13.08 ZN ZN A 128 B 292 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 322 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -15.06 51.94 67.95 -14.23 50.17 66.49 coo 24.74 78.07 5.59 24.32 79.03 7.46 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 48.81 64.16 26.34 49.30 62.16 26.73 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 13 SER^? 13.94 ZN ZN B 128 B 292 ASP B 90 ASP.? 20.48 ZN ZN B 128 B 322 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 35.42 71.28 22.94 36.24 69.06 22.37 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 24.74 78.07 5.59 24.32 79.03 7.46 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 48.81 64.16 26.34 49.30 62.16 26.73 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER B 13 SER^? 13.94 ZN ZN B 128 B 292 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 322 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 35.42 71.28 22.94 36.24 69.06 22.37 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 24.74 78.07 5.59 24.32 79.03 7.46 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 48.81 64.16 26.34 49.30 62.16 26.73 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER B 44 SER^? 13.00 ZN ZN B 128 B 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 322 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -27.80 41.88 38.27 -27.32 41.64 40.63 coo 24.74 78.07 5.59 24.32 79.03 7.46 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER B 44 SER^? 13.00 ZN ZN B 128 B 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 322 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -27.80 41.88 38.27 -27.32 41.64 40.63 coo 24.74 78.07 5.59 24.32 79.03 7.46 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER B 44 SER^? 13.00 ZN ZN B 128 B 292 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 322 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -27.80 41.88 38.27 -27.32 41.64 40.63 coo 24.74 78.07 5.59 24.32 79.03 7.46 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER C 13 SER^? 14.25 ZN ZN C 128 B 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 322 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 24.74 78.07 5.59 24.32 79.03 7.46 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 B 194 SER C 13 SER^? 14.25 ZN ZN C 128 B 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 322 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 24.74 78.07 5.59 24.32 79.03 7.46 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 B 194 SER C 13 SER^? 14.25 ZN ZN C 128 B 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 322 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 24.74 78.07 5.59 24.32 79.03 7.46 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 B 194 SER C 13 SER^? 14.25 ZN ZN C 128 B 292 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 322 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 24.74 78.07 5.59 24.32 79.03 7.46 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 B 194 SER C 44 SER^? 13.15 ZN ZN C 128 B 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 322 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -8.23 46.92 64.43 -10.34 48.09 64.36 coo 24.74 78.07 5.59 24.32 79.03 7.46 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 B 194 SER C 44 SER^? 13.15 ZN ZN C 128 B 292 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 322 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -8.23 46.92 64.43 -10.34 48.09 64.36 coo 24.74 78.07 5.59 24.32 79.03 7.46 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 48.81 64.16 26.34 49.30 62.16 26.73 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 B 194 SER D 13 SER^? 14.41 ZN ZN D 128 B 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 322 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 48.81 64.16 26.34 49.30 62.16 26.73 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 B 194 SER D 13 SER^? 14.41 ZN ZN D 128 B 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 322 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 48.81 64.16 26.34 49.30 62.16 26.73 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 B 194 SER D 44 SER^? 13.11 ZN ZN D 128 B 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 322 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -25.20 33.87 41.85 -23.76 35.78 42.26 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 48.81 64.16 26.34 49.30 62.16 26.73 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 B 194 SER D 44 SER^? 13.11 ZN ZN D 128 B 292 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 322 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 35.42 71.28 22.94 36.24 69.06 22.37 -25.20 33.87 41.85 -23.76 35.78 42.26 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 48.81 64.16 26.34 49.30 62.16 26.73 -31.62 26.29 51.88 -30.63 27.88 52.82 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 19 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 36 ARG.? 14.54 ZN ZN D 128 B 342 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 531 ARG D 36 ARG.? 10.17 ZN ZN A 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -29.05 33.74 68.19 -28.81 35.05 65.43 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -32.18 43.37 61.68 -31.14 45.24 63.88 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 342 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 531 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -12.88 45.85 50.29 -9.95 45.19 50.84 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 342 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 531 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -12.88 45.85 50.29 -9.95 45.19 50.84 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG B 36 ARG.? 14.53 ZN ZN C 128 B 342 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 531 ARG C 36 ARG.? 10.67 ZN ZN B 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -15.69 56.10 43.84 -17.06 58.00 41.84 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 342 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 531 ARG C 36 ARG.? 10.67 ZN ZN B 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -15.69 56.10 43.84 -17.06 58.00 41.84 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 342 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 531 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -21.38 38.31 55.98 -23.17 35.84 55.80 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 342 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 531 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -12.88 45.85 50.29 -9.95 45.19 50.84 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 342 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 531 ARG A 12 ARG^? 10.24 ZN ZN A 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -26.71 45.35 59.66 -27.06 47.43 61.87 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 342 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 531 ARG A 12 ARG^? 10.24 ZN ZN A 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -26.71 45.35 59.66 -27.06 47.43 61.87 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG D 36 ARG.? 10.17 ZN ZN A 128 B 342 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 531 ARG A 36 ARG.? 14.54 ZN ZN D 128 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -32.18 43.37 61.68 -31.14 45.24 63.88 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -29.05 33.74 68.19 -28.81 35.05 65.43 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 10 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 36 ARG.? 14.54 ZN ZN D 128 A 342 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 531 ARG D 36 ARG.? 10.17 ZN ZN A 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -29.05 33.74 68.19 -28.81 35.05 65.43 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -32.18 43.37 61.68 -31.14 45.24 63.88 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 342 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 531 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -12.88 45.85 50.29 -9.95 45.19 50.84 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG B 36 ARG.? 14.53 ZN ZN C 128 A 342 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 531 ARG C 36 ARG.? 10.67 ZN ZN B 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -15.69 56.10 43.84 -17.06 58.00 41.84 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 342 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 531 ARG C 36 ARG.? 10.67 ZN ZN B 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -15.69 56.10 43.84 -17.06 58.00 41.84 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 342 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 531 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -21.38 38.31 55.98 -23.17 35.84 55.80 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 342 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 531 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -19.64 50.95 45.34 -21.61 53.09 44.31 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 342 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 531 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -7.28 49.73 38.22 -8.28 50.76 40.96 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 342 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 531 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -7.28 49.73 38.22 -8.28 50.76 40.96 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 A 325 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 342 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 531 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -12.88 45.85 50.29 -9.95 45.19 50.84 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 A 325 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 342 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 531 ARG D 36 ARG.? 10.17 ZN ZN A 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -32.18 43.37 61.68 -31.14 45.24 63.88 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 A 325 ARG D 36 ARG.? 10.17 ZN ZN A 128 A 342 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 531 ARG A 36 ARG.? 14.54 ZN ZN D 128 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -32.18 43.37 61.68 -31.14 45.24 63.88 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -29.05 33.74 68.19 -28.81 35.05 65.43 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 11 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 35 SER A 60 SER.? 16.46 ZN ZN A 128 A 217 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -31.07 46.42 88.10 -29.75 44.46 87.48 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 35 SER A 13 SER^? 14.04 ZN ZN A 128 A 217 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 35 SER B 60 SER.? 16.61 ZN ZN B 128 A 217 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -18.29 55.80 18.16 -16.70 54.11 18.90 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 35 SER B 13 SER^? 13.94 ZN ZN B 128 A 217 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1avf_c04 GASTRICSIN user 5 3 # 5 A 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 35 SER C 60 SER.? 15.14 ZN ZN C 128 A 217 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 8.18 57.58 47.56 10.27 57.39 47.78 coo -11.96 5.74 52.90 -10.55 6.74 51.22 12.55 55.11 50.39 10.44 55.82 51.40 coo -5.22 1.43 56.08 -5.36 2.84 54.49 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1avf_c04 GASTRICSIN user 6 3 # 6 A 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 35 SER C 13 SER^? 14.25 ZN ZN C 128 A 217 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1avf_c04 GASTRICSIN user 7 3 # 7 A 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 35 SER D 60 SER.? 15.90 ZN ZN D 128 A 217 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -38.49 16.22 55.46 -39.72 18.27 55.05 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1avf_c04 GASTRICSIN user 8 3 # 8 A 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 35 SER D 13 SER^? 14.41 ZN ZN D 128 A 217 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -21.74 43.31 43.14 -23.53 43.14 44.28 1avf_c04 source 1avf GASTRICSIN : 8 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 57 ASP.? 17.22 ZN ZN A 128 J 35 SER A 60 SER.? 16.46 ZN ZN A 128 J 217 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -31.07 46.42 88.10 -29.75 44.46 87.48 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 J 35 SER A 13 SER^? 14.04 ZN ZN A 128 J 217 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP B 57 ASP.? 17.37 ZN ZN B 128 J 35 SER B 60 SER.? 16.61 ZN ZN B 128 J 217 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -18.29 55.80 18.16 -16.70 54.11 18.90 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 J 35 SER B 13 SER^? 13.94 ZN ZN B 128 J 217 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1avf_c05 GASTRICSIN user 5 3 # 5 J 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 J 35 SER C 60 SER.? 15.14 ZN ZN C 128 J 217 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 8.18 57.58 47.56 10.27 57.39 47.78 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 12.55 55.11 50.39 10.44 55.82 51.40 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1avf_c05 GASTRICSIN user 6 3 # 6 J 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 J 35 SER C 13 SER^? 14.25 ZN ZN C 128 J 217 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1avf_c05 GASTRICSIN user 7 3 # 7 J 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 J 35 SER D 60 SER.? 15.90 ZN ZN D 128 J 217 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -38.49 16.22 55.46 -39.72 18.27 55.05 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1avf_c05 GASTRICSIN user 8 3 # 8 J 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 J 35 SER D 13 SER^? 14.41 ZN ZN D 128 J 217 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -21.74 43.31 43.14 -23.53 43.14 44.28 1avf_c05 source 1avf GASTRICSIN : 8 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 16 PHE.? 16.30 ZN ZN A 128 A 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -18.40 57.13 61.09 -15.92 55.92 60.55 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 19.99 54.53 64.11 20.55 58.78 68.33 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 A 223 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 265 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 30.70 47.50 67.53 29.83 49.47 67.39 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 19.99 54.53 64.11 20.55 58.78 68.33 -39.27 61.49 31.97 -43.88 61.90 29.42 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 A 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 77 PHE.? 6.21 ZN ZN B 128 A 223 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -21.11 45.75 32.44 -23.89 45.86 32.80 coo 30.70 47.50 67.53 29.83 49.47 67.39 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 19.99 54.53 64.11 20.55 58.78 68.33 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE C 16 PHE.? 16.61 ZN ZN C 128 A 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -11.21 38.35 63.24 -13.14 39.96 64.53 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 19.99 54.53 64.11 20.55 58.78 68.33 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE C 74 PHE^? 15.05 ZN ZN C 128 A 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -9.43 52.07 65.61 -10.77 54.53 65.79 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 19.99 54.53 64.11 20.55 58.78 68.33 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE C 99 PHE^? 14.04 ZN ZN C 128 A 223 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 265 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -14.56 53.53 56.74 -15.34 51.98 58.97 coo 30.70 47.50 67.53 29.83 49.47 67.39 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 19.99 54.53 64.11 20.55 58.78 68.33 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE D 16 PHE.? 16.58 ZN ZN D 128 A 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -16.01 34.48 43.33 -17.02 36.72 41.96 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE D 94 PHE^? 9.41 ZN ZN D 128 A 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -21.52 29.39 44.56 -21.12 27.85 46.87 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE D 99 PHE^? 14.35 ZN ZN D 128 A 223 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 265 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 39.74 52.86 65.74 41.15 55.14 66.52 -29.67 42.10 49.53 -27.93 42.65 47.39 coo 30.70 47.50 67.53 29.83 49.47 67.39 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 19.99 54.53 64.11 20.55 58.78 68.33 -28.66 23.49 42.59 -29.87 18.31 40.35 1ax4_c04 source 1ax4 TRYPTOPHANASE : 10 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 16 PHE.? 16.30 ZN ZN A 128 B 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -18.40 57.13 61.09 -15.92 55.92 60.55 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 5.43 58.06 80.08 8.57 53.00 79.37 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 B 223 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 265 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 10.43 61.66 91.81 9.80 60.04 90.61 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 5.43 58.06 80.08 8.57 53.00 79.37 -39.27 61.49 31.97 -43.88 61.90 29.42 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 B 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 77 PHE.? 6.21 ZN ZN B 128 B 223 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -21.11 45.75 32.44 -23.89 45.86 32.80 coo 10.43 61.66 91.81 9.80 60.04 90.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 5.43 58.06 80.08 8.57 53.00 79.37 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE C 16 PHE.? 16.61 ZN ZN C 128 B 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -11.21 38.35 63.24 -13.14 39.96 64.53 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 5.43 58.06 80.08 8.57 53.00 79.37 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE C 74 PHE^? 15.05 ZN ZN C 128 B 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -9.43 52.07 65.61 -10.77 54.53 65.79 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 5.43 58.06 80.08 8.57 53.00 79.37 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE C 99 PHE^? 14.04 ZN ZN C 128 B 223 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 265 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -14.56 53.53 56.74 -15.34 51.98 58.97 coo 10.43 61.66 91.81 9.80 60.04 90.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 5.43 58.06 80.08 8.57 53.00 79.37 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE D 16 PHE.? 16.58 ZN ZN D 128 B 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -16.01 34.48 43.33 -17.02 36.72 41.96 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE D 94 PHE^? 9.41 ZN ZN D 128 B 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -21.52 29.39 44.56 -21.12 27.85 46.87 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE D 99 PHE^? 14.35 ZN ZN D 128 B 223 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 265 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 7.48 54.94 99.62 7.67 52.27 100.42 -29.67 42.10 49.53 -27.93 42.65 47.39 coo 10.43 61.66 91.81 9.80 60.04 90.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 5.43 58.06 80.08 8.57 53.00 79.37 -28.66 23.49 42.59 -29.87 18.31 40.35 1ax4_c05 source 1ax4 TRYPTOPHANASE : 10 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 16 PHE.? 16.30 ZN ZN A 128 C 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 C 223 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 265 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -39.27 61.49 31.97 -43.88 61.90 29.42 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 C 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 77 PHE.? 6.21 ZN ZN B 128 C 223 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -21.11 45.75 32.44 -23.89 45.86 32.80 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE C 16 PHE.? 16.61 ZN ZN C 128 C 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -11.21 38.35 63.24 -13.14 39.96 64.53 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE C 74 PHE^? 15.05 ZN ZN C 128 C 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -9.43 52.07 65.61 -10.77 54.53 65.79 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE C 94 PHE^? 9.63 ZN ZN C 128 C 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -4.76 42.24 62.13 -3.25 41.33 59.94 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE D 94 PHE^? 9.41 ZN ZN D 128 C 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -21.52 29.39 44.56 -21.12 27.85 46.87 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.11 33.22 59.92 -32.56 30.92 63.52 1ax4_c06 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 16 PHE.? 16.30 ZN ZN A 128 D 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 D 223 ASP B 91 ASP.? 21.34 ZN ZN B 128 D 265 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -39.27 61.49 31.97 -43.88 61.90 29.42 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE B 16 PHE.? 16.34 ZN ZN B 128 D 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 77 PHE.? 6.21 ZN ZN B 128 D 223 ASP B 32 ASP.? -2.88 ZN ZN B 128s D 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -21.11 45.75 32.44 -23.89 45.86 32.80 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE C 16 PHE.? 16.61 ZN ZN C 128 D 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -11.21 38.35 63.24 -13.14 39.96 64.53 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE C 74 PHE^? 15.05 ZN ZN C 128 D 223 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 265 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -9.43 52.07 65.61 -10.77 54.53 65.79 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE D 16 PHE.? 16.58 ZN ZN D 128 D 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -16.01 34.48 43.33 -17.02 36.72 41.96 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE D 94 PHE^? 9.41 ZN ZN D 128 D 223 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 265 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -21.52 29.39 44.56 -21.12 27.85 46.87 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.11 33.22 59.92 -32.56 30.92 63.52 1ax4_c07 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 13 SER^? 14.04 ZN ZN A 128 A 266 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 294 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 32.07 25.76 77.83 34.46 26.05 77.46 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 33.07 35.01 79.81 33.39 33.02 79.13 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 35.53 30.26 79.89 34.62 28.71 78.80 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER A 13 SER^? 14.04 ZN ZN A 128 A 266 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 294 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 32.07 25.76 77.83 34.46 26.05 77.46 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 33.07 35.01 79.81 33.39 33.02 79.13 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 35.53 30.26 79.89 34.62 28.71 78.80 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 110 SER B 13 SER^? 13.94 ZN ZN B 128 A 266 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 294 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 32.07 25.76 77.83 34.46 26.05 77.46 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 33.07 35.01 79.81 33.39 33.02 79.13 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 35.53 30.26 79.89 34.62 28.71 78.80 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 110 SER B 13 SER^? 13.94 ZN ZN B 128 A 266 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 294 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 32.07 25.76 77.83 34.46 26.05 77.46 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 33.07 35.01 79.81 33.39 33.02 79.13 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 35.53 30.26 79.89 34.62 28.71 78.80 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 110 SER C 13 SER^? 14.25 ZN ZN C 128 A 266 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 294 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 32.07 25.76 77.83 34.46 26.05 77.46 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 33.07 35.01 79.81 33.39 33.02 79.13 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 35.53 30.26 79.89 34.62 28.71 78.80 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 110 SER D 13 SER^? 14.41 ZN ZN D 128 A 266 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 294 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 32.07 25.76 77.83 34.46 26.05 77.46 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 33.07 35.01 79.81 33.39 33.02 79.13 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 35.53 30.26 79.89 34.62 28.71 78.80 -18.46 42.11 47.13 -20.09 43.42 47.28 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 6 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 13 SER^? 14.04 ZN ZN A 128 B 266 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 294 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 51.18 33.22 36.61 49.29 31.79 37.02 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 44.19 39.32 34.54 45.21 37.66 35.38 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 45.79 34.26 34.63 47.54 33.80 35.70 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER A 13 SER^? 14.04 ZN ZN A 128 B 266 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 294 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 51.18 33.22 36.61 49.29 31.79 37.02 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 44.19 39.32 34.54 45.21 37.66 35.38 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 45.79 34.26 34.63 47.54 33.80 35.70 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 3 3 # 3 B 110 SER B 13 SER^? 13.94 ZN ZN B 128 B 266 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 294 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 51.18 33.22 36.61 49.29 31.79 37.02 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 44.19 39.32 34.54 45.21 37.66 35.38 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 45.79 34.26 34.63 47.54 33.80 35.70 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 4 3 # 4 B 110 SER B 13 SER^? 13.94 ZN ZN B 128 B 266 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 294 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 51.18 33.22 36.61 49.29 31.79 37.02 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 44.19 39.32 34.54 45.21 37.66 35.38 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 45.79 34.26 34.63 47.54 33.80 35.70 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 5 3 # 5 B 110 SER C 13 SER^? 14.25 ZN ZN C 128 B 266 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 294 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 51.18 33.22 36.61 49.29 31.79 37.02 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 44.19 39.32 34.54 45.21 37.66 35.38 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 45.79 34.26 34.63 47.54 33.80 35.70 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 6 3 # 6 B 110 SER D 13 SER^? 14.41 ZN ZN D 128 B 266 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 294 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 51.18 33.22 36.61 49.29 31.79 37.02 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 44.19 39.32 34.54 45.21 37.66 35.38 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 45.79 34.26 34.63 47.54 33.80 35.70 -18.46 42.11 47.13 -20.09 43.42 47.28 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 6 hits 1azw_c01 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 171 ARG A 36 ARG.? 14.54 ZN ZN D 128 A 190 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 13.63 3.81 28.83 14.49 2.91 31.59 -29.05 33.74 68.19 -28.81 35.05 65.43 coo 24.97 7.47 37.69 21.24 10.69 35.89 -27.08 41.78 78.19 -22.69 42.64 82.54 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 171 ARG B 36 ARG.? 14.53 ZN ZN C 128 A 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 0.61 46.90 50.78 -0.23 46.71 52.70 coo 13.63 3.81 28.83 14.49 2.91 31.59 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 24.97 7.47 37.69 21.24 10.69 35.89 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 171 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 190 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 0.61 46.90 50.78 -0.23 46.71 52.70 coo 13.63 3.81 28.83 14.49 2.91 31.59 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 24.97 7.47 37.69 21.24 10.69 35.89 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 171 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 0.61 46.90 50.78 -0.23 46.71 52.70 coo 13.63 3.81 28.83 14.49 2.91 31.59 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 24.97 7.47 37.69 21.24 10.69 35.89 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 5 3 # 5 A 85 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 171 ARG B 36 ARG.? 14.53 ZN ZN C 128 A 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 0.88 50.97 54.56 -1.00 50.36 53.86 coo 13.63 3.81 28.83 14.49 2.91 31.59 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 24.97 7.47 37.69 21.24 10.69 35.89 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 6 3 # 6 A 85 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 171 ARG A 36 ARG.? 14.54 ZN ZN D 128 A 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 13.63 3.81 28.83 14.49 2.91 31.59 -29.05 33.74 68.19 -28.81 35.05 65.43 coo 24.97 7.47 37.69 21.24 10.69 35.89 -36.76 27.60 54.86 -39.44 24.48 51.40 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 7 3 # 7 A 85 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 171 ARG D 42 ARG^? 14.89 ZN ZN D 128 A 190 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 13.63 3.81 28.83 14.49 2.91 31.59 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 24.97 7.47 37.69 21.24 10.69 35.89 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 8 3 # 8 A 85 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 171 ARG A 36 ARG.? 14.54 ZN ZN D 128 A 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 22.59 2.26 43.22 21.17 3.47 42.27 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 13.63 3.81 28.83 14.49 2.91 31.59 -29.05 33.74 68.19 -28.81 35.05 65.43 coo 24.97 7.47 37.69 21.24 10.69 35.89 -36.76 27.60 54.86 -39.44 24.48 51.40 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 8 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 171 ARG A 36 ARG.? 14.54 ZN ZN D 128 B 190 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 2.83 4.83 10.84 1.96 4.32 7.97 -29.05 33.74 68.19 -28.81 35.05 65.43 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -27.08 41.78 78.19 -22.69 42.64 82.54 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 171 ARG B 36 ARG.? 14.53 ZN ZN C 128 B 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 0.61 46.90 50.78 -0.23 46.71 52.70 coo 2.83 4.83 10.84 1.96 4.32 7.97 -7.28 49.73 38.22 -8.28 50.76 40.96 coo -8.96 9.04 2.88 -5.39 12.11 5.08 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 171 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 190 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 0.61 46.90 50.78 -0.23 46.71 52.70 coo 2.83 4.83 10.84 1.96 4.32 7.97 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 4 3 # 4 B 85 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 171 ARG B 36 ARG.? 14.53 ZN ZN C 128 B 190 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 0.88 50.97 54.56 -1.00 50.36 53.86 coo 2.83 4.83 10.84 1.96 4.32 7.97 -7.28 49.73 38.22 -8.28 50.76 40.96 coo -8.96 9.04 2.88 -5.39 12.11 5.08 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 5 3 # 5 B 85 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 171 ARG A 36 ARG.? 14.54 ZN ZN D 128 B 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 2.83 4.83 10.84 1.96 4.32 7.97 -29.05 33.74 68.19 -28.81 35.05 65.43 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -36.76 27.60 54.86 -39.44 24.48 51.40 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 6 3 # 6 B 85 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 171 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 190 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 2.83 4.83 10.84 1.96 4.32 7.97 -29.08 38.55 44.25 -27.07 40.84 43.98 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 7 3 # 7 B 85 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 171 ARG A 36 ARG.? 14.54 ZN ZN D 128 B 190 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 2.83 4.83 10.84 1.96 4.32 7.97 -29.05 33.74 68.19 -28.81 35.05 65.43 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -36.76 27.60 54.86 -39.44 24.48 51.40 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 7 hits 1azy_c01 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 58 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 92 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 11.38 23.30 3.20 9.27 23.34 3.13 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 2.67 19.36 1.56 3.51 21.24 1.94 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 58 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 92 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 11.38 23.30 3.20 9.27 23.34 3.13 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 2.67 19.36 1.56 3.51 21.24 1.94 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 A 40 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 58 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 92 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 11.38 23.30 3.20 9.27 23.34 3.13 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 2.67 19.36 1.56 3.51 21.24 1.94 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 A 40 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 58 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 92 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 11.38 23.30 3.20 9.27 23.34 3.13 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 2.67 19.36 1.56 3.51 21.24 1.94 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 5 3 # 5 A 40 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 58 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 92 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 11.45 52.92 44.80 10.43 52.05 43.19 coo 11.38 23.30 3.20 9.27 23.34 3.13 7.13 51.72 45.00 6.65 51.50 42.95 coo 2.67 19.36 1.56 3.51 21.24 1.94 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 6 3 # 6 A 40 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 58 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 92 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 11.45 52.92 44.80 10.43 52.05 43.19 coo 11.38 23.30 3.20 9.27 23.34 3.13 7.13 51.72 45.00 6.65 51.50 42.95 coo 2.67 19.36 1.56 3.51 21.24 1.94 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 7 3 # 7 A 40 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 58 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 92 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 11.38 23.30 3.20 9.27 23.34 3.13 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 2.67 19.36 1.56 3.51 21.24 1.94 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 8 3 # 8 A 40 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 58 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 92 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 12.70 27.74 1.76 10.77 27.11 1.24 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 11.38 23.30 3.20 9.27 23.34 3.13 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 2.67 19.36 1.56 3.51 21.24 1.94 -31.62 26.29 51.88 -30.63 27.88 52.82 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 8 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 59 HIS.? 17.66 ZN ZN A 128 B 58 GLU A 58 GLU.? 14.95 ZN ZN A 128 B 92 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 10.74 36.24 16.20 9.81 34.52 16.97 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 5.02 36.40 17.74 5.55 34.41 17.37 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 0.68 29.04 20.43 2.46 29.56 19.46 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS A 59 HIS.? 17.66 ZN ZN A 128 B 58 GLU A 58 GLU.? 14.95 ZN ZN A 128 B 92 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 10.74 36.24 16.20 9.81 34.52 16.97 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 5.02 36.40 17.74 5.55 34.41 17.37 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 0.68 29.04 20.43 2.46 29.56 19.46 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 B 40 HIS B 59 HIS.? 17.68 ZN ZN B 128 B 58 GLU B 58 GLU.? 14.99 ZN ZN B 128 B 92 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 10.74 36.24 16.20 9.81 34.52 16.97 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 5.02 36.40 17.74 5.55 34.41 17.37 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 0.68 29.04 20.43 2.46 29.56 19.46 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 B 40 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 58 GLU C 58 GLU.? 14.59 ZN ZN C 128 B 92 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 10.74 36.24 16.20 9.81 34.52 16.97 11.45 52.92 44.80 10.43 52.05 43.19 coo 5.02 36.40 17.74 5.55 34.41 17.37 7.13 51.72 45.00 6.65 51.50 42.95 coo 0.68 29.04 20.43 2.46 29.56 19.46 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 5 3 # 5 B 40 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 58 GLU D 58 GLU.? 14.54 ZN ZN D 128 B 92 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 10.74 36.24 16.20 9.81 34.52 16.97 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 5.02 36.40 17.74 5.55 34.41 17.37 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 0.68 29.04 20.43 2.46 29.56 19.46 -27.59 25.34 55.74 -27.28 26.44 53.99 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 5 hits 1b2m_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 62 GLU.? 19.31 ZN ZN A 128 B 88 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 89 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 44.53 38.98 5.35 43.53 40.60 6.22 -26.58 51.13 91.45 -26.69 53.13 90.74 coo 58.74 13.49 55.78 58.72 14.38 57.67 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 62 GLU.? 19.86 ZN ZN B 128 B 88 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 89 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 44.53 38.98 5.35 43.53 40.60 6.22 -23.75 52.55 14.67 -25.59 53.44 15.21 coo 58.74 13.49 55.78 58.72 14.38 57.67 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 60.89 12.20 60.42 60.43 13.81 61.68 -26.02 47.31 76.45 -26.60 46.79 74.50 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 2 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 62 GLU.? 19.31 ZN ZN A 128 B 88 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 89 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 44.53 38.98 5.35 43.53 40.60 6.22 -26.58 51.13 91.45 -26.69 53.13 90.74 coo 58.74 13.49 55.78 58.72 14.38 57.67 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 60.89 12.20 60.42 60.43 13.81 61.68 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 62 GLU.? 19.86 ZN ZN B 128 B 88 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 89 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 44.53 38.98 5.35 43.53 40.60 6.22 -23.75 52.55 14.67 -25.59 53.44 15.21 coo 58.74 13.49 55.78 58.72 14.38 57.67 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 60.89 12.20 60.42 60.43 13.81 61.68 -26.02 47.31 76.45 -26.60 46.79 74.50 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 2 hits 1b66_c02 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 91 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 129 SER A 13 SER^? 14.04 ZN ZN A 128 coo 24.39 47.01 49.70 26.42 47.04 49.21 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 25.98 44.20 42.23 28.53 42.98 43.43 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 30.00 49.76 45.68 28.73 48.72 47.47 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 91 ARG A 29 ARG.? 13.64 ZN ZN A 128 A 129 SER A 60 SER.? 16.46 ZN ZN A 128 coo 24.39 47.01 49.70 26.42 47.04 49.21 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 25.98 44.20 42.23 28.53 42.98 43.43 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 30.00 49.76 45.68 28.73 48.72 47.47 -31.07 46.42 88.10 -29.75 44.46 87.48 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 A 18 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 91 ARG B 29 ARG.? 13.89 ZN ZN B 128 A 129 SER B 60 SER.? 16.61 ZN ZN B 128 coo 24.39 47.01 49.70 26.42 47.04 49.21 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 25.98 44.20 42.23 28.53 42.98 43.43 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 30.00 49.76 45.68 28.73 48.72 47.47 -18.29 55.80 18.16 -16.70 54.11 18.90 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 A 18 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 91 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 129 SER C 13 SER^? 14.25 ZN ZN C 128 coo 24.39 47.01 49.70 26.42 47.04 49.21 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 25.98 44.20 42.23 28.53 42.98 43.43 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 30.00 49.76 45.68 28.73 48.72 47.47 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 A 18 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 91 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 129 SER C 60 SER.? 15.14 ZN ZN C 128 coo 24.39 47.01 49.70 26.42 47.04 49.21 11.45 52.92 44.80 10.43 52.05 43.19 coo 25.98 44.20 42.23 28.53 42.98 43.43 7.46 50.67 50.27 10.29 51.53 51.14 coo 30.00 49.76 45.68 28.73 48.72 47.47 12.55 55.11 50.39 10.44 55.82 51.40 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 A 18 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 91 ARG D 29 ARG.? 13.42 ZN ZN D 128 A 129 SER D 60 SER.? 15.90 ZN ZN D 128 coo 24.39 47.01 49.70 26.42 47.04 49.21 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 25.98 44.20 42.23 28.53 42.98 43.43 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 30.00 49.76 45.68 28.73 48.72 47.47 -38.49 16.22 55.46 -39.72 18.27 55.05 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 6 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 91 ARG A 42 ARG^? 15.09 ZN ZN A 128 B 129 SER A 13 SER^? 14.04 ZN ZN A 128 coo 18.19 17.03 40.71 18.55 17.18 38.64 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 25.60 21.10 38.54 23.57 20.93 36.25 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 21.33 14.29 34.62 19.25 14.88 35.71 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS A 59 HIS.? 17.66 ZN ZN A 128 B 91 ARG A 29 ARG.? 13.64 ZN ZN A 128 B 129 SER A 60 SER.? 16.46 ZN ZN A 128 coo 18.19 17.03 40.71 18.55 17.18 38.64 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 25.60 21.10 38.54 23.57 20.93 36.25 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 21.33 14.29 34.62 19.25 14.88 35.71 -31.07 46.42 88.10 -29.75 44.46 87.48 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 91 ARG B 42 ARG^? 15.17 ZN ZN B 128 B 129 SER B 13 SER^? 13.94 ZN ZN B 128 coo 18.19 17.03 40.71 18.55 17.18 38.64 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 25.60 21.10 38.54 23.57 20.93 36.25 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 21.33 14.29 34.62 19.25 14.88 35.71 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 91 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 129 SER B 13 SER^? 13.94 ZN ZN B 128 coo 18.19 17.03 40.71 18.55 17.18 38.64 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 25.60 21.10 38.54 23.57 20.93 36.25 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 21.33 14.29 34.62 19.25 14.88 35.71 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 B 18 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 91 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 129 SER C 13 SER^? 14.25 ZN ZN C 128 coo 18.19 17.03 40.71 18.55 17.18 38.64 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 25.60 21.10 38.54 23.57 20.93 36.25 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 21.33 14.29 34.62 19.25 14.88 35.71 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 B 18 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 91 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 129 SER D 13 SER^? 14.41 ZN ZN D 128 coo 18.19 17.03 40.71 18.55 17.18 38.64 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 25.60 21.10 38.54 23.57 20.93 36.25 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 21.33 14.29 34.62 19.25 14.88 35.71 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 7 3 # 7 B 18 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 91 ARG D 29 ARG.? 13.42 ZN ZN D 128 B 129 SER D 60 SER.? 15.90 ZN ZN D 128 coo 18.19 17.03 40.71 18.55 17.18 38.64 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 25.60 21.10 38.54 23.57 20.93 36.25 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 21.33 14.29 34.62 19.25 14.88 35.71 -38.49 16.22 55.46 -39.72 18.27 55.05 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 7 hits 1b6t_c01 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 77 PHE.? 6.06 ZN ZN A 128 A 159 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 188 LYS A 33 LYS.? 11.45 ZN ZN A 128 coo 13.91 34.58 14.67 12.95 36.00 12.47 -20.65 46.43 74.00 -19.92 49.13 73.70 coo 20.97 28.40 16.26 20.19 30.15 15.34 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 22.55 41.65 15.60 18.92 37.20 14.63 -32.13 43.51 68.59 -35.31 47.47 65.43 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE C 77 PHE.? 5.68 ZN ZN C 128 A 159 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 188 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 13.91 34.58 14.67 12.95 36.00 12.47 -3.10 52.12 57.92 -2.59 49.92 59.60 coo 20.97 28.40 16.26 20.19 30.15 15.34 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 22.55 41.65 15.60 18.92 37.20 14.63 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE C 94 PHE^? 9.63 ZN ZN C 128 A 159 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 188 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 13.91 34.58 14.67 12.95 36.00 12.47 -4.76 42.24 62.13 -3.25 41.33 59.94 coo 20.97 28.40 16.26 20.19 30.15 15.34 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 22.55 41.65 15.60 18.92 37.20 14.63 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE D 77 PHE.? 5.25 ZN ZN D 128 A 159 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 188 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.30 30.46 48.64 -29.26 29.22 47.17 coo 20.97 28.40 16.26 20.19 30.15 15.34 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 22.55 41.65 15.60 18.92 37.20 14.63 -30.11 33.22 59.92 -32.56 30.92 63.52 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 4 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 57 ASP.? 17.22 ZN ZN A 128 35 SER A 60 SER.? 16.46 ZN ZN A 128 215 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 35 SER A 13 SER^? 14.04 ZN ZN A 128 215 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 66.00 46.17 80.29 64.31 47.92 79.91 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 63.61 40.10 74.06 64.05 42.07 74.70 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP B 57 ASP.? 17.37 ZN ZN B 128 35 SER B 60 SER.? 16.61 ZN ZN B 128 215 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 66.00 46.17 80.29 64.31 47.92 79.91 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 63.61 40.10 74.06 64.05 42.07 74.70 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 35 SER B 13 SER^? 13.94 ZN ZN B 128 215 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 66.00 46.17 80.29 64.31 47.92 79.91 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 63.61 40.10 74.06 64.05 42.07 74.70 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1bbs_c06 RENIN user 5 3 # 5 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 35 SER C 60 SER.? 15.14 ZN ZN C 128 215 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 8.18 57.58 47.56 10.27 57.39 47.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 12.55 55.11 50.39 10.44 55.82 51.40 coo 63.61 40.10 74.06 64.05 42.07 74.70 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1bbs_c06 RENIN user 6 3 # 6 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 35 SER C 13 SER^? 14.25 ZN ZN C 128 215 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 66.00 46.17 80.29 64.31 47.92 79.91 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 63.61 40.10 74.06 64.05 42.07 74.70 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1bbs_c06 RENIN user 7 3 # 7 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 35 SER D 60 SER.? 15.90 ZN ZN D 128 215 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 66.00 46.17 80.29 64.31 47.92 79.91 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 63.61 40.10 74.06 64.05 42.07 74.70 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1bbs_c06 RENIN user 8 3 # 8 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 35 SER D 13 SER^? 14.41 ZN ZN D 128 215 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 66.00 46.17 80.29 64.31 47.92 79.91 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 63.61 40.10 74.06 64.05 42.07 74.70 -21.74 43.31 43.14 -23.53 43.14 44.28 1bbs_c06 source 1bbs RENIN : 8 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 57 ASP.? 17.22 ZN ZN A 128 35 SER A 60 SER.? 16.46 ZN ZN A 128 215 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 35 SER A 13 SER^? 14.04 ZN ZN A 128 215 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 66.00 46.17 80.29 64.31 47.92 79.91 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 63.61 40.10 74.06 64.05 42.07 74.70 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP B 57 ASP.? 17.37 ZN ZN B 128 35 SER B 60 SER.? 16.61 ZN ZN B 128 215 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 66.00 46.17 80.29 64.31 47.92 79.91 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 63.61 40.10 74.06 64.05 42.07 74.70 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 35 SER B 13 SER^? 13.94 ZN ZN B 128 215 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 66.00 46.17 80.29 64.31 47.92 79.91 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 63.61 40.10 74.06 64.05 42.07 74.70 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1bbs_c07 RENIN user 5 3 # 5 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 35 SER C 60 SER.? 15.14 ZN ZN C 128 215 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 8.18 57.58 47.56 10.27 57.39 47.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 12.55 55.11 50.39 10.44 55.82 51.40 coo 63.61 40.10 74.06 64.05 42.07 74.70 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1bbs_c07 RENIN user 6 3 # 6 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 35 SER C 13 SER^? 14.25 ZN ZN C 128 215 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 66.00 46.17 80.29 64.31 47.92 79.91 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 63.61 40.10 74.06 64.05 42.07 74.70 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1bbs_c07 RENIN user 7 3 # 7 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 35 SER D 60 SER.? 15.90 ZN ZN D 128 215 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 66.00 46.17 80.29 64.31 47.92 79.91 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 63.61 40.10 74.06 64.05 42.07 74.70 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1bbs_c07 RENIN user 8 3 # 8 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 35 SER D 13 SER^? 14.41 ZN ZN D 128 215 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 61.19 45.85 78.73 62.86 45.48 77.48 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 66.00 46.17 80.29 64.31 47.92 79.91 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 63.61 40.10 74.06 64.05 42.07 74.70 -21.74 43.31 43.14 -23.53 43.14 44.28 1bbs_c07 source 1bbs RENIN : 8 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 141 THR A 14 THR.? 9.34 ZN ZN A 128 A 235 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 6.21 93.81 36.58 4.58 96.33 37.17 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 6.80 92.87 28.33 4.91 92.74 27.40 -23.51 50.82 61.06 -23.73 50.87 63.22 coo 12.98 90.36 47.57 11.26 89.62 46.62 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 141 THR D 35 THR.? 11.51 ZN ZN A 128 A 235 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 6.21 93.81 36.58 4.58 96.33 37.17 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 12.98 90.36 47.57 11.26 89.62 46.62 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 141 THR C 35 THR.? 11.32 ZN ZN B 128 A 235 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 6.80 92.87 28.33 4.91 92.74 27.40 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 12.98 90.36 47.57 11.26 89.62 46.62 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 141 THR D 35 THR.? 11.51 ZN ZN A 128 A 235 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 6.21 93.81 36.58 4.58 96.33 37.17 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 12.98 90.36 47.57 11.26 89.62 46.62 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 141 THR D 35 THR.? 11.51 ZN ZN A 128 A 235 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 6.21 93.81 36.58 4.58 96.33 37.17 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 12.98 90.36 47.57 11.26 89.62 46.62 -13.22 48.33 58.62 -13.88 46.78 59.86 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 5 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG C 12 ARG^? 8.72 ZN ZN C 128 D 141 THR C 35 THR.? 11.32 ZN ZN B 128 D 235 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -12.31 51.29 42.82 -14.33 50.63 43.21 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG D 12 ARG^? 9.28 ZN ZN D 128 D 141 THR D 35 THR.? 11.51 ZN ZN A 128 D 235 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -28.60 38.86 63.25 -27.28 40.41 64.00 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -21.74 43.31 43.14 -23.53 43.14 44.28 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 12 ARG^? 10.24 ZN ZN A 128 C 141 THR D 35 THR.? 11.51 ZN ZN A 128 C 235 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -26.71 45.35 59.66 -27.06 47.43 61.87 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.60 38.86 63.25 -27.28 40.41 64.00 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG C 12 ARG^? 8.72 ZN ZN C 128 C 141 THR C 35 THR.? 11.32 ZN ZN B 128 C 235 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -12.31 51.29 42.82 -14.33 50.63 43.21 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG D 12 ARG^? 9.28 ZN ZN D 128 C 141 THR D 35 THR.? 11.51 ZN ZN A 128 C 235 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.60 38.86 63.25 -27.28 40.41 64.00 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG D 12 ARG^? 9.28 ZN ZN D 128 C 141 THR D 35 THR.? 11.51 ZN ZN A 128 C 235 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.60 38.86 63.25 -27.28 40.41 64.00 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -13.22 48.33 58.62 -13.88 46.78 59.86 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 141 THR C 35 THR.? 11.32 ZN ZN B 128 B 235 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 8.13 67.41 100.27 7.18 68.35 97.45 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 14.55 73.52 89.47 12.81 73.95 90.56 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 141 THR D 35 THR.? 11.51 ZN ZN A 128 B 235 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 8.13 67.41 100.27 7.18 68.35 97.45 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 8.28 67.78 108.81 6.22 67.65 109.43 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 14.55 73.52 89.47 12.81 73.95 90.56 -21.74 43.31 43.14 -23.53 43.14 44.28 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 32 ASP.? -2.97 ZN ZN A 128s 16 HIS A 30 HIS.? -4.18 ZN ZN A 128s 67 GLY A 48 GLY.? 17.74 ZN ZN A 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -14.39 62.00 71.61 -14.01 61.28 71.39 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 32 ASP.? -2.97 ZN ZN A 128s 16 HIS A 83 HIS^? -3.82 ZN ZN A 128s 67 GLY A 48 GLY.? 17.74 ZN ZN A 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -14.39 62.00 71.61 -14.01 61.28 71.39 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 32 ASP.? -2.97 ZN ZN A 128s 16 HIS A 83 HIS^? -3.82 ZN ZN A 128s 67 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 91 ASP.? 21.24 ZN ZN A 128 16 HIS A 47 HIS^? 20.92 ZN ZN A 128 67 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP A 97 ASP^? 13.17 ZN ZN A 128 16 HIS A 10 HIS^? 15.73 ZN ZN A 128 67 GLY C 25 GLY~? 8.98 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 1.59 40.69 50.63 1.30 40.60 51.34 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP A 97 ASP^? 13.17 ZN ZN A 128 16 HIS A 10 HIS^? 15.73 ZN ZN A 128 67 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP A 97 ASP^? 13.17 ZN ZN A 128 16 HIS A 10 HIS^? 15.73 ZN ZN A 128 67 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -36.16 37.72 57.44 -35.40 37.57 57.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP A 97 ASP^? 13.17 ZN ZN A 128 16 HIS C 10 HIS^? 15.40 ZN ZN C 128 67 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -36.16 37.72 57.44 -35.40 37.57 57.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s 16 HIS B 30 HIS.? -4.20 ZN ZN B 128s 67 GLY B 48 GLY.? 17.93 ZN ZN B 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.76 43.88 34.82 -37.17 43.31 35.01 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s 16 HIS B 30 HIS.? -4.20 ZN ZN B 128s 67 GLY C 108 GLY.? 21.83 ZN ZN B 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -34.13 68.48 40.48 -34.31 67.88 41.05 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s 16 HIS B 83 HIS^? -3.82 ZN ZN B 128s 67 GLY B 48 GLY.? 17.93 ZN ZN B 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -37.76 43.88 34.82 -37.17 43.31 35.01 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s 16 HIS B 83 HIS^? -3.82 ZN ZN B 128s 67 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP B 91 ASP.? 21.34 ZN ZN B 128 16 HIS B 47 HIS^? 20.89 ZN ZN B 128 67 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -36.16 37.72 57.44 -35.40 37.57 57.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 14 3 # 14 14 ASP B 97 ASP^? 13.03 ZN ZN B 128 16 HIS B 10 HIS^? 15.59 ZN ZN B 128 67 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 15 3 # 15 14 ASP B 97 ASP^? 13.03 ZN ZN B 128 16 HIS B 10 HIS^? 15.59 ZN ZN B 128 67 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -36.16 37.72 57.44 -35.40 37.57 57.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 16 3 # 16 14 ASP B 97 ASP^? 13.03 ZN ZN B 128 16 HIS D 10 HIS^? 15.91 ZN ZN D 128 67 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 17 3 # 17 14 ASP C 32 ASP^? -2.40 ZN ZN C 128s 16 HIS C 30 HIS^? -3.56 ZN ZN C 128s 67 GLY C 48 GLY.? 18.12 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 0.61 46.90 50.78 -0.23 46.71 52.70 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.53 40.99 70.60 -2.12 41.62 70.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 18 3 # 18 14 ASP C 32 ASP^? -2.40 ZN ZN C 128s 16 HIS C 83 HIS^? -3.45 ZN ZN C 128s 67 GLY C 48 GLY.? 18.12 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 0.88 50.97 54.56 -1.00 50.36 53.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.53 40.99 70.60 -2.12 41.62 70.55 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 19 3 # 19 14 ASP C 32 ASP^? -2.40 ZN ZN C 128s 16 HIS C 83 HIS^? -3.45 ZN ZN C 128s 67 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 0.88 50.97 54.56 -1.00 50.36 53.86 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 20 3 # 20 14 ASP C 91 ASP.? 22.72 ZN ZN C 128 16 HIS C 47 HIS^? 21.11 ZN ZN C 128 67 GLY A 38 GLY.? 15.25 ZN ZN A 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -22.49 34.05 68.94 -22.88 34.72 69.19 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 21 3 # 21 14 ASP C 91 ASP.? 22.72 ZN ZN C 128 16 HIS C 47 HIS^? 21.11 ZN ZN C 128 67 GLY C 25 GLY~? 8.98 ZN ZN C 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 1.59 40.69 50.63 1.30 40.60 51.34 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 22 3 # 22 14 ASP C 97 ASP^? 13.06 ZN ZN C 128 16 HIS C 10 HIS^? 15.40 ZN ZN C 128 67 GLY A 34 GLY.? 11.12 ZN ZN A 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -31.48 39.85 67.82 -31.13 40.18 68.47 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 23 3 # 23 14 ASP C 97 ASP^? 13.06 ZN ZN C 128 16 HIS C 10 HIS^? 15.40 ZN ZN C 128 67 GLY B 34 GLY.? 11.32 ZN ZN B 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.36 54.29 38.63 -11.83 54.10 38.04 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 24 3 # 24 14 ASP C 97 ASP^? 13.06 ZN ZN C 128 16 HIS C 10 HIS^? 15.40 ZN ZN C 128 67 GLY B 38 GLY.? 15.25 ZN ZN B 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.63 44.13 37.54 -9.13 44.63 37.25 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 25 3 # 25 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s 16 HIS D 30 HIS^? -3.68 ZN ZN D 128s 67 GLY D 48 GLY.? 18.01 ZN ZN D 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -20.69 25.90 36.16 -21.15 26.62 36.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 26 3 # 26 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s 16 HIS D 83 HIS^? -3.55 ZN ZN D 128s 67 GLY D 48 GLY.? 18.01 ZN ZN D 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -20.69 25.90 36.16 -21.15 26.62 36.21 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 27 3 # 27 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s 16 HIS D 83 HIS^? -3.55 ZN ZN D 128s 67 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 28 3 # 28 14 ASP D 97 ASP^? 13.24 ZN ZN D 128 16 HIS D 10 HIS^? 15.91 ZN ZN D 128 67 GLY A 34 GLY.? 11.12 ZN ZN A 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -31.48 39.85 67.82 -31.13 40.18 68.47 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 29 3 # 29 14 ASP D 97 ASP^? 13.24 ZN ZN D 128 16 HIS D 10 HIS^? 15.91 ZN ZN D 128 67 GLY A 38 GLY.? 15.25 ZN ZN A 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -22.49 34.05 68.94 -22.88 34.72 69.19 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 30 3 # 30 14 ASP D 97 ASP^? 13.24 ZN ZN D 128 16 HIS D 10 HIS^? 15.91 ZN ZN D 128 67 GLY B 34 GLY.? 11.32 ZN ZN B 128 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -11.36 54.29 38.63 -11.83 54.10 38.04 1be1_c02 source 1be1 GLUTAMATE MUTASE : 30 hits 1be1_c02 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 107 GLU.? 11.70 ZN ZN D 128 70 HIS D 30 HIS^? -3.68 ZN ZN D 128s 281 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 66.09 46.17 155.81 66.77 48.19 155.70 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 69.05 50.55 157.03 68.00 52.29 156.51 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 100.93 36.73 156.02 100.47 38.42 157.18 0.61 46.90 50.78 -0.23 46.71 52.70 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 1 hits 1bfd_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG B 36 ARG.? 14.53 ZN ZN C 128 A 451 GLU B 103 GLU~? 15.19 ZN ZN C 128 A 540 GLU B 107 GLU.? 12.06 ZN ZN C 128 coo 79.04 80.20 80.81 79.58 81.40 83.63 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 81.34 87.29 87.22 82.36 86.09 88.61 -2.48 40.28 42.03 -4.43 39.67 41.46 coo 79.94 80.46 88.84 81.11 81.36 87.27 -0.05 48.66 43.11 -0.32 50.61 42.31 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG C 29 ARG.? 13.36 ZN ZN C 128 B 451 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 540 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 82.21 41.07 119.14 83.95 40.66 116.59 7.46 50.67 50.27 10.29 51.53 51.14 coo 86.52 35.28 112.74 87.08 36.38 110.99 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 83.38 41.19 112.55 85.47 40.59 112.72 7.13 51.72 45.00 6.65 51.50 42.95 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 29 ARG.? 13.64 ZN ZN A 128 183 LYS A 81 LYS.? 12.55 ZN ZN A 128 317 ARG A 42 ARG^? 15.09 ZN ZN A 128 coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 82.09 117.51 66.37 80.60 114.32 71.44 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 65.21 120.62 58.76 63.62 123.14 59.66 -14.23 45.62 66.89 -13.61 45.68 63.87 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG A 29 ARG.? 13.64 ZN ZN A 128 183 LYS A 81 LYS.? 12.55 ZN ZN A 128 317 ARG D 36 ARG.? 10.17 ZN ZN A 128 coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 82.09 117.51 66.37 80.60 114.32 71.44 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 65.21 120.62 58.76 63.62 123.14 59.66 -32.18 43.37 61.68 -31.14 45.24 63.88 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG B 29 ARG.? 13.89 ZN ZN B 128 183 LYS B 51 LYS^? 16.33 ZN ZN B 128 317 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 76.57 109.19 73.41 73.86 110.26 72.16 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 82.09 117.51 66.37 80.60 114.32 71.44 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 65.21 120.62 58.76 63.62 123.14 59.66 -19.64 50.95 45.34 -21.61 53.09 44.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG D 29 ARG.? 13.42 ZN ZN D 128 183 LYS D 81 LYS.? 12.28 ZN ZN D 128 317 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 82.09 117.51 66.37 80.60 114.32 71.44 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 65.21 120.62 58.76 63.62 123.14 59.66 -21.38 38.31 55.98 -23.17 35.84 55.80 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG D 29 ARG.? 13.42 ZN ZN D 128 183 LYS D 81 LYS.? 12.28 ZN ZN D 128 317 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 76.57 109.19 73.41 73.86 110.26 72.16 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 82.09 117.51 66.37 80.60 114.32 71.44 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 65.21 120.62 58.76 63.62 123.14 59.66 -29.08 38.55 44.25 -27.07 40.84 43.98 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 5 hits 1bib_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 72 GLY.? 17.64 ZN ZN C 128 48 HIS A 47 HIS^? 20.92 ZN ZN A 128 99 ASP A 91 ASP.? 21.24 ZN ZN A 128 coo 12.38 5.55 24.25 13.27 5.59 24.39 -8.59 55.12 68.83 -9.23 54.89 69.30 coo 18.80 12.68 24.53 17.69 13.54 26.08 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 17.07 18.51 26.62 16.67 17.07 28.09 -17.26 66.98 68.26 -15.96 67.19 69.91 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY A 108 GLY.? 9.79 ZN ZN D 128 48 HIS D 59 HIS.? 17.27 ZN ZN D 128 99 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 12.38 5.55 24.25 13.27 5.59 24.39 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 18.80 12.68 24.53 17.69 13.54 26.08 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 17.07 18.51 26.62 16.67 17.07 28.09 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY B 54 GLY^? 9.98 ZN ZN B 128 48 HIS B 30 HIS.? -4.20 ZN ZN B 128s 99 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 12.38 5.55 24.25 13.27 5.59 24.39 -20.73 49.16 24.95 -21.20 49.33 24.28 coo 18.80 12.68 24.53 17.69 13.54 26.08 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 17.07 18.51 26.62 16.67 17.07 28.09 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY B 72 GLY.? 17.47 ZN ZN D 128 48 HIS B 47 HIS^? 20.89 ZN ZN B 128 99 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo 12.38 5.55 24.25 13.27 5.59 24.39 -32.83 36.73 37.76 -32.46 37.24 37.22 coo 18.80 12.68 24.53 17.69 13.54 26.08 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 17.07 18.51 26.62 16.67 17.07 28.09 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 5 3 # 5 30 GLY B 108 GLY.? 9.90 ZN ZN C 128 48 HIS C 59 HIS.? 17.15 ZN ZN C 128 99 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 12.38 5.55 24.25 13.27 5.59 24.39 2.73 45.52 45.80 2.60 46.11 45.24 coo 18.80 12.68 24.53 17.69 13.54 26.08 11.45 52.92 44.80 10.43 52.05 43.19 coo 17.07 18.51 26.62 16.67 17.07 28.09 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 6 3 # 6 30 GLY C 72 GLY.? 17.57 ZN ZN A 128 48 HIS C 47 HIS^? 21.11 ZN ZN C 128 99 ASP C 91 ASP.? 22.72 ZN ZN C 128 coo 12.38 5.55 24.25 13.27 5.59 24.39 -8.50 47.01 71.89 -7.91 47.25 71.32 coo 18.80 12.68 24.53 17.69 13.54 26.08 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 17.07 18.51 26.62 16.67 17.07 28.09 -1.22 34.88 70.14 -0.71 32.98 70.85 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 7 3 # 7 30 GLY D 72 GLY.? 17.67 ZN ZN B 128 48 HIS D 47 HIS^? 21.18 ZN ZN D 128 99 ASP D 91 ASP.? 22.90 ZN ZN D 128 coo 12.38 5.55 24.25 13.27 5.59 24.39 -25.01 34.28 34.53 -25.35 33.80 35.13 coo 18.80 12.68 24.53 17.69 13.54 26.08 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 17.07 18.51 26.62 16.67 17.07 28.09 -15.13 23.89 36.32 -13.65 22.60 35.55 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 7 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 128 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 225 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 38.56 19.11 14.83 37.12 21.00 16.76 7.46 50.67 50.27 10.29 51.53 51.14 coo 36.48 24.43 22.02 36.86 26.34 21.13 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 40.16 23.71 17.01 38.52 24.96 17.40 7.13 51.72 45.00 6.65 51.50 42.95 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 168 ARG A 36 ARG.? 14.54 ZN ZN D 128 A 187 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 62.47 12.00 59.65 61.76 10.14 60.31 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 55.10 8.37 73.00 55.48 9.59 70.20 -29.05 33.74 68.19 -28.81 35.05 65.43 coo 66.76 10.09 66.23 61.80 8.06 65.82 -27.08 41.78 78.19 -22.69 42.64 82.54 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 168 ARG B 36 ARG.? 14.53 ZN ZN C 128 A 187 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 62.47 12.00 59.65 61.76 10.14 60.31 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 55.10 8.37 73.00 55.48 9.59 70.20 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 66.76 10.09 66.23 61.80 8.06 65.82 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 168 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 187 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 62.47 12.00 59.65 61.76 10.14 60.31 0.88 50.97 54.56 -1.00 50.36 53.86 coo 55.10 8.37 73.00 55.48 9.59 70.20 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 66.76 10.09 66.23 61.80 8.06 65.82 2.93 47.75 63.91 7.07 48.43 67.33 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 3 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS B 83 HIS^? -3.82 ZN ZN B 128s B1168 ARG B 36 ARG.? 14.53 ZN ZN C 128 B1187 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 35.03 5.72 103.61 36.82 5.00 102.79 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 41.91 5.48 91.85 40.59 6.81 94.28 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -14.88 50.71 28.23 -16.26 47.48 23.80 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 1 hits 1brw_c01 naa= 3 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 1 3 # 1 191 ASN A 18 ASN.? 16.39 ZN ZN A 128 194 HIS A 47 HIS^? 20.92 ZN ZN A 128 196 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo 40.94 71.26 25.74 40.29 70.59 23.82 -22.68 62.48 66.52 -24.06 63.34 65.13 coo 38.86 67.47 19.31 37.78 65.73 19.79 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 41.10 73.64 20.13 38.52 73.39 19.02 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 2 3 # 2 191 ASN B 18 ASN.? 16.24 ZN ZN B 128 194 HIS B 47 HIS^? 20.89 ZN ZN B 128 196 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo 40.94 71.26 25.74 40.29 70.59 23.82 -35.92 52.23 39.87 -36.26 53.93 41.12 coo 38.86 67.47 19.31 37.78 65.73 19.79 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 41.10 73.64 20.13 38.52 73.39 19.02 -35.98 46.77 41.76 -37.33 44.77 43.20 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 3 3 # 3 191 ASN C 18 ASN.? 16.75 ZN ZN C 128 194 HIS C 47 HIS^? 21.11 ZN ZN C 128 196 TYR C 93 TYR^? 17.98 ZN ZN C 128 coo 40.94 71.26 25.74 40.29 70.59 23.82 -2.99 35.22 62.77 -3.32 33.34 61.83 coo 38.86 67.47 19.31 37.78 65.73 19.79 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 41.10 73.64 20.13 38.52 73.39 19.02 -6.81 37.29 66.15 -8.85 36.99 68.07 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 4 3 # 4 191 ASN D 18 ASN.? 16.75 ZN ZN D 128 194 HIS D 47 HIS^? 21.18 ZN ZN D 128 196 TYR D 93 TYR^? 18.01 ZN ZN D 128 coo 40.94 71.26 25.74 40.29 70.59 23.82 -15.23 25.74 43.96 -13.30 25.49 44.87 coo 38.86 67.47 19.31 37.78 65.73 19.79 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 41.10 73.64 20.13 38.52 73.39 19.02 -16.06 30.04 40.46 -15.16 31.88 38.54 1bwl_c01 source 1bwl NADPH DEHYDROGENASE 1 : 4 hits 1bwl_c01 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN D 95 ASN^? 12.80 ZN ZN D 128 192 ASP D 91 ASP.? 22.90 ZN ZN D 128 195 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -17.20 28.58 35.23 -16.55 27.59 33.50 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 1 hits 1bwp_c01 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 16.88 2.43 18.09 16.20 3.65 19.72 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 16.00 9.54 19.61 16.53 10.80 21.20 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 20.15 8.89 19.42 18.82 8.12 20.82 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 108 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 144 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 16.88 2.43 18.09 16.20 3.65 19.72 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 16.00 9.54 19.61 16.53 10.80 21.20 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 20.15 8.89 19.42 18.82 8.12 20.82 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 16.88 2.43 18.09 16.20 3.65 19.72 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 16.00 9.54 19.61 16.53 10.80 21.20 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 20.15 8.89 19.42 18.82 8.12 20.82 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 16.88 2.43 18.09 16.20 3.65 19.72 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 16.00 9.54 19.61 16.53 10.80 21.20 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 20.15 8.89 19.42 18.82 8.12 20.82 -21.74 43.31 43.14 -23.53 43.14 44.28 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 4 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 35.12 16.22 2.69 37.05 17.04 2.40 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN B 95 ASN^? 12.67 ZN ZN B 128 B 108 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 144 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 35.12 16.22 2.69 37.05 17.04 2.40 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 35.12 16.22 2.69 37.05 17.04 2.40 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 B 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 35.12 16.22 2.69 37.05 17.04 2.40 -21.74 43.31 43.14 -23.53 43.14 44.28 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 4 hits 1c2t_c03 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 13 SER^? 14.04 ZN ZN A 128 A 235 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 263 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 30.32 56.27 16.76 31.62 57.99 17.94 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 31.33 62.80 9.68 31.68 62.04 11.62 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 30.23 62.32 14.77 30.86 60.47 15.53 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 2 3 # 2 A 110 SER A 13 SER^? 14.04 ZN ZN A 128 A 235 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 263 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 30.32 56.27 16.76 31.62 57.99 17.94 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 31.33 62.80 9.68 31.68 62.04 11.62 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 30.23 62.32 14.77 30.86 60.47 15.53 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 3 3 # 3 A 110 SER B 13 SER^? 13.94 ZN ZN B 128 A 235 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 263 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 30.32 56.27 16.76 31.62 57.99 17.94 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 31.33 62.80 9.68 31.68 62.04 11.62 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 30.23 62.32 14.77 30.86 60.47 15.53 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 4 3 # 4 A 110 SER C 13 SER^? 14.25 ZN ZN C 128 A 235 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 263 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 30.32 56.27 16.76 31.62 57.99 17.94 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 31.33 62.80 9.68 31.68 62.04 11.62 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 30.23 62.32 14.77 30.86 60.47 15.53 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 5 3 # 5 A 110 SER D 13 SER^? 14.41 ZN ZN D 128 A 235 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 263 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 30.32 56.27 16.76 31.62 57.99 17.94 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 31.33 62.80 9.68 31.68 62.04 11.62 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 30.23 62.32 14.77 30.86 60.47 15.53 -18.46 42.11 47.13 -20.09 43.42 47.28 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 5 hits 1c4x_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 28 GLU~? 12.19 ZN ZN A 128 A 65 ARG A 29 ARG.? 13.64 ZN ZN A 128 A 85 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -33.40 55.75 75.93 -32.70 57.39 77.09 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -31.22 50.95 82.45 -31.20 48.79 84.59 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 86 GLU^? 14.11 ZN ZN A 128 A 65 ARG A 29 ARG.? 13.64 ZN ZN A 128 A 85 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -23.80 59.27 78.25 -23.36 59.70 80.28 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -31.22 50.95 82.45 -31.20 48.79 84.59 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 65 ARG B 29 ARG.? 13.89 ZN ZN B 128 A 85 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -26.33 60.76 29.16 -28.24 60.05 29.68 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -20.37 56.56 24.53 -21.49 56.80 21.70 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 65 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 85 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -0.05 48.66 43.11 -0.32 50.61 42.31 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 7.46 50.67 50.27 10.29 51.53 51.14 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1c54_c00 RIBONUCLEASE SA user 5 3 # 5 A 54 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 65 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 85 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 5.96 41.55 51.41 5.95 40.38 49.65 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 7.46 50.67 50.27 10.29 51.53 51.14 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1c54_c00 RIBONUCLEASE SA user 6 3 # 6 A 54 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 65 ARG D 29 ARG.? 13.42 ZN ZN D 128 A 85 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -25.28 18.69 44.67 -26.61 17.28 43.81 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -31.52 17.79 54.63 -34.40 17.26 55.46 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -31.62 26.29 51.88 -30.63 27.88 52.82 1c54_c00 source 1c54 RIBONUCLEASE SA : 6 hits 1c54_c00 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN A 18 ASN.? 16.39 ZN ZN A 128 A 399 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 408 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -22.68 62.48 66.52 -24.06 63.34 65.13 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 3 1c82_c00 HYALURONATE LYASE user 2 3 # 2 A 349 ASN B 18 ASN.? 16.24 ZN ZN B 128 A 399 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 408 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -35.92 52.23 39.87 -36.26 53.93 41.12 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -35.98 46.77 41.76 -37.33 44.77 43.20 ULMN 3 1c82_c00 HYALURONATE LYASE user 3 3 # 3 A 349 ASN C 18 ASN.? 16.75 ZN ZN C 128 A 399 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 408 TYR C 93 TYR^? 17.98 ZN ZN C 128 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -2.99 35.22 62.77 -3.32 33.34 61.83 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -6.81 37.29 66.15 -8.85 36.99 68.07 ULMN 3 1c82_c00 HYALURONATE LYASE user 4 3 # 4 A 349 ASN D 18 ASN.? 16.75 ZN ZN D 128 A 399 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 408 TYR D 93 TYR^? 18.01 ZN ZN D 128 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -15.23 25.74 43.96 -13.30 25.49 44.87 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -16.06 30.04 40.46 -15.16 31.88 38.54 1c82_c00 source 1c82 HYALURONATE LYASE : 4 hits 1c82_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 408 TYR B 93 TYR^? 18.00 ZN ZN B 128 A 480 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -35.98 46.77 41.76 -37.33 44.77 43.20 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -19.64 50.95 45.34 -21.61 53.09 44.31 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 408 TYR C 93 TYR^? 17.98 ZN ZN C 128 A 480 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -6.81 37.29 66.15 -8.85 36.99 68.07 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -21.38 38.31 55.98 -23.17 35.84 55.80 1c82_c02 source 1c82 HYALURONATE LYASE : 2 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 16 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 67 GLY A 34 GLY.? 11.12 ZN ZN A 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -31.48 39.85 67.82 -31.13 40.18 68.47 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 16 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 67 GLY A 34 GLY.? 11.12 ZN ZN A 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -31.48 39.85 67.82 -31.13 40.18 68.47 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 16 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 67 GLY B 34 GLY.? 11.32 ZN ZN B 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -11.36 54.29 38.63 -11.83 54.10 38.04 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 16 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 67 GLY B 34 GLY.? 11.32 ZN ZN B 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -11.36 54.29 38.63 -11.83 54.10 38.04 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 16 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 67 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 0.61 46.90 50.78 -0.23 46.71 52.70 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 16 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 67 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 0.88 50.97 54.56 -1.00 50.36 53.86 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 7 3 # 7 A 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 16 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 67 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 8 3 # 8 A 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 16 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 67 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 9 3 # 9 A 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 16 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 67 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -36.16 37.72 57.44 -35.40 37.57 57.55 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 9 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 32 ASP.? -2.97 ZN ZN A 128s C 16 HIS A 30 HIS.? -4.18 ZN ZN A 128s C 67 GLY A 34 GLY.? 11.12 ZN ZN A 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 6.38 39.80 88.71 6.88 38.89 86.87 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 17.63 42.50 89.25 18.11 42.29 88.64 -31.48 39.85 67.82 -31.13 40.18 68.47 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 32 ASP.? -2.97 ZN ZN A 128s C 16 HIS A 83 HIS^? -3.82 ZN ZN A 128s C 67 GLY A 34 GLY.? 11.12 ZN ZN A 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 6.38 39.80 88.71 6.88 38.89 86.87 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 17.63 42.50 89.25 18.11 42.29 88.64 -31.48 39.85 67.82 -31.13 40.18 68.47 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 16 HIS B 30 HIS.? -4.20 ZN ZN B 128s C 67 GLY B 34 GLY.? 11.32 ZN ZN B 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 6.38 39.80 88.71 6.88 38.89 86.87 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 17.63 42.50 89.25 18.11 42.29 88.64 -11.36 54.29 38.63 -11.83 54.10 38.04 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 16 HIS B 83 HIS^? -3.82 ZN ZN B 128s C 67 GLY B 34 GLY.? 11.32 ZN ZN B 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 6.38 39.80 88.71 6.88 38.89 86.87 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 17.63 42.50 89.25 18.11 42.29 88.64 -11.36 54.29 38.63 -11.83 54.10 38.04 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 16 HIS C 30 HIS^? -3.56 ZN ZN C 128s C 67 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 6.38 39.80 88.71 6.88 38.89 86.87 0.61 46.90 50.78 -0.23 46.71 52.70 coo 17.63 42.50 89.25 18.11 42.29 88.64 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 16 HIS C 83 HIS^? -3.45 ZN ZN C 128s C 67 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 6.38 39.80 88.71 6.88 38.89 86.87 0.88 50.97 54.56 -1.00 50.36 53.86 coo 17.63 42.50 89.25 18.11 42.29 88.64 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 7 3 # 7 C 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s C 16 HIS D 30 HIS^? -3.68 ZN ZN D 128s C 67 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 6.38 39.80 88.71 6.88 38.89 86.87 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 17.63 42.50 89.25 18.11 42.29 88.64 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 8 3 # 8 C 14 ASP D 32 ASP^? -2.55 ZN ZN D 128s C 16 HIS D 83 HIS^? -3.55 ZN ZN D 128s C 67 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo 10.04 44.27 88.44 9.47 42.32 89.03 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 6.38 39.80 88.71 6.88 38.89 86.87 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 17.63 42.50 89.25 18.11 42.29 88.64 -36.16 37.72 57.44 -35.40 37.57 57.55 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 8 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN A 18 ASN.? 16.39 ZN ZN A 128 A 225 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 234 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo 26.32 35.76 46.63 26.28 33.63 46.67 -22.68 62.48 66.52 -24.06 63.34 65.13 coo 27.04 28.61 41.75 26.86 28.65 43.84 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 21.80 30.48 43.67 23.70 29.06 45.12 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN B 18 ASN.? 16.24 ZN ZN B 128 A 225 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 234 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo 26.32 35.76 46.63 26.28 33.63 46.67 -35.92 52.23 39.87 -36.26 53.93 41.12 coo 27.04 28.61 41.75 26.86 28.65 43.84 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 21.80 30.48 43.67 23.70 29.06 45.12 -35.98 46.77 41.76 -37.33 44.77 43.20 ULMN 3 1cb8_c00 CHONDROITINASE AC user 3 3 # 3 A 175 ASN D 18 ASN.? 16.75 ZN ZN D 128 A 225 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 234 TYR D 93 TYR^? 18.01 ZN ZN D 128 coo 26.32 35.76 46.63 26.28 33.63 46.67 -15.23 25.74 43.96 -13.30 25.49 44.87 coo 27.04 28.61 41.75 26.86 28.65 43.84 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 21.80 30.48 43.67 23.70 29.06 45.12 -16.06 30.04 40.46 -15.16 31.88 38.54 1cb8_c00 source 1cb8 CHONDROITINASE AC : 3 hits 1cb8_c00 naa= 3 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN B 95 ASN^? 12.67 ZN ZN B 128 108 HIS D 10 HIS^? 15.91 ZN ZN D 128 144 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c04 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c04 naa= 3 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN B 95 ASN^? 12.67 ZN ZN B 128 108 HIS D 10 HIS^? 15.91 ZN ZN D 128 144 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c05 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c05 naa= 3 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN B 95 ASN^? 12.67 ZN ZN B 128 108 HIS D 10 HIS^? 15.91 ZN ZN D 128 144 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c06 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c06 naa= 3 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 2 3 # 2 106 ASN B 95 ASN^? 12.67 ZN ZN B 128 108 HIS D 10 HIS^? 15.91 ZN ZN D 128 144 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 3 3 # 3 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 4 3 # 4 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -21.74 43.31 43.14 -23.53 43.14 44.28 1cde_c07 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 4 hits 1cde_c07 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP B 64 ASP.? 14.94 ZN ZN B 128 264 GLU B 28 GLU~? 11.81 ZN ZN B 128 328 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 45.62 80.42 43.69 45.65 82.01 45.07 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 59.69 92.71 39.85 58.53 92.03 41.47 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 -13.57 55.26 21.18 -14.41 55.74 19.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP C 64 ASP.? 14.22 ZN ZN C 128 264 GLU B 107 GLU.? 12.06 ZN ZN C 128 328 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 45.62 80.42 43.69 45.65 82.01 45.07 8.74 58.91 56.74 6.81 58.81 55.87 coo 59.69 92.71 39.85 58.53 92.03 41.47 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 45.39 90.72 40.63 45.07 89.14 41.90 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP D 64 ASP.? 14.34 ZN ZN D 128 264 GLU A 107 GLU.? 11.70 ZN ZN D 128 328 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 45.62 80.42 43.69 45.65 82.01 45.07 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.07 20.84 58.32 -40.41 18.78 58.10 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 3 hits 1cdg_c00 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 262 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 358 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 26.19 60.87 43.98 27.48 59.27 43.30 0.61 46.90 50.78 -0.23 46.71 52.70 coo 27.13 54.07 50.45 26.96 54.19 48.35 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 27.06 50.43 44.36 27.99 52.27 44.74 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 262 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 358 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 26.19 60.87 43.98 27.48 59.27 43.30 0.61 46.90 50.78 -0.23 46.71 52.70 coo 27.13 54.07 50.45 26.96 54.19 48.35 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 27.06 50.43 44.36 27.99 52.27 44.74 7.13 51.72 45.00 6.65 51.50 42.95 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 262 GLU A 107 GLU.? 11.70 ZN ZN D 128 A 358 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 26.19 60.87 43.98 27.48 59.27 43.30 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 27.13 54.07 50.45 26.96 54.19 48.35 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 27.06 50.43 44.36 27.99 52.27 44.74 -34.12 20.46 61.00 -33.75 20.62 63.08 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 262 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 358 GLU A 107 GLU.? 11.70 ZN ZN D 128 coo 26.19 60.87 43.98 27.48 59.27 43.30 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 27.13 54.07 50.45 26.96 54.19 48.35 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 27.06 50.43 44.36 27.99 52.27 44.74 -29.77 27.41 62.12 -31.06 28.03 63.69 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 4 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 262 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 358 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 44.98 77.01 48.39 44.42 78.67 47.18 0.61 46.90 50.78 -0.23 46.71 52.70 coo 41.60 83.57 54.16 42.46 83.24 52.25 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 44.05 87.61 48.73 43.15 85.67 48.52 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 262 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 358 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 44.98 77.01 48.39 44.42 78.67 47.18 0.61 46.90 50.78 -0.23 46.71 52.70 coo 41.60 83.57 54.16 42.46 83.24 52.25 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 44.05 87.61 48.73 43.15 85.67 48.52 7.13 51.72 45.00 6.65 51.50 42.95 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 262 GLU A 107 GLU.? 11.70 ZN ZN D 128 B 358 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 44.98 77.01 48.39 44.42 78.67 47.18 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 41.60 83.57 54.16 42.46 83.24 52.25 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 44.05 87.61 48.73 43.15 85.67 48.52 -34.12 20.46 61.00 -33.75 20.62 63.08 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 262 GLU D 58 GLU.? 14.54 ZN ZN D 128 B 358 GLU A 107 GLU.? 11.70 ZN ZN D 128 coo 44.98 77.01 48.39 44.42 78.67 47.18 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 41.60 83.57 54.16 42.46 83.24 52.25 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 44.05 87.61 48.73 43.15 85.67 48.52 -29.77 27.41 62.12 -31.06 28.03 63.69 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 4 hits 1chm_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 57 ASP.? 17.22 ZN ZN A 128 37 SER A 60 SER.? 16.46 ZN ZN A 128 216 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 12.23 24.31 30.40 14.55 23.96 31.03 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 13.93 25.52 22.10 14.75 24.44 23.75 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP A 97 ASP^? 13.17 ZN ZN A 128 37 SER A 13 SER^? 14.04 ZN ZN A 128 216 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 12.23 24.31 30.40 14.55 23.96 31.03 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 13.93 25.52 22.10 14.75 24.44 23.75 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP B 57 ASP.? 17.37 ZN ZN B 128 37 SER B 60 SER.? 16.61 ZN ZN B 128 216 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 12.23 24.31 30.40 14.55 23.96 31.03 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 13.93 25.52 22.10 14.75 24.44 23.75 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP B 97 ASP^? 13.03 ZN ZN B 128 37 SER B 13 SER^? 13.94 ZN ZN B 128 216 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 12.23 24.31 30.40 14.55 23.96 31.03 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 13.93 25.52 22.10 14.75 24.44 23.75 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 3 # 5 34 ASP C 57 ASP.? 16.82 ZN ZN C 128 37 SER C 60 SER.? 15.14 ZN ZN C 128 216 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 8.18 57.58 47.56 10.27 57.39 47.78 coo 12.23 24.31 30.40 14.55 23.96 31.03 12.55 55.11 50.39 10.44 55.82 51.40 coo 13.93 25.52 22.10 14.75 24.44 23.75 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 3 # 6 34 ASP C 97 ASP^? 13.06 ZN ZN C 128 37 SER C 13 SER^? 14.25 ZN ZN C 128 216 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 12.23 24.31 30.40 14.55 23.96 31.03 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 13.93 25.52 22.10 14.75 24.44 23.75 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 7 3 # 7 34 ASP D 57 ASP.? 16.88 ZN ZN D 128 37 SER D 60 SER.? 15.90 ZN ZN D 128 216 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 12.23 24.31 30.40 14.55 23.96 31.03 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 13.93 25.52 22.10 14.75 24.44 23.75 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 8 3 # 8 34 ASP D 97 ASP^? 13.24 ZN ZN D 128 37 SER D 13 SER^? 14.41 ZN ZN D 128 216 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 16.90 26.20 29.49 16.22 24.50 28.41 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 12.23 24.31 30.40 14.55 23.96 31.03 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 13.93 25.52 22.10 14.75 24.44 23.75 -21.74 43.31 43.14 -23.53 43.14 44.28 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 8 hits 1cms_c04 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 28 GLU~? 12.19 ZN ZN A 128 447 HIS A 83 HIS^? -3.82 ZN ZN A 128s 485 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -33.40 55.75 75.93 -32.70 57.39 77.09 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 2 3 # 2 361 GLU B 28 GLU~? 11.81 ZN ZN B 128 447 HIS B 30 HIS.? -4.20 ZN ZN B 128s 485 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -26.33 60.76 29.16 -28.24 60.05 29.68 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -20.72 56.25 32.46 -21.75 54.52 33.04 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 3 3 # 3 361 GLU B 28 GLU~? 11.81 ZN ZN B 128 447 HIS B 83 HIS^? -3.82 ZN ZN B 128s 485 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -26.33 60.76 29.16 -28.24 60.05 29.68 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 4 3 # 4 361 GLU C 28 GLU~? 12.07 ZN ZN C 128 447 HIS C 30 HIS^? -3.56 ZN ZN C 128s 485 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo -7.99 19.51 30.67 -8.74 17.98 29.42 5.96 41.55 51.41 5.95 40.38 49.65 coo -15.81 17.12 25.99 -13.91 16.92 26.88 0.61 46.90 50.78 -0.23 46.71 52.70 coo -13.17 13.85 30.36 -11.76 15.41 30.53 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 5 3 # 5 361 GLU C 28 GLU~? 12.07 ZN ZN C 128 447 HIS C 83 HIS^? -3.45 ZN ZN C 128s 485 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo -7.99 19.51 30.67 -8.74 17.98 29.42 5.96 41.55 51.41 5.95 40.38 49.65 coo -15.81 17.12 25.99 -13.91 16.92 26.88 0.88 50.97 54.56 -1.00 50.36 53.86 coo -13.17 13.85 30.36 -11.76 15.41 30.53 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 6 3 # 6 361 GLU D 28 GLU.? 12.56 ZN ZN D 128 447 HIS D 30 HIS^? -3.68 ZN ZN D 128s 485 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -23.77 18.70 55.29 -22.97 18.07 57.14 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -28.44 21.48 51.55 -28.88 19.99 50.09 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 6 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR C 40 TYR^? 12.78 ZN ZN C 128 A 173 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 48 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 24.35 4.55 25.11 25.94 3.23 25.53 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR D 40 TYR^? 12.58 ZN ZN D 128 A 173 ASP D 32 ASP^? -2.55 ZN ZN D 128s C 48 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 24.35 4.55 25.11 25.94 3.23 25.53 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -29.08 38.55 44.25 -27.07 40.84 43.98 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG D 42 ARG^? 14.89 ZN ZN D 128 C 101 TYR D 40 TYR^? 12.58 ZN ZN D 128 C 173 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 32.27 5.62 48.15 31.93 6.48 51.06 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 29.64 3.64 57.39 31.22 5.14 55.65 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -29.32 31.61 55.53 -28.20 30.46 54.16 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG C 42 ARG^? 15.11 ZN ZN C 128 D 101 TYR C 40 TYR^? 12.78 ZN ZN C 128 D 173 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 69.08 8.58 32.60 69.70 10.81 30.58 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 71.77 11.86 24.26 70.23 12.22 26.56 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 71.60 6.14 19.25 70.26 6.87 20.69 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG D 42 ARG^? 14.89 ZN ZN D 128 D 101 TYR D 40 TYR^? 12.58 ZN ZN D 128 D 173 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 69.08 8.58 32.60 69.70 10.81 30.58 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 71.77 11.86 24.26 70.23 12.22 26.56 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 71.60 6.14 19.25 70.26 6.87 20.69 -29.32 31.61 55.53 -28.20 30.46 54.16 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR C 40 TYR^? 12.78 ZN ZN C 128 B 173 ASP C 32 ASP^? -2.40 ZN ZN C 128s D 48 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR D 40 TYR^? 12.58 ZN ZN D 128 B 173 ASP D 32 ASP^? -2.55 ZN ZN D 128s D 48 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -29.08 38.55 44.25 -27.07 40.84 43.98 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 56 ILE A 85 ILE^? 5.78 ZN ZN A 128 A 82 TYR A 52 TYR^? 7.20 ZN ZN A 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -23.46 53.74 74.31 -23.47 53.29 72.96 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -20.95 49.22 77.42 -22.18 46.73 77.85 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 56 ILE A 67 ILE^? 11.60 ZN ZN A 128 A 82 TYR A 52 TYR^? 7.20 ZN ZN A 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -16.55 49.63 78.84 -16.31 48.42 78.22 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -20.95 49.22 77.42 -22.18 46.73 77.85 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 56 ILE A 9 ILE^? 13.54 ZN ZN D 128 A 82 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -18.74 35.87 59.52 -17.99 35.41 58.37 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 56 ILE B 85 ILE^? 5.86 ZN ZN B 128 A 82 TYR B 52 TYR^? 7.51 ZN ZN B 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -27.28 50.69 32.06 -26.85 50.64 33.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -23.54 46.80 28.87 -20.82 47.32 28.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 56 ILE B 67 ILE^? 11.98 ZN ZN B 128 A 82 TYR B 52 TYR^? 7.51 ZN ZN B 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -25.30 42.46 27.69 -24.23 41.76 28.36 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -23.54 46.80 28.87 -20.82 47.32 28.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 56 ILE B 9 ILE^? 13.08 ZN ZN C 128 A 82 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -11.55 40.86 46.93 -10.66 40.78 48.06 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 56 ILE C 4 ILE.? 14.34 ZN ZN C 128 A 82 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -12.31 57.78 58.99 -12.40 56.53 58.29 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 56 ILE C 85 ILE^? 6.14 ZN ZN C 128 A 82 TYR C 52 TYR^? 7.59 ZN ZN C 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 0.84 45.59 59.02 -0.45 45.17 58.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.13 52.00 59.76 1.13 53.77 57.61 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 56 ILE C 67 ILE^? 12.06 ZN ZN C 128 A 82 TYR C 52 TYR^? 7.59 ZN ZN C 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 8.74 58.91 56.74 6.81 58.81 55.87 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 1.05 53.75 64.07 -0.04 54.63 63.80 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 1.13 52.00 59.76 1.13 53.77 57.61 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 56 ILE C 9 ILE^? 18.39 ZN ZN B 128 A 82 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -19.91 55.06 52.98 -21.09 55.16 52.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 11 3 # 11 A 37 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 56 ILE D 4 ILE.? 14.41 ZN ZN D 128 A 82 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -34.28 41.00 47.17 -33.03 40.78 47.91 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 12 3 # 12 A 37 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 56 ILE D 85 ILE^? 6.08 ZN ZN D 128 A 82 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -26.27 24.80 47.46 -25.61 26.02 47.84 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -32.42 26.30 46.60 -34.28 26.82 48.63 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 13 3 # 13 A 37 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 56 ILE D 67 ILE^? 12.16 ZN ZN D 128 A 82 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -33.96 26.64 42.04 -34.58 27.89 42.25 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -32.42 26.30 46.60 -34.28 26.82 48.63 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 14 3 # 14 A 37 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 56 ILE D 9 ILE^? 18.41 ZN ZN A 128 A 82 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -29.74 47.75 53.29 -29.00 48.05 54.52 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -34.83 43.92 51.78 -36.80 42.61 53.27 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 14 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 56 ILE A 85 ILE^? 5.78 ZN ZN A 128 B 82 TYR A 52 TYR^? 7.20 ZN ZN A 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -23.46 53.74 74.31 -23.47 53.29 72.96 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -20.95 49.22 77.42 -22.18 46.73 77.85 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 64 ASP.? 14.79 ZN ZN A 128 B 56 ILE A 67 ILE^? 11.60 ZN ZN A 128 B 82 TYR A 52 TYR^? 7.20 ZN ZN A 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -16.55 49.63 78.84 -16.31 48.42 78.22 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -20.95 49.22 77.42 -22.18 46.73 77.85 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 56 ILE A 4 ILE.? 14.73 ZN ZN A 128 B 82 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -14.81 38.90 68.20 -15.93 39.57 67.59 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 56 ILE A 4 ILE.? 14.73 ZN ZN A 128 B 82 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -14.81 38.90 68.20 -15.93 39.57 67.59 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 56 ILE A 9 ILE^? 13.54 ZN ZN D 128 B 82 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -18.74 35.87 59.52 -17.99 35.41 58.37 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 56 ILE B 85 ILE^? 5.86 ZN ZN B 128 B 82 TYR B 52 TYR^? 7.51 ZN ZN B 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -27.28 50.69 32.06 -26.85 50.64 33.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -23.54 46.80 28.87 -20.82 47.32 28.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP B 64 ASP.? 14.94 ZN ZN B 128 B 56 ILE B 67 ILE^? 11.98 ZN ZN B 128 B 82 TYR B 52 TYR^? 7.51 ZN ZN B 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -25.30 42.46 27.69 -24.23 41.76 28.36 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -23.54 46.80 28.87 -20.82 47.32 28.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 56 ILE B 9 ILE^? 13.08 ZN ZN C 128 B 82 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -11.55 40.86 46.93 -10.66 40.78 48.06 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 56 ILE C 4 ILE.? 14.34 ZN ZN C 128 B 82 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -12.31 57.78 58.99 -12.40 56.53 58.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 10 3 # 10 B 37 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 56 ILE C 85 ILE^? 6.14 ZN ZN C 128 B 82 TYR C 52 TYR^? 7.59 ZN ZN C 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 0.84 45.59 59.02 -0.45 45.17 58.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.13 52.00 59.76 1.13 53.77 57.61 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 11 3 # 11 B 37 ASP C 64 ASP.? 14.22 ZN ZN C 128 B 56 ILE C 67 ILE^? 12.06 ZN ZN C 128 B 82 TYR C 52 TYR^? 7.59 ZN ZN C 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 8.74 58.91 56.74 6.81 58.81 55.87 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 1.05 53.75 64.07 -0.04 54.63 63.80 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 1.13 52.00 59.76 1.13 53.77 57.61 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 12 3 # 12 B 37 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 56 ILE C 4 ILE.? 14.34 ZN ZN C 128 B 82 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -12.31 57.78 58.99 -12.40 56.53 58.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 13 3 # 13 B 37 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 56 ILE C 4 ILE.? 14.34 ZN ZN C 128 B 82 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -12.31 57.78 58.99 -12.40 56.53 58.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 14 3 # 14 B 37 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 56 ILE C 9 ILE^? 18.39 ZN ZN B 128 B 82 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -19.91 55.06 52.98 -21.09 55.16 52.24 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 15 3 # 15 B 37 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 56 ILE D 85 ILE^? 6.08 ZN ZN D 128 B 82 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -26.27 24.80 47.46 -25.61 26.02 47.84 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -32.42 26.30 46.60 -34.28 26.82 48.63 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 16 3 # 16 B 37 ASP D 64 ASP.? 14.34 ZN ZN D 128 B 56 ILE D 67 ILE^? 12.16 ZN ZN D 128 B 82 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -33.96 26.64 42.04 -34.58 27.89 42.25 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -32.42 26.30 46.60 -34.28 26.82 48.63 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 17 3 # 17 B 37 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 56 ILE D 9 ILE^? 18.41 ZN ZN A 128 B 82 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -29.74 47.75 53.29 -29.00 48.05 54.52 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -34.83 43.92 51.78 -36.80 42.61 53.27 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 17 hits 1d6o_c01 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 177 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 201 LEU A 31 LEU.? 9.07 ZN ZN A 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -32.19 43.61 74.94 -31.73 41.83 76.04 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 33 LYS.? 11.38 ZN ZN B 128 A 177 GLU B 80 GLU.? 14.47 ZN ZN B 128 A 201 LEU B 31 LEU.? 9.08 ZN ZN B 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -14.69 55.97 38.01 -16.66 60.81 39.16 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -15.05 56.03 31.28 -13.61 54.92 30.11 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 51 LYS^? 16.33 ZN ZN B 128 A 177 GLU B 70 GLU^? 18.94 ZN ZN B 128 A 201 LEU B 68 LEU^? 16.05 ZN ZN B 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -31.09 41.96 26.62 -33.10 42.71 26.94 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 177 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 201 LEU B 31 LEU.? 9.08 ZN ZN B 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -15.05 56.03 31.28 -13.61 54.92 30.11 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS C 51 LYS^? 16.36 ZN ZN C 128 A 177 GLU C 70 GLU^? 19.15 ZN ZN C 128 A 201 LEU C 68 LEU^? 16.22 ZN ZN C 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 2.93 47.75 63.91 7.07 48.43 67.33 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -0.72 48.58 72.21 1.10 47.61 72.77 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 3.04 50.46 68.55 3.56 48.64 69.61 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 177 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 201 LEU C 31 LEU^? 8.29 ZN ZN C 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 0.65 56.08 51.29 4.22 57.96 54.91 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -0.67 51.48 47.39 0.53 53.25 47.02 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 177 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 201 LEU C 31 LEU^? 8.29 ZN ZN C 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 0.65 56.08 51.29 4.22 57.96 54.91 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.13 51.72 45.00 6.65 51.50 42.95 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -0.67 51.48 47.39 0.53 53.25 47.02 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS D 33 LYS.? 12.24 ZN ZN D 128 A 177 GLU A 103 GLU~? 15.51 ZN ZN D 128 A 201 LEU A 105 LEU~? 10.03 ZN ZN D 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.11 33.22 59.92 -32.56 30.92 63.52 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -20.80 26.87 64.77 -19.76 28.50 65.63 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -23.68 32.88 60.16 -23.32 34.83 59.33 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 177 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 201 LEU D 31 LEU^? 8.29 ZN ZN D 128 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -31.76 27.53 58.96 -33.91 27.51 59.08 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 9 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 51 LYS^? 15.98 ZN ZN A 128 B 177 GLU A 70 GLU^? 19.90 ZN ZN A 128 B 201 LEU A 68 LEU^? 15.77 ZN ZN A 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -19.26 55.16 77.77 -19.13 57.75 83.14 coo 27.00 6.35 51.01 26.30 4.53 50.18 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -14.39 55.02 79.76 -14.55 57.18 79.61 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 81 LYS.? 12.55 ZN ZN A 128 B 177 GLU A 58 GLU.? 14.95 ZN ZN A 128 B 201 LEU A 31 LEU.? 9.07 ZN ZN A 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 27.00 6.35 51.01 26.30 4.53 50.18 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -32.19 43.61 74.94 -31.73 41.83 76.04 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 33 LYS.? 11.38 ZN ZN B 128 B 177 GLU B 80 GLU.? 14.47 ZN ZN B 128 B 201 LEU B 31 LEU.? 9.08 ZN ZN B 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -14.69 55.97 38.01 -16.66 60.81 39.16 coo 27.00 6.35 51.01 26.30 4.53 50.18 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -15.05 56.03 31.28 -13.61 54.92 30.11 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS B 51 LYS^? 16.33 ZN ZN B 128 B 177 GLU B 70 GLU^? 18.94 ZN ZN B 128 B 201 LEU B 68 LEU^? 16.05 ZN ZN B 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 27.00 6.35 51.01 26.30 4.53 50.18 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -31.09 41.96 26.62 -33.10 42.71 26.94 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 81 LYS.? 12.71 ZN ZN B 128 B 177 GLU B 58 GLU.? 14.99 ZN ZN B 128 B 201 LEU B 31 LEU.? 9.08 ZN ZN B 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 27.00 6.35 51.01 26.30 4.53 50.18 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -15.05 56.03 31.28 -13.61 54.92 30.11 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS C 51 LYS^? 16.36 ZN ZN C 128 B 177 GLU C 70 GLU^? 19.15 ZN ZN C 128 B 201 LEU C 68 LEU^? 16.22 ZN ZN C 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 2.93 47.75 63.91 7.07 48.43 67.33 coo 27.00 6.35 51.01 26.30 4.53 50.18 -0.72 48.58 72.21 1.10 47.61 72.77 coo 23.74 1.68 49.50 22.87 -0.24 49.97 3.04 50.46 68.55 3.56 48.64 69.61 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS C 81 LYS.? 11.89 ZN ZN C 128 B 177 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 201 LEU C 31 LEU^? 8.29 ZN ZN C 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 0.65 56.08 51.29 4.22 57.96 54.91 coo 27.00 6.35 51.01 26.30 4.53 50.18 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -0.67 51.48 47.39 0.53 53.25 47.02 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS D 81 LYS.? 12.28 ZN ZN D 128 B 177 GLU D 58 GLU.? 14.54 ZN ZN D 128 B 201 LEU D 31 LEU^? 8.29 ZN ZN D 128 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 27.00 6.35 51.01 26.30 4.53 50.18 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -31.76 27.53 58.96 -33.91 27.51 59.08 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 8 hits 1daa_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 739 GLY A 38 GLY.? 15.25 ZN ZN A 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 11.37 50.89 2.29 11.05 51.63 2.25 -22.49 34.05 68.94 -22.88 34.72 69.19 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 11.37 50.89 2.29 11.05 51.63 2.25 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 646 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 739 GLY B 38 GLY.? 15.25 ZN ZN B 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 -8.63 44.13 37.54 -9.13 44.63 37.25 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 646 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 739 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 11.37 50.89 2.29 11.05 51.63 2.25 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 739 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 739 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 646 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 739 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 11.45 52.92 44.80 10.43 52.05 43.19 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 8.18 57.58 47.56 10.27 57.39 47.78 coo 11.37 50.89 2.29 11.05 51.63 2.25 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 646 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 11.37 50.89 2.29 11.05 51.63 2.25 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 646 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 739 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 11.37 50.89 2.29 11.05 51.63 2.25 -27.38 22.98 60.43 -27.77 23.26 61.11 1ddj_c12 source 1ddj PLASMINOGEN : 9 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 739 GLY A 38 GLY.? 15.25 ZN ZN A 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -22.49 34.05 68.94 -22.88 34.72 69.19 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 646 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 739 GLY B 38 GLY.? 15.25 ZN ZN B 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -8.63 44.13 37.54 -9.13 44.63 37.25 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 646 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 739 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 739 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 739 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 646 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 739 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 11.45 52.92 44.80 10.43 52.05 43.19 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 8.18 57.58 47.56 10.27 57.39 47.78 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1ddj_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 646 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 646 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 739 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -36.16 37.72 57.44 -35.40 37.57 57.55 ULMN 3 1ddj_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 646 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 739 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -27.38 22.98 60.43 -27.77 23.26 61.11 1ddj_c13 source 1ddj PLASMINOGEN : 10 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 739 GLY A 38 GLY.? 15.25 ZN ZN A 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 16.06 55.72 54.73 15.97 56.49 56.70 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 9.38 49.29 65.28 9.01 50.03 65.31 -22.49 34.05 68.94 -22.88 34.72 69.19 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 16.06 55.72 54.73 15.97 56.49 56.70 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 9.38 49.29 65.28 9.01 50.03 65.31 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 646 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 739 GLY B 38 GLY.? 15.25 ZN ZN B 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 16.06 55.72 54.73 15.97 56.49 56.70 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 -8.63 44.13 37.54 -9.13 44.63 37.25 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 646 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 739 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 16.06 55.72 54.73 15.97 56.49 56.70 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 9.38 49.29 65.28 9.01 50.03 65.31 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 739 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 16.06 55.72 54.73 15.97 56.49 56.70 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 739 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 16.06 55.72 54.73 15.97 56.49 56.70 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 646 ASP C 57 ASP.? 16.82 ZN ZN C 128 C 739 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 11.45 52.92 44.80 10.43 52.05 43.19 coo 16.06 55.72 54.73 15.97 56.49 56.70 8.18 57.58 47.56 10.27 57.39 47.78 coo 9.38 49.29 65.28 9.01 50.03 65.31 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 646 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 16.06 55.72 54.73 15.97 56.49 56.70 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 9.38 49.29 65.28 9.01 50.03 65.31 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 646 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 739 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo 15.33 59.81 59.60 13.98 60.99 60.69 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 16.06 55.72 54.73 15.97 56.49 56.70 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 9.38 49.29 65.28 9.01 50.03 65.31 -36.16 37.72 57.44 -35.40 37.57 57.55 1ddj_c14 source 1ddj PLASMINOGEN : 9 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 D 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 D 739 GLY A 38 GLY.? 15.25 ZN ZN A 128 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -22.49 34.05 68.94 -22.88 34.72 69.19 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 10 HIS^? 15.73 ZN ZN A 128 D 646 ASP A 97 ASP^? 13.17 ZN ZN A 128 D 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 10 HIS^? 15.59 ZN ZN B 128 D 646 ASP B 97 ASP^? 13.03 ZN ZN B 128 D 739 GLY B 38 GLY.? 15.25 ZN ZN B 128 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -8.63 44.13 37.54 -9.13 44.63 37.25 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 D 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 739 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS C 10 HIS^? 15.40 ZN ZN C 128 D 646 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 739 GLY C 38 GLY.? 13.07 ZN ZN C 128 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -8.85 58.20 48.91 -9.08 57.49 48.72 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS D 10 HIS^? 15.91 ZN ZN D 128 D 646 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 739 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS D 10 HIS^? 15.91 ZN ZN D 128 D 646 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 739 GLY D 38 GLY.? 13.27 ZN ZN D 128 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -36.16 37.72 57.44 -35.40 37.57 57.55 1ddj_c15 source 1ddj PLASMINOGEN : 7 hits 1ddj_c15 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 96 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 137 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 1.83 2.95 4.76 1.26 0.98 4.81 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -35.58 45.32 81.43 -37.46 44.65 80.73 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 2 3 # 2 A 50 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 96 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 137 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 1.83 2.95 4.76 1.26 0.98 4.81 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -16.19 59.88 24.88 -15.11 61.60 25.47 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -20.72 56.25 32.46 -21.75 54.52 33.04 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 2 hits 1de3_c00 naa= 3 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 1 3 # 1 A 236 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 270 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 302 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 31.95 29.75 57.34 28.52 26.19 61.27 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 33.21 25.89 58.06 33.02 25.68 60.13 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 28.85 22.90 58.20 30.22 22.78 59.84 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 2 3 # 2 A 236 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 270 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 302 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 31.95 29.75 57.34 28.52 26.19 61.27 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 33.21 25.89 58.06 33.02 25.68 60.13 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 28.85 22.90 58.20 30.22 22.78 59.84 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 3 3 # 3 A 236 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 270 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 302 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 31.95 29.75 57.34 28.52 26.19 61.27 0.65 56.08 51.29 4.22 57.96 54.91 coo 33.21 25.89 58.06 33.02 25.68 60.13 0.88 50.97 54.56 -1.00 50.36 53.86 coo 28.85 22.90 58.20 30.22 22.78 59.84 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 4 3 # 4 A 236 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 270 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 302 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 31.95 29.75 57.34 28.52 26.19 61.27 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 33.21 25.89 58.06 33.02 25.68 60.13 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 28.85 22.90 58.20 30.22 22.78 59.84 -29.32 31.61 55.53 -28.20 30.46 54.16 1de6_c00 source 1de6 L-RHAMNOSE ISOMERASE : 4 hits 1de6_c00 naa= 3 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 1 3 # 1 B 236 LYS A 81 LYS.? 12.55 ZN ZN A 128 B 270 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 302 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 38.57 31.68 38.20 37.57 30.37 32.27 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 35.21 33.33 36.56 35.91 33.91 34.66 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 33.27 29.36 33.58 33.68 31.25 32.69 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 2 3 # 2 B 236 LYS B 81 LYS.? 12.71 ZN ZN B 128 B 270 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 302 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 38.57 31.68 38.20 37.57 30.37 32.27 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 35.21 33.33 36.56 35.91 33.91 34.66 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 33.27 29.36 33.58 33.68 31.25 32.69 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 3 3 # 3 B 236 LYS C 81 LYS.? 11.89 ZN ZN C 128 B 270 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 302 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 38.57 31.68 38.20 37.57 30.37 32.27 0.65 56.08 51.29 4.22 57.96 54.91 coo 35.21 33.33 36.56 35.91 33.91 34.66 0.88 50.97 54.56 -1.00 50.36 53.86 coo 33.27 29.36 33.58 33.68 31.25 32.69 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 4 3 # 4 B 236 LYS D 81 LYS.? 12.28 ZN ZN D 128 B 270 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 302 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 38.57 31.68 38.20 37.57 30.37 32.27 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 35.21 33.33 36.56 35.91 33.91 34.66 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 33.27 29.36 33.58 33.68 31.25 32.69 -29.32 31.61 55.53 -28.20 30.46 54.16 1de6_c01 source 1de6 L-RHAMNOSE ISOMERASE : 4 hits 1de6_c01 naa= 3 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 1 3 # 1 C 236 LYS A 81 LYS.? 12.55 ZN ZN A 128 C 270 HIS A 83 HIS^? -3.82 ZN ZN A 128s C 302 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 14.14 13.22 49.33 13.72 16.13 54.74 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 12.62 17.05 49.17 11.38 17.06 50.85 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 15.59 19.87 52.59 13.47 19.78 52.76 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 2 3 # 2 C 236 LYS B 81 LYS.? 12.71 ZN ZN B 128 C 270 HIS B 83 HIS^? -3.82 ZN ZN B 128s C 302 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 14.14 13.22 49.33 13.72 16.13 54.74 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 12.62 17.05 49.17 11.38 17.06 50.85 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 15.59 19.87 52.59 13.47 19.78 52.76 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 3 3 # 3 C 236 LYS C 81 LYS.? 11.89 ZN ZN C 128 C 270 HIS C 83 HIS^? -3.45 ZN ZN C 128s C 302 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 14.14 13.22 49.33 13.72 16.13 54.74 0.65 56.08 51.29 4.22 57.96 54.91 coo 12.62 17.05 49.17 11.38 17.06 50.85 0.88 50.97 54.56 -1.00 50.36 53.86 coo 15.59 19.87 52.59 13.47 19.78 52.76 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 4 3 # 4 C 236 LYS D 81 LYS.? 12.28 ZN ZN D 128 C 270 HIS D 83 HIS^? -3.55 ZN ZN D 128s C 302 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 14.14 13.22 49.33 13.72 16.13 54.74 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 12.62 17.05 49.17 11.38 17.06 50.85 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 15.59 19.87 52.59 13.47 19.78 52.76 -29.32 31.61 55.53 -28.20 30.46 54.16 1de6_c02 source 1de6 L-RHAMNOSE ISOMERASE : 4 hits 1de6_c02 naa= 3 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 1 3 # 1 D 236 LYS A 81 LYS.? 12.55 ZN ZN A 128 D 270 HIS A 83 HIS^? -3.82 ZN ZN A 128s D 302 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 22.81 12.92 30.93 27.72 14.83 27.49 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 26.34 11.31 32.03 27.15 10.82 30.17 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 29.89 15.23 31.62 30.32 13.38 30.56 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 2 3 # 2 D 236 LYS B 81 LYS.? 12.71 ZN ZN B 128 D 270 HIS B 83 HIS^? -3.82 ZN ZN B 128s D 302 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 22.81 12.92 30.93 27.72 14.83 27.49 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 26.34 11.31 32.03 27.15 10.82 30.17 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 29.89 15.23 31.62 30.32 13.38 30.56 -16.91 52.67 35.82 -18.80 51.89 35.31 1de6_c03 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c03 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 28 GLU~? 12.19 ZN ZN A 128 A 226 THR D 35 THR.? 11.51 ZN ZN A 128 A 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 7.24 97.46 49.60 8.11 95.69 48.80 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 226 THR D 35 THR.? 11.51 ZN ZN A 128 A 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 7.24 97.46 49.60 8.11 95.69 48.80 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 70 GLU^? 19.90 ZN ZN A 128 A 226 THR C 92 THR.? 15.22 ZN ZN C 128 A 229 LYS C 19 LYS.? 17.60 ZN ZN C 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 7.24 97.46 49.60 8.11 95.69 48.80 -1.81 38.46 67.24 -0.75 40.31 66.94 coo 10.53 97.56 43.71 9.33 93.71 47.17 0.64 35.92 60.53 5.63 36.47 64.53 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 226 THR C 35 THR.? 11.32 ZN ZN B 128 A 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 7.24 97.46 49.60 8.11 95.69 48.80 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 226 THR C 35 THR.? 11.32 ZN ZN B 128 A 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 7.24 97.46 49.60 8.11 95.69 48.80 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 70 GLU^? 18.94 ZN ZN B 128 A 226 THR D 92 THR.? 15.38 ZN ZN D 128 A 229 LYS D 19 LYS.? 15.46 ZN ZN D 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.23 25.46 39.42 -20.30 24.86 39.60 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.96 22.44 46.27 -19.09 18.04 45.40 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 226 THR C 35 THR.? 11.32 ZN ZN B 128 A 229 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 5.96 41.55 51.41 5.95 40.38 49.65 coo 7.24 97.46 49.60 8.11 95.69 48.80 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 226 THR B 35 THR.? 8.83 ZN ZN B 128 A 229 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 7.13 51.72 45.00 6.65 51.50 42.95 coo 7.24 97.46 49.60 8.11 95.69 48.80 -11.91 51.72 35.90 -12.77 51.64 33.90 coo 10.53 97.56 43.71 9.33 93.71 47.17 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU C 70 GLU^? 19.15 ZN ZN C 128 A 226 THR A 92 THR.? 14.81 ZN ZN A 128 A 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -0.72 48.58 72.21 1.10 47.61 72.77 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.17 62.44 69.62 -18.23 61.18 71.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU C 103 GLU.? 13.37 ZN ZN B 128 A 226 THR A 21 THR.? 15.61 ZN ZN A 128 A 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 7.24 97.46 49.60 8.11 95.69 48.80 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU C 107 GLU.? 20.28 ZN ZN B 128 A 226 THR A 21 THR.? 15.61 ZN ZN A 128 A 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -32.00 66.19 44.45 -32.39 64.60 45.80 coo 7.24 97.46 49.60 8.11 95.69 48.80 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 226 THR A 35 THR.? 8.83 ZN ZN A 128 A 229 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 9.66 102.78 70.07 9.79 101.18 71.42 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 7.24 97.46 49.60 8.11 95.69 48.80 -28.69 39.43 70.39 -28.36 40.10 72.45 coo 10.53 97.56 43.71 9.33 93.71 47.17 -27.08 41.78 78.19 -22.69 42.64 82.54 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 12 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 28 GLU~? 12.19 ZN ZN A 128 B 226 THR D 35 THR.? 11.51 ZN ZN A 128 B 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 20.74 95.78 68.68 19.29 96.84 69.83 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 58 GLU.? 14.95 ZN ZN A 128 B 226 THR D 35 THR.? 11.51 ZN ZN A 128 B 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 20.74 95.78 68.68 19.29 96.84 69.83 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 70 GLU^? 19.90 ZN ZN A 128 B 226 THR C 92 THR.? 15.22 ZN ZN C 128 B 229 LYS C 19 LYS.? 17.60 ZN ZN C 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 20.74 95.78 68.68 19.29 96.84 69.83 -1.81 38.46 67.24 -0.75 40.31 66.94 coo 22.32 101.61 71.64 17.89 98.63 71.55 0.64 35.92 60.53 5.63 36.47 64.53 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 28 GLU~? 11.81 ZN ZN B 128 B 226 THR C 35 THR.? 11.32 ZN ZN B 128 B 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 20.74 95.78 68.68 19.29 96.84 69.83 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 58 GLU.? 14.99 ZN ZN B 128 B 226 THR C 35 THR.? 11.32 ZN ZN B 128 B 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 20.74 95.78 68.68 19.29 96.84 69.83 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 70 GLU^? 18.94 ZN ZN B 128 B 226 THR D 92 THR.? 15.38 ZN ZN D 128 B 229 LYS D 19 LYS.? 15.46 ZN ZN D 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.23 25.46 39.42 -20.30 24.86 39.60 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.96 22.44 46.27 -19.09 18.04 45.40 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU C 28 GLU~? 12.07 ZN ZN C 128 B 226 THR C 35 THR.? 11.32 ZN ZN B 128 B 229 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 5.96 41.55 51.41 5.95 40.38 49.65 coo 20.74 95.78 68.68 19.29 96.84 69.83 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU C 58 GLU.? 14.59 ZN ZN C 128 B 226 THR B 35 THR.? 8.83 ZN ZN B 128 B 229 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 7.13 51.72 45.00 6.65 51.50 42.95 coo 20.74 95.78 68.68 19.29 96.84 69.83 -11.91 51.72 35.90 -12.77 51.64 33.90 coo 22.32 101.61 71.64 17.89 98.63 71.55 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU C 70 GLU^? 19.15 ZN ZN C 128 B 226 THR A 92 THR.? 14.81 ZN ZN A 128 B 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -0.72 48.58 72.21 1.10 47.61 72.77 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.17 62.44 69.62 -18.23 61.18 71.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU C 103 GLU.? 13.37 ZN ZN B 128 B 226 THR A 21 THR.? 15.61 ZN ZN A 128 B 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 20.74 95.78 68.68 19.29 96.84 69.83 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU C 107 GLU.? 20.28 ZN ZN B 128 B 226 THR A 21 THR.? 15.61 ZN ZN A 128 B 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -32.00 66.19 44.45 -32.39 64.60 45.80 coo 20.74 95.78 68.68 19.29 96.84 69.83 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 57 GLU D 58 GLU.? 14.54 ZN ZN D 128 B 226 THR A 35 THR.? 8.83 ZN ZN A 128 B 229 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 15.90 87.61 49.61 13.92 86.96 49.36 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 20.74 95.78 68.68 19.29 96.84 69.83 -28.69 39.43 70.39 -28.36 40.10 72.45 coo 22.32 101.61 71.64 17.89 98.63 71.55 -27.08 41.78 78.19 -22.69 42.64 82.54 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 12 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 28 GLU~? 12.19 ZN ZN A 128 C 226 THR D 35 THR.? 11.51 ZN ZN A 128 C 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 22.16 45.88 73.63 23.23 47.70 73.25 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 58 GLU.? 14.95 ZN ZN A 128 C 226 THR D 35 THR.? 11.51 ZN ZN A 128 C 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 22.16 45.88 73.63 23.23 47.70 73.25 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 70 GLU^? 19.90 ZN ZN A 128 C 226 THR C 92 THR.? 15.22 ZN ZN C 128 C 229 LYS C 19 LYS.? 17.60 ZN ZN C 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 22.16 45.88 73.63 23.23 47.70 73.25 -1.81 38.46 67.24 -0.75 40.31 66.94 coo 28.90 45.91 73.55 25.22 49.72 72.97 0.64 35.92 60.53 5.63 36.47 64.53 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 28 GLU~? 11.81 ZN ZN B 128 C 226 THR C 35 THR.? 11.32 ZN ZN B 128 C 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 22.16 45.88 73.63 23.23 47.70 73.25 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 58 GLU.? 14.99 ZN ZN B 128 C 226 THR C 35 THR.? 11.32 ZN ZN B 128 C 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 22.16 45.88 73.63 23.23 47.70 73.25 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 70 GLU^? 18.94 ZN ZN B 128 C 226 THR D 92 THR.? 15.38 ZN ZN D 128 C 229 LYS D 19 LYS.? 15.46 ZN ZN D 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.23 25.46 39.42 -20.30 24.86 39.60 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.96 22.44 46.27 -19.09 18.04 45.40 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU C 28 GLU~? 12.07 ZN ZN C 128 C 226 THR C 35 THR.? 11.32 ZN ZN B 128 C 229 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 5.96 41.55 51.41 5.95 40.38 49.65 coo 22.16 45.88 73.63 23.23 47.70 73.25 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU C 58 GLU.? 14.59 ZN ZN C 128 C 226 THR B 35 THR.? 8.83 ZN ZN B 128 C 229 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 7.13 51.72 45.00 6.65 51.50 42.95 coo 22.16 45.88 73.63 23.23 47.70 73.25 -11.91 51.72 35.90 -12.77 51.64 33.90 coo 28.90 45.91 73.55 25.22 49.72 72.97 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU C 70 GLU^? 19.15 ZN ZN C 128 C 226 THR A 92 THR.? 14.81 ZN ZN A 128 C 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -0.72 48.58 72.21 1.10 47.61 72.77 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.17 62.44 69.62 -18.23 61.18 71.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU C 103 GLU.? 13.37 ZN ZN B 128 C 226 THR A 21 THR.? 15.61 ZN ZN A 128 C 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 22.16 45.88 73.63 23.23 47.70 73.25 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU C 107 GLU.? 20.28 ZN ZN B 128 C 226 THR A 21 THR.? 15.61 ZN ZN A 128 C 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -32.00 66.19 44.45 -32.39 64.60 45.80 coo 22.16 45.88 73.63 23.23 47.70 73.25 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 57 GLU D 58 GLU.? 14.54 ZN ZN D 128 C 226 THR A 35 THR.? 8.83 ZN ZN A 128 C 229 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 5.43 40.40 61.63 4.27 41.99 60.90 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 22.16 45.88 73.63 23.23 47.70 73.25 -28.69 39.43 70.39 -28.36 40.10 72.45 coo 28.90 45.91 73.55 25.22 49.72 72.97 -27.08 41.78 78.19 -22.69 42.64 82.54 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 12 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 28 GLU~? 12.19 ZN ZN A 128 D 226 THR D 35 THR.? 11.51 ZN ZN A 128 D 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 11.79 47.62 52.67 10.10 46.51 53.39 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 58 GLU.? 14.95 ZN ZN A 128 D 226 THR D 35 THR.? 11.51 ZN ZN A 128 D 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 11.79 47.62 52.67 10.10 46.51 53.39 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 70 GLU^? 19.90 ZN ZN A 128 D 226 THR C 92 THR.? 15.22 ZN ZN C 128 D 229 LYS C 19 LYS.? 17.60 ZN ZN C 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 11.79 47.62 52.67 10.10 46.51 53.39 -1.81 38.46 67.24 -0.75 40.31 66.94 coo 10.05 41.79 49.80 7.94 44.71 53.76 0.64 35.92 60.53 5.63 36.47 64.53 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 28 GLU~? 11.81 ZN ZN B 128 D 226 THR C 35 THR.? 11.32 ZN ZN B 128 D 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 11.79 47.62 52.67 10.10 46.51 53.39 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 58 GLU.? 14.99 ZN ZN B 128 D 226 THR C 35 THR.? 11.32 ZN ZN B 128 D 229 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 11.79 47.62 52.67 10.10 46.51 53.39 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 70 GLU^? 18.94 ZN ZN B 128 D 226 THR D 92 THR.? 15.38 ZN ZN D 128 D 229 LYS D 19 LYS.? 15.46 ZN ZN D 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.23 25.46 39.42 -20.30 24.86 39.60 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.96 22.44 46.27 -19.09 18.04 45.40 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU C 28 GLU~? 12.07 ZN ZN C 128 D 226 THR C 35 THR.? 11.32 ZN ZN B 128 D 229 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 5.96 41.55 51.41 5.95 40.38 49.65 coo 11.79 47.62 52.67 10.10 46.51 53.39 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU C 58 GLU.? 14.59 ZN ZN C 128 D 226 THR B 35 THR.? 8.83 ZN ZN B 128 D 229 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 7.13 51.72 45.00 6.65 51.50 42.95 coo 11.79 47.62 52.67 10.10 46.51 53.39 -11.91 51.72 35.90 -12.77 51.64 33.90 coo 10.05 41.79 49.80 7.94 44.71 53.76 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU C 70 GLU^? 19.15 ZN ZN C 128 D 226 THR A 92 THR.? 14.81 ZN ZN A 128 D 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -0.72 48.58 72.21 1.10 47.61 72.77 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.17 62.44 69.62 -18.23 61.18 71.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU C 103 GLU.? 13.37 ZN ZN B 128 D 226 THR A 21 THR.? 15.61 ZN ZN A 128 D 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 11.79 47.62 52.67 10.10 46.51 53.39 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU C 107 GLU.? 20.28 ZN ZN B 128 D 226 THR A 21 THR.? 15.61 ZN ZN A 128 D 229 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -32.00 66.19 44.45 -32.39 64.60 45.80 coo 11.79 47.62 52.67 10.10 46.51 53.39 -27.73 60.81 64.10 -25.94 61.33 62.99 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 57 GLU D 58 GLU.? 14.54 ZN ZN D 128 D 226 THR A 35 THR.? 8.83 ZN ZN A 128 D 229 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 26.07 55.89 66.14 25.33 56.50 68.01 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 11.79 47.62 52.67 10.10 46.51 53.39 -28.69 39.43 70.39 -28.36 40.10 72.45 coo 10.05 41.79 49.80 7.94 44.71 53.76 -27.08 41.78 78.19 -22.69 42.64 82.54 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 12 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 200 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 229 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 1.13 77.49 40.64 0.62 75.57 39.98 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 0.84 91.24 49.01 2.91 91.61 49.23 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 10.53 97.56 43.71 9.33 93.71 47.17 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 200 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 1.13 77.49 40.64 0.62 75.57 39.98 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 0.84 91.24 49.01 2.91 91.61 49.23 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 10.53 97.56 43.71 9.33 93.71 47.17 -30.11 33.22 59.92 -32.56 30.92 63.52 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS B 59 HIS.? 17.68 ZN ZN B 128 B 200 ASP B 64 ASP.? 14.94 ZN ZN B 128 B 229 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 9.24 94.26 88.22 8.02 94.07 89.92 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 17.54 90.31 75.01 17.17 92.01 73.80 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 22.32 101.61 71.64 17.89 98.63 71.55 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 200 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 9.24 94.26 88.22 8.02 94.07 89.92 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 17.54 90.31 75.01 17.17 92.01 73.80 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 22.32 101.61 71.64 17.89 98.63 71.55 -30.11 33.22 59.92 -32.56 30.92 63.52 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS B 59 HIS.? 17.68 ZN ZN B 128 C 200 ASP B 64 ASP.? 14.94 ZN ZN B 128 C 229 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 26.77 65.84 83.49 27.06 67.76 84.27 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 19.52 52.01 79.59 20.28 51.65 77.65 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 28.90 45.91 73.55 25.22 49.72 72.97 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 200 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 26.77 65.84 83.49 27.06 67.76 84.27 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 19.52 52.01 79.59 20.28 51.65 77.65 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 28.90 45.91 73.55 25.22 49.72 72.97 -30.11 33.22 59.92 -32.56 30.92 63.52 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS B 59 HIS.? 17.68 ZN ZN B 128 D 200 ASP B 64 ASP.? 14.94 ZN ZN B 128 D 229 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 4.60 52.95 52.50 5.57 51.29 53.40 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 10.05 41.79 49.80 7.94 44.71 53.76 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS C 10 HIS^? 15.40 ZN ZN C 128 D 200 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 229 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 4.60 52.95 52.50 5.57 51.29 53.40 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 10.05 41.79 49.80 7.94 44.71 53.76 -30.11 33.22 59.92 -32.56 30.92 63.52 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR B 89 THR.? 18.91 ZN ZN B 128 A 45 THR B 92 THR.? 15.12 ZN ZN B 128 A 161 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo 26.16 88.25 79.16 25.22 89.47 80.71 -39.38 49.52 32.40 -39.94 47.46 32.72 coo 27.73 89.90 76.08 29.24 91.46 75.95 -37.24 47.79 36.87 -36.06 47.31 35.09 coo 33.83 91.15 88.62 31.07 91.06 83.02 -39.27 61.49 31.97 -43.88 61.90 29.42 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR B 89 THR.? 18.91 ZN ZN B 128 B 45 THR B 92 THR.? 15.12 ZN ZN B 128 B 161 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo 7.39 128.28 94.56 8.34 126.36 94.79 -39.38 49.52 32.40 -39.94 47.46 32.72 coo 5.75 129.25 91.25 4.29 128.16 90.07 -37.24 47.79 36.87 -36.06 47.31 35.09 coo -0.17 119.75 99.65 2.51 123.83 95.70 -39.27 61.49 31.97 -43.88 61.90 29.42 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c03 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 183 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 278 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 19.43 18.53 42.32 17.66 18.80 40.15 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 21.92 15.80 36.19 17.64 19.44 36.35 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 15.46 19.03 31.40 15.01 18.25 33.31 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 183 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 278 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 19.43 18.53 42.32 17.66 18.80 40.15 8.07 52.98 53.71 8.63 50.62 55.11 coo 21.92 15.80 36.19 17.64 19.44 36.35 0.65 56.08 51.29 4.22 57.96 54.91 coo 15.46 19.03 31.40 15.01 18.25 33.31 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 183 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 278 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 19.43 18.53 42.32 17.66 18.80 40.15 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 21.92 15.80 36.19 17.64 19.44 36.35 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 15.46 19.03 31.40 15.01 18.25 33.31 -29.32 31.61 55.53 -28.20 30.46 54.16 1do8_c00 source 1do8 MALIC ENZYME : 3 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 55 TYR^? 11.76 ZN ZN A 128 B 183 LYS A 81 LYS.? 12.55 ZN ZN A 128 B 278 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 58.62 15.99 58.34 60.98 14.60 58.93 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 60.11 10.60 53.63 62.59 10.74 58.67 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 66.50 7.32 58.45 66.26 9.42 58.23 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 55 TYR.? 11.96 ZN ZN B 128 B 183 LYS B 81 LYS.? 12.71 ZN ZN B 128 B 278 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 58.62 15.99 58.34 60.98 14.60 58.93 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 60.11 10.60 53.63 62.59 10.74 58.67 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 66.50 7.32 58.45 66.26 9.42 58.23 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR C 55 TYR.? 11.30 ZN ZN C 128 B 183 LYS C 81 LYS.? 11.89 ZN ZN C 128 B 278 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 58.62 15.99 58.34 60.98 14.60 58.93 8.07 52.98 53.71 8.63 50.62 55.11 coo 60.11 10.60 53.63 62.59 10.74 58.67 0.65 56.08 51.29 4.22 57.96 54.91 coo 66.50 7.32 58.45 66.26 9.42 58.23 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR D 55 TYR.? 11.30 ZN ZN D 128 B 183 LYS D 81 LYS.? 12.28 ZN ZN D 128 B 278 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 58.62 15.99 58.34 60.98 14.60 58.93 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 60.11 10.60 53.63 62.59 10.74 58.67 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 66.50 7.32 58.45 66.26 9.42 58.23 -29.32 31.61 55.53 -28.20 30.46 54.16 1do8_c01 source 1do8 MALIC ENZYME : 4 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 55 TYR^? 11.76 ZN ZN A 128 C 183 LYS A 81 LYS.? 12.55 ZN ZN A 128 C 278 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR C 55 TYR.? 11.30 ZN ZN C 128 C 183 LYS C 81 LYS.? 11.89 ZN ZN C 128 C 278 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 8.07 52.98 53.71 8.63 50.62 55.11 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 0.65 56.08 51.29 4.22 57.96 54.91 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR D 55 TYR.? 11.30 ZN ZN D 128 C 183 LYS D 81 LYS.? 12.28 ZN ZN D 128 C 278 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -29.32 31.61 55.53 -28.20 30.46 54.16 1do8_c02 source 1do8 MALIC ENZYME : 3 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 55 TYR^? 11.76 ZN ZN A 128 D 183 LYS A 81 LYS.? 12.55 ZN ZN A 128 D 278 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 55 TYR.? 11.96 ZN ZN B 128 D 183 LYS B 81 LYS.? 12.71 ZN ZN B 128 D 278 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR C 55 TYR.? 11.30 ZN ZN C 128 D 183 LYS C 81 LYS.? 11.89 ZN ZN C 128 D 278 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 8.07 52.98 53.71 8.63 50.62 55.11 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 0.65 56.08 51.29 4.22 57.96 54.91 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR D 55 TYR.? 11.30 ZN ZN D 128 D 183 LYS D 81 LYS.? 12.28 ZN ZN D 128 D 278 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -29.32 31.61 55.53 -28.20 30.46 54.16 1do8_c03 source 1do8 MALIC ENZYME : 4 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 E 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 E 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 11.39 26.86 25.95 9.85 26.64 27.36 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 10.90 32.83 25.96 10.83 30.68 25.98 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 4.57 20.60 30.29 4.74 21.36 30.66 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 E 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 E 193 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 11.39 26.86 25.95 9.85 26.64 27.36 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 10.90 32.83 25.96 10.83 30.68 25.98 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 4.57 20.60 30.29 4.74 21.36 30.66 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 E 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 E 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 11.39 26.86 25.95 9.85 26.64 27.36 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 10.90 32.83 25.96 10.83 30.68 25.98 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 4.57 20.60 30.29 4.74 21.36 30.66 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 E 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 E 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 11.39 26.86 25.95 9.85 26.64 27.36 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 10.90 32.83 25.96 10.83 30.68 25.98 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 4.57 20.60 30.29 4.74 21.36 30.66 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 5 3 # 5 E 57 HIS C 59 HIS.? 17.15 ZN ZN C 128 E 102 ASP C 57 ASP.? 16.82 ZN ZN C 128 E 193 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 11.39 26.86 25.95 9.85 26.64 27.36 11.45 52.92 44.80 10.43 52.05 43.19 coo 10.90 32.83 25.96 10.83 30.68 25.98 8.18 57.58 47.56 10.27 57.39 47.78 coo 4.57 20.60 30.29 4.74 21.36 30.66 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 6 3 # 6 E 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 E 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 E 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 11.39 26.86 25.95 9.85 26.64 27.36 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 10.90 32.83 25.96 10.83 30.68 25.98 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 4.57 20.60 30.29 4.74 21.36 30.66 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 7 3 # 7 E 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 E 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 E 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 11.39 26.86 25.95 9.85 26.64 27.36 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 10.90 32.83 25.96 10.83 30.68 25.98 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 4.57 20.60 30.29 4.74 21.36 30.66 -27.38 22.98 60.43 -27.77 23.26 61.11 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 7 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 108 GLY.? 9.79 ZN ZN D 128 B 144 GLU A 107 GLU.? 11.70 ZN ZN D 128 B 164 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 88.87 114.43 152.30 88.45 115.15 152.32 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 85.20 111.99 152.05 86.60 110.89 150.91 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 88.14 113.46 145.73 86.79 113.92 147.30 -34.12 20.46 61.00 -33.75 20.62 63.08 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 B 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 164 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 88.87 114.43 152.30 88.45 115.15 152.32 2.73 45.52 45.80 2.60 46.11 45.24 coo 85.20 111.99 152.05 86.60 110.89 150.91 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 88.14 113.46 145.73 86.79 113.92 147.30 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 B 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 164 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 88.87 114.43 152.30 88.45 115.15 152.32 2.73 45.52 45.80 2.60 46.11 45.24 coo 85.20 111.99 152.05 86.60 110.89 150.91 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 88.14 113.46 145.73 86.79 113.92 147.30 7.13 51.72 45.00 6.65 51.50 42.95 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 108 GLY.? 9.79 ZN ZN D 128 C 144 GLU A 107 GLU.? 11.70 ZN ZN D 128 C 164 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 56.28 104.55 135.84 56.09 105.34 136.05 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 58.46 103.90 139.48 57.57 102.00 139.16 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 51.71 102.03 140.09 53.02 103.62 140.54 -34.12 20.46 61.00 -33.75 20.62 63.08 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 C 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 C 164 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 56.28 104.55 135.84 56.09 105.34 136.05 2.73 45.52 45.80 2.60 46.11 45.24 coo 58.46 103.90 139.48 57.57 102.00 139.16 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 51.71 102.03 140.09 53.02 103.62 140.54 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 C 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 C 164 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 56.28 104.55 135.84 56.09 105.34 136.05 2.73 45.52 45.80 2.60 46.11 45.24 coo 58.46 103.90 139.48 57.57 102.00 139.16 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 51.71 102.03 140.09 53.02 103.62 140.54 7.13 51.72 45.00 6.65 51.50 42.95 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 108 GLY.? 9.79 ZN ZN D 128 D 144 GLU A 107 GLU.? 11.70 ZN ZN D 128 D 164 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 86.19 80.64 132.77 86.38 79.85 132.93 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 84.75 81.24 136.88 85.62 83.14 136.43 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 91.47 83.05 136.24 90.35 81.38 136.84 -34.12 20.46 61.00 -33.75 20.62 63.08 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 D 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 D 164 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 86.19 80.64 132.77 86.38 79.85 132.93 2.73 45.52 45.80 2.60 46.11 45.24 coo 84.75 81.24 136.88 85.62 83.14 136.43 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 91.47 83.05 136.24 90.35 81.38 136.84 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 D 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 D 164 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 86.19 80.64 132.77 86.38 79.85 132.93 2.73 45.52 45.80 2.60 46.11 45.24 coo 84.75 81.24 136.88 85.62 83.14 136.43 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 91.47 83.05 136.24 90.35 81.38 136.84 7.13 51.72 45.00 6.65 51.50 42.95 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 108 GLY.? 9.79 ZN ZN D 128 E 144 GLU A 107 GLU.? 11.70 ZN ZN D 128 E 164 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 90.07 81.07 170.50 90.23 80.26 170.38 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 87.05 81.30 167.53 86.38 82.74 168.94 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 84.40 80.02 173.80 85.08 79.06 172.03 -34.12 20.46 61.00 -33.75 20.62 63.08 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 E 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 E 164 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 90.07 81.07 170.50 90.23 80.26 170.38 2.73 45.52 45.80 2.60 46.11 45.24 coo 87.05 81.30 167.53 86.38 82.74 168.94 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 84.40 80.02 173.80 85.08 79.06 172.03 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 E 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 E 164 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 90.07 81.07 170.50 90.23 80.26 170.38 2.73 45.52 45.80 2.60 46.11 45.24 coo 87.05 81.30 167.53 86.38 82.74 168.94 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 84.40 80.02 173.80 85.08 79.06 172.03 7.13 51.72 45.00 6.65 51.50 42.95 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 108 GLY.? 9.79 ZN ZN D 128 F 144 GLU A 107 GLU.? 11.70 ZN ZN D 128 F 164 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 57.12 70.68 155.10 57.52 69.95 155.02 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 60.62 73.13 154.21 59.05 74.26 153.35 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 56.75 71.71 148.46 58.44 71.01 149.54 -34.12 20.46 61.00 -33.75 20.62 63.08 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 F 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 F 164 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 57.12 70.68 155.10 57.52 69.95 155.02 2.73 45.52 45.80 2.60 46.11 45.24 coo 60.62 73.13 154.21 59.05 74.26 153.35 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 56.75 71.71 148.46 58.44 71.01 149.54 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 108 GLY.? 9.90 ZN ZN C 128 F 144 GLU B 107 GLU.? 12.06 ZN ZN C 128 F 164 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 57.12 70.68 155.10 57.52 69.95 155.02 2.73 45.52 45.80 2.60 46.11 45.24 coo 60.62 73.13 154.21 59.05 74.26 153.35 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 56.75 71.71 148.46 58.44 71.01 149.54 7.13 51.72 45.00 6.65 51.50 42.95 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c17 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 13 SER^? 14.04 ZN ZN A 128 A 208 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 236 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 49.19 42.85 125.39 50.92 43.54 123.63 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 57.80 42.94 129.59 56.47 43.28 127.93 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 55.54 41.70 125.00 53.71 42.50 124.53 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER A 13 SER^? 14.04 ZN ZN A 128 A 208 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 236 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 49.19 42.85 125.39 50.92 43.54 123.63 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 57.80 42.94 129.59 56.47 43.28 127.93 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 55.54 41.70 125.00 53.71 42.50 124.53 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER B 13 SER^? 13.94 ZN ZN B 128 A 208 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 236 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 49.19 42.85 125.39 50.92 43.54 123.63 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 57.80 42.94 129.59 56.47 43.28 127.93 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 55.54 41.70 125.00 53.71 42.50 124.53 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER B 13 SER^? 13.94 ZN ZN B 128 A 208 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 236 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 49.19 42.85 125.39 50.92 43.54 123.63 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 57.80 42.94 129.59 56.47 43.28 127.93 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 55.54 41.70 125.00 53.71 42.50 124.53 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 5 3 # 5 A 80 SER C 13 SER^? 14.25 ZN ZN C 128 A 208 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 236 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 49.19 42.85 125.39 50.92 43.54 123.63 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 57.80 42.94 129.59 56.47 43.28 127.93 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 55.54 41.70 125.00 53.71 42.50 124.53 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 6 3 # 6 A 80 SER D 13 SER^? 14.41 ZN ZN D 128 A 208 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 236 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 49.19 42.85 125.39 50.92 43.54 123.63 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 57.80 42.94 129.59 56.47 43.28 127.93 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 55.54 41.70 125.00 53.71 42.50 124.53 -18.46 42.11 47.13 -20.09 43.42 47.28 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 6 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 13 SER^? 14.04 ZN ZN A 128 B 208 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 236 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 55.25 19.46 97.60 53.04 19.32 98.76 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 57.34 11.46 102.30 56.11 13.10 101.70 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 55.03 16.17 103.08 54.39 17.23 101.45 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 2 3 # 2 B 80 SER A 13 SER^? 14.04 ZN ZN A 128 B 208 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 236 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 55.25 19.46 97.60 53.04 19.32 98.76 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 57.34 11.46 102.30 56.11 13.10 101.70 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 55.03 16.17 103.08 54.39 17.23 101.45 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 3 3 # 3 B 80 SER B 13 SER^? 13.94 ZN ZN B 128 B 208 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 236 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 55.25 19.46 97.60 53.04 19.32 98.76 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 57.34 11.46 102.30 56.11 13.10 101.70 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 55.03 16.17 103.08 54.39 17.23 101.45 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 4 3 # 4 B 80 SER B 13 SER^? 13.94 ZN ZN B 128 B 208 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 236 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 55.25 19.46 97.60 53.04 19.32 98.76 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 57.34 11.46 102.30 56.11 13.10 101.70 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 55.03 16.17 103.08 54.39 17.23 101.45 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 5 3 # 5 B 80 SER C 13 SER^? 14.25 ZN ZN C 128 B 208 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 236 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 55.25 19.46 97.60 53.04 19.32 98.76 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 57.34 11.46 102.30 56.11 13.10 101.70 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 55.03 16.17 103.08 54.39 17.23 101.45 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 6 3 # 6 B 80 SER D 13 SER^? 14.41 ZN ZN D 128 B 208 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 236 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 55.25 19.46 97.60 53.04 19.32 98.76 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 57.34 11.46 102.30 56.11 13.10 101.70 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 55.03 16.17 103.08 54.39 17.23 101.45 -18.46 42.11 47.13 -20.09 43.42 47.28 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 6 hits 1dwo_c01 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS B 51 LYS^? 16.33 ZN ZN B 128 A 215 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 277 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo 0.50 24.09 51.68 1.51 29.34 52.35 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 13.06 30.79 51.73 11.40 35.76 53.48 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 13.04 31.88 60.72 10.57 35.34 57.49 -39.27 61.49 31.97 -43.88 61.90 29.42 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 1 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS B 51 LYS^? 16.33 ZN ZN B 128 B 215 LYS B 19 LYS.? 16.80 ZN ZN B 128 B 277 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo 6.78 45.91 16.15 7.82 40.81 15.84 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 17.88 38.77 19.81 16.38 34.23 17.24 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 20.33 37.78 11.20 16.77 34.53 13.47 -39.27 61.49 31.97 -43.88 61.90 29.42 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 1 hits 1e19_c01 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 43 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 65 GLU A 58 GLU.? 14.95 ZN ZN A 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 19.55 18.91 30.27 18.21 18.65 31.84 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 10.90 21.31 28.81 12.14 22.15 30.31 -35.58 45.32 81.43 -37.46 44.65 80.73 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 43 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 65 GLU A 28 GLU~? 12.19 ZN ZN A 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 19.55 18.91 30.27 18.21 18.65 31.84 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 10.90 21.31 28.81 12.14 22.15 30.31 -33.40 55.75 75.93 -32.70 57.39 77.09 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 43 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 65 GLU A 58 GLU.? 14.95 ZN ZN A 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 19.55 18.91 30.27 18.21 18.65 31.84 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 10.90 21.31 28.81 12.14 22.15 30.31 -35.58 45.32 81.43 -37.46 44.65 80.73 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 43 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 65 GLU B 58 GLU.? 14.99 ZN ZN B 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 19.55 18.91 30.27 18.21 18.65 31.84 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 10.90 21.31 28.81 12.14 22.15 30.31 -16.19 59.88 24.88 -15.11 61.60 25.47 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 43 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 65 GLU B 80 GLU.? 14.47 ZN ZN B 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 19.55 18.91 30.27 18.21 18.65 31.84 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 10.90 21.31 28.81 12.14 22.15 30.31 -9.61 50.34 31.62 -7.67 49.64 31.13 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 43 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 65 GLU B 28 GLU~? 11.81 ZN ZN B 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 19.55 18.91 30.27 18.21 18.65 31.84 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 10.90 21.31 28.81 12.14 22.15 30.31 -26.33 60.76 29.16 -28.24 60.05 29.68 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 43 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 65 GLU B 58 GLU.? 14.99 ZN ZN B 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 19.55 18.91 30.27 18.21 18.65 31.84 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 10.90 21.31 28.81 12.14 22.15 30.31 -16.19 59.88 24.88 -15.11 61.60 25.47 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 8 3 # 8 B 41 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 43 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 65 GLU C 80 GLU.? 11.53 ZN ZN C 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.61 46.90 50.78 -0.23 46.71 52.70 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.88 50.97 54.56 -1.00 50.36 53.86 coo 10.90 21.31 28.81 12.14 22.15 30.31 -4.16 58.03 47.91 -5.06 56.59 46.66 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 9 3 # 9 B 41 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 43 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 65 GLU B 107 GLU.? 12.06 ZN ZN C 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.88 50.97 54.56 -1.00 50.36 53.86 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.61 46.90 50.78 -0.23 46.71 52.70 coo 10.90 21.31 28.81 12.14 22.15 30.31 -0.05 48.66 43.11 -0.32 50.61 42.31 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 10 3 # 10 B 41 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 43 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 65 GLU C 28 GLU~? 12.07 ZN ZN C 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.88 50.97 54.56 -1.00 50.36 53.86 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.61 46.90 50.78 -0.23 46.71 52.70 coo 10.90 21.31 28.81 12.14 22.15 30.31 5.96 41.55 51.41 5.95 40.38 49.65 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 11 3 # 11 B 41 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 43 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 65 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.88 50.97 54.56 -1.00 50.36 53.86 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.61 46.90 50.78 -0.23 46.71 52.70 coo 10.90 21.31 28.81 12.14 22.15 30.31 7.13 51.72 45.00 6.65 51.50 42.95 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 12 3 # 12 B 41 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 43 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 65 GLU D 80 GLU.? 11.79 ZN ZN D 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 19.55 18.91 30.27 18.21 18.65 31.84 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 10.90 21.31 28.81 12.14 22.15 30.31 -37.55 31.59 59.30 -36.06 33.05 59.71 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 13 3 # 13 B 41 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 43 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 65 GLU D 28 GLU.? 12.56 ZN ZN D 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 19.55 18.91 30.27 18.21 18.65 31.84 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 10.90 21.31 28.81 12.14 22.15 30.31 -23.77 18.70 55.29 -22.97 18.07 57.14 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 14 3 # 14 B 41 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 43 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 65 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 20.15 22.08 34.36 20.84 20.10 34.21 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 19.55 18.91 30.27 18.21 18.65 31.84 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 10.90 21.31 28.81 12.14 22.15 30.31 -34.12 20.46 61.00 -33.75 20.62 63.08 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 14 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 56 ALA.? 16.32 ZN ZN A 128 A 136 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 140 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 55.90 7.49 23.83 56.71 8.23 22.76 -27.19 42.31 85.39 -27.19 42.07 86.90 coo 59.38 10.02 17.51 59.95 9.89 20.21 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 59.52 3.69 18.67 62.31 6.19 22.58 -27.08 41.78 78.19 -22.69 42.64 82.54 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 56 ALA.? 16.57 ZN ZN B 128 A 136 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 140 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 55.90 7.49 23.83 56.71 8.23 22.76 -15.28 51.03 20.87 -15.04 51.05 19.36 coo 59.38 10.02 17.51 59.95 9.89 20.21 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 59.52 3.69 18.67 62.31 6.19 22.58 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA C 56 ALA.? 16.16 ZN ZN C 128 A 136 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 140 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 55.90 7.49 23.83 56.71 8.23 22.76 7.75 58.58 51.94 9.07 59.36 51.88 coo 59.38 10.02 17.51 59.95 9.89 20.21 8.07 52.98 53.71 8.63 50.62 55.11 coo 59.52 3.69 18.67 62.31 6.19 22.58 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA D 56 ALA.? 16.15 ZN ZN D 128 A 136 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 140 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 55.90 7.49 23.83 56.71 8.23 22.76 -40.71 21.54 53.92 -41.78 20.44 53.84 coo 59.38 10.02 17.51 59.95 9.89 20.21 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 59.52 3.69 18.67 62.31 6.19 22.58 -36.76 27.60 54.86 -39.44 24.48 51.40 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 4 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 35 SER A 13 SER^? 14.04 ZN ZN A 128 A 218 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 47.22 22.34 8.57 45.16 22.02 9.13 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 43.58 20.85 5.15 44.62 23.01 5.76 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 44.05 16.99 12.67 44.05 18.89 11.74 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 35 SER B 13 SER^? 13.94 ZN ZN B 128 A 218 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 47.22 22.34 8.57 45.16 22.02 9.13 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 43.58 20.85 5.15 44.62 23.01 5.76 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 44.05 16.99 12.67 44.05 18.89 11.74 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 35 SER C 60 SER.? 15.14 ZN ZN C 128 A 218 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 47.22 22.34 8.57 45.16 22.02 9.13 8.18 57.58 47.56 10.27 57.39 47.78 coo 43.58 20.85 5.15 44.62 23.01 5.76 12.55 55.11 50.39 10.44 55.82 51.40 coo 44.05 16.99 12.67 44.05 18.89 11.74 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 35 SER C 13 SER^? 14.25 ZN ZN C 128 A 218 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 47.22 22.34 8.57 45.16 22.02 9.13 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 43.58 20.85 5.15 44.62 23.01 5.76 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 44.05 16.99 12.67 44.05 18.89 11.74 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 5 3 # 5 A 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 35 SER D 13 SER^? 14.41 ZN ZN D 128 A 218 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 47.22 22.34 8.57 45.16 22.02 9.13 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 43.58 20.85 5.15 44.62 23.01 5.76 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 44.05 16.99 12.67 44.05 18.89 11.74 -21.74 43.31 43.14 -23.53 43.14 44.28 1eag_c04 source 1eag PEPTIDE INHIBITOR : 5 hits 1eag_c04 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 57 ASP.? 17.22 ZN ZN A 128 P 35 SER A 60 SER.? 16.46 ZN ZN A 128 P 215 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 10.15 33.41 11.98 7.98 33.66 12.07 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 7.57 37.60 10.00 8.86 37.02 12.03 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 4.04 29.97 8.82 4.78 31.15 10.46 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 P 35 SER A 13 SER^? 14.04 ZN ZN A 128 P 215 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 10.15 33.41 11.98 7.98 33.66 12.07 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 7.57 37.60 10.00 8.86 37.02 12.03 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 4.04 29.97 8.82 4.78 31.15 10.46 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 P 35 SER B 13 SER^? 13.94 ZN ZN B 128 P 215 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 10.15 33.41 11.98 7.98 33.66 12.07 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 7.57 37.60 10.00 8.86 37.02 12.03 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 4.04 29.97 8.82 4.78 31.15 10.46 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 P 35 SER C 60 SER.? 15.14 ZN ZN C 128 P 215 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 10.15 33.41 11.98 7.98 33.66 12.07 8.18 57.58 47.56 10.27 57.39 47.78 coo 7.57 37.60 10.00 8.86 37.02 12.03 12.55 55.11 50.39 10.44 55.82 51.40 coo 4.04 29.97 8.82 4.78 31.15 10.46 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 5 3 # 5 P 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 P 35 SER C 13 SER^? 14.25 ZN ZN C 128 P 215 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 10.15 33.41 11.98 7.98 33.66 12.07 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 7.57 37.60 10.00 8.86 37.02 12.03 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 4.04 29.97 8.82 4.78 31.15 10.46 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 6 3 # 6 P 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 P 35 SER D 60 SER.? 15.90 ZN ZN D 128 P 215 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 10.15 33.41 11.98 7.98 33.66 12.07 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 7.57 37.60 10.00 8.86 37.02 12.03 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 4.04 29.97 8.82 4.78 31.15 10.46 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 7 3 # 7 P 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 P 35 SER D 13 SER^? 14.41 ZN ZN D 128 P 215 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 10.15 33.41 11.98 7.98 33.66 12.07 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 7.57 37.60 10.00 8.86 37.02 12.03 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 4.04 29.97 8.82 4.78 31.15 10.46 -21.74 43.31 43.14 -23.53 43.14 44.28 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 7 hits 1eed_c04 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 246 ASP A 64 ASP.? 14.79 ZN ZN A 128 B 275 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 43.18 49.30 68.39 44.75 49.87 69.78 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 38.73 55.10 77.62 36.80 55.01 78.46 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 246 ASP B 64 ASP.? 14.94 ZN ZN B 128 B 275 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 43.18 49.30 68.39 44.75 49.87 69.78 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 38.73 55.10 77.62 36.80 55.01 78.46 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 246 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 275 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 43.18 49.30 68.39 44.75 49.87 69.78 8.18 57.58 47.56 10.27 57.39 47.78 coo 38.73 55.10 77.62 36.80 55.01 78.46 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 246 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 275 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 43.18 49.30 68.39 44.75 49.87 69.78 8.18 57.58 47.56 10.27 57.39 47.78 coo 38.73 55.10 77.62 36.80 55.01 78.46 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 246 ASP C 64 ASP.? 14.22 ZN ZN C 128 B 275 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 43.18 49.30 68.39 44.75 49.87 69.78 8.74 58.91 56.74 6.81 58.81 55.87 coo 38.73 55.10 77.62 36.80 55.01 78.46 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 B 107 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 246 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 275 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 43.18 49.30 68.39 44.75 49.87 69.78 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 38.73 55.10 77.62 36.80 55.01 78.46 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 B 107 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 246 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 275 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 43.18 49.30 68.39 44.75 49.87 69.78 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 38.73 55.10 77.62 36.80 55.01 78.46 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 B 107 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 246 ASP D 64 ASP.? 14.34 ZN ZN D 128 B 275 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 34.84 56.77 81.62 34.95 54.74 82.03 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 43.18 49.30 68.39 44.75 49.87 69.78 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 38.73 55.10 77.62 36.80 55.01 78.46 -31.62 26.29 51.88 -30.63 27.88 52.82 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 8 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 32 ASP.? -2.97 ZN ZN A 128s C 246 ASP A 64 ASP.? 14.79 ZN ZN A 128 C 275 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 1.90 35.26 72.76 3.20 35.74 71.18 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 12.03 20.33 71.56 10.48 19.25 70.56 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 3.92 29.96 71.75 4.22 31.96 72.31 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 246 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 275 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 1.90 35.26 72.76 3.20 35.74 71.18 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 12.03 20.33 71.56 10.48 19.25 70.56 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 3.92 29.96 71.75 4.22 31.96 72.31 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 246 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 275 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 1.90 35.26 72.76 3.20 35.74 71.18 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 12.03 20.33 71.56 10.48 19.25 70.56 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 3.92 29.96 71.75 4.22 31.96 72.31 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 246 ASP B 64 ASP.? 14.94 ZN ZN B 128 C 275 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 1.90 35.26 72.76 3.20 35.74 71.18 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 12.03 20.33 71.56 10.48 19.25 70.56 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 3.92 29.96 71.75 4.22 31.96 72.31 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 246 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 275 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 1.90 35.26 72.76 3.20 35.74 71.18 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 12.03 20.33 71.56 10.48 19.25 70.56 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 3.92 29.96 71.75 4.22 31.96 72.31 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 246 ASP D 32 ASP^? -2.55 ZN ZN D 128s C 275 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 1.90 35.26 72.76 3.20 35.74 71.18 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 12.03 20.33 71.56 10.48 19.25 70.56 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 3.92 29.96 71.75 4.22 31.96 72.31 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 C 107 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 246 ASP C 64 ASP.? 14.22 ZN ZN C 128 C 275 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 1.90 35.26 72.76 3.20 35.74 71.18 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 12.03 20.33 71.56 10.48 19.25 70.56 8.74 58.91 56.74 6.81 58.81 55.87 coo 3.92 29.96 71.75 4.22 31.96 72.31 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 C 107 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 246 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 275 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 1.90 35.26 72.76 3.20 35.74 71.18 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 12.03 20.33 71.56 10.48 19.25 70.56 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 3.92 29.96 71.75 4.22 31.96 72.31 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 9 3 # 9 C 107 ASP D 32 ASP^? -2.55 ZN ZN D 128s C 246 ASP D 64 ASP.? 14.34 ZN ZN D 128 C 275 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 1.90 35.26 72.76 3.20 35.74 71.18 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 12.03 20.33 71.56 10.48 19.25 70.56 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 3.92 29.96 71.75 4.22 31.96 72.31 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 10 3 # 10 C 107 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 246 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 275 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 1.90 35.26 72.76 3.20 35.74 71.18 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 12.03 20.33 71.56 10.48 19.25 70.56 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 3.92 29.96 71.75 4.22 31.96 72.31 -18.46 42.11 47.13 -20.09 43.42 47.28 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 10 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 32 ASP.? -2.97 ZN ZN A 128s D 246 ASP A 57 ASP.? 17.22 ZN ZN A 128 D 275 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 23.50 26.43 88.52 24.76 26.47 90.29 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 33.16 21.44 85.29 34.07 21.53 83.40 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 32 ASP.? -2.97 ZN ZN A 128s D 246 ASP A 64 ASP.? 14.79 ZN ZN A 128 D 275 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 23.50 26.43 88.52 24.76 26.47 90.29 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 33.16 21.44 85.29 34.07 21.53 83.40 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP B 32 ASP.? -2.88 ZN ZN B 128s D 246 ASP B 57 ASP.? 17.37 ZN ZN B 128 D 275 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 23.50 26.43 88.52 24.76 26.47 90.29 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 33.16 21.44 85.29 34.07 21.53 83.40 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP B 32 ASP.? -2.88 ZN ZN B 128s D 246 ASP B 64 ASP.? 14.94 ZN ZN B 128 D 275 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 23.50 26.43 88.52 24.76 26.47 90.29 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 33.16 21.44 85.29 34.07 21.53 83.40 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP C 32 ASP^? -2.40 ZN ZN C 128s D 246 ASP C 57 ASP.? 16.82 ZN ZN C 128 D 275 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 23.50 26.43 88.52 24.76 26.47 90.29 8.18 57.58 47.56 10.27 57.39 47.78 coo 33.16 21.44 85.29 34.07 21.53 83.40 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 D 107 ASP C 32 ASP^? -2.40 ZN ZN C 128s D 246 ASP C 64 ASP.? 14.22 ZN ZN C 128 D 275 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 23.50 26.43 88.52 24.76 26.47 90.29 8.74 58.91 56.74 6.81 58.81 55.87 coo 33.16 21.44 85.29 34.07 21.53 83.40 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 D 107 ASP D 32 ASP^? -2.55 ZN ZN D 128s D 246 ASP D 57 ASP.? 16.88 ZN ZN D 128 D 275 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 23.50 26.43 88.52 24.76 26.47 90.29 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 33.16 21.44 85.29 34.07 21.53 83.40 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 8 3 # 8 D 107 ASP D 32 ASP^? -2.55 ZN ZN D 128s D 246 ASP D 64 ASP.? 14.34 ZN ZN D 128 D 275 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 37.41 19.89 81.58 37.64 21.98 81.53 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 23.50 26.43 88.52 24.76 26.47 90.29 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 33.16 21.44 85.29 34.07 21.53 83.40 -31.62 26.29 51.88 -30.63 27.88 52.82 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 8 hits 1ehy_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 97 ASP^? 13.17 ZN ZN A 128 153 ARG A 42 ARG^? 15.09 ZN ZN A 128 177 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 6.83 2.75 19.17 7.40 0.75 19.11 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP B 57 ASP.? 17.37 ZN ZN B 128 153 ARG B 29 ARG.? 13.89 ZN ZN B 128 177 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 6.83 2.75 19.17 7.40 0.75 19.11 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 3 # 3 150 ASP B 97 ASP^? 13.03 ZN ZN B 128 153 ARG B 42 ARG^? 15.17 ZN ZN B 128 177 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 6.83 2.75 19.17 7.40 0.75 19.11 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 3 # 4 150 ASP C 57 ASP.? 16.82 ZN ZN C 128 153 ARG C 29 ARG.? 13.36 ZN ZN C 128 177 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 6.83 2.75 19.17 7.40 0.75 19.11 8.18 57.58 47.56 10.27 57.39 47.78 coo 1.78 0.50 17.43 2.55 -2.31 16.44 7.46 50.67 50.27 10.29 51.53 51.14 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 5 3 # 5 150 ASP C 97 ASP^? 13.06 ZN ZN C 128 153 ARG C 42 ARG^? 15.11 ZN ZN C 128 177 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 6.83 2.75 19.17 7.40 0.75 19.11 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 6 3 # 6 150 ASP D 97 ASP^? 13.24 ZN ZN D 128 153 ARG D 42 ARG^? 14.89 ZN ZN D 128 177 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 6.83 2.75 19.17 7.40 0.75 19.11 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -24.77 44.27 50.01 -22.89 43.34 50.12 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 6 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 49 ALA^? 15.93 ZN ZN A 128 A 257 ALA A 87 ALA^? 12.75 ZN ZN A 128 A 328 ASP A 90 ASP.? 20.22 ZN ZN A 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -15.43 59.12 73.84 -14.71 59.38 75.17 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.53 60.02 74.19 -22.12 60.70 72.96 coo 38.17 34.10 6.67 37.72 32.06 6.84 -21.48 68.18 71.21 -23.15 68.60 72.44 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 49 ALA^? 15.93 ZN ZN A 128 A 257 ALA A 87 ALA^? 12.75 ZN ZN A 128 A 328 ASP A 91 ASP.? 21.24 ZN ZN A 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -15.43 59.12 73.84 -14.71 59.38 75.17 coo 43.22 26.73 5.37 41.81 27.09 5.79 -21.53 60.02 74.19 -22.12 60.70 72.96 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.26 66.98 68.26 -15.96 67.19 69.91 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 71 ALA.? 18.90 ZN ZN A 128 A 257 ALA A 49 ALA^? 15.93 ZN ZN A 128 A 328 ASP A 91 ASP.? 21.24 ZN ZN A 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.85 57.79 70.32 -10.50 59.22 69.90 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.43 59.12 73.84 -14.71 59.38 75.17 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.26 66.98 68.26 -15.96 67.19 69.91 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 87 ALA^? 12.75 ZN ZN A 128 A 257 ALA A 49 ALA^? 15.93 ZN ZN A 128 A 328 ASP A 91 ASP.? 21.24 ZN ZN A 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -21.53 60.02 74.19 -22.12 60.70 72.96 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.43 59.12 73.84 -14.71 59.38 75.17 coo 38.17 34.10 6.67 37.72 32.06 6.84 -17.26 66.98 68.26 -15.96 67.19 69.91 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 49 ALA^? 16.22 ZN ZN B 128 A 257 ALA B 87 ALA^? 12.80 ZN ZN B 128 A 328 ASP B 90 ASP.? 20.48 ZN ZN B 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.75 44.14 32.50 -35.24 43.58 31.16 coo 43.22 26.73 5.37 41.81 27.09 5.79 -33.86 50.50 32.29 -34.33 51.24 33.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 -41.70 52.65 35.26 -41.90 54.02 33.70 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA B 49 ALA^? 16.22 ZN ZN B 128 A 257 ALA B 87 ALA^? 12.80 ZN ZN B 128 A 328 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.75 44.14 32.50 -35.24 43.58 31.16 coo 43.22 26.73 5.37 41.81 27.09 5.79 -33.86 50.50 32.29 -34.33 51.24 33.52 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 71 ALA.? 18.94 ZN ZN B 128 A 257 ALA B 49 ALA^? 16.22 ZN ZN B 128 A 328 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.70 39.55 36.03 -36.14 39.66 36.51 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.75 44.14 32.50 -35.24 43.58 31.16 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 87 ALA^? 12.80 ZN ZN B 128 A 257 ALA B 49 ALA^? 16.22 ZN ZN B 128 A 328 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -33.86 50.50 32.29 -34.33 51.24 33.52 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.75 44.14 32.50 -35.24 43.58 31.16 coo 38.17 34.10 6.67 37.72 32.06 6.84 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA C 49 ALA^? 16.41 ZN ZN C 128 A 257 ALA C 71 ALA.? 19.01 ZN ZN C 128 A 328 ASP C 91 ASP.? 22.72 ZN ZN C 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.09 43.99 68.78 1.05 44.60 69.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.22 34.88 70.14 -0.71 32.98 70.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA C 49 ALA^? 16.41 ZN ZN C 128 A 257 ALA C 87 ALA^? 13.17 ZN ZN C 128 A 328 ASP C 90 ASP.? 21.10 ZN ZN C 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.09 43.99 68.78 1.05 44.60 69.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 2.48 41.23 63.72 1.86 39.89 63.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 2.93 33.32 67.19 5.03 33.43 67.23 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA C 49 ALA^? 16.41 ZN ZN C 128 A 257 ALA C 87 ALA^? 13.17 ZN ZN C 128 A 328 ASP C 91 ASP.? 22.72 ZN ZN C 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.09 43.99 68.78 1.05 44.60 69.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 2.48 41.23 63.72 1.86 39.89 63.37 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.22 34.88 70.14 -0.71 32.98 70.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA C 71 ALA.? 19.01 ZN ZN C 128 A 257 ALA C 49 ALA^? 16.41 ZN ZN C 128 A 328 ASP C 91 ASP.? 22.72 ZN ZN C 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.09 43.99 68.78 1.05 44.60 69.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.22 34.88 70.14 -0.71 32.98 70.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA C 87 ALA^? 13.17 ZN ZN C 128 A 257 ALA C 49 ALA^? 16.41 ZN ZN C 128 A 328 ASP C 91 ASP.? 22.72 ZN ZN C 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 2.48 41.23 63.72 1.86 39.89 63.37 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.09 43.99 68.78 1.05 44.60 69.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -1.22 34.88 70.14 -0.71 32.98 70.85 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA D 49 ALA^? 16.16 ZN ZN D 128 A 257 ALA D 87 ALA^? 12.91 ZN ZN D 128 A 328 ASP D 90 ASP.? 20.62 ZN ZN D 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -23.96 25.36 38.04 -24.83 24.52 37.10 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.32 22.30 43.02 -20.89 22.62 43.40 coo 38.17 34.10 6.67 37.72 32.06 6.84 -14.45 19.85 39.76 -14.81 17.95 40.62 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA D 49 ALA^? 16.16 ZN ZN D 128 A 257 ALA D 87 ALA^? 12.91 ZN ZN D 128 A 328 ASP D 91 ASP.? 22.90 ZN ZN D 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -23.96 25.36 38.04 -24.83 24.52 37.10 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.32 22.30 43.02 -20.89 22.62 43.40 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.13 23.89 36.32 -13.65 22.60 35.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA D 71 ALA.? 18.99 ZN ZN D 128 A 257 ALA D 49 ALA^? 16.16 ZN ZN D 128 A 328 ASP D 91 ASP.? 22.90 ZN ZN D 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 43.22 26.73 5.37 41.81 27.09 5.79 -23.96 25.36 38.04 -24.83 24.52 37.10 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.13 23.89 36.32 -13.65 22.60 35.55 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA D 87 ALA^? 12.91 ZN ZN D 128 A 257 ALA D 49 ALA^? 16.16 ZN ZN D 128 A 328 ASP D 91 ASP.? 22.90 ZN ZN D 128 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.32 22.30 43.02 -20.89 22.62 43.40 coo 43.22 26.73 5.37 41.81 27.09 5.79 -23.96 25.36 38.04 -24.83 24.52 37.10 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.13 23.89 36.32 -13.65 22.60 35.55 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 17 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS B 51 LYS^? 16.33 ZN ZN B 128 A 193 GLU B 70 GLU^? 18.94 ZN ZN B 128 A 217 VAL B 50 VAL^? 10.92 ZN ZN B 128 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -29.75 46.77 28.66 -32.67 46.99 23.53 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -31.68 46.25 31.86 -30.63 47.18 33.52 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS C 33 LYS.? 11.91 ZN ZN C 128 A 193 GLU B 103 GLU~? 15.19 ZN ZN C 128 A 217 VAL B 104 VAL~? 12.95 ZN ZN C 128 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -6.57 50.97 46.70 -3.25 53.30 43.27 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -2.48 40.28 42.03 -4.43 39.67 41.46 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -4.99 45.64 42.47 -6.12 46.23 40.69 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS D 33 LYS.? 12.24 ZN ZN D 128 A 193 GLU A 103 GLU~? 15.51 ZN ZN D 128 A 217 VAL A 104 VAL~? 13.08 ZN ZN D 128 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -30.11 33.22 59.92 -32.56 30.92 63.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -20.80 26.87 64.77 -19.76 28.50 65.63 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -25.23 30.59 64.05 -24.48 31.72 65.74 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 3 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 11 THR^? 14.69 ZN ZN D 128 A 159 LYS D 33 LYS.? 12.24 ZN ZN D 128 A 193 GLU A 103 GLU~? 15.51 ZN ZN D 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -21.95 40.72 59.07 -22.88 39.66 60.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -30.11 33.22 59.92 -32.56 30.92 63.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -20.80 26.87 64.77 -19.76 28.50 65.63 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 35 THR.? 8.83 ZN ZN A 128 A 159 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 193 GLU A 58 GLU.? 14.95 ZN ZN A 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -28.69 39.43 70.39 -28.36 40.10 72.45 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -27.08 41.78 78.19 -22.69 42.64 82.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -35.58 45.32 81.43 -37.46 44.65 80.73 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 89 THR.? 18.72 ZN ZN A 128 A 159 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 193 GLU A 28 GLU~? 12.19 ZN ZN A 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -19.06 65.09 74.03 -16.96 64.91 73.52 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -25.66 62.13 69.69 -25.48 65.02 74.91 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -33.40 55.75 75.93 -32.70 57.39 77.09 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 11 THR^? 14.42 ZN ZN C 128 A 159 LYS C 33 LYS.? 11.91 ZN ZN C 128 A 193 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -6.57 50.97 46.70 -3.25 53.30 43.27 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 35 THR.? 8.83 ZN ZN B 128 A 159 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 193 GLU B 58 GLU.? 14.99 ZN ZN B 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -11.91 51.72 35.90 -12.77 51.64 33.90 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -14.88 50.71 28.23 -16.26 47.48 23.80 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -16.19 59.88 24.88 -15.11 61.60 25.47 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 89 THR.? 18.91 ZN ZN B 128 A 159 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 193 GLU B 28 GLU~? 11.81 ZN ZN B 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -39.38 49.52 32.40 -39.94 47.46 32.72 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -34.93 54.65 36.44 -38.00 53.50 31.57 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -26.33 60.76 29.16 -28.24 60.05 29.68 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR C 89 THR.? 19.23 ZN ZN C 128 A 159 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 193 GLU C 28 GLU~? 12.07 ZN ZN C 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 3.40 37.97 68.34 2.23 38.61 70.05 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.64 35.92 60.53 5.63 36.47 64.53 coo -5.33 11.71 69.72 -4.62 11.92 67.73 5.96 41.55 51.41 5.95 40.38 49.65 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR D 89 THR.? 18.97 ZN ZN D 128 A 159 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 193 GLU D 28 GLU.? 12.56 ZN ZN D 128 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -19.13 20.42 38.63 -19.24 21.85 36.98 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -16.96 22.44 46.27 -19.09 18.04 45.40 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -23.77 18.70 55.29 -22.97 18.07 57.14 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 8 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 103 GLU~? 15.51 ZN ZN D 128 A 260 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 270 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 50.99 29.43 12.86 52.11 29.45 14.65 -20.80 26.87 64.77 -19.76 28.50 65.63 coo 39.80 27.50 22.98 42.20 26.56 21.34 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 48.83 21.70 19.50 47.44 24.99 15.25 -30.11 33.22 59.92 -32.56 30.92 63.52 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU B 80 GLU.? 14.47 ZN ZN B 128 A 260 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 270 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 50.99 29.43 12.86 52.11 29.45 14.65 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 39.80 27.50 22.98 42.20 26.56 21.34 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 48.83 21.70 19.50 47.44 24.99 15.25 -14.69 55.97 38.01 -16.66 60.81 39.16 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 2 hits 1euy_c00 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 159 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 162 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 0.65 56.08 51.29 4.22 57.96 54.91 coo 29.80 39.37 7.24 28.18 38.06 7.48 0.61 46.90 50.78 -0.23 46.71 52.70 coo 30.26 35.04 5.34 28.61 35.92 4.39 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 2 3 # 2 A 156 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 159 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 162 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 29.80 39.37 7.24 28.18 38.06 7.48 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 30.26 35.04 5.34 28.61 35.92 4.39 -31.62 26.29 51.88 -30.63 27.88 52.82 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 2 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS C 30 HIS^? -3.56 ZN ZN C 128s C 62 LYS C 51 LYS^? 16.36 ZN ZN C 128 F 35 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 15.40 22.79 16.66 13.93 24.10 15.98 0.61 46.90 50.78 -0.23 46.71 52.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 2.93 47.75 63.91 7.07 48.43 67.33 coo 16.32 15.30 17.19 17.71 14.73 18.69 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS D 30 HIS^? -3.68 ZN ZN D 128s C 62 LYS D 51 LYS^? 16.00 ZN ZN D 128 F 35 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 15.40 22.79 16.66 13.93 24.10 15.98 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 19.95 18.98 4.81 18.82 20.94 10.49 -28.66 23.49 42.59 -29.87 18.31 40.35 coo 16.32 15.30 17.19 17.71 14.73 18.69 -29.32 31.61 55.53 -28.20 30.46 54.16 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 2 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 51 LYS^? 15.98 ZN ZN A 128 C 105 HIS A 30 HIS.? -4.18 ZN ZN A 128s D 35 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 38.76 28.25 7.87 36.33 26.41 13.58 -19.26 55.16 77.77 -19.13 57.75 83.14 coo 34.93 19.72 17.37 34.72 18.17 15.98 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 41.01 23.02 20.83 40.65 24.26 22.55 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 51 LYS^? 16.33 ZN ZN B 128 C 105 HIS B 30 HIS.? -4.20 ZN ZN B 128s D 35 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 38.76 28.25 7.87 36.33 26.41 13.58 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 34.93 19.72 17.37 34.72 18.17 15.98 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 41.01 23.02 20.83 40.65 24.26 22.55 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS C 51 LYS^? 16.36 ZN ZN C 128 C 105 HIS C 30 HIS^? -3.56 ZN ZN C 128s D 35 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 38.76 28.25 7.87 36.33 26.41 13.58 2.93 47.75 63.91 7.07 48.43 67.33 coo 34.93 19.72 17.37 34.72 18.17 15.98 0.61 46.90 50.78 -0.23 46.71 52.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS D 51 LYS^? 16.00 ZN ZN D 128 C 105 HIS D 30 HIS^? -3.68 ZN ZN D 128s D 35 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 38.76 28.25 7.87 36.33 26.41 13.58 -28.66 23.49 42.59 -29.87 18.31 40.35 coo 34.93 19.72 17.37 34.72 18.17 15.98 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 41.01 23.02 20.83 40.65 24.26 22.55 -29.32 31.61 55.53 -28.20 30.46 54.16 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c04 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE C 77 PHE.? 5.68 ZN ZN C 128 A 210 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 244 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 9.23 46.77 25.11 11.48 48.39 24.76 -3.10 52.12 57.92 -2.59 49.92 59.60 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -1.20 42.34 17.67 3.19 45.13 19.06 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE D 77 PHE.? 5.25 ZN ZN D 128 A 210 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 244 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.30 30.46 48.64 -29.26 29.22 47.17 coo 10.51 37.86 19.71 9.07 39.38 20.04 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -1.20 42.34 17.67 3.19 45.13 19.06 -30.11 33.22 59.92 -32.56 30.92 63.52 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE C 77 PHE.? 5.68 ZN ZN C 128 B 210 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 244 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 8.76 47.85 34.91 11.08 46.36 35.41 -3.10 52.12 57.92 -2.59 49.92 59.60 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -2.38 51.82 41.62 2.07 49.19 40.42 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE D 77 PHE.? 5.25 ZN ZN D 128 B 210 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 244 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.30 30.46 48.64 -29.26 29.22 47.17 coo 9.06 56.85 40.30 7.71 55.27 39.90 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -2.38 51.82 41.62 2.07 49.19 40.42 -30.11 33.22 59.92 -32.56 30.92 63.52 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR C 52 TYR^? 7.59 ZN ZN C 128 A 142 LEU C 2 LEU.? 13.41 ZN ZN C 128 A 165 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 1.13 52.00 59.76 1.13 53.77 57.61 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -4.99 59.57 60.62 -5.25 60.21 58.58 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR D 52 TYR^? 7.54 ZN ZN D 128 A 142 LEU D 2 LEU.? 13.41 ZN ZN D 128 A 165 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -32.42 26.30 46.60 -34.28 26.82 48.63 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -38.22 34.22 45.30 -38.58 34.48 47.41 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -28.66 23.49 42.59 -29.87 18.31 40.35 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 52 TYR^? 7.20 ZN ZN A 128 B 142 LEU A 2 LEU.? 13.32 ZN ZN A 128 B 165 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -20.95 49.22 77.42 -22.18 46.73 77.85 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -15.57 40.98 75.17 -16.63 40.33 76.94 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 52 TYR^? 7.51 ZN ZN B 128 B 142 LEU B 2 LEU.? 13.10 ZN ZN B 128 B 165 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -23.54 46.80 28.87 -20.82 47.32 28.41 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -17.23 39.30 31.08 -16.79 40.87 29.68 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR C 52 TYR^? 7.59 ZN ZN C 128 B 142 LEU C 2 LEU.? 13.41 ZN ZN C 128 B 165 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 1.13 52.00 59.76 1.13 53.77 57.61 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -4.99 59.57 60.62 -5.25 60.21 58.58 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR D 52 TYR^? 7.54 ZN ZN D 128 B 142 LEU D 2 LEU.? 13.41 ZN ZN D 128 B 165 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -32.42 26.30 46.60 -34.28 26.82 48.63 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -38.22 34.22 45.30 -38.58 34.48 47.41 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -28.66 23.49 42.59 -29.87 18.31 40.35 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 52 TYR^? 7.20 ZN ZN A 128 C 142 LEU A 2 LEU.? 13.32 ZN ZN A 128 C 165 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -20.95 49.22 77.42 -22.18 46.73 77.85 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -15.57 40.98 75.17 -16.63 40.33 76.94 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 52 TYR^? 7.51 ZN ZN B 128 C 142 LEU B 2 LEU.? 13.10 ZN ZN B 128 C 165 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -23.54 46.80 28.87 -20.82 47.32 28.41 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -17.23 39.30 31.08 -16.79 40.87 29.68 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR C 52 TYR^? 7.59 ZN ZN C 128 C 142 LEU C 2 LEU.? 13.41 ZN ZN C 128 C 165 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 1.13 52.00 59.76 1.13 53.77 57.61 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -4.99 59.57 60.62 -5.25 60.21 58.58 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR D 52 TYR^? 7.54 ZN ZN D 128 C 142 LEU D 2 LEU.? 13.41 ZN ZN D 128 C 165 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -32.42 26.30 46.60 -34.28 26.82 48.63 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -38.22 34.22 45.30 -38.58 34.48 47.41 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -28.66 23.49 42.59 -29.87 18.31 40.35 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 52 TYR^? 7.20 ZN ZN A 128 D 142 LEU A 2 LEU.? 13.32 ZN ZN A 128 D 165 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -20.95 49.22 77.42 -22.18 46.73 77.85 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -15.57 40.98 75.17 -16.63 40.33 76.94 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 52 TYR^? 7.51 ZN ZN B 128 D 142 LEU B 2 LEU.? 13.10 ZN ZN B 128 D 165 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -23.54 46.80 28.87 -20.82 47.32 28.41 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -17.23 39.30 31.08 -16.79 40.87 29.68 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR C 52 TYR^? 7.59 ZN ZN C 128 D 142 LEU C 2 LEU.? 13.41 ZN ZN C 128 D 165 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 1.13 52.00 59.76 1.13 53.77 57.61 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -4.99 59.57 60.62 -5.25 60.21 58.58 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR D 52 TYR^? 7.54 ZN ZN D 128 D 142 LEU D 2 LEU.? 13.41 ZN ZN D 128 D 165 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -32.42 26.30 46.60 -34.28 26.82 48.63 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -38.22 34.22 45.30 -38.58 34.48 47.41 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -28.66 23.49 42.59 -29.87 18.31 40.35 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER C 13 SER^? 14.25 ZN ZN C 128 A 48 THR C 14 THR.? 9.55 ZN ZN C 128 A 165 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -11.64 41.49 55.94 -9.73 42.48 56.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -6.57 50.97 46.70 -3.25 53.30 43.27 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER C 13 SER^? 14.25 ZN ZN C 128 B 48 THR C 14 THR.? 9.55 ZN ZN C 128 B 165 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -11.64 41.49 55.94 -9.73 42.48 56.15 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -6.57 50.97 46.70 -3.25 53.30 43.27 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER C 13 SER^? 14.25 ZN ZN C 128 C 48 THR C 14 THR.? 9.55 ZN ZN C 128 C 165 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -11.64 41.49 55.94 -9.73 42.48 56.15 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -6.57 50.97 46.70 -3.25 53.30 43.27 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 13 SER^? 14.04 ZN ZN A 128 D 48 THR A 14 THR.? 9.34 ZN ZN A 128 D 165 LYS A 33 LYS.? 11.45 ZN ZN A 128 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -23.51 50.82 61.06 -23.73 50.87 63.22 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -32.13 43.51 68.59 -35.31 47.47 65.43 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 13 SER^? 13.94 ZN ZN B 128 D 48 THR B 14 THR.? 9.29 ZN ZN B 128 D 165 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -24.73 49.75 45.33 -24.61 49.96 43.21 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER C 13 SER^? 14.25 ZN ZN C 128 D 48 THR C 14 THR.? 9.55 ZN ZN C 128 D 165 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -11.64 41.49 55.94 -9.73 42.48 56.15 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER D 13 SER^? 14.41 ZN ZN D 128 D 48 THR D 14 THR.? 9.56 ZN ZN D 128 D 165 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -18.99 35.81 50.60 -20.41 34.18 50.44 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -30.11 33.22 59.92 -32.56 30.92 63.52 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c07 naa= 3 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 1 3 # 1 B 267 ASP A 57 ASP.? 17.22 ZN ZN A 128 B 268 HIS A 59 HIS.? 17.66 ZN ZN A 128 B 334 TYR A 55 TYR^? 11.76 ZN ZN A 128 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -27.79 47.98 83.72 -27.46 50.77 83.49 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 2 3 # 2 B 267 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 268 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 334 TYR A 93 TYR^? 17.82 ZN ZN A 128 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -17.49 60.90 64.70 -15.26 61.56 63.14 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 3 3 # 3 B 267 ASP B 57 ASP.? 17.37 ZN ZN B 128 B 268 HIS B 59 HIS.? 17.68 ZN ZN B 128 B 334 TYR B 55 TYR.? 11.96 ZN ZN B 128 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -20.53 53.10 22.67 -23.31 53.51 22.82 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 4 3 # 4 B 267 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 268 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 334 TYR C 55 TYR.? 11.30 ZN ZN C 128 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 8.18 57.58 47.56 10.27 57.39 47.78 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 11.45 52.92 44.80 10.43 52.05 43.19 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 8.07 52.98 53.71 8.63 50.62 55.11 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 5 3 # 5 B 267 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 268 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 334 TYR C 93 TYR^? 17.98 ZN ZN C 128 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -6.81 37.29 66.15 -8.85 36.99 68.07 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 6 3 # 6 B 267 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 268 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 334 TYR D 55 TYR.? 11.30 ZN ZN D 128 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -35.27 19.83 52.49 -33.13 18.64 51.13 1fgj_c01 source 1fgj HYDROXYLAMINE OXIDOREDUCTASE : 6 hits 1fgj_c01 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 136 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 246 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 13.48 30.30 107.06 11.75 30.99 109.44 7.46 50.67 50.27 10.29 51.53 51.14 coo 9.46 32.37 115.82 8.50 34.20 115.47 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 11.99 34.33 109.92 10.08 34.19 110.77 7.13 51.72 45.00 6.65 51.50 42.95 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 1 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 136 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 246 GLU C 58 GLU.? 14.59 ZN ZN C 128 coo 13.94 29.84 106.80 11.67 30.40 108.79 7.46 50.67 50.27 10.29 51.53 51.14 coo 9.52 31.97 115.23 8.45 33.74 114.72 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 11.92 33.82 109.35 10.10 33.50 110.39 7.13 51.72 45.00 6.65 51.50 42.95 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 1 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 281 ARG A 42 ARG^? 15.09 ZN ZN A 128 A 289 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 54.86 40.00 47.23 55.57 38.60 48.67 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 52.08 40.18 50.14 50.83 38.93 47.73 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 57.82 31.70 50.73 57.94 34.00 49.17 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 281 ARG B 42 ARG^? 15.17 ZN ZN B 128 A 289 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 54.86 40.00 47.23 55.57 38.60 48.67 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 52.08 40.18 50.14 50.83 38.93 47.73 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 57.82 31.70 50.73 57.94 34.00 49.17 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 281 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 289 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 54.86 40.00 47.23 55.57 38.60 48.67 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 52.08 40.18 50.14 50.83 38.93 47.73 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 57.82 31.70 50.73 57.94 34.00 49.17 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 4 3 # 4 A 54 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 281 ARG D 42 ARG^? 14.89 ZN ZN D 128 A 289 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 54.86 40.00 47.23 55.57 38.60 48.67 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 52.08 40.18 50.14 50.83 38.93 47.73 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 57.82 31.70 50.73 57.94 34.00 49.17 -34.73 38.00 51.16 -37.53 38.10 51.02 1foh_c00 source 1foh PHENOL HYDROXYLASE : 4 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 281 ARG A 42 ARG^? 15.09 ZN ZN A 128 B 289 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 90.56 80.24 98.04 90.36 81.53 96.34 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 86.62 80.67 97.51 87.37 82.00 100.10 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 91.83 88.28 92.88 92.60 85.93 94.14 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 281 ARG B 42 ARG^? 15.17 ZN ZN B 128 B 289 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 90.56 80.24 98.04 90.36 81.53 96.34 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 86.62 80.67 97.51 87.37 82.00 100.10 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 91.83 88.28 92.88 92.60 85.93 94.14 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 281 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 289 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 90.56 80.24 98.04 90.36 81.53 96.34 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 86.62 80.67 97.51 87.37 82.00 100.10 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 91.83 88.28 92.88 92.60 85.93 94.14 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 281 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 289 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 90.56 80.24 98.04 90.36 81.53 96.34 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 86.62 80.67 97.51 87.37 82.00 100.10 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 91.83 88.28 92.88 92.60 85.93 94.14 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 5 3 # 5 B 54 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 281 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 289 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 90.56 80.24 98.04 90.36 81.53 96.34 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 86.62 80.67 97.51 87.37 82.00 100.10 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 91.83 88.28 92.88 92.60 85.93 94.14 -34.73 38.00 51.16 -37.53 38.10 51.02 1foh_c01 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 281 ARG A 42 ARG^? 15.09 ZN ZN A 128 C 289 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 46.12 77.15 48.13 44.44 77.61 45.70 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 42.69 86.18 51.69 41.59 83.63 51.54 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 281 ARG A 42 ARG^? 15.09 ZN ZN A 128 C 289 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 46.12 77.15 48.13 44.44 77.61 45.70 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 42.69 86.18 51.69 41.59 83.63 51.54 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 281 ARG B 42 ARG^? 15.17 ZN ZN B 128 C 289 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 46.12 77.15 48.13 44.44 77.61 45.70 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 42.69 86.18 51.69 41.59 83.63 51.54 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 281 ARG B 42 ARG^? 15.17 ZN ZN B 128 C 289 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 46.12 77.15 48.13 44.44 77.61 45.70 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 42.69 86.18 51.69 41.59 83.63 51.54 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 5 3 # 5 C 54 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 281 ARG C 42 ARG^? 15.11 ZN ZN C 128 C 289 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 46.12 77.15 48.13 44.44 77.61 45.70 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 42.69 86.18 51.69 41.59 83.63 51.54 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 6 3 # 6 C 54 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 281 ARG C 42 ARG^? 15.11 ZN ZN C 128 C 289 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 46.12 77.15 48.13 44.44 77.61 45.70 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 42.69 86.18 51.69 41.59 83.63 51.54 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 7 3 # 7 C 54 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 281 ARG D 42 ARG^? 14.89 ZN ZN D 128 C 289 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 46.12 77.15 48.13 44.44 77.61 45.70 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 42.69 86.18 51.69 41.59 83.63 51.54 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 8 3 # 8 C 54 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 281 ARG D 42 ARG^? 14.89 ZN ZN D 128 C 289 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 42.34 76.83 49.10 43.06 78.59 50.01 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 46.12 77.15 48.13 44.44 77.61 45.70 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 42.69 86.18 51.69 41.59 83.63 51.54 -34.73 38.00 51.16 -37.53 38.10 51.02 1foh_c02 source 1foh PHENOL HYDROXYLASE : 8 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 D 281 ARG A 42 ARG^? 15.09 ZN ZN A 128 D 289 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 78.52 44.93 104.78 78.72 44.49 107.76 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 72.35 36.51 104.82 72.00 39.20 105.46 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 D 281 ARG A 42 ARG^? 15.09 ZN ZN A 128 D 289 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 78.52 44.93 104.78 78.72 44.49 107.76 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 72.35 36.51 104.82 72.00 39.20 105.46 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 D 281 ARG B 42 ARG^? 15.17 ZN ZN B 128 D 289 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 78.52 44.93 104.78 78.72 44.49 107.76 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 72.35 36.51 104.82 72.00 39.20 105.46 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 4 3 # 4 D 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 D 281 ARG B 42 ARG^? 15.17 ZN ZN B 128 D 289 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 78.52 44.93 104.78 78.72 44.49 107.76 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 72.35 36.51 104.82 72.00 39.20 105.46 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 5 3 # 5 D 54 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 281 ARG C 42 ARG^? 15.11 ZN ZN C 128 D 289 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 78.52 44.93 104.78 78.72 44.49 107.76 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 72.35 36.51 104.82 72.00 39.20 105.46 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 6 3 # 6 D 54 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 281 ARG C 42 ARG^? 15.11 ZN ZN C 128 D 289 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 78.52 44.93 104.78 78.72 44.49 107.76 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 72.35 36.51 104.82 72.00 39.20 105.46 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 7 3 # 7 D 54 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 281 ARG D 42 ARG^? 14.89 ZN ZN D 128 D 289 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 78.52 44.93 104.78 78.72 44.49 107.76 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 72.35 36.51 104.82 72.00 39.20 105.46 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 8 3 # 8 D 54 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 281 ARG D 42 ARG^? 14.89 ZN ZN D 128 D 289 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 75.05 45.80 106.18 74.73 43.88 105.51 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 78.52 44.93 104.78 78.72 44.49 107.76 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 72.35 36.51 104.82 72.00 39.20 105.46 -34.73 38.00 51.16 -37.53 38.10 51.02 1foh_c03 source 1foh PHENOL HYDROXYLASE : 8 hits 1foh_c03 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 33 LYS.? 11.45 ZN ZN A 128 A 331 GLU A 28 GLU~? 12.19 ZN ZN A 128 B 188 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 130.22 155.23 83.49 125.21 153.71 84.04 -32.13 43.51 68.59 -35.31 47.47 65.43 coo 120.90 152.23 75.28 120.94 153.09 77.19 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 122.04 152.80 81.06 120.71 154.37 81.46 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 331 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 188 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 130.22 155.23 83.49 125.21 153.71 84.04 0.65 56.08 51.29 4.22 57.96 54.91 coo 120.90 152.23 75.28 120.94 153.09 77.19 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 122.04 152.80 81.06 120.71 154.37 81.46 0.61 46.90 50.78 -0.23 46.71 52.70 1fuq_c00 source 1fuq FUMARASE C : 2 hits 1fuq_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 201 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 204 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.88 50.97 54.56 -1.00 50.36 53.86 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -20.72 56.25 32.46 -21.75 54.52 33.04 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 3 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 28 GLU~? 12.19 ZN ZN A 128 516 HIS A 83 HIS^? -3.82 ZN ZN A 128s 559 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 49.01 14.50 52.53 46.99 14.61 52.78 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 41.59 7.83 54.15 41.16 9.87 53.87 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 42.22 14.55 52.50 43.91 14.87 53.60 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU A 107 GLU.? 11.70 ZN ZN D 128 516 HIS D 83 HIS^? -3.55 ZN ZN D 128s 559 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 49.01 14.50 52.53 46.99 14.61 52.78 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 41.59 7.83 54.15 41.16 9.87 53.87 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 42.22 14.55 52.50 43.91 14.87 53.60 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU B 28 GLU~? 11.81 ZN ZN B 128 516 HIS B 83 HIS^? -3.82 ZN ZN B 128s 559 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 49.01 14.50 52.53 46.99 14.61 52.78 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 41.59 7.83 54.15 41.16 9.87 53.87 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 42.22 14.55 52.50 43.91 14.87 53.60 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU B 107 GLU.? 12.06 ZN ZN C 128 516 HIS C 83 HIS^? -3.45 ZN ZN C 128s 559 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 49.01 14.50 52.53 46.99 14.61 52.78 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 41.59 7.83 54.15 41.16 9.87 53.87 0.88 50.97 54.56 -1.00 50.36 53.86 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU C 28 GLU~? 12.07 ZN ZN C 128 516 HIS C 83 HIS^? -3.45 ZN ZN C 128s 559 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.96 41.55 51.41 5.95 40.38 49.65 coo 41.59 7.83 54.15 41.16 9.87 53.87 0.88 50.97 54.56 -1.00 50.36 53.86 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU D 28 GLU.? 12.56 ZN ZN D 128 516 HIS D 83 HIS^? -3.55 ZN ZN D 128s 559 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 49.01 14.50 52.53 46.99 14.61 52.78 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 41.59 7.83 54.15 41.16 9.87 53.87 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 42.22 14.55 52.50 43.91 14.87 53.60 -27.59 25.34 55.74 -27.28 26.44 53.99 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 6 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 47 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 161 TYR B 55 TYR.? 11.96 ZN ZN B 128 coo 37.12 18.35 73.76 37.09 16.69 72.44 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 29.81 8.06 73.13 30.21 10.11 72.95 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 37.29 15.56 67.90 37.37 13.79 70.08 -20.53 53.10 22.67 -23.31 53.51 22.82 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU B 58 GLU.? 14.99 ZN ZN B 128 B 47 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 161 TYR B 55 TYR.? 11.96 ZN ZN B 128 coo 53.87 35.49 53.22 55.44 35.72 54.61 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 63.47 43.65 53.95 61.45 43.07 54.06 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 56.38 35.81 59.19 58.25 35.77 57.10 -20.53 53.10 22.67 -23.31 53.51 22.82 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 64 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 155 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo 3.12 38.70 24.20 3.24 38.59 26.33 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 1.90 38.00 29.77 3.91 38.35 29.95 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 9.89 36.55 37.38 9.27 37.99 36.08 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 64 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 155 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo 3.12 38.70 24.20 3.24 38.59 26.33 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 1.90 38.00 29.77 3.91 38.35 29.95 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 9.89 36.55 37.38 9.27 37.99 36.08 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 64 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 155 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo 3.12 38.70 24.20 3.24 38.59 26.33 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 1.90 38.00 29.77 3.91 38.35 29.95 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 9.89 36.55 37.38 9.27 37.99 36.08 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 64 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 155 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo 3.12 38.70 24.20 3.24 38.59 26.33 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 1.90 38.00 29.77 3.91 38.35 29.95 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 9.89 36.55 37.38 9.27 37.99 36.08 -19.89 34.86 45.47 -21.06 36.60 45.16 1gns_c00 source 1gns SUBTILISIN BPN' : 4 hits 1gns_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 108 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 144 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 51.28 61.14 17.85 51.16 61.61 19.96 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 52.62 57.63 23.12 50.77 57.51 22.26 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 46.65 56.95 20.09 48.42 58.17 20.01 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 108 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 144 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 51.28 61.14 17.85 51.16 61.61 19.96 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 52.62 57.63 23.12 50.77 57.51 22.26 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 46.65 56.95 20.09 48.42 58.17 20.01 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 108 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 144 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 51.28 61.14 17.85 51.16 61.61 19.96 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 52.62 57.63 23.12 50.77 57.51 22.26 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 46.65 56.95 20.09 48.42 58.17 20.01 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 108 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 144 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 51.28 61.14 17.85 51.16 61.61 19.96 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 52.62 57.63 23.12 50.77 57.51 22.26 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 46.65 56.95 20.09 48.42 58.17 20.01 -25.08 39.18 47.70 -23.31 39.57 46.61 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 4 hits 1grc_c02 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 84 ASN^? 8.90 ZN ZN A 128 B 108 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 144 ASP A 57 ASP.? 17.22 ZN ZN A 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 -27.80 52.43 77.67 -27.36 52.78 79.72 coo 41.00 107.18 12.86 42.70 107.82 11.96 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 31.60 110.69 6.14 29.69 109.74 5.94 -31.66 41.62 85.16 -32.16 42.63 86.92 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN B 84 ASN^? 9.22 ZN ZN B 128 B 108 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 144 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 -24.87 54.45 28.53 -25.79 53.87 26.69 coo 41.00 107.18 12.86 42.70 107.82 11.96 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 31.60 110.69 6.14 29.69 109.74 5.94 -13.57 55.26 21.18 -14.41 55.74 19.31 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN B 84 ASN^? 9.22 ZN ZN B 128 B 108 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 144 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 -24.87 54.45 28.53 -25.79 53.87 26.69 coo 41.00 107.18 12.86 42.70 107.82 11.96 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 31.60 110.69 6.14 29.69 109.74 5.94 -13.57 55.26 21.18 -14.41 55.74 19.31 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN B 84 ASN^? 9.22 ZN ZN B 128 B 108 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 144 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 -24.87 54.45 28.53 -25.79 53.87 26.69 coo 41.00 107.18 12.86 42.70 107.82 11.96 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 31.60 110.69 6.14 29.69 109.74 5.94 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 B 106 ASN C 84 ASN^? 8.97 ZN ZN C 128 B 108 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 144 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 4.63 46.66 55.03 6.28 47.10 56.31 coo 41.00 107.18 12.86 42.70 107.82 11.96 0.61 46.90 50.78 -0.23 46.71 52.70 coo 31.60 110.69 6.14 29.69 109.74 5.94 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 B 106 ASN C 84 ASN^? 8.97 ZN ZN C 128 B 108 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 144 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 4.63 46.66 55.03 6.28 47.10 56.31 coo 41.00 107.18 12.86 42.70 107.82 11.96 0.88 50.97 54.56 -1.00 50.36 53.86 coo 31.60 110.69 6.14 29.69 109.74 5.94 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 3 # 7 B 106 ASN C 84 ASN^? 8.97 ZN ZN C 128 B 108 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 144 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 4.63 46.66 55.03 6.28 47.10 56.31 coo 41.00 107.18 12.86 42.70 107.82 11.96 0.88 50.97 54.56 -1.00 50.36 53.86 coo 31.60 110.69 6.14 29.69 109.74 5.94 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 3 # 8 B 106 ASN D 84 ASN^? 8.98 ZN ZN D 128 B 108 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 144 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 -28.44 21.48 51.55 -28.88 19.99 50.09 coo 41.00 107.18 12.86 42.70 107.82 11.96 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 3 # 9 B 106 ASN D 84 ASN^? 8.98 ZN ZN D 128 B 108 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 144 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 -28.44 21.48 51.55 -28.88 19.99 50.09 coo 41.00 107.18 12.86 42.70 107.82 11.96 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 31.60 110.69 6.14 29.69 109.74 5.94 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 10 3 # 10 B 106 ASN D 84 ASN^? 8.98 ZN ZN D 128 B 108 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 144 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 36.64 101.02 13.15 38.55 101.84 12.78 -28.44 21.48 51.55 -28.88 19.99 50.09 coo 41.00 107.18 12.86 42.70 107.82 11.96 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 31.60 110.69 6.14 29.69 109.74 5.94 -41.38 20.76 48.99 -40.62 22.36 50.18 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 10 hits 1grc_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 81 LYS.? 12.55 ZN ZN A 128 210 ARG A 12 ARG^? 10.24 ZN ZN A 128 225 ARG D 36 ARG.? 10.17 ZN ZN A 128 coo 17.51 28.50 73.42 17.24 23.02 75.86 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 24.74 11.56 73.05 25.29 14.32 71.80 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 27.81 15.44 77.10 25.66 16.50 75.19 -32.18 43.37 61.68 -31.14 45.24 63.88 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 81 LYS.? 12.55 ZN ZN A 128 210 ARG D 36 ARG.? 10.17 ZN ZN A 128 225 ARG A 12 ARG^? 10.24 ZN ZN A 128 coo 17.51 28.50 73.42 17.24 23.02 75.86 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 24.74 11.56 73.05 25.29 14.32 71.80 -32.18 43.37 61.68 -31.14 45.24 63.88 coo 27.81 15.44 77.10 25.66 16.50 75.19 -26.71 45.35 59.66 -27.06 47.43 61.87 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 81 LYS.? 12.71 ZN ZN B 128 210 ARG B 12 ARG^? 9.84 ZN ZN B 128 225 ARG C 36 ARG.? 10.67 ZN ZN B 128 coo 17.51 28.50 73.42 17.24 23.02 75.86 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 24.74 11.56 73.05 25.29 14.32 71.80 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 27.81 15.44 77.10 25.66 16.50 75.19 -15.69 56.10 43.84 -17.06 58.00 41.84 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 81 LYS.? 12.71 ZN ZN B 128 210 ARG C 36 ARG.? 10.67 ZN ZN B 128 225 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 17.51 28.50 73.42 17.24 23.02 75.86 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 24.74 11.56 73.05 25.29 14.32 71.80 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 27.81 15.44 77.10 25.66 16.50 75.19 -19.64 50.95 45.34 -21.61 53.09 44.31 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 4 hits 1gsa_c00 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 73 GLN.? 17.59 ZN ZN A 128 A 296 GLU A 70 GLU^? 19.90 ZN ZN A 128 A 383 TYR A 52 TYR^? 7.20 ZN ZN A 128 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -9.15 53.35 73.23 -9.40 53.35 75.36 coo 40.93 4.45 2.36 38.91 3.75 2.26 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 30.54 7.22 6.23 31.38 5.79 3.97 -20.95 49.22 77.42 -22.18 46.73 77.85 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN C 73 GLN^? 18.24 ZN ZN C 128 A 296 GLU C 70 GLU^? 19.15 ZN ZN C 128 A 383 TYR C 52 TYR^? 7.59 ZN ZN C 128 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -5.47 50.48 71.48 -3.53 51.28 71.85 coo 40.93 4.45 2.36 38.91 3.75 2.26 -0.72 48.58 72.21 1.10 47.61 72.77 coo 30.54 7.22 6.23 31.38 5.79 3.97 1.13 52.00 59.76 1.13 53.77 57.61 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN D 73 GLN^? 18.12 ZN ZN D 128 A 296 GLU D 70 GLU^? 19.86 ZN ZN D 128 A 383 TYR D 52 TYR^? 7.54 ZN ZN D 128 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -28.90 32.15 35.00 -30.16 30.48 34.54 coo 40.93 4.45 2.36 38.91 3.75 2.26 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 30.54 7.22 6.23 31.38 5.79 3.97 -32.42 26.30 46.60 -34.28 26.82 48.63 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 3 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 327 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 339 ARG B 29 ARG.? 13.89 ZN ZN B 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 82.23 40.35 159.87 85.09 40.67 161.01 -20.37 56.56 24.53 -21.49 56.80 21.70 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 327 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 339 ARG B 29 ARG.? 13.89 ZN ZN B 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 82.23 40.35 159.87 85.09 40.67 161.01 -20.37 56.56 24.53 -21.49 56.80 21.70 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 327 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 339 ARG A 29 ARG.? 13.64 ZN ZN A 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.22 50.95 82.45 -31.20 48.79 84.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 327 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 339 ARG A 29 ARG.? 13.64 ZN ZN A 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.22 50.95 82.45 -31.20 48.79 84.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 327 GLU A 80 GLU.? 14.45 ZN ZN A 128 A 339 ARG A 36 ARG.? 14.54 ZN ZN D 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 8.18 57.58 47.56 10.27 57.39 47.78 coo 75.11 41.01 160.30 76.65 40.06 161.41 -27.62 36.67 74.75 -28.01 34.63 75.18 coo 82.23 40.35 159.87 85.09 40.67 161.01 -29.05 33.74 68.19 -28.81 35.05 65.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 327 GLU A 107 GLU.? 11.70 ZN ZN D 128 A 339 ARG A 36 ARG.? 14.54 ZN ZN D 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 8.74 58.91 56.74 6.81 58.81 55.87 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 -29.05 33.74 68.19 -28.81 35.05 65.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 327 GLU B 80 GLU.? 14.47 ZN ZN B 128 A 339 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 75.11 41.01 160.30 76.65 40.06 161.41 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 -7.28 49.73 38.22 -8.28 50.76 40.96 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 327 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 339 ARG B 29 ARG.? 13.89 ZN ZN B 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 82.23 40.35 159.87 85.09 40.67 161.01 -20.37 56.56 24.53 -21.49 56.80 21.70 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 327 GLU B 80 GLU.? 14.47 ZN ZN B 128 A 339 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 82.23 40.35 159.87 85.09 40.67 161.01 -7.28 49.73 38.22 -8.28 50.76 40.96 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 327 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 339 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo 85.81 57.99 116.01 86.03 55.86 115.89 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 82.23 40.35 159.87 85.09 40.67 161.01 -7.28 49.73 38.22 -8.28 50.76 40.96 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 10 hits 1hto_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 200 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 226 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 23.24 46.58 4.39 24.43 46.59 2.66 0.61 46.90 50.78 -0.23 46.71 52.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 34.47 51.09 7.19 28.58 51.18 7.53 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 200 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 226 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 23.24 46.58 4.39 24.43 46.59 2.66 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 -28.66 23.49 42.59 -29.87 18.31 40.35 1i29_c01 source 1i29 CSDB : 2 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL B 45 VAL^? 13.72 ZN ZN B 128 A 200 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 226 LYS C 113 LYS.? 25.09 ZN ZN B 128 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -31.49 42.50 37.64 -32.37 43.25 35.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 34.47 51.09 7.19 28.58 51.18 7.53 -39.27 61.49 31.97 -43.88 61.90 29.42 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL B 76 VAL^? 11.00 ZN ZN B 128 A 200 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 226 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -20.22 41.36 34.04 -18.65 40.30 35.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 34.47 51.09 7.19 28.58 51.18 7.53 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL C 45 VAL^? 14.04 ZN ZN C 128 A 200 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 226 LYS C 33 LYS.? 11.91 ZN ZN C 128 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -6.16 44.59 66.61 -4.46 45.02 67.90 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 34.47 51.09 7.19 28.58 51.18 7.53 -6.57 50.97 46.70 -3.25 53.30 43.27 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL D 45 VAL^? 13.71 ZN ZN D 128 A 200 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 226 LYS D 33 LYS.? 12.24 ZN ZN D 128 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.29 31.37 39.73 -23.83 29.32 39.37 coo 24.51 43.28 11.18 25.17 44.50 9.58 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 34.47 51.09 7.19 28.58 51.18 7.53 -30.11 33.22 59.92 -32.56 30.92 63.52 1i29_c03 source 1i29 CSDB : 4 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER B 13 SER^? 13.94 ZN ZN B 128 A 173 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 211 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 18.77 77.82 11.69 20.55 80.22 10.73 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -21.74 43.31 43.14 -23.53 43.14 44.28 1ig8_c00 source 1ig8 HEXOKINASE PII : 1 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 32 ASP.? -2.97 ZN ZN A 128s 158 THR D 35 THR.? 11.51 ZN ZN A 128 317 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -28.60 38.86 63.25 -27.28 40.41 64.00 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 158 THR A 11 THR^? 14.69 ZN ZN D 128 317 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -21.95 40.72 59.07 -22.88 39.66 60.69 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 97 ASP^? 13.17 ZN ZN A 128 158 THR A 14 THR.? 9.34 ZN ZN A 128 317 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -23.51 50.82 61.06 -23.73 50.87 63.22 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 32 ASP.? -2.88 ZN ZN B 128s 158 THR C 35 THR.? 11.32 ZN ZN B 128 317 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -12.31 51.29 42.82 -14.33 50.63 43.21 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 158 THR B 11 THR^? 14.42 ZN ZN C 128 317 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -15.35 45.63 47.22 -13.97 46.20 45.66 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP B 97 ASP^? 13.03 ZN ZN B 128 158 THR B 14 THR.? 9.29 ZN ZN B 128 317 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -24.73 49.75 45.33 -24.61 49.96 43.21 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -16.91 52.67 35.82 -18.80 51.89 35.31 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 6 hits 1inp_c02 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 28 GLU~? 12.19 ZN ZN A 128 A 61 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 162 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -33.40 55.75 75.93 -32.70 57.39 77.09 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -35.58 45.32 81.43 -37.46 44.65 80.73 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 61 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 162 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -26.33 60.76 29.16 -28.24 60.05 29.68 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -16.19 59.88 24.88 -15.11 61.60 25.47 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 61 GLU C 80 GLU.? 11.53 ZN ZN C 128 A 162 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -0.05 48.66 43.11 -0.32 50.61 42.31 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -4.16 58.03 47.91 -5.06 56.59 46.66 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 61 GLU B 103 GLU~? 15.19 ZN ZN C 128 A 162 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.96 41.55 51.41 5.95 40.38 49.65 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -2.48 40.28 42.03 -4.43 39.67 41.46 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 5 3 # 5 A 14 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 61 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 162 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.96 41.55 51.41 5.95 40.38 49.65 coo -4.89 20.85 5.22 -3.95 21.69 6.91 7.13 51.72 45.00 6.65 51.50 42.95 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 6 3 # 6 A 14 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 61 GLU C 86 GLU^? 14.08 ZN ZN C 128 A 162 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.96 41.55 51.41 5.95 40.38 49.65 coo -4.89 20.85 5.22 -3.95 21.69 6.91 6.41 43.35 62.15 8.10 44.52 62.72 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 7 3 # 7 A 14 GLU D 28 GLU.? 12.56 ZN ZN D 128 A 61 GLU A 103 GLU~? 15.51 ZN ZN D 128 A 162 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -23.77 18.70 55.29 -22.97 18.07 57.14 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -20.80 26.87 64.77 -19.76 28.50 65.63 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 8 3 # 8 A 14 GLU D 28 GLU.? 12.56 ZN ZN D 128 A 61 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 162 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -23.77 18.70 55.29 -22.97 18.07 57.14 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -34.12 20.46 61.00 -33.75 20.62 63.08 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -27.59 25.34 55.74 -27.28 26.44 53.99 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 8 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 201 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 204 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.88 50.97 54.56 -1.00 50.36 53.86 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -20.72 56.25 32.46 -21.75 54.52 33.04 1j70_c00 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 201 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 204 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.88 50.97 54.56 -1.00 50.36 53.86 coo -6.99 108.94 26.28 -8.54 109.57 27.55 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG C 36 ARG.? 10.67 ZN ZN B 128 B 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -20.72 56.25 32.46 -21.75 54.52 33.04 1j70_c01 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG B 12 ARG^? 9.84 ZN ZN B 128 C 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s C 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 30.92 14.23 15.70 28.82 13.90 13.48 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 20.16 5.55 18.86 20.00 7.59 19.34 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 24.92 3.29 16.90 24.41 4.92 15.69 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG C 12 ARG^? 8.72 ZN ZN C 128 C 201 HIS C 83 HIS^? -3.45 ZN ZN C 128s C 204 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 30.92 14.23 15.70 28.82 13.90 13.48 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.88 50.97 54.56 -1.00 50.36 53.86 coo 24.92 3.29 16.90 24.41 4.92 15.69 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG C 36 ARG.? 10.67 ZN ZN B 128 C 201 HIS B 83 HIS^? -3.82 ZN ZN B 128s C 204 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 30.92 14.23 15.70 28.82 13.90 13.48 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 20.16 5.55 18.86 20.00 7.59 19.34 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 24.92 3.29 16.90 24.41 4.92 15.69 -20.72 56.25 32.46 -21.75 54.52 33.04 1j70_c02 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c02 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER A 13 SER^? 14.04 ZN ZN A 128 A 308 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 338 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 37.44 15.05 21.90 37.18 17.02 20.71 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 45.75 18.77 19.41 43.72 18.70 19.99 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 41.13 18.39 17.83 39.67 17.70 19.17 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 2 3 # 2 A 202 SER B 13 SER^? 13.94 ZN ZN B 128 A 308 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 338 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 37.44 15.05 21.90 37.18 17.02 20.71 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 45.75 18.77 19.41 43.72 18.70 19.99 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 41.13 18.39 17.83 39.67 17.70 19.17 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 3 3 # 3 A 202 SER C 13 SER^? 14.25 ZN ZN C 128 A 308 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 338 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 37.44 15.05 21.90 37.18 17.02 20.71 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 45.75 18.77 19.41 43.72 18.70 19.99 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 41.13 18.39 17.83 39.67 17.70 19.17 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 4 3 # 4 A 202 SER D 13 SER^? 14.41 ZN ZN D 128 A 308 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 338 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 37.44 15.05 21.90 37.18 17.02 20.71 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 45.75 18.77 19.41 43.72 18.70 19.99 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 41.13 18.39 17.83 39.67 17.70 19.17 -18.46 42.11 47.13 -20.09 43.42 47.28 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 4 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER A 13 SER^? 14.04 ZN ZN A 128 B 308 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 338 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 67.81 2.11 21.29 69.09 3.00 23.04 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 64.20 9.21 26.15 65.67 7.96 25.24 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 66.92 5.20 26.82 67.69 4.22 25.14 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 2 3 # 2 B 202 SER B 13 SER^? 13.94 ZN ZN B 128 B 308 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 338 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 67.81 2.11 21.29 69.09 3.00 23.04 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 64.20 9.21 26.15 65.67 7.96 25.24 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 66.92 5.20 26.82 67.69 4.22 25.14 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 3 3 # 3 B 202 SER C 13 SER^? 14.25 ZN ZN C 128 B 308 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 338 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 67.81 2.11 21.29 69.09 3.00 23.04 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 64.20 9.21 26.15 65.67 7.96 25.24 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 66.92 5.20 26.82 67.69 4.22 25.14 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 4 3 # 4 B 202 SER D 13 SER^? 14.41 ZN ZN D 128 B 308 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 338 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 67.81 2.11 21.29 69.09 3.00 23.04 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 64.20 9.21 26.15 65.67 7.96 25.24 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 66.92 5.20 26.82 67.69 4.22 25.14 -18.46 42.11 47.13 -20.09 43.42 47.28 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 4 hits 1jkm_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 56 LYS C 33 LYS.? 11.91 ZN ZN C 128 A 258 ARG C 29 ARG.? 13.36 ZN ZN C 128 coo 42.33 1.56 26.99 42.38 2.91 28.66 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 7.46 50.67 50.27 10.29 51.53 51.14 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 56 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 258 ARG D 29 ARG.? 13.42 ZN ZN D 128 coo 42.33 1.56 26.99 42.38 2.91 28.66 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -31.52 17.79 54.63 -34.40 17.26 55.46 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 56 LYS C 33 LYS.? 11.91 ZN ZN C 128 B 258 ARG C 29 ARG.? 13.36 ZN ZN C 128 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 2.64 1.83 34.81 1.56 1.13 32.02 7.46 50.67 50.27 10.29 51.53 51.14 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU D 86 GLU^? 14.30 ZN ZN D 128 B 56 LYS D 19 LYS.? 15.46 ZN ZN D 128 B 258 ARG D 29 ARG.? 13.42 ZN ZN D 128 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 2.64 1.83 34.81 1.56 1.13 32.02 -31.52 17.79 54.63 -34.40 17.26 55.46 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU B 107 GLU.? 12.06 ZN ZN C 128 C 56 LYS C 33 LYS.? 11.91 ZN ZN C 128 C 258 ARG C 29 ARG.? 13.36 ZN ZN C 128 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 7.46 50.67 50.27 10.29 51.53 51.14 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU D 86 GLU^? 14.30 ZN ZN D 128 C 56 LYS D 19 LYS.? 15.46 ZN ZN D 128 C 258 ARG D 29 ARG.? 13.42 ZN ZN D 128 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -31.52 17.79 54.63 -34.40 17.26 55.46 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU B 107 GLU.? 12.06 ZN ZN C 128 D 56 LYS C 33 LYS.? 11.91 ZN ZN C 128 D 258 ARG C 29 ARG.? 13.36 ZN ZN C 128 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 7.46 50.67 50.27 10.29 51.53 51.14 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU D 86 GLU^? 14.30 ZN ZN D 128 D 56 LYS D 19 LYS.? 15.46 ZN ZN D 128 D 258 ARG D 29 ARG.? 13.42 ZN ZN D 128 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -31.52 17.79 54.63 -34.40 17.26 55.46 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 52 TYR^? 7.20 ZN ZN A 128 A 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 24.46 23.36 17.42 25.88 24.61 18.33 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 27.06 24.40 21.98 27.51 26.43 21.46 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 24.46 23.36 17.42 25.88 24.61 18.33 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 27.06 24.40 21.98 27.51 26.43 21.46 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 A 609 TYR B 52 TYR^? 7.51 ZN ZN B 128 A 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 24.46 23.36 17.42 25.88 24.61 18.33 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 27.06 24.40 21.98 27.51 26.43 21.46 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 A 609 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 24.46 23.36 17.42 25.88 24.61 18.33 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 27.06 24.40 21.98 27.51 26.43 21.46 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 A 609 TYR C 52 TYR^? 7.59 ZN ZN C 128 A 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 1.13 52.00 59.76 1.13 53.77 57.61 coo 24.46 23.36 17.42 25.88 24.61 18.33 0.88 50.97 54.56 -1.00 50.36 53.86 coo 27.06 24.40 21.98 27.51 26.43 21.46 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 A 609 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 8.07 52.98 53.71 8.63 50.62 55.11 coo 24.46 23.36 17.42 25.88 24.61 18.33 0.88 50.97 54.56 -1.00 50.36 53.86 coo 27.06 24.40 21.98 27.51 26.43 21.46 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 7 3 # 7 A 609 TYR D 52 TYR^? 7.54 ZN ZN D 128 A 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 24.46 23.36 17.42 25.88 24.61 18.33 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 27.06 24.40 21.98 27.51 26.43 21.46 -28.44 21.48 51.55 -28.88 19.99 50.09 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 8 3 # 8 A 609 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 22.52 29.89 18.33 23.85 28.06 20.03 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 24.46 23.36 17.42 25.88 24.61 18.33 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 27.06 24.40 21.98 27.51 26.43 21.46 -28.44 21.48 51.55 -28.88 19.99 50.09 1kdg_c02 source 1kdg CELLOBIOSE DEHYDROGENASE : 8 hits 1kdg_c02 naa= 3 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 52 TYR^? 7.20 ZN ZN A 128 B 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR A 55 TYR^? 11.76 ZN ZN A 128 B 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 B 609 TYR B 52 TYR^? 7.51 ZN ZN B 128 B 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 B 609 TYR B 55 TYR.? 11.96 ZN ZN B 128 B 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 B 609 TYR C 52 TYR^? 7.59 ZN ZN C 128 B 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 1.13 52.00 59.76 1.13 53.77 57.61 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 0.88 50.97 54.56 -1.00 50.36 53.86 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 B 609 TYR C 55 TYR.? 11.30 ZN ZN C 128 B 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 8.07 52.98 53.71 8.63 50.62 55.11 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 0.88 50.97 54.56 -1.00 50.36 53.86 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 7 3 # 7 B 609 TYR D 52 TYR^? 7.54 ZN ZN D 128 B 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -28.44 21.48 51.55 -28.88 19.99 50.09 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 8 3 # 8 B 609 TYR D 55 TYR.? 11.30 ZN ZN D 128 B 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -28.44 21.48 51.55 -28.88 19.99 50.09 1kdg_c03 source 1kdg CELLOBIOSE DEHYDROGENASE : 8 hits 1kdg_c03 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG B 29 ARG.? 13.89 ZN ZN B 128 A 351 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 386 LEU B 53 LEU^? 11.32 ZN ZN B 128 coo 57.36 53.34 128.83 58.45 50.56 128.34 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 60.60 50.64 133.59 60.63 48.82 132.56 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 63.28 54.23 126.45 63.53 52.07 126.70 -25.29 50.30 24.89 -27.13 50.14 23.79 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 1 hits 1knp_c00 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 32 ASP.? -2.97 ZN ZN A 128s 262 LYS A 81 LYS.? 12.55 ZN ZN A 128 336 ARG A 42 ARG^? 15.09 ZN ZN A 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 63.59 44.40 18.32 63.20 49.74 17.95 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 72.60 57.42 15.86 71.61 56.68 18.70 -14.23 45.62 66.89 -13.61 45.68 63.87 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 32 ASP.? -2.88 ZN ZN B 128s 262 LYS B 81 LYS.? 12.71 ZN ZN B 128 336 ARG B 42 ARG^? 15.17 ZN ZN B 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 63.59 44.40 18.32 63.20 49.74 17.95 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 72.60 57.42 15.86 71.61 56.68 18.70 -22.13 39.38 39.45 -22.11 38.65 42.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP C 32 ASP^? -2.40 ZN ZN C 128s 262 LYS C 81 LYS.? 11.89 ZN ZN C 128 336 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 0.65 56.08 51.29 4.22 57.96 54.91 coo 72.60 57.42 15.86 71.61 56.68 18.70 -7.28 49.73 38.22 -8.28 50.76 40.96 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP C 32 ASP^? -2.40 ZN ZN C 128s 262 LYS C 81 LYS.? 11.89 ZN ZN C 128 336 ARG C 36 ARG.? 10.67 ZN ZN B 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 0.65 56.08 51.29 4.22 57.96 54.91 coo 72.60 57.42 15.86 71.61 56.68 18.70 -15.69 56.10 43.84 -17.06 58.00 41.84 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP C 32 ASP^? -2.40 ZN ZN C 128s 262 LYS C 81 LYS.? 11.89 ZN ZN C 128 336 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 63.59 44.40 18.32 63.20 49.74 17.95 0.65 56.08 51.29 4.22 57.96 54.91 coo 72.60 57.42 15.86 71.61 56.68 18.70 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP D 32 ASP^? -2.55 ZN ZN D 128s 262 LYS D 81 LYS.? 12.28 ZN ZN D 128 336 ARG A 36 ARG.? 14.54 ZN ZN D 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 63.59 44.40 18.32 63.20 49.74 17.95 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 72.60 57.42 15.86 71.61 56.68 18.70 -29.05 33.74 68.19 -28.81 35.05 65.43 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP D 32 ASP^? -2.55 ZN ZN D 128s 262 LYS D 81 LYS.? 12.28 ZN ZN D 128 336 ARG D 36 ARG.? 10.17 ZN ZN A 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 63.59 44.40 18.32 63.20 49.74 17.95 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 72.60 57.42 15.86 71.61 56.68 18.70 -32.18 43.37 61.68 -31.14 45.24 63.88 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP D 32 ASP^? -2.55 ZN ZN D 128s 262 LYS D 81 LYS.? 12.28 ZN ZN D 128 336 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 61.88 50.78 12.96 63.84 50.60 13.71 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 63.59 44.40 18.32 63.20 49.74 17.95 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 72.60 57.42 15.86 71.61 56.68 18.70 -29.08 38.55 44.25 -27.07 40.84 43.98 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 8 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 42 ARG^? 15.09 ZN ZN A 128 245 HIS C 10 HIS^? 15.40 ZN ZN C 128 343 THR A 14 THR.? 9.34 ZN ZN A 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 5.34 86.23 43.48 6.16 87.26 45.12 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 9.06 92.76 42.80 7.04 92.63 42.14 -23.51 50.82 61.06 -23.73 50.87 63.22 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG B 42 ARG^? 15.17 ZN ZN B 128 245 HIS D 10 HIS^? 15.91 ZN ZN D 128 343 THR B 14 THR.? 9.29 ZN ZN B 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 5.34 86.23 43.48 6.16 87.26 45.12 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 9.06 92.76 42.80 7.04 92.63 42.14 -24.73 49.75 45.33 -24.61 49.96 43.21 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG C 12 ARG^? 8.72 ZN ZN C 128 245 HIS D 10 HIS^? 15.91 ZN ZN D 128 343 THR B 14 THR.? 9.29 ZN ZN B 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 5.34 86.23 43.48 6.16 87.26 45.12 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 9.06 92.76 42.80 7.04 92.63 42.14 -24.73 49.75 45.33 -24.61 49.96 43.21 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG C 36 ARG.? 10.67 ZN ZN B 128 245 HIS B 10 HIS^? 15.59 ZN ZN B 128 343 THR C 11 THR^? 14.35 ZN ZN C 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 5.34 86.23 43.48 6.16 87.26 45.12 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 9.06 92.76 42.80 7.04 92.63 42.14 -17.36 49.55 51.91 -16.04 50.82 50.77 ULMN 3 1lci_c00 LUCIFERASE user 5 3 # 5 218 ARG C 42 ARG^? 15.11 ZN ZN C 128 245 HIS A 10 HIS^? 15.73 ZN ZN A 128 343 THR C 14 THR.? 9.55 ZN ZN C 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 5.34 86.23 43.48 6.16 87.26 45.12 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 9.06 92.76 42.80 7.04 92.63 42.14 -11.64 41.49 55.94 -9.73 42.48 56.15 ULMN 3 1lci_c00 LUCIFERASE user 6 3 # 6 218 ARG D 12 ARG^? 9.28 ZN ZN D 128 245 HIS C 10 HIS^? 15.40 ZN ZN C 128 343 THR A 14 THR.? 9.34 ZN ZN A 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 5.34 86.23 43.48 6.16 87.26 45.12 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 9.06 92.76 42.80 7.04 92.63 42.14 -23.51 50.82 61.06 -23.73 50.87 63.22 ULMN 3 1lci_c00 LUCIFERASE user 7 3 # 7 218 ARG D 36 ARG.? 10.17 ZN ZN A 128 245 HIS A 10 HIS^? 15.73 ZN ZN A 128 343 THR D 11 THR^? 14.18 ZN ZN D 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -32.18 43.37 61.68 -31.14 45.24 63.88 coo 5.34 86.23 43.48 6.16 87.26 45.12 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 9.06 92.76 42.80 7.04 92.63 42.14 -25.16 43.60 54.40 -26.66 42.42 55.40 ULMN 3 1lci_c00 LUCIFERASE user 8 3 # 8 218 ARG D 42 ARG^? 14.89 ZN ZN D 128 245 HIS B 10 HIS^? 15.59 ZN ZN B 128 343 THR D 14 THR.? 9.56 ZN ZN D 128 coo 18.11 85.25 41.19 18.04 83.33 43.59 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 5.34 86.23 43.48 6.16 87.26 45.12 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 9.06 92.76 42.80 7.04 92.63 42.14 -18.99 35.81 50.60 -20.41 34.18 50.44 1lci_c00 source 1lci LUCIFERASE : 8 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 97 ASP^? 13.17 ZN ZN A 128 169 ARG A 42 ARG^? 15.09 ZN ZN A 128 193 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 20.88 15.91 3.60 20.25 17.72 4.50 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 18.81 19.85 7.63 17.55 19.89 5.97 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP B 57 ASP.? 17.37 ZN ZN B 128 169 ARG B 29 ARG.? 13.89 ZN ZN B 128 193 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 20.88 15.91 3.60 20.25 17.72 4.50 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 18.81 19.85 7.63 17.55 19.89 5.97 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 3 3 # 3 166 ASP B 97 ASP^? 13.03 ZN ZN B 128 169 ARG B 42 ARG^? 15.17 ZN ZN B 128 193 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 20.88 15.91 3.60 20.25 17.72 4.50 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 18.81 19.85 7.63 17.55 19.89 5.97 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 4 3 # 4 166 ASP C 57 ASP.? 16.82 ZN ZN C 128 169 ARG C 29 ARG.? 13.36 ZN ZN C 128 193 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 20.88 15.91 3.60 20.25 17.72 4.50 8.18 57.58 47.56 10.27 57.39 47.78 coo 17.70 17.91 -0.80 15.74 19.74 0.84 7.46 50.67 50.27 10.29 51.53 51.14 coo 18.81 19.85 7.63 17.55 19.89 5.97 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 5 3 # 5 166 ASP C 97 ASP^? 13.06 ZN ZN C 128 169 ARG C 42 ARG^? 15.11 ZN ZN C 128 193 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 20.88 15.91 3.60 20.25 17.72 4.50 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 18.81 19.85 7.63 17.55 19.89 5.97 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 6 3 # 6 166 ASP D 97 ASP^? 13.24 ZN ZN D 128 169 ARG D 42 ARG^? 14.89 ZN ZN D 128 193 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 20.88 15.91 3.60 20.25 17.72 4.50 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 18.81 19.85 7.63 17.55 19.89 5.97 -24.77 44.27 50.01 -22.89 43.34 50.12 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 6 hits 1ldm_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 45 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 261 PHE C 74 PHE^? 15.05 ZN ZN C 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -9.43 52.07 65.61 -10.77 54.53 65.79 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 45 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 261 PHE A 94 PHE^? 9.23 ZN ZN A 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -20.26 55.80 68.38 -22.98 56.19 68.94 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 45 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 261 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 45 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 261 PHE A 94 PHE^? 9.23 ZN ZN A 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -20.26 55.80 68.38 -22.98 56.19 68.94 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 45 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 261 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 45 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 261 PHE D 74 PHE^? 14.94 ZN ZN D 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -29.53 36.49 40.87 -31.48 38.47 40.51 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 7 3 # 7 A 44 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 45 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 261 PHE B 94 PHE^? 9.33 ZN ZN B 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -30.29 47.77 38.05 -29.70 50.41 37.36 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 8 3 # 8 A 44 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 45 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 261 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 9 3 # 9 A 44 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 45 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 261 PHE B 94 PHE^? 9.33 ZN ZN B 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -30.29 47.77 38.05 -29.70 50.41 37.36 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 10 3 # 10 A 44 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 45 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 261 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 11 3 # 11 A 44 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 45 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 261 PHE A 74 PHE^? 15.18 ZN ZN A 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -11.97 47.81 69.31 -10.39 45.49 69.36 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 12 3 # 12 A 44 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 45 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 261 PHE C 74 PHE^? 15.05 ZN ZN C 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -9.43 52.07 65.61 -10.77 54.53 65.79 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 13 3 # 13 A 44 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 45 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 261 PHE C 94 PHE^? 9.63 ZN ZN C 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.61 46.90 50.78 -0.23 46.71 52.70 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.88 50.97 54.56 -1.00 50.36 53.86 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -4.76 42.24 62.13 -3.25 41.33 59.94 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 14 3 # 14 A 44 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 45 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 261 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.61 46.90 50.78 -0.23 46.71 52.70 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.88 50.97 54.56 -1.00 50.36 53.86 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 15 3 # 15 A 44 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 45 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 261 PHE C 94 PHE^? 9.63 ZN ZN C 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.88 50.97 54.56 -1.00 50.36 53.86 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.61 46.90 50.78 -0.23 46.71 52.70 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -4.76 42.24 62.13 -3.25 41.33 59.94 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 16 3 # 16 A 44 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 45 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 261 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.88 50.97 54.56 -1.00 50.36 53.86 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.61 46.90 50.78 -0.23 46.71 52.70 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 17 3 # 17 A 44 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 45 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 261 PHE B 74 PHE^? 15.25 ZN ZN B 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -24.88 37.89 37.15 -23.16 35.68 37.15 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 18 3 # 18 A 44 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 45 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 261 PHE D 74 PHE^? 14.94 ZN ZN D 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -29.53 36.49 40.87 -31.48 38.47 40.51 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 19 3 # 19 A 44 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 45 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 261 PHE D 94 PHE^? 9.41 ZN ZN D 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -21.52 29.39 44.56 -21.12 27.85 46.87 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 20 3 # 20 A 44 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 45 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 261 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 21 3 # 21 A 44 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 45 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 261 PHE D 94 PHE^? 9.41 ZN ZN D 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -21.52 29.39 44.56 -21.12 27.85 46.87 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 22 3 # 22 A 44 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 45 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 261 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo 49.89 1.93 30.83 50.54 1.43 32.81 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -26.13 36.91 53.13 -25.06 34.30 52.99 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 22 hits 1luc_c00 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 265 GLU A 28 GLU~? 12.19 ZN ZN A 128 A 369 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 17.36 23.57 72.04 18.68 21.92 71.98 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 265 GLU A 28 GLU~? 12.19 ZN ZN A 128 A 369 ASP A 57 ASP.? 17.22 ZN ZN A 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 17.36 23.57 72.04 18.68 21.92 71.98 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 -31.66 41.62 85.16 -32.16 42.63 86.92 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 265 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 369 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 17.36 23.57 72.04 18.68 21.92 71.98 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 265 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 369 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.57 55.26 21.18 -14.41 55.74 19.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 265 GLU C 103 GLU.? 13.37 ZN ZN B 128 A 369 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 265 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 369 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.18 57.58 47.56 10.27 57.39 47.78 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.96 41.55 51.41 5.95 40.38 49.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 265 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 369 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.74 58.91 56.74 6.81 58.81 55.87 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.96 41.55 51.41 5.95 40.38 49.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 265 GLU C 103 GLU.? 13.37 ZN ZN B 128 A 369 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 265 GLU D 28 GLU.? 12.56 ZN ZN D 128 A 369 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 265 GLU D 28 GLU.? 12.56 ZN ZN D 128 A 369 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 17.36 23.57 72.04 18.68 21.92 71.98 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.07 20.84 58.32 -40.41 18.78 58.10 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 10 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 279 GLU A 70 GLU^? 19.90 ZN ZN A 128 A 369 ASP A 57 ASP.? 17.22 ZN ZN A 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 16.54 46.37 63.94 14.77 45.79 62.95 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 -31.66 41.62 85.16 -32.16 42.63 86.92 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 279 GLU B 80 GLU.? 14.47 ZN ZN B 128 A 369 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 16.54 46.37 63.94 14.77 45.79 62.95 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 279 GLU A 70 GLU^? 19.90 ZN ZN A 128 A 369 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 16.54 46.37 63.94 14.77 45.79 62.95 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 279 GLU D 103 GLU.? 16.17 ZN ZN A 128 A 369 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 16.54 46.37 63.94 14.77 45.79 62.95 -31.28 51.42 58.86 -30.79 51.26 56.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 279 GLU A 80 GLU.? 14.45 ZN ZN A 128 A 369 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 16.54 46.37 63.94 14.77 45.79 62.95 -27.62 36.67 74.75 -28.01 34.63 75.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 279 GLU D 70 GLU^? 19.86 ZN ZN D 128 A 369 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 11.74 38.14 80.19 10.63 36.40 80.65 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 16.54 46.37 63.94 14.77 45.79 62.95 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 279 GLU B 70 GLU^? 18.94 ZN ZN B 128 A 369 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 16.54 46.37 63.94 14.77 45.79 62.95 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.32 31.61 55.53 -28.20 30.46 54.16 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 7 hits 1m53_c06 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 57 ASP.? 17.22 ZN ZN A 128 35 SER A 60 SER.? 16.46 ZN ZN A 128 215 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 20.97 14.47 32.28 19.66 15.96 31.62 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 16.04 14.72 33.82 17.27 13.71 31.95 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 20.65 22.00 33.80 20.06 20.56 32.39 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 35 SER A 13 SER^? 14.04 ZN ZN A 128 215 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 20.97 14.47 32.28 19.66 15.96 31.62 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 16.04 14.72 33.82 17.27 13.71 31.95 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 20.65 22.00 33.80 20.06 20.56 32.39 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 35 SER B 13 SER^? 13.94 ZN ZN B 128 215 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 20.97 14.47 32.28 19.66 15.96 31.62 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 16.04 14.72 33.82 17.27 13.71 31.95 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 20.65 22.00 33.80 20.06 20.56 32.39 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 35 SER C 60 SER.? 15.14 ZN ZN C 128 215 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 20.97 14.47 32.28 19.66 15.96 31.62 8.18 57.58 47.56 10.27 57.39 47.78 coo 16.04 14.72 33.82 17.27 13.71 31.95 12.55 55.11 50.39 10.44 55.82 51.40 coo 20.65 22.00 33.80 20.06 20.56 32.39 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 5 3 # 5 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 35 SER C 13 SER^? 14.25 ZN ZN C 128 215 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 20.97 14.47 32.28 19.66 15.96 31.62 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 16.04 14.72 33.82 17.27 13.71 31.95 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 20.65 22.00 33.80 20.06 20.56 32.39 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 6 3 # 6 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 35 SER D 60 SER.? 15.90 ZN ZN D 128 215 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 20.97 14.47 32.28 19.66 15.96 31.62 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 16.04 14.72 33.82 17.27 13.71 31.95 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 20.65 22.00 33.80 20.06 20.56 32.39 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 7 3 # 7 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 35 SER D 13 SER^? 14.41 ZN ZN D 128 215 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 20.97 14.47 32.28 19.66 15.96 31.62 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 16.04 14.72 33.82 17.27 13.71 31.95 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 20.65 22.00 33.80 20.06 20.56 32.39 -21.74 43.31 43.14 -23.53 43.14 44.28 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 7 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 A 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 B 367 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 A 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 B 367 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 A 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 B 367 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 A 501 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 367 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 34 GLY.? 11.12 ZN ZN A 128 A 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 B 367 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -31.48 39.85 67.82 -31.13 40.18 68.47 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 34 GLY.? 11.12 ZN ZN A 128 A 501 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 367 TYR D 55 TYR.? 11.30 ZN ZN D 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -31.48 39.85 67.82 -31.13 40.18 68.47 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -35.27 19.83 52.49 -33.13 18.64 51.13 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 25 GLY~? 8.72 ZN ZN B 128 A 501 ASP B 64 ASP.? 14.94 ZN ZN B 128 B 367 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -24.85 59.69 34.87 -25.34 59.12 35.01 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 25 GLY~? 8.72 ZN ZN B 128 A 501 ASP B 64 ASP.? 14.94 ZN ZN B 128 B 367 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -24.85 59.69 34.87 -25.34 59.12 35.01 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 25 GLY~? 8.72 ZN ZN B 128 A 501 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 367 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -24.85 59.69 34.87 -25.34 59.12 35.01 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 34 GLY.? 11.32 ZN ZN B 128 A 501 ASP B 64 ASP.? 14.94 ZN ZN B 128 B 367 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -11.36 54.29 38.63 -11.83 54.10 38.04 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY C 25 GLY~? 8.98 ZN ZN C 128 A 501 ASP C 64 ASP.? 14.22 ZN ZN C 128 B 367 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.59 40.69 50.63 1.30 40.60 51.34 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 8.74 58.91 56.74 6.81 58.81 55.87 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY C 34 GLY.? 11.55 ZN ZN C 128 A 501 ASP C 64 ASP.? 14.22 ZN ZN C 128 B 367 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -10.25 50.55 45.92 -9.76 50.87 45.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 8.74 58.91 56.74 6.81 58.81 55.87 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY C 34 GLY.? 11.55 ZN ZN C 128 A 501 ASP C 64 ASP.? 14.22 ZN ZN C 128 B 367 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -10.25 50.55 45.92 -9.76 50.87 45.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 8.74 58.91 56.74 6.81 58.81 55.87 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY D 25 GLY~? 8.97 ZN ZN D 128 A 501 ASP D 64 ASP.? 14.34 ZN ZN D 128 B 367 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -22.04 22.93 56.13 -21.85 23.17 55.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY D 34 GLY.? 11.12 ZN ZN D 128 A 501 ASP D 64 ASP.? 14.34 ZN ZN D 128 B 367 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -28.08 36.39 60.37 -28.54 35.99 60.96 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY D 34 GLY.? 11.12 ZN ZN D 128 A 501 ASP D 64 ASP.? 14.34 ZN ZN D 128 B 367 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -28.08 36.39 60.37 -28.54 35.99 60.96 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -13.98 42.26 35.98 -11.85 41.33 34.40 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 16 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 D 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 E 367 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 D 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 E 367 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 D 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 E 367 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 25 GLY~? 9.17 ZN ZN A 128 D 501 ASP A 91 ASP.? 21.24 ZN ZN A 128 E 367 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -33.08 54.40 71.92 -32.41 54.60 71.63 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 34 GLY.? 11.12 ZN ZN A 128 D 501 ASP A 64 ASP.? 14.79 ZN ZN A 128 E 367 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -31.48 39.85 67.82 -31.13 40.18 68.47 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 34 GLY.? 11.12 ZN ZN A 128 D 501 ASP C 97 ASP^? 13.06 ZN ZN C 128 E 367 TYR D 55 TYR.? 11.30 ZN ZN D 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -31.48 39.85 67.82 -31.13 40.18 68.47 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -35.27 19.83 52.49 -33.13 18.64 51.13 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 25 GLY~? 8.72 ZN ZN B 128 D 501 ASP B 64 ASP.? 14.94 ZN ZN B 128 E 367 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -24.85 59.69 34.87 -25.34 59.12 35.01 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 25 GLY~? 8.72 ZN ZN B 128 D 501 ASP B 64 ASP.? 14.94 ZN ZN B 128 E 367 TYR D 40 TYR^? 12.58 ZN ZN D 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -24.85 59.69 34.87 -25.34 59.12 35.01 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.73 38.00 51.16 -37.53 38.10 51.02 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 25 GLY~? 8.72 ZN ZN B 128 D 501 ASP B 91 ASP.? 21.34 ZN ZN B 128 E 367 TYR C 40 TYR^? 12.78 ZN ZN C 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -24.85 59.69 34.87 -25.34 59.12 35.01 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -9.42 57.42 55.22 -8.85 60.18 55.10 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 34 GLY.? 11.32 ZN ZN B 128 D 501 ASP B 64 ASP.? 14.94 ZN ZN B 128 E 367 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -11.36 54.29 38.63 -11.83 54.10 38.04 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY C 25 GLY~? 8.98 ZN ZN C 128 D 501 ASP C 64 ASP.? 14.22 ZN ZN C 128 E 367 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.59 40.69 50.63 1.30 40.60 51.34 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 8.74 58.91 56.74 6.81 58.81 55.87 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY C 34 GLY.? 11.55 ZN ZN C 128 D 501 ASP C 64 ASP.? 14.22 ZN ZN C 128 E 367 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -10.25 50.55 45.92 -9.76 50.87 45.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 8.74 58.91 56.74 6.81 58.81 55.87 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY C 34 GLY.? 11.55 ZN ZN C 128 D 501 ASP C 64 ASP.? 14.22 ZN ZN C 128 E 367 TYR A 40 TYR^? 13.15 ZN ZN A 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -10.25 50.55 45.92 -9.76 50.87 45.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 8.74 58.91 56.74 6.81 58.81 55.87 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -19.24 38.51 70.38 -18.99 36.30 72.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY C 38 GLY.? 13.07 ZN ZN C 128 D 501 ASP A 97 ASP^? 13.17 ZN ZN A 128 E 367 TYR B 52 TYR^? 7.51 ZN ZN B 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -8.85 58.20 48.91 -9.08 57.49 48.72 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -23.54 46.80 28.87 -20.82 47.32 28.41 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY D 25 GLY~? 8.97 ZN ZN D 128 D 501 ASP D 64 ASP.? 14.34 ZN ZN D 128 E 367 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -22.04 22.93 56.13 -21.85 23.17 55.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -13.98 42.26 35.98 -11.85 41.33 34.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY D 34 GLY.? 11.12 ZN ZN D 128 D 501 ASP D 64 ASP.? 14.34 ZN ZN D 128 E 367 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -28.08 36.39 60.37 -28.54 35.99 60.96 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY D 34 GLY.? 11.12 ZN ZN D 128 D 501 ASP D 64 ASP.? 14.34 ZN ZN D 128 E 367 TYR B 40 TYR^? 13.12 ZN ZN B 128 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -28.08 36.39 60.37 -28.54 35.99 60.96 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -13.98 42.26 35.98 -11.85 41.33 34.40 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 17 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 55 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 84 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 4.60 40.33 20.42 7.25 39.50 20.05 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 9.71 44.83 15.47 10.13 41.43 19.93 -27.08 41.78 78.19 -22.69 42.64 82.54 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 55 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 84 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 4.60 40.33 20.42 7.25 39.50 20.05 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 9.71 44.83 15.47 10.13 41.43 19.93 -27.08 41.78 78.19 -22.69 42.64 82.54 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 55 TYR A 93 TYR^? 17.82 ZN ZN A 128 A 84 LYS A 19 LYS.? 16.70 ZN ZN A 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 4.60 40.33 20.42 7.25 39.50 20.05 -17.49 60.90 64.70 -15.26 61.56 63.14 coo 9.71 44.83 15.47 10.13 41.43 19.93 -25.66 62.13 69.69 -25.48 65.02 74.91 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 55 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 84 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 4.60 40.33 20.42 7.25 39.50 20.05 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 55 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 84 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 4.60 40.33 20.42 7.25 39.50 20.05 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 55 TYR B 93 TYR^? 18.00 ZN ZN B 128 A 84 LYS B 19 LYS.? 16.80 ZN ZN B 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 4.60 40.33 20.42 7.25 39.50 20.05 -35.98 46.77 41.76 -37.33 44.77 43.20 coo 9.71 44.83 15.47 10.13 41.43 19.93 -34.93 54.65 36.44 -38.00 53.50 31.57 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 55 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 84 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 8.18 57.58 47.56 10.27 57.39 47.78 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.07 52.98 53.71 8.63 50.62 55.11 coo 9.71 44.83 15.47 10.13 41.43 19.93 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 3 # 8 A 50 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 55 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 84 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 8.74 58.91 56.74 6.81 58.81 55.87 coo 4.60 40.33 20.42 7.25 39.50 20.05 8.07 52.98 53.71 8.63 50.62 55.11 coo 9.71 44.83 15.47 10.13 41.43 19.93 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 9 3 # 9 A 50 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 55 TYR C 93 TYR^? 17.98 ZN ZN C 128 A 84 LYS C 19 LYS.? 17.60 ZN ZN C 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 4.60 40.33 20.42 7.25 39.50 20.05 -6.81 37.29 66.15 -8.85 36.99 68.07 coo 9.71 44.83 15.47 10.13 41.43 19.93 0.64 35.92 60.53 5.63 36.47 64.53 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 10 3 # 10 A 50 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 55 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 84 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 4.60 40.33 20.42 7.25 39.50 20.05 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 9.71 44.83 15.47 10.13 41.43 19.93 -36.76 27.60 54.86 -39.44 24.48 51.40 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 11 3 # 11 A 50 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 55 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 84 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 4.60 40.33 20.42 7.25 39.50 20.05 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 9.71 44.83 15.47 10.13 41.43 19.93 -36.76 27.60 54.86 -39.44 24.48 51.40 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 12 3 # 12 A 50 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 55 TYR D 93 TYR^? 18.01 ZN ZN D 128 A 84 LYS D 19 LYS.? 15.46 ZN ZN D 128 coo 11.09 42.89 24.44 11.32 42.06 22.49 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 4.60 40.33 20.42 7.25 39.50 20.05 -16.06 30.04 40.46 -15.16 31.88 38.54 coo 9.71 44.83 15.47 10.13 41.43 19.93 -16.96 22.44 46.27 -19.09 18.04 45.40 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 12 hits 1mrq_c02 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 197 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 223 ALA A 75 ALA^? 11.02 ZN ZN A 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -14.68 47.50 72.94 -15.20 48.23 74.17 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 223 ALA A 22 ALA.? 9.97 ZN ZN A 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -30.72 49.15 73.99 -28.78 49.60 73.32 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -27.72 57.67 66.22 -26.73 57.38 67.36 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 223 ALA A 56 ALA.? 16.32 ZN ZN A 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -30.72 49.15 73.99 -28.78 49.60 73.32 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -27.19 42.31 85.39 -27.19 42.07 86.90 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 223 ALA A 22 ALA.? 9.97 ZN ZN A 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -27.72 57.67 66.22 -26.73 57.38 67.36 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 223 ALA A 24 ALA~? 12.69 ZN ZN A 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -32.45 57.72 70.15 -33.80 58.43 70.21 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 223 ALA A 75 ALA^? 11.02 ZN ZN A 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -14.68 47.50 72.94 -15.20 48.23 74.17 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 197 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 223 ALA B 75 ALA^? 11.14 ZN ZN B 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -23.83 40.41 33.40 -24.40 41.11 32.17 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 223 ALA B 22 ALA.? 9.88 ZN ZN B 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.72 56.25 32.46 -21.75 54.52 33.04 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -30.03 55.57 39.93 -30.02 54.67 38.71 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 223 ALA B 56 ALA.? 16.57 ZN ZN B 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.72 56.25 32.46 -21.75 54.52 33.04 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -15.28 51.03 20.87 -15.04 51.05 19.36 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 A 114 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 223 ALA B 22 ALA.? 9.88 ZN ZN B 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -30.03 55.57 39.93 -30.02 54.67 38.71 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 A 114 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 223 ALA B 24 ALA~? 12.38 ZN ZN B 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -28.35 60.12 36.25 -28.70 61.61 36.18 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 A 114 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 223 ALA B 75 ALA^? 11.14 ZN ZN B 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -23.83 40.41 33.40 -24.40 41.11 32.17 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 A 114 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 197 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 223 ALA C 75 ALA^? 11.02 ZN ZN C 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -5.45 53.01 63.68 -3.95 52.79 63.75 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 A 114 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 223 ALA B 101 ALA~? 15.64 ZN ZN C 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.61 46.90 50.78 -0.23 46.71 52.70 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -8.24 41.54 41.80 -7.29 41.59 40.60 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 A 114 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 223 ALA C 22 ALA.? 10.24 ZN ZN C 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.61 46.90 50.78 -0.23 46.71 52.70 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -3.42 37.06 56.15 -2.84 38.26 56.86 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 A 114 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 223 ALA C 56 ALA.? 16.16 ZN ZN C 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.61 46.90 50.78 -0.23 46.71 52.70 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 7.75 58.58 51.94 9.07 59.36 51.88 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 A 114 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 223 ALA C 22 ALA.? 10.24 ZN ZN C 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.88 50.97 54.56 -1.00 50.36 53.86 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -3.42 37.06 56.15 -2.84 38.26 56.86 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 A 114 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 223 ALA C 24 ALA~? 12.72 ZN ZN C 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.88 50.97 54.56 -1.00 50.36 53.86 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 1.38 37.40 52.53 2.19 36.38 51.72 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 A 114 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 223 ALA C 75 ALA^? 11.02 ZN ZN C 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.88 50.97 54.56 -1.00 50.36 53.86 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -5.45 53.01 63.68 -3.95 52.79 63.75 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 A 114 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 223 ALA A 101 ALA~? 15.72 ZN ZN D 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -20.21 32.72 64.73 -20.57 31.87 65.94 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 A 114 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 223 ALA D 22 ALA.? 10.37 ZN ZN D 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -16.97 26.63 50.50 -18.20 26.22 49.69 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 A 114 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 223 ALA D 56 ALA.? 16.15 ZN ZN D 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -40.71 21.54 53.92 -41.78 20.44 53.84 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 A 114 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 223 ALA D 22 ALA.? 10.37 ZN ZN D 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -31.62 26.29 51.88 -30.63 27.88 52.82 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -16.97 26.63 50.50 -18.20 26.22 49.69 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 A 114 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 223 ALA D 24 ALA~? 12.57 ZN ZN D 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -31.62 26.29 51.88 -30.63 27.88 52.82 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -18.79 22.28 54.28 -18.09 21.25 55.14 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 A 114 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 223 ALA D 75 ALA^? 10.80 ZN ZN D 128 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -31.62 26.29 51.88 -30.63 27.88 52.82 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -31.65 32.85 42.77 -31.81 31.34 42.74 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 25 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 197 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 223 ALA A 75 ALA^? 11.02 ZN ZN A 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -14.68 47.50 72.94 -15.20 48.23 74.17 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 223 ALA A 22 ALA.? 9.97 ZN ZN A 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -30.72 49.15 73.99 -28.78 49.60 73.32 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -27.72 57.67 66.22 -26.73 57.38 67.36 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 223 ALA A 56 ALA.? 16.32 ZN ZN A 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -30.72 49.15 73.99 -28.78 49.60 73.32 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -27.19 42.31 85.39 -27.19 42.07 86.90 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 223 ALA A 22 ALA.? 9.97 ZN ZN A 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -27.72 57.67 66.22 -26.73 57.38 67.36 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 223 ALA A 24 ALA~? 12.69 ZN ZN A 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -32.45 57.72 70.15 -33.80 58.43 70.21 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 197 ASP A 32 ASP.? -2.97 ZN ZN A 128s B 223 ALA A 75 ALA^? 11.02 ZN ZN A 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -14.68 47.50 72.94 -15.20 48.23 74.17 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 197 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 223 ALA B 75 ALA^? 11.14 ZN ZN B 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -23.83 40.41 33.40 -24.40 41.11 32.17 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 223 ALA B 22 ALA.? 9.88 ZN ZN B 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.72 56.25 32.46 -21.75 54.52 33.04 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -30.03 55.57 39.93 -30.02 54.67 38.71 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 223 ALA B 56 ALA.? 16.57 ZN ZN B 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.72 56.25 32.46 -21.75 54.52 33.04 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -15.28 51.03 20.87 -15.04 51.05 19.36 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 B 114 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 223 ALA B 22 ALA.? 9.88 ZN ZN B 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -30.03 55.57 39.93 -30.02 54.67 38.71 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 11 3 # 11 B 114 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 223 ALA B 24 ALA~? 12.38 ZN ZN B 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -28.35 60.12 36.25 -28.70 61.61 36.18 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 12 3 # 12 B 114 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 197 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 223 ALA B 75 ALA^? 11.14 ZN ZN B 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -23.83 40.41 33.40 -24.40 41.11 32.17 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 13 3 # 13 B 114 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 197 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 223 ALA C 75 ALA^? 11.02 ZN ZN C 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -5.45 53.01 63.68 -3.95 52.79 63.75 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 14 3 # 14 B 114 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 223 ALA B 101 ALA~? 15.64 ZN ZN C 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.61 46.90 50.78 -0.23 46.71 52.70 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -8.24 41.54 41.80 -7.29 41.59 40.60 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 15 3 # 15 B 114 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 223 ALA C 22 ALA.? 10.24 ZN ZN C 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.61 46.90 50.78 -0.23 46.71 52.70 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -3.42 37.06 56.15 -2.84 38.26 56.86 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 16 3 # 16 B 114 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 223 ALA C 56 ALA.? 16.16 ZN ZN C 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.61 46.90 50.78 -0.23 46.71 52.70 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 7.75 58.58 51.94 9.07 59.36 51.88 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 17 3 # 17 B 114 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 223 ALA C 22 ALA.? 10.24 ZN ZN C 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.88 50.97 54.56 -1.00 50.36 53.86 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -3.42 37.06 56.15 -2.84 38.26 56.86 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 18 3 # 18 B 114 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 223 ALA C 24 ALA~? 12.72 ZN ZN C 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.88 50.97 54.56 -1.00 50.36 53.86 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 1.38 37.40 52.53 2.19 36.38 51.72 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 19 3 # 19 B 114 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 197 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 223 ALA C 75 ALA^? 11.02 ZN ZN C 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.88 50.97 54.56 -1.00 50.36 53.86 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -5.45 53.01 63.68 -3.95 52.79 63.75 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 20 3 # 20 B 114 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 223 ALA A 101 ALA~? 15.72 ZN ZN D 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -20.21 32.72 64.73 -20.57 31.87 65.94 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 21 3 # 21 B 114 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 223 ALA D 22 ALA.? 10.37 ZN ZN D 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -16.97 26.63 50.50 -18.20 26.22 49.69 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 22 3 # 22 B 114 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 223 ALA D 56 ALA.? 16.15 ZN ZN D 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -40.71 21.54 53.92 -41.78 20.44 53.84 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 23 3 # 23 B 114 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 223 ALA D 22 ALA.? 10.37 ZN ZN D 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -31.62 26.29 51.88 -30.63 27.88 52.82 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -16.97 26.63 50.50 -18.20 26.22 49.69 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 24 3 # 24 B 114 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 223 ALA D 24 ALA~? 12.57 ZN ZN D 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -31.62 26.29 51.88 -30.63 27.88 52.82 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -18.79 22.28 54.28 -18.09 21.25 55.14 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 25 3 # 25 B 114 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 197 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 223 ALA D 75 ALA^? 10.80 ZN ZN D 128 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -31.62 26.29 51.88 -30.63 27.88 52.82 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -31.65 32.85 42.77 -31.81 31.34 42.74 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 25 hits 1n2t_c03 naa= 3 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 52 TYR^? 7.20 ZN ZN A 128 A 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 24.69 23.24 17.44 26.23 24.43 18.22 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 27.47 24.40 22.13 27.89 26.42 21.78 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 24.69 23.24 17.44 26.23 24.43 18.22 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 27.47 24.40 22.13 27.89 26.42 21.78 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 A 609 TYR B 52 TYR^? 7.51 ZN ZN B 128 A 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 24.69 23.24 17.44 26.23 24.43 18.22 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 27.47 24.40 22.13 27.89 26.42 21.78 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 A 609 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 24.69 23.24 17.44 26.23 24.43 18.22 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 27.47 24.40 22.13 27.89 26.42 21.78 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 A 609 TYR C 52 TYR^? 7.59 ZN ZN C 128 A 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 1.13 52.00 59.76 1.13 53.77 57.61 coo 24.69 23.24 17.44 26.23 24.43 18.22 0.88 50.97 54.56 -1.00 50.36 53.86 coo 27.47 24.40 22.13 27.89 26.42 21.78 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 A 609 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 8.07 52.98 53.71 8.63 50.62 55.11 coo 24.69 23.24 17.44 26.23 24.43 18.22 0.88 50.97 54.56 -1.00 50.36 53.86 coo 27.47 24.40 22.13 27.89 26.42 21.78 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 7 3 # 7 A 609 TYR D 52 TYR^? 7.54 ZN ZN D 128 A 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 24.69 23.24 17.44 26.23 24.43 18.22 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 27.47 24.40 22.13 27.89 26.42 21.78 -28.44 21.48 51.55 -28.88 19.99 50.09 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 8 3 # 8 A 609 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 23.89 30.33 18.51 26.53 29.83 17.65 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 24.69 23.24 17.44 26.23 24.43 18.22 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 27.47 24.40 22.13 27.89 26.42 21.78 -28.44 21.48 51.55 -28.88 19.99 50.09 1naa_c02 source 1naa CELLOBIOSE DEHYDROGENASE : 8 hits 1naa_c02 naa= 3 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 52 TYR^? 7.20 ZN ZN A 128 B 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR A 55 TYR^? 11.76 ZN ZN A 128 B 689 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 732 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 B 609 TYR B 52 TYR^? 7.51 ZN ZN B 128 B 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 B 609 TYR B 55 TYR.? 11.96 ZN ZN B 128 B 689 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 732 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 B 609 TYR C 52 TYR^? 7.59 ZN ZN C 128 B 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 1.13 52.00 59.76 1.13 53.77 57.61 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 0.88 50.97 54.56 -1.00 50.36 53.86 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 B 609 TYR C 55 TYR.? 11.30 ZN ZN C 128 B 689 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 732 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 8.07 52.98 53.71 8.63 50.62 55.11 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 0.88 50.97 54.56 -1.00 50.36 53.86 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 7 3 # 7 B 609 TYR D 52 TYR^? 7.54 ZN ZN D 128 B 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -28.44 21.48 51.55 -28.88 19.99 50.09 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 8 3 # 8 B 609 TYR D 55 TYR.? 11.30 ZN ZN D 128 B 689 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 732 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -28.44 21.48 51.55 -28.88 19.99 50.09 1naa_c03 source 1naa CELLOBIOSE DEHYDROGENASE : 8 hits 1naa_c03 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 208 HIS A 30 HIS.? -4.18 ZN ZN A 128s C 104 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 20.72 31.33 73.27 20.15 33.36 73.56 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 17.00 33.82 71.84 16.59 31.98 70.88 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 20.06 38.06 74.21 21.19 36.81 72.96 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 208 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 104 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 20.72 31.33 73.27 20.15 33.36 73.56 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 17.00 33.82 71.84 16.59 31.98 70.88 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 20.06 38.06 74.21 21.19 36.81 72.96 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 205 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 208 HIS B 30 HIS.? -4.20 ZN ZN B 128s C 104 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 20.72 31.33 73.27 20.15 33.36 73.56 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 17.00 33.82 71.84 16.59 31.98 70.88 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 20.06 38.06 74.21 21.19 36.81 72.96 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 205 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 208 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 104 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 20.72 31.33 73.27 20.15 33.36 73.56 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 17.00 33.82 71.84 16.59 31.98 70.88 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 20.06 38.06 74.21 21.19 36.81 72.96 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 205 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 208 HIS C 30 HIS^? -3.56 ZN ZN C 128s C 104 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 20.72 31.33 73.27 20.15 33.36 73.56 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 17.00 33.82 71.84 16.59 31.98 70.88 0.61 46.90 50.78 -0.23 46.71 52.70 coo 20.06 38.06 74.21 21.19 36.81 72.96 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 205 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 208 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 104 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 20.72 31.33 73.27 20.15 33.36 73.56 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 17.00 33.82 71.84 16.59 31.98 70.88 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 20.06 38.06 74.21 21.19 36.81 72.96 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 7 3 # 7 A 205 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 208 HIS D 30 HIS^? -3.68 ZN ZN D 128s C 104 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 20.72 31.33 73.27 20.15 33.36 73.56 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 17.00 33.82 71.84 16.59 31.98 70.88 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 20.06 38.06 74.21 21.19 36.81 72.96 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 8 3 # 8 A 205 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 208 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 104 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 20.72 31.33 73.27 20.15 33.36 73.56 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 17.00 33.82 71.84 16.59 31.98 70.88 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 20.06 38.06 74.21 21.19 36.81 72.96 -18.46 42.11 47.13 -20.09 43.42 47.28 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 8 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS A 10 HIS^? 15.73 ZN ZN A 128 E 205 ASP C 97 ASP^? 13.06 ZN ZN C 128 E 208 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 36.32 11.24 30.83 37.00 13.22 30.81 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 38.79 15.70 26.44 37.66 14.35 27.62 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 34.24 14.63 26.81 34.14 16.25 25.49 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 104 HIS A 83 HIS^? -3.82 ZN ZN A 128s E 205 ASP A 32 ASP.? -2.97 ZN ZN A 128s E 208 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 36.32 11.24 30.83 37.00 13.22 30.81 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 38.79 15.70 26.44 37.66 14.35 27.62 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 34.24 14.63 26.81 34.14 16.25 25.49 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 104 HIS B 10 HIS^? 15.59 ZN ZN B 128 E 205 ASP D 97 ASP^? 13.24 ZN ZN D 128 E 208 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 36.32 11.24 30.83 37.00 13.22 30.81 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 38.79 15.70 26.44 37.66 14.35 27.62 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 34.24 14.63 26.81 34.14 16.25 25.49 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 104 HIS B 83 HIS^? -3.82 ZN ZN B 128s E 205 ASP B 32 ASP.? -2.88 ZN ZN B 128s E 208 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 36.32 11.24 30.83 37.00 13.22 30.81 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 38.79 15.70 26.44 37.66 14.35 27.62 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 34.24 14.63 26.81 34.14 16.25 25.49 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 104 HIS C 10 HIS^? 15.40 ZN ZN C 128 E 205 ASP A 97 ASP^? 13.17 ZN ZN A 128 E 208 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 36.32 11.24 30.83 37.00 13.22 30.81 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 38.79 15.70 26.44 37.66 14.35 27.62 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 34.24 14.63 26.81 34.14 16.25 25.49 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 104 HIS C 83 HIS^? -3.45 ZN ZN C 128s E 205 ASP C 32 ASP^? -2.40 ZN ZN C 128s E 208 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 36.32 11.24 30.83 37.00 13.22 30.81 0.88 50.97 54.56 -1.00 50.36 53.86 coo 38.79 15.70 26.44 37.66 14.35 27.62 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 34.24 14.63 26.81 34.14 16.25 25.49 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 7 3 # 7 A 104 HIS D 10 HIS^? 15.91 ZN ZN D 128 E 205 ASP B 97 ASP^? 13.03 ZN ZN B 128 E 208 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 36.32 11.24 30.83 37.00 13.22 30.81 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 38.79 15.70 26.44 37.66 14.35 27.62 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 34.24 14.63 26.81 34.14 16.25 25.49 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 8 3 # 8 A 104 HIS D 83 HIS^? -3.55 ZN ZN D 128s E 205 ASP D 32 ASP^? -2.55 ZN ZN D 128s E 208 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 36.32 11.24 30.83 37.00 13.22 30.81 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 38.79 15.70 26.44 37.66 14.35 27.62 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 34.24 14.63 26.81 34.14 16.25 25.49 -27.59 25.34 55.74 -27.28 26.44 53.99 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 8 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP A 32 ASP.? -2.97 ZN ZN A 128s C 208 HIS A 30 HIS.? -4.18 ZN ZN A 128s E 104 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 36.50 67.03 37.59 36.77 66.38 35.61 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 33.45 66.12 34.16 32.13 66.40 35.76 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 38.29 64.94 31.33 38.08 64.16 33.27 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 208 HIS A 10 HIS^? 15.73 ZN ZN A 128 E 104 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 36.50 67.03 37.59 36.77 66.38 35.61 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 33.45 66.12 34.16 32.13 66.40 35.76 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 38.29 64.94 31.33 38.08 64.16 33.27 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 C 205 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 208 HIS B 30 HIS.? -4.20 ZN ZN B 128s E 104 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 36.50 67.03 37.59 36.77 66.38 35.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 33.45 66.12 34.16 32.13 66.40 35.76 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 38.29 64.94 31.33 38.08 64.16 33.27 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 C 205 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 208 HIS B 10 HIS^? 15.59 ZN ZN B 128 E 104 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 36.50 67.03 37.59 36.77 66.38 35.61 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 33.45 66.12 34.16 32.13 66.40 35.76 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 38.29 64.94 31.33 38.08 64.16 33.27 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 C 205 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 208 HIS C 30 HIS^? -3.56 ZN ZN C 128s E 104 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 36.50 67.03 37.59 36.77 66.38 35.61 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 33.45 66.12 34.16 32.13 66.40 35.76 0.61 46.90 50.78 -0.23 46.71 52.70 coo 38.29 64.94 31.33 38.08 64.16 33.27 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 C 205 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 208 HIS C 10 HIS^? 15.40 ZN ZN C 128 E 104 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 36.50 67.03 37.59 36.77 66.38 35.61 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 33.45 66.12 34.16 32.13 66.40 35.76 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 38.29 64.94 31.33 38.08 64.16 33.27 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 7 3 # 7 C 205 ASP D 32 ASP^? -2.55 ZN ZN D 128s C 208 HIS D 30 HIS^? -3.68 ZN ZN D 128s E 104 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 36.50 67.03 37.59 36.77 66.38 35.61 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 33.45 66.12 34.16 32.13 66.40 35.76 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 38.29 64.94 31.33 38.08 64.16 33.27 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 8 3 # 8 C 205 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 208 HIS D 10 HIS^? 15.91 ZN ZN D 128 E 104 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 36.50 67.03 37.59 36.77 66.38 35.61 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 33.45 66.12 34.16 32.13 66.40 35.76 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 38.29 64.94 31.33 38.08 64.16 33.27 -18.46 42.11 47.13 -20.09 43.42 47.28 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 8 hits 1ndo_c02 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 290 LYS A 33 LYS.? 11.45 ZN ZN A 128 A 405 ARG A 12 ARG^? 10.24 ZN ZN A 128 coo 41.33 25.99 28.05 41.95 26.95 29.80 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 37.11 33.75 31.82 38.72 27.95 29.90 -32.13 43.51 68.59 -35.31 47.47 65.43 coo 42.28 27.98 41.30 43.16 28.14 38.35 -26.71 45.35 59.66 -27.06 47.43 61.87 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 290 LYS D 33 LYS.? 12.24 ZN ZN D 128 A 405 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 41.33 25.99 28.05 41.95 26.95 29.80 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 37.11 33.75 31.82 38.72 27.95 29.90 -30.11 33.22 59.92 -32.56 30.92 63.52 coo 42.28 27.98 41.30 43.16 28.14 38.35 -21.38 38.31 55.98 -23.17 35.84 55.80 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 2 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 28 GLU~? 12.19 ZN ZN A 128 B 128 HIS A 83 HIS^? -3.82 ZN ZN A 128s C 263 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 12.51 16.35 80.99 13.16 14.90 82.37 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 11.58 14.94 93.26 12.25 14.03 91.50 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 62 GLU.? 19.31 ZN ZN A 128 B 128 HIS A 59 HIS.? 17.66 ZN ZN A 128 C 263 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 6.12 5.94 82.00 7.16 6.32 83.81 -26.58 51.13 91.45 -26.69 53.13 90.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 11.58 14.94 93.26 12.25 14.03 91.50 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU A 80 GLU.? 14.45 ZN ZN A 128 B 128 HIS A 30 HIS.? -4.18 ZN ZN A 128s C 263 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -27.62 36.67 74.75 -28.01 34.63 75.18 coo 12.51 16.35 80.99 13.16 14.90 82.37 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 11.58 14.94 93.26 12.25 14.03 91.50 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU A 80 GLU.? 14.45 ZN ZN A 128 B 128 HIS A 83 HIS^? -3.82 ZN ZN A 128s C 263 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -27.62 36.67 74.75 -28.01 34.63 75.18 coo 12.51 16.35 80.99 13.16 14.90 82.37 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 11.58 14.94 93.26 12.25 14.03 91.50 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU B 80 GLU.? 14.47 ZN ZN B 128 B 128 HIS B 30 HIS.? -4.20 ZN ZN B 128s C 263 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 12.51 16.35 80.99 13.16 14.90 82.37 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 11.58 14.94 93.26 12.25 14.03 91.50 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU C 80 GLU.? 11.53 ZN ZN C 128 B 128 HIS C 30 HIS^? -3.56 ZN ZN C 128s C 263 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -4.16 58.03 47.91 -5.06 56.59 46.66 coo 12.51 16.35 80.99 13.16 14.90 82.37 0.61 46.90 50.78 -0.23 46.71 52.70 coo 11.58 14.94 93.26 12.25 14.03 91.50 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 B 59 GLU D 80 GLU.? 11.79 ZN ZN D 128 B 128 HIS D 30 HIS^? -3.68 ZN ZN D 128s C 263 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -37.55 31.59 59.30 -36.06 33.05 59.71 coo 12.51 16.35 80.99 13.16 14.90 82.37 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 11.58 14.94 93.26 12.25 14.03 91.50 -36.37 16.36 61.26 -35.21 16.95 62.91 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 B 59 GLU D 103 GLU.? 16.17 ZN ZN A 128 B 128 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 263 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -31.28 51.42 58.86 -30.79 51.26 56.79 coo 12.51 16.35 80.99 13.16 14.90 82.37 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 11.58 14.94 93.26 12.25 14.03 91.50 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 B 59 GLU D 103 GLU.? 16.17 ZN ZN A 128 B 128 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 263 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 6.12 5.94 82.00 7.16 6.32 83.81 -31.28 51.42 58.86 -30.79 51.26 56.79 coo 12.51 16.35 80.99 13.16 14.90 82.37 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 11.58 14.94 93.26 12.25 14.03 91.50 -17.83 49.51 56.44 -17.15 47.54 56.54 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 9 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 10 HIS^? 15.73 ZN ZN A 128 D 59 GLU D 103 GLU.? 16.17 ZN ZN A 128 D 128 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -31.28 51.42 58.86 -30.79 51.26 56.79 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 59 HIS.? 17.66 ZN ZN A 128 D 59 GLU A 80 GLU.? 14.45 ZN ZN A 128 D 128 HIS A 30 HIS.? -4.18 ZN ZN A 128s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -27.62 36.67 74.75 -28.01 34.63 75.18 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -30.72 49.15 73.99 -28.78 49.60 73.32 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 59 HIS.? 17.68 ZN ZN B 128 D 59 GLU B 80 GLU.? 14.47 ZN ZN B 128 D 128 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -9.61 50.34 31.62 -7.67 49.64 31.13 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS C 10 HIS^? 15.40 ZN ZN C 128 D 59 GLU D 103 GLU.? 16.17 ZN ZN A 128 D 128 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -31.28 51.42 58.86 -30.79 51.26 56.79 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS C 59 HIS.? 17.15 ZN ZN C 128 D 59 GLU C 80 GLU.? 11.53 ZN ZN C 128 D 128 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 11.45 52.92 44.80 10.43 52.05 43.19 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -4.16 58.03 47.91 -5.06 56.59 46.66 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS D 59 HIS.? 17.27 ZN ZN D 128 D 59 GLU D 80 GLU.? 11.79 ZN ZN D 128 D 128 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -37.55 31.59 59.30 -36.06 33.05 59.71 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -27.59 25.34 55.74 -27.28 26.44 53.99 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 6 hits 1ni4_c01 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 42 ARG^? 15.09 ZN ZN A 128 A 101 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 132 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 11.61 22.83 17.30 14.06 21.71 15.78 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 11.37 24.94 11.48 12.48 24.45 13.28 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 16.14 18.17 13.37 15.92 19.81 14.71 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 42 ARG^? 15.17 ZN ZN B 128 A 101 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 132 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 11.61 22.83 17.30 14.06 21.71 15.78 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 11.37 24.94 11.48 12.48 24.45 13.28 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 16.14 18.17 13.37 15.92 19.81 14.71 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 101 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 132 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 11.61 22.83 17.30 14.06 21.71 15.78 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 11.37 24.94 11.48 12.48 24.45 13.28 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 16.14 18.17 13.37 15.92 19.81 14.71 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG D 42 ARG^? 14.89 ZN ZN D 128 A 101 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 132 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 11.61 22.83 17.30 14.06 21.71 15.78 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 11.37 24.94 11.48 12.48 24.45 13.28 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 16.14 18.17 13.37 15.92 19.81 14.71 -21.74 43.31 43.14 -23.53 43.14 44.28 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 42 ARG^? 15.09 ZN ZN A 128 B 101 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 132 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 11.61 3.43 18.38 9.11 4.29 16.86 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 11.74 0.51 12.98 10.75 1.32 14.67 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 6.93 7.52 14.08 7.18 6.08 15.65 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 42 ARG^? 15.17 ZN ZN B 128 B 101 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 132 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 11.61 3.43 18.38 9.11 4.29 16.86 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 11.74 0.51 12.98 10.75 1.32 14.67 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 6.93 7.52 14.08 7.18 6.08 15.65 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 101 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 132 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 11.61 3.43 18.38 9.11 4.29 16.86 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 11.74 0.51 12.98 10.75 1.32 14.67 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 6.93 7.52 14.08 7.18 6.08 15.65 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 101 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 132 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 11.61 3.43 18.38 9.11 4.29 16.86 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 11.74 0.51 12.98 10.75 1.32 14.67 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 6.93 7.52 14.08 7.18 6.08 15.65 -21.74 43.31 43.14 -23.53 43.14 44.28 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 42 ARG^? 15.09 ZN ZN A 128 A 101 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 132 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 11.50 22.77 17.24 14.00 21.62 15.86 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 11.19 25.00 11.76 12.16 24.45 13.59 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 16.04 18.11 13.43 15.88 19.70 14.83 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 42 ARG^? 15.17 ZN ZN B 128 A 101 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 132 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 11.50 22.77 17.24 14.00 21.62 15.86 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 11.19 25.00 11.76 12.16 24.45 13.59 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 16.04 18.11 13.43 15.88 19.70 14.83 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 101 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 132 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 11.50 22.77 17.24 14.00 21.62 15.86 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 11.19 25.00 11.76 12.16 24.45 13.59 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 16.04 18.11 13.43 15.88 19.70 14.83 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG D 42 ARG^? 14.89 ZN ZN D 128 A 101 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 132 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 11.50 22.77 17.24 14.00 21.62 15.86 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 11.19 25.00 11.76 12.16 24.45 13.59 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 16.04 18.11 13.43 15.88 19.70 14.83 -21.74 43.31 43.14 -23.53 43.14 44.28 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 42 ARG^? 15.09 ZN ZN A 128 B 101 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 132 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 11.48 3.09 18.25 9.01 4.07 16.77 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 11.83 0.33 13.01 10.88 1.04 14.81 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 6.85 7.33 14.07 7.10 5.88 15.60 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 42 ARG^? 15.17 ZN ZN B 128 B 101 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 132 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 11.48 3.09 18.25 9.01 4.07 16.77 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 11.83 0.33 13.01 10.88 1.04 14.81 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 6.85 7.33 14.07 7.10 5.88 15.60 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 101 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 132 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 11.48 3.09 18.25 9.01 4.07 16.77 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 11.83 0.33 13.01 10.88 1.04 14.81 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 6.85 7.33 14.07 7.10 5.88 15.60 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 101 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 132 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 11.48 3.09 18.25 9.01 4.07 16.77 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 11.83 0.33 13.01 10.88 1.04 14.81 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 6.85 7.33 14.07 7.10 5.88 15.60 -21.74 43.31 43.14 -23.53 43.14 44.28 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 13 SER^? 14.04 ZN ZN A 128 A 154 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 261 ARG A 12 ARG^? 10.24 ZN ZN A 128 coo 16.10 74.10 3.11 17.18 73.52 5.20 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 16.07 84.71 8.14 15.20 82.81 8.14 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 10.59 77.85 4.81 13.09 76.36 5.76 -26.71 45.35 59.66 -27.06 47.43 61.87 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 44 SER^? 13.08 ZN ZN A 128 A 154 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 261 ARG A 42 ARG^? 15.09 ZN ZN A 128 coo 16.10 74.10 3.11 17.18 73.52 5.20 -15.06 51.94 67.95 -14.23 50.17 66.49 coo 16.07 84.71 8.14 15.20 82.81 8.14 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 10.59 77.85 4.81 13.09 76.36 5.76 -14.23 45.62 66.89 -13.61 45.68 63.87 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER B 44 SER^? 13.00 ZN ZN B 128 A 154 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 261 ARG B 42 ARG^? 15.17 ZN ZN B 128 coo 16.10 74.10 3.11 17.18 73.52 5.20 -27.80 41.88 38.27 -27.32 41.64 40.63 coo 16.07 84.71 8.14 15.20 82.81 8.14 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 10.59 77.85 4.81 13.09 76.36 5.76 -22.13 39.38 39.45 -22.11 38.65 42.43 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER C 13 SER^? 14.25 ZN ZN C 128 A 154 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 261 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 16.10 74.10 3.11 17.18 73.52 5.20 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 16.07 84.71 8.14 15.20 82.81 8.14 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 10.59 77.85 4.81 13.09 76.36 5.76 -12.88 45.85 50.29 -9.95 45.19 50.84 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER C 44 SER^? 13.15 ZN ZN C 128 A 154 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 261 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 16.10 74.10 3.11 17.18 73.52 5.20 -8.23 46.92 64.43 -10.34 48.09 64.36 coo 16.07 84.71 8.14 15.20 82.81 8.14 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 10.59 77.85 4.81 13.09 76.36 5.76 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER D 13 SER^? 14.41 ZN ZN D 128 A 154 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 261 ARG D 12 ARG^? 9.28 ZN ZN D 128 coo 16.10 74.10 3.11 17.18 73.52 5.20 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 16.07 84.71 8.14 15.20 82.81 8.14 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 10.59 77.85 4.81 13.09 76.36 5.76 -21.38 38.31 55.98 -23.17 35.84 55.80 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 7 3 # 7 A 62 SER D 44 SER^? 13.11 ZN ZN D 128 A 154 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 261 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 16.10 74.10 3.11 17.18 73.52 5.20 -25.20 33.87 41.85 -23.76 35.78 42.26 coo 16.07 84.71 8.14 15.20 82.81 8.14 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 10.59 77.85 4.81 13.09 76.36 5.76 -29.08 38.55 44.25 -27.07 40.84 43.98 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 7 hits 1o98_c00 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 96 GLU A 86 GLU^? 14.11 ZN ZN A 128 A 132 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 31.23 12.29 16.44 30.82 11.56 18.39 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 26.82 3.20 24.36 27.99 4.86 24.98 -23.80 59.27 78.25 -23.36 59.70 80.28 coo 29.99 0.62 22.18 30.38 6.69 20.81 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 96 GLU B 86 GLU^? 14.21 ZN ZN B 128 A 132 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 31.23 12.29 16.44 30.82 11.56 18.39 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 26.82 3.20 24.36 27.99 4.86 24.98 -32.66 52.13 28.08 -32.88 52.09 25.98 coo 29.99 0.62 22.18 30.38 6.69 20.81 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 96 GLU C 86 GLU^? 14.08 ZN ZN C 128 A 132 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 31.23 12.29 16.44 30.82 11.56 18.39 2.93 33.32 67.19 5.03 33.43 67.23 coo 26.82 3.20 24.36 27.99 4.86 24.98 6.41 43.35 62.15 8.10 44.52 62.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 96 GLU C 86 GLU^? 14.08 ZN ZN C 128 A 132 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 31.23 12.29 16.44 30.82 11.56 18.39 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 26.82 3.20 24.36 27.99 4.86 24.98 6.41 43.35 62.15 8.10 44.52 62.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 96 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 132 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 31.23 12.29 16.44 30.82 11.56 18.39 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 26.82 3.20 24.36 27.99 4.86 24.98 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 29.99 0.62 22.18 30.38 6.69 20.81 -28.66 23.49 42.59 -29.87 18.31 40.35 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 96 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 132 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 31.23 12.29 16.44 30.82 11.56 18.39 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 26.82 3.20 24.36 27.99 4.86 24.98 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 29.99 0.62 22.18 30.38 6.69 20.81 -28.66 23.49 42.59 -29.87 18.31 40.35 1onr_c00 source 1onr TRANSALDOLASE B : 6 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 90 ASP.? 20.22 ZN ZN A 128 B 96 GLU A 86 GLU^? 14.11 ZN ZN A 128 B 132 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 26.69 48.45 7.18 27.85 50.13 7.74 -23.80 59.27 78.25 -23.36 59.70 80.28 coo 29.82 45.80 5.07 30.26 51.81 3.56 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP B 90 ASP.? 20.48 ZN ZN B 128 B 96 GLU B 86 GLU^? 14.21 ZN ZN B 128 B 132 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 26.69 48.45 7.18 27.85 50.13 7.74 -32.66 52.13 28.08 -32.88 52.09 25.98 coo 29.82 45.80 5.07 30.26 51.81 3.56 -29.75 46.77 28.66 -32.67 46.99 23.53 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP C 90 ASP.? 21.10 ZN ZN C 128 B 96 GLU C 86 GLU^? 14.08 ZN ZN C 128 B 132 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 31.16 57.31 -0.94 30.73 56.64 1.01 2.93 33.32 67.19 5.03 33.43 67.23 coo 26.69 48.45 7.18 27.85 50.13 7.74 6.41 43.35 62.15 8.10 44.52 62.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 96 GLU C 86 GLU^? 14.08 ZN ZN C 128 B 132 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 26.69 48.45 7.18 27.85 50.13 7.74 6.41 43.35 62.15 8.10 44.52 62.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP D 90 ASP.? 20.62 ZN ZN D 128 B 96 GLU D 86 GLU^? 14.30 ZN ZN D 128 B 132 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 26.69 48.45 7.18 27.85 50.13 7.74 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 29.82 45.80 5.07 30.26 51.81 3.56 -28.66 23.49 42.59 -29.87 18.31 40.35 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 96 GLU D 86 GLU^? 14.30 ZN ZN D 128 B 132 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 26.69 48.45 7.18 27.85 50.13 7.74 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 29.82 45.80 5.07 30.26 51.81 3.56 -28.66 23.49 42.59 -29.87 18.31 40.35 1onr_c01 source 1onr TRANSALDOLASE B : 6 hits 1onr_c01 naa= 3 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 1 3 # 1 191 HIS D 83 HIS^? -3.55 ZN ZN D 128s 194 ASN D 84 ASN^? 8.98 ZN ZN D 128 196 TYR D 55 TYR.? 11.30 ZN ZN D 128 coo 40.21 70.60 24.49 39.36 69.94 22.74 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 39.62 68.39 19.02 38.50 66.72 19.87 -28.44 21.48 51.55 -28.88 19.99 50.09 coo 40.89 73.30 19.79 38.36 73.12 18.60 -35.27 19.83 52.49 -33.13 18.64 51.13 1oya_c00 source 1oya OLD YELLOW ENZYME (OXIDIZED) (OYE) (E.C.1.6.99: 1 hits 1oya_c00 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 13 SER^? 14.04 ZN ZN A 128 A 708 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 740 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER A 13 SER^? 14.04 ZN ZN A 128 A 708 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 740 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER B 13 SER^? 13.94 ZN ZN B 128 A 708 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 740 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER B 13 SER^? 13.94 ZN ZN B 128 A 708 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 740 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER C 13 SER^? 14.25 ZN ZN C 128 A 708 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 740 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER D 13 SER^? 14.41 ZN ZN D 128 A 708 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 740 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -18.46 42.11 47.13 -20.09 43.42 47.28 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 6 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 13 SER^? 14.04 ZN ZN A 128 B 708 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 740 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 4.44 13.29 37.64 6.01 11.66 38.49 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 6.39 7.18 30.33 6.92 8.20 32.17 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 8.57 10.09 34.47 7.10 10.73 35.82 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 13 SER^? 14.04 ZN ZN A 128 B 708 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 740 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 4.44 13.29 37.64 6.01 11.66 38.49 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 6.39 7.18 30.33 6.92 8.20 32.17 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 8.57 10.09 34.47 7.10 10.73 35.82 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER B 13 SER^? 13.94 ZN ZN B 128 B 708 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 740 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 4.44 13.29 37.64 6.01 11.66 38.49 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 6.39 7.18 30.33 6.92 8.20 32.17 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 8.57 10.09 34.47 7.10 10.73 35.82 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER B 13 SER^? 13.94 ZN ZN B 128 B 708 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 740 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 4.44 13.29 37.64 6.01 11.66 38.49 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 6.39 7.18 30.33 6.92 8.20 32.17 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 8.57 10.09 34.47 7.10 10.73 35.82 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER C 13 SER^? 14.25 ZN ZN C 128 B 708 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 740 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 4.44 13.29 37.64 6.01 11.66 38.49 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 6.39 7.18 30.33 6.92 8.20 32.17 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 8.57 10.09 34.47 7.10 10.73 35.82 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER D 13 SER^? 14.41 ZN ZN D 128 B 708 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 740 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 4.44 13.29 37.64 6.01 11.66 38.49 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 6.39 7.18 30.33 6.92 8.20 32.17 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 8.57 10.09 34.47 7.10 10.73 35.82 -18.46 42.11 47.13 -20.09 43.42 47.28 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 6 hits 1pfq_c01 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 259 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 552 ASP D 91 ASP.? 22.90 ZN ZN D 128 coo 11.34 95.90 25.54 12.13 96.42 23.67 11.45 52.92 44.80 10.43 52.05 43.19 coo 14.91 97.39 18.63 13.39 95.60 20.20 8.07 52.98 53.71 8.63 50.62 55.11 coo 46.37 82.54 38.83 45.97 84.66 38.77 -15.13 23.89 36.32 -13.65 22.60 35.55 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 259 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 552 ASP C 91 ASP.? 22.72 ZN ZN C 128 coo 11.34 95.90 25.54 12.13 96.42 23.67 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 14.91 97.39 18.63 13.39 95.60 20.20 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 46.37 82.54 38.83 45.97 84.66 38.77 -1.22 34.88 70.14 -0.71 32.98 70.85 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 2 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA B 24 ALA~? 12.38 ZN ZN B 128 A 126 LEU C 105 LEU.? 13.75 ZN ZN B 128 A 158 GLU C 107 GLU.? 20.28 ZN ZN B 128 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.35 60.12 36.25 -28.70 61.61 36.18 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -25.91 63.21 42.61 -24.65 61.58 41.92 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -32.00 66.19 44.45 -32.39 64.60 45.80 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 1 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA B 24 ALA~? 12.38 ZN ZN B 128 B 126 LEU C 105 LEU.? 13.75 ZN ZN B 128 B 158 GLU C 107 GLU.? 20.28 ZN ZN B 128 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.35 60.12 36.25 -28.70 61.61 36.18 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -25.91 63.21 42.61 -24.65 61.58 41.92 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -32.00 66.19 44.45 -32.39 64.60 45.80 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 1 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA B 24 ALA~? 12.38 ZN ZN B 128 C 126 LEU C 105 LEU.? 13.75 ZN ZN B 128 C 158 GLU C 107 GLU.? 20.28 ZN ZN B 128 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.35 60.12 36.25 -28.70 61.61 36.18 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -25.91 63.21 42.61 -24.65 61.58 41.92 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -32.00 66.19 44.45 -32.39 64.60 45.80 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 1 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 270 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 382 MET A 1 MET?? 18.16 ZN ZN A 128 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -22.76 44.44 87.32 -23.27 43.38 85.56 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -27.08 41.78 78.19 -22.69 42.64 82.54 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -11.66 42.62 77.60 -8.71 43.64 74.51 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 270 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 382 MET B 1 MET?? 18.24 ZN ZN B 128 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -18.76 47.29 19.05 -17.56 47.54 20.78 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -14.88 50.71 28.23 -16.26 47.48 23.80 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -19.98 36.01 28.75 -21.58 33.56 32.04 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 270 LYS C 81 LYS.? 11.89 ZN ZN C 128 A 382 MET C 1 MET?? 18.00 ZN ZN C 128 coo -27.63 121.99 45.48 -26.66 123.86 45.68 8.74 58.91 56.74 6.81 58.81 55.87 coo -32.20 115.91 49.56 -31.37 121.03 53.12 0.65 56.08 51.29 4.22 57.96 54.91 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -4.14 60.32 65.32 -7.54 58.81 67.40 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 270 LYS D 81 LYS.? 12.28 ZN ZN D 128 A 382 MET D 1 MET?? 17.82 ZN ZN D 128 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -41.38 20.76 48.99 -40.62 22.36 50.18 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -36.76 27.60 54.86 -39.44 24.48 51.40 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -39.32 33.99 40.60 -36.37 36.72 39.01 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 4 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 90 ASP.? 20.22 ZN ZN A 128 B 270 LYS A 19 LYS.? 16.70 ZN ZN A 128 B 382 MET A 46 MET?? 16.02 ZN ZN C 128 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -25.66 62.13 69.69 -25.48 65.02 74.91 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -13.34 57.85 66.03 -11.60 57.25 63.22 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP B 90 ASP.? 20.48 ZN ZN B 128 B 270 LYS B 19 LYS.? 16.80 ZN ZN B 128 B 382 MET B 46 MET?? 15.98 ZN ZN D 128 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -34.93 54.65 36.44 -38.00 53.50 31.57 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -33.98 41.81 40.42 -34.01 40.08 43.13 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP C 90 ASP.? 21.10 ZN ZN C 128 B 270 LYS C 19 LYS.? 17.60 ZN ZN C 128 B 382 MET C 46 MET?? 16.34 ZN ZN A 128 coo -11.82 154.51 43.38 -12.86 152.74 43.79 2.93 33.32 67.19 5.03 33.43 67.23 coo -5.09 158.39 43.41 -0.74 158.80 47.15 0.64 35.92 60.53 5.63 36.47 64.53 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -8.28 42.10 68.53 -11.44 41.59 69.49 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP D 90 ASP.? 20.62 ZN ZN D 128 B 270 LYS D 19 LYS.? 15.46 ZN ZN D 128 B 382 MET D 46 MET?? 16.32 ZN ZN B 128 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -16.96 22.44 46.27 -19.09 18.04 45.40 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -20.22 32.77 38.01 -19.00 35.69 36.99 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 4 hits 1pjq_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 192 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 195 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 2.03 47.14 19.75 1.72 46.26 21.64 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 192 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 195 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 2.03 47.14 19.75 1.72 46.26 21.64 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 192 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 195 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 2.03 47.14 19.75 1.72 46.26 21.64 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 192 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 195 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 2.03 47.14 19.75 1.72 46.26 21.64 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -17.20 28.58 35.23 -16.55 27.59 33.50 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 4 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 192 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 195 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo -1.08 51.41 10.34 0.65 52.62 10.17 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 11.36 52.33 5.59 10.18 53.87 6.47 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 7.99 56.74 7.55 6.88 55.39 8.70 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 95 ASN^? 12.67 ZN ZN B 128 B 192 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 195 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo -1.08 51.41 10.34 0.65 52.62 10.17 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 11.36 52.33 5.59 10.18 53.87 6.47 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 7.99 56.74 7.55 6.88 55.39 8.70 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 192 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 195 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo -1.08 51.41 10.34 0.65 52.62 10.17 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 11.36 52.33 5.59 10.18 53.87 6.47 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 7.99 56.74 7.55 6.88 55.39 8.70 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN D 95 ASN^? 12.80 ZN ZN D 128 B 192 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 195 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo -1.08 51.41 10.34 0.65 52.62 10.17 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 11.36 52.33 5.59 10.18 53.87 6.47 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 7.99 56.74 7.55 6.88 55.39 8.70 -17.20 28.58 35.23 -16.55 27.59 33.50 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 4 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 28 GLU~? 12.19 ZN ZN A 128 A 67 ARG A 29 ARG.? 13.64 ZN ZN A 128 A 86 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 18.15 3.28 18.56 20.10 2.92 19.20 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 21.52 6.83 26.64 21.22 5.53 23.85 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 67 ARG B 29 ARG.? 13.89 ZN ZN B 128 A 86 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 18.15 3.28 18.56 20.10 2.92 19.20 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 21.52 6.83 26.64 21.22 5.53 23.85 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU B 28 GLU~? 11.81 ZN ZN B 128 A 67 ARG B 29 ARG.? 13.89 ZN ZN B 128 A 86 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 18.15 3.28 18.56 20.10 2.92 19.20 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 21.52 6.83 26.64 21.22 5.53 23.85 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 67 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 86 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 18.15 3.28 18.56 20.10 2.92 19.20 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 21.52 6.83 26.64 21.22 5.53 23.85 7.46 50.67 50.27 10.29 51.53 51.14 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1pyl_c00 RIBONUCLEASE user 5 3 # 5 A 56 GLU C 28 GLU~? 12.07 ZN ZN C 128 A 67 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 86 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 18.15 3.28 18.56 20.10 2.92 19.20 5.96 41.55 51.41 5.95 40.38 49.65 coo 21.52 6.83 26.64 21.22 5.53 23.85 7.46 50.67 50.27 10.29 51.53 51.14 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1pyl_c00 RIBONUCLEASE user 6 3 # 6 A 56 GLU D 28 GLU.? 12.56 ZN ZN D 128 A 67 ARG D 29 ARG.? 13.42 ZN ZN D 128 A 86 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 18.15 3.28 18.56 20.10 2.92 19.20 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 21.52 6.83 26.64 21.22 5.53 23.85 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1pyl_c00 RIBONUCLEASE user 7 3 # 7 A 56 GLU D 28 GLU.? 12.56 ZN ZN D 128 A 67 ARG D 29 ARG.? 13.42 ZN ZN D 128 A 86 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 18.15 3.28 18.56 20.10 2.92 19.20 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 21.52 6.83 26.64 21.22 5.53 23.85 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -31.62 26.29 51.88 -30.63 27.88 52.82 1pyl_c00 source 1pyl RIBONUCLEASE : 7 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 28 GLU~? 12.19 ZN ZN A 128 B 67 ARG A 29 ARG.? 13.64 ZN ZN A 128 B 86 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -33.40 55.75 75.93 -32.70 57.39 77.09 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU B 28 GLU~? 11.81 ZN ZN B 128 B 67 ARG B 29 ARG.? 13.89 ZN ZN B 128 B 86 HIS B 30 HIS.? -4.20 ZN ZN B 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -20.72 56.25 32.46 -21.75 54.52 33.04 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 28 GLU~? 11.81 ZN ZN B 128 B 67 ARG B 29 ARG.? 13.89 ZN ZN B 128 B 86 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -26.33 60.76 29.16 -28.24 60.05 29.68 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 67 ARG C 29 ARG.? 13.36 ZN ZN C 128 B 86 HIS C 30 HIS^? -3.56 ZN ZN C 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 7.46 50.67 50.27 10.29 51.53 51.14 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 0.61 46.90 50.78 -0.23 46.71 52.70 ULMN 3 1pyl_c01 RIBONUCLEASE user 5 3 # 5 B 56 GLU C 28 GLU~? 12.07 ZN ZN C 128 B 67 ARG C 29 ARG.? 13.36 ZN ZN C 128 B 86 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 5.96 41.55 51.41 5.95 40.38 49.65 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 7.46 50.67 50.27 10.29 51.53 51.14 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1pyl_c01 RIBONUCLEASE user 6 3 # 6 B 56 GLU D 28 GLU.? 12.56 ZN ZN D 128 B 67 ARG D 29 ARG.? 13.42 ZN ZN D 128 B 86 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1pyl_c01 RIBONUCLEASE user 7 3 # 7 B 56 GLU D 28 GLU.? 12.56 ZN ZN D 128 B 67 ARG D 29 ARG.? 13.42 ZN ZN D 128 B 86 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -23.77 18.70 55.29 -22.97 18.07 57.14 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -31.62 26.29 51.88 -30.63 27.88 52.82 ULMN 3 1pyl_c01 RIBONUCLEASE user 8 3 # 8 B 56 GLU D 58 GLU.? 14.54 ZN ZN D 128 B 67 ARG D 29 ARG.? 13.42 ZN ZN D 128 B 86 HIS D 30 HIS^? -3.68 ZN ZN D 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -27.59 25.34 55.74 -27.28 26.44 53.99 ULMN 3 1pyl_c01 RIBONUCLEASE user 9 3 # 9 B 56 GLU D 58 GLU.? 14.54 ZN ZN D 128 B 67 ARG D 29 ARG.? 13.42 ZN ZN D 128 B 86 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -31.52 17.79 54.63 -34.40 17.26 55.46 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -31.62 26.29 51.88 -30.63 27.88 52.82 1pyl_c01 source 1pyl RIBONUCLEASE : 9 hits 1pyl_c01 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN C 84 ASN^? 8.97 ZN ZN C 128 A 239 ARG C 29 ARG.? 13.36 ZN ZN C 128 A 246 TYR C 55 TYR.? 11.30 ZN ZN C 128 coo 2.50 7.27 18.06 0.76 7.28 16.81 4.63 46.66 55.03 6.28 47.10 56.31 coo -1.16 0.95 13.41 -2.50 3.71 13.61 7.46 50.67 50.27 10.29 51.53 51.14 coo 1.59 5.18 12.30 -0.74 6.52 11.61 8.07 52.98 53.71 8.63 50.62 55.11 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 1 hits 1qaz_c00 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 60 SER.? 16.46 ZN ZN A 128 A 310 GLU A 58 GLU.? 14.95 ZN ZN A 128 A 399 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 2.67 37.96 55.23 1.78 40.01 56.16 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 6.61 38.44 63.61 6.69 38.31 61.50 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 4.95 41.82 59.53 3.85 40.70 58.14 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 60 SER.? 16.61 ZN ZN B 128 A 310 GLU B 58 GLU.? 14.99 ZN ZN B 128 A 399 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 2.67 37.96 55.23 1.78 40.01 56.16 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 6.61 38.44 63.61 6.69 38.31 61.50 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 4.95 41.82 59.53 3.85 40.70 58.14 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 3 3 # 3 A 189 SER C 60 SER.? 15.14 ZN ZN C 128 A 310 GLU C 58 GLU.? 14.59 ZN ZN C 128 A 399 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 2.67 37.96 55.23 1.78 40.01 56.16 12.55 55.11 50.39 10.44 55.82 51.40 coo 6.61 38.44 63.61 6.69 38.31 61.50 7.13 51.72 45.00 6.65 51.50 42.95 coo 4.95 41.82 59.53 3.85 40.70 58.14 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 4 3 # 4 A 189 SER D 60 SER.? 15.90 ZN ZN D 128 A 310 GLU D 58 GLU.? 14.54 ZN ZN D 128 A 399 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 2.67 37.96 55.23 1.78 40.01 56.16 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 6.61 38.44 63.61 6.69 38.31 61.50 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 4.95 41.82 59.53 3.85 40.70 58.14 -36.37 16.36 61.26 -35.21 16.95 62.91 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 4 hits 1qe3_c00 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 107 GLU.? 11.70 ZN ZN D 128 A 143 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 170 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo -2.40 27.37 52.92 -1.22 29.09 52.71 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 1.36 26.79 49.43 3.17 26.89 50.50 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 7.24 31.80 48.14 6.27 25.92 49.70 -36.76 27.60 54.86 -39.44 24.48 51.40 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 1 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 107 GLU.? 11.70 ZN ZN D 128 B 143 HIS D 30 HIS^? -3.68 ZN ZN D 128s B 170 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 13.90 37.16 5.96 12.00 36.26 6.12 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 13.52 33.69 9.79 13.20 31.83 8.88 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 7.52 28.83 11.02 13.59 28.74 9.95 -36.76 27.60 54.86 -39.44 24.48 51.40 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 1 hits 1qfe_c01 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 13 SER^? 14.04 ZN ZN A 128 A 641 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 680 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 34.48 40.33 79.08 36.40 39.98 80.55 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 40.64 47.22 77.43 39.90 45.49 78.43 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 38.53 44.50 81.45 37.60 42.73 80.84 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 2 3 # 2 A 554 SER A 13 SER^? 14.04 ZN ZN A 128 A 641 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 680 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 34.48 40.33 79.08 36.40 39.98 80.55 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 40.64 47.22 77.43 39.90 45.49 78.43 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 38.53 44.50 81.45 37.60 42.73 80.84 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 3 3 # 3 A 554 SER B 13 SER^? 13.94 ZN ZN B 128 A 641 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 680 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 34.48 40.33 79.08 36.40 39.98 80.55 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 40.64 47.22 77.43 39.90 45.49 78.43 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 38.53 44.50 81.45 37.60 42.73 80.84 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 4 3 # 4 A 554 SER B 13 SER^? 13.94 ZN ZN B 128 A 641 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 680 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 34.48 40.33 79.08 36.40 39.98 80.55 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 40.64 47.22 77.43 39.90 45.49 78.43 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 38.53 44.50 81.45 37.60 42.73 80.84 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 5 3 # 5 A 554 SER C 13 SER^? 14.25 ZN ZN C 128 A 641 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 680 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 34.48 40.33 79.08 36.40 39.98 80.55 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 40.64 47.22 77.43 39.90 45.49 78.43 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 38.53 44.50 81.45 37.60 42.73 80.84 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 6 3 # 6 A 554 SER D 13 SER^? 14.41 ZN ZN D 128 A 641 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 680 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 34.48 40.33 79.08 36.40 39.98 80.55 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 40.64 47.22 77.43 39.90 45.49 78.43 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 38.53 44.50 81.45 37.60 42.73 80.84 -18.46 42.11 47.13 -20.09 43.42 47.28 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 6 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 C 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 C 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 39.01 29.77 22.02 37.48 31.30 19.84 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 39.51 34.34 13.63 37.63 32.61 14.79 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 C 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 C 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 39.01 29.77 22.02 37.48 31.30 19.84 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 39.51 34.34 13.63 37.63 32.61 14.79 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 45.78 31.11 9.51 44.25 30.06 10.53 -29.32 31.61 55.53 -28.20 30.46 54.16 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 D 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 D 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 D 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 D 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -29.32 31.61 55.53 -28.20 30.46 54.16 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 A 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 55.48 26.51 40.65 55.39 23.99 39.43 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 48.87 29.19 44.63 49.10 27.34 43.63 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 52.39 23.42 32.10 54.51 23.27 34.29 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 A 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s C 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 55.48 26.51 40.65 55.39 23.99 39.43 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 48.87 29.19 44.63 49.10 27.34 43.63 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 52.39 23.42 32.10 54.51 23.27 34.29 -29.08 38.55 44.25 -27.07 40.84 43.98 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 B 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s D 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 B 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s D 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -29.08 38.55 44.25 -27.07 40.84 43.98 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 G 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 G 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 G 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 G 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -29.32 31.61 55.53 -28.20 30.46 54.16 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 H 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 H 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 H 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 H 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -29.32 31.61 55.53 -28.20 30.46 54.16 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 E 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s G 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 E 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s G 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -29.08 38.55 44.25 -27.07 40.84 43.98 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR C 40 TYR^? 12.78 ZN ZN C 128 F 236 ASP C 32 ASP^? -2.40 ZN ZN C 128s H 110 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -9.42 57.42 55.22 -8.85 60.18 55.10 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR D 40 TYR^? 12.58 ZN ZN D 128 F 236 ASP D 32 ASP^? -2.55 ZN ZN D 128s H 110 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -34.73 38.00 51.16 -37.53 38.10 51.02 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -29.08 38.55 44.25 -27.07 40.84 43.98 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 147 THR A 14 THR.? 9.34 ZN ZN A 128 A 294 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -23.51 50.82 61.06 -23.73 50.87 63.22 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 147 THR C 35 THR.? 11.32 ZN ZN B 128 A 294 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 147 THR B 11 THR^? 14.42 ZN ZN C 128 A 294 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -15.35 45.63 47.22 -13.97 46.20 45.66 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 147 THR B 14 THR.? 9.29 ZN ZN B 128 A 294 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -24.73 49.75 45.33 -24.61 49.96 43.21 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -16.91 52.67 35.82 -18.80 51.89 35.31 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 4 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 261 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 329 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 34.02 79.89 42.60 34.73 78.01 41.86 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.57 55.26 21.18 -14.41 55.74 19.31 1qho_c05 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 260 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 329 ASP A 57 ASP.? 17.22 ZN ZN A 128 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -31.66 41.62 85.16 -32.16 42.63 86.92 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 260 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 329 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 30.73 81.29 37.61 31.23 82.07 35.69 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.57 55.26 21.18 -14.41 55.74 19.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 260 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 329 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 28.46 69.88 26.74 30.40 70.70 26.53 8.74 58.91 56.74 6.81 58.81 55.87 coo 30.73 81.29 37.61 31.23 82.07 35.69 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 37.87 70.12 31.80 36.61 69.74 30.15 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 260 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 329 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 28.46 69.88 26.74 30.40 70.70 26.53 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 30.73 81.29 37.61 31.23 82.07 35.69 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.07 20.84 58.32 -40.41 18.78 58.10 1qho_c07 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c07 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 13 SER^? 14.04 ZN ZN A 128 A 207 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 235 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 15.54 46.73 17.13 17.06 48.44 16.17 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 23.60 50.31 20.82 21.66 50.51 20.06 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 20.17 51.16 17.08 18.31 50.28 17.44 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 13 SER^? 13.94 ZN ZN B 128 A 207 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 235 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 15.54 46.73 17.13 17.06 48.44 16.17 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 23.60 50.31 20.82 21.66 50.51 20.06 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 20.17 51.16 17.08 18.31 50.28 17.44 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER C 13 SER^? 14.25 ZN ZN C 128 A 207 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 235 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 15.54 46.73 17.13 17.06 48.44 16.17 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 23.60 50.31 20.82 21.66 50.51 20.06 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 20.17 51.16 17.08 18.31 50.28 17.44 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER D 13 SER^? 14.41 ZN ZN D 128 A 207 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 235 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 15.54 46.73 17.13 17.06 48.44 16.17 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 23.60 50.31 20.82 21.66 50.51 20.06 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 20.17 51.16 17.08 18.31 50.28 17.44 -18.46 42.11 47.13 -20.09 43.42 47.28 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 4 hits 1qj4_c00 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 109 ALA.? 12.23 ZN ZN D 128 A 148 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 163 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 1.42 19.18 21.84 1.11 19.57 23.28 -30.13 20.47 61.13 -30.71 19.50 60.10 coo 0.71 19.67 27.92 2.43 19.16 26.83 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 7.15 16.22 27.50 6.15 18.00 27.94 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA B 49 ALA^? 16.22 ZN ZN B 128 A 148 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 163 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo 1.42 19.18 21.84 1.11 19.57 23.28 -34.75 44.14 32.50 -35.24 43.58 31.16 coo 0.71 19.67 27.92 2.43 19.16 26.83 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 7.15 16.22 27.50 6.15 18.00 27.94 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA B 109 ALA.? 11.51 ZN ZN C 128 A 148 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 163 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 1.42 19.18 21.84 1.11 19.57 23.28 5.85 47.64 45.49 6.61 48.23 46.67 coo 0.71 19.67 27.92 2.43 19.16 26.83 11.45 52.92 44.80 10.43 52.05 43.19 coo 7.15 16.22 27.50 6.15 18.00 27.94 8.18 57.58 47.56 10.27 57.39 47.78 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 109 ALA.? 12.23 ZN ZN D 128 B 148 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 163 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -30.13 20.47 61.13 -30.71 19.50 60.10 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA B 49 ALA^? 16.22 ZN ZN B 128 B 148 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 163 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -34.75 44.14 32.50 -35.24 43.58 31.16 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA B 109 ALA.? 11.51 ZN ZN C 128 B 148 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 163 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo -33.97 19.78 54.18 -33.40 20.11 52.82 5.85 47.64 45.49 6.61 48.23 46.67 coo -33.17 20.01 48.16 -34.95 19.37 49.06 11.45 52.92 44.80 10.43 52.05 43.19 coo -39.82 16.62 48.85 -38.59 18.24 48.48 8.18 57.58 47.56 10.27 57.39 47.78 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 109 ALA.? 12.23 ZN ZN D 128 C 148 HIS D 59 HIS.? 17.27 ZN ZN D 128 C 163 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -30.13 20.47 61.13 -30.71 19.50 60.10 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA B 109 ALA.? 11.51 ZN ZN C 128 C 148 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 163 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 5.85 47.64 45.49 6.61 48.23 46.67 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 11.45 52.92 44.80 10.43 52.05 43.19 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 8.18 57.58 47.56 10.27 57.39 47.78 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 49 ALA^? 15.93 ZN ZN A 128 D 148 HIS A 47 HIS^? 20.92 ZN ZN A 128 D 163 ASP A 91 ASP.? 21.24 ZN ZN A 128 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -15.43 59.12 73.84 -14.71 59.38 75.17 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -17.26 66.98 68.26 -15.96 67.19 69.91 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 109 ALA.? 12.23 ZN ZN D 128 D 148 HIS D 59 HIS.? 17.27 ZN ZN D 128 D 163 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -30.13 20.47 61.13 -30.71 19.50 60.10 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA B 49 ALA^? 16.22 ZN ZN B 128 D 148 HIS B 47 HIS^? 20.89 ZN ZN B 128 D 163 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -34.75 44.14 32.50 -35.24 43.58 31.16 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA B 109 ALA.? 11.51 ZN ZN C 128 D 148 HIS C 59 HIS.? 17.15 ZN ZN C 128 D 163 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 5.85 47.64 45.49 6.61 48.23 46.67 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 11.45 52.92 44.80 10.43 52.05 43.19 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 D 51 ALA D 49 ALA^? 16.16 ZN ZN D 128 D 148 HIS D 47 HIS^? 21.18 ZN ZN D 128 D 163 ASP D 91 ASP.? 22.90 ZN ZN D 128 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -23.96 25.36 38.04 -24.83 24.52 37.10 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -15.13 23.89 36.32 -13.65 22.60 35.55 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c03 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 109 ALA.? 12.23 ZN ZN D 128 F 148 HIS D 59 HIS.? 17.27 ZN ZN D 128 F 163 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -30.13 20.47 61.13 -30.71 19.50 60.10 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA B 109 ALA.? 11.51 ZN ZN C 128 F 148 HIS C 59 HIS.? 17.15 ZN ZN C 128 F 163 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 5.85 47.64 45.49 6.61 48.23 46.67 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 11.45 52.92 44.80 10.43 52.05 43.19 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 8.18 57.58 47.56 10.27 57.39 47.78 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 49 ALA^? 15.93 ZN ZN A 128 G 148 HIS A 47 HIS^? 20.92 ZN ZN A 128 G 163 ASP A 91 ASP.? 21.24 ZN ZN A 128 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -15.43 59.12 73.84 -14.71 59.38 75.17 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -17.26 66.98 68.26 -15.96 67.19 69.91 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 49 ALA^? 16.22 ZN ZN B 128 G 148 HIS B 47 HIS^? 20.89 ZN ZN B 128 G 163 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -34.75 44.14 32.50 -35.24 43.58 31.16 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA C 49 ALA^? 16.41 ZN ZN C 128 G 148 HIS C 47 HIS^? 21.11 ZN ZN C 128 G 163 ASP C 91 ASP.? 22.72 ZN ZN C 128 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -0.09 43.99 68.78 1.05 44.60 69.61 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -1.22 34.88 70.14 -0.71 32.98 70.85 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA D 49 ALA^? 16.16 ZN ZN D 128 G 148 HIS D 47 HIS^? 21.18 ZN ZN D 128 G 163 ASP D 91 ASP.? 22.90 ZN ZN D 128 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -23.96 25.36 38.04 -24.83 24.52 37.10 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -15.13 23.89 36.32 -13.65 22.60 35.55 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA D 61 ALA.? 19.60 ZN ZN D 128 G 148 HIS D 59 HIS.? 17.27 ZN ZN D 128 G 163 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -37.19 13.11 53.70 -37.94 11.80 53.61 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -40.07 20.84 58.32 -40.41 18.78 58.10 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 109 ALA.? 12.23 ZN ZN D 128 H 148 HIS D 59 HIS.? 17.27 ZN ZN D 128 H 163 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -30.13 20.47 61.13 -30.71 19.50 60.10 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA B 49 ALA^? 16.22 ZN ZN B 128 H 148 HIS B 47 HIS^? 20.89 ZN ZN B 128 H 163 ASP B 91 ASP.? 21.34 ZN ZN B 128 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -34.75 44.14 32.50 -35.24 43.58 31.16 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -42.02 48.13 37.63 -42.45 47.31 35.73 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA B 109 ALA.? 11.51 ZN ZN C 128 H 148 HIS C 59 HIS.? 17.15 ZN ZN C 128 H 163 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 5.85 47.64 45.49 6.61 48.23 46.67 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 11.45 52.92 44.80 10.43 52.05 43.19 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 8.18 57.58 47.56 10.27 57.39 47.78 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c07 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 186 ASN A 18 ASN.? 16.39 ZN ZN A 128 A 260 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo 11.81 33.10 11.71 13.07 31.45 11.40 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 11.43 26.53 7.41 13.01 27.56 8.43 -22.68 62.48 66.52 -24.06 63.34 65.13 coo 21.53 26.33 6.96 20.26 25.69 7.52 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 186 ASN B 18 ASN.? 16.24 ZN ZN B 128 A 260 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo 11.81 33.10 11.71 13.07 31.45 11.40 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 11.43 26.53 7.41 13.01 27.56 8.43 -35.92 52.23 39.87 -36.26 53.93 41.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 186 ASN C 18 ASN.? 16.75 ZN ZN C 128 A 260 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo 11.81 33.10 11.71 13.07 31.45 11.40 2.93 33.32 67.19 5.03 33.43 67.23 coo 11.43 26.53 7.41 13.01 27.56 8.43 -2.99 35.22 62.77 -3.32 33.34 61.83 coo 21.53 26.33 6.96 20.26 25.69 7.52 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 186 ASN D 18 ASN.? 16.75 ZN ZN D 128 A 260 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo 11.81 33.10 11.71 13.07 31.45 11.40 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 11.43 26.53 7.41 13.01 27.56 8.43 -15.23 25.74 43.96 -13.30 25.49 44.87 coo 21.53 26.33 6.96 20.26 25.69 7.52 -23.96 25.36 38.04 -24.83 24.52 37.10 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 4 hits 1r4f_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 610 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 661 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 75.99 81.56 1.86 73.91 81.34 2.28 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 71.04 78.84 0.46 71.54 76.90 1.02 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 75.40 81.38 12.06 74.88 79.42 12.63 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 610 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 661 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 75.99 81.56 1.86 73.91 81.34 2.28 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 71.04 78.84 0.46 71.54 76.90 1.02 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 75.40 81.38 12.06 74.88 79.42 12.63 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 610 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 661 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 75.99 81.56 1.86 73.91 81.34 2.28 8.18 57.58 47.56 10.27 57.39 47.78 coo 71.04 78.84 0.46 71.54 76.90 1.02 11.45 52.92 44.80 10.43 52.05 43.19 coo 75.40 81.38 12.06 74.88 79.42 12.63 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 610 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 661 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 75.99 81.56 1.86 73.91 81.34 2.28 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 71.04 78.84 0.46 71.54 76.90 1.02 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 75.40 81.38 12.06 74.88 79.42 12.63 -31.62 26.29 51.88 -30.63 27.88 52.82 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 57 ASP.? 17.22 ZN ZN A 128 C 610 HIS A 59 HIS.? 17.66 ZN ZN A 128 C 661 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -36.79 45.73 85.78 -38.28 45.69 84.31 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP B 57 ASP.? 17.37 ZN ZN B 128 C 610 HIS B 59 HIS.? 17.68 ZN ZN B 128 C 661 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -16.45 61.27 20.51 -16.17 62.71 22.01 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP C 57 ASP.? 16.82 ZN ZN C 128 C 610 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 661 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo -17.65 80.52 58.00 -16.23 80.79 56.41 8.18 57.58 47.56 10.27 57.39 47.78 coo -16.56 83.18 53.03 -16.33 85.18 53.60 11.45 52.92 44.80 10.43 52.05 43.19 coo -8.38 80.78 62.24 -7.53 82.67 62.02 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP D 57 ASP.? 16.88 ZN ZN D 128 C 610 HIS D 59 HIS.? 17.27 ZN ZN D 128 C 661 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -31.62 26.29 51.88 -30.63 27.88 52.82 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 84 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 140 GLY D 34 GLY.? 11.12 ZN ZN D 128 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -28.08 36.39 60.37 -28.54 35.99 60.96 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 84 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 140 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 84 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 140 GLY C 34 GLY.? 11.55 ZN ZN C 128 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -10.25 50.55 45.92 -9.76 50.87 45.25 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 84 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 140 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1rgq_c01 NS4A PEPTIDE user 5 3 # 5 B 60 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 84 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 140 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1rgq_c01 NS4A PEPTIDE user 6 3 # 6 B 60 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 84 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 140 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 11.45 52.92 44.80 10.43 52.05 43.19 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 8.18 57.58 47.56 10.27 57.39 47.78 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1rgq_c01 NS4A PEPTIDE user 7 3 # 7 B 60 HIS D 47 HIS^? 21.18 ZN ZN D 128 B 84 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 140 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -25.01 34.28 34.53 -25.35 33.80 35.13 1rgq_c01 source 1rgq NS4A PEPTIDE : 7 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 35 SER A 13 SER^? 14.04 ZN ZN A 128 215 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 12.20 12.71 75.45 13.69 13.84 74.03 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 5.22 15.03 71.43 7.19 14.88 70.83 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 35 SER B 13 SER^? 13.94 ZN ZN B 128 215 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 12.20 12.71 75.45 13.69 13.84 74.03 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 5.22 15.03 71.43 7.19 14.88 70.83 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 35 SER C 13 SER^? 14.25 ZN ZN C 128 215 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 12.20 12.71 75.45 13.69 13.84 74.03 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 5.22 15.03 71.43 7.19 14.88 70.83 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 35 SER D 13 SER^? 14.41 ZN ZN D 128 215 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 11.85 17.24 72.81 11.09 15.37 72.36 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 12.20 12.71 75.45 13.69 13.84 74.03 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 5.22 15.03 71.43 7.19 14.88 70.83 -21.74 43.31 43.14 -23.53 43.14 44.28 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 4 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU B 70 GLU^? 18.94 ZN ZN B 128 A 288 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 329 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 29.27 18.78 14.99 27.16 18.62 14.76 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 49.52 10.06 10.36 50.99 9.65 8.92 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 57.80 12.92 13.83 53.77 8.42 12.15 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU B 103 GLU~? 15.19 ZN ZN C 128 A 288 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 329 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 29.27 18.78 14.99 27.16 18.62 14.76 -2.48 40.28 42.03 -4.43 39.67 41.46 coo 49.52 10.06 10.36 50.99 9.65 8.92 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 57.80 12.92 13.83 53.77 8.42 12.15 -29.75 46.77 28.66 -32.67 46.99 23.53 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 103 GLU~? 15.51 ZN ZN D 128 B 288 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 329 LYS A 51 LYS^? 15.98 ZN ZN A 128 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -20.80 26.87 64.77 -19.76 28.50 65.63 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -19.26 55.16 77.77 -19.13 57.75 83.14 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU B 103 GLU~? 15.19 ZN ZN C 128 B 288 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 329 LYS B 51 LYS^? 16.33 ZN ZN B 128 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -2.48 40.28 42.03 -4.43 39.67 41.46 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -29.75 46.77 28.66 -32.67 46.99 23.53 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 102 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 195 SER C 13 SER^? 14.25 ZN ZN C 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 102 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 195 SER A 13 SER^? 14.04 ZN ZN A 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 102 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 195 SER D 13 SER^? 14.41 ZN ZN D 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 3 # 8 B 57 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 102 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 195 SER B 13 SER^? 13.94 ZN ZN B 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -22.32 47.02 46.39 -24.11 45.44 46.82 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 8 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 30 HIS.? -4.20 ZN ZN B 128s B 102 ASP B 32 ASP.? -2.88 ZN ZN B 128s B 193 GLY B 54 GLY^? 9.98 ZN ZN B 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -20.72 56.25 32.46 -21.75 54.52 33.04 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -20.73 49.16 24.95 -21.20 49.33 24.28 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 102 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 193 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 11.45 52.92 44.80 10.43 52.05 43.19 coo -0.27 31.24 43.51 -1.49 29.62 42.98 8.18 57.58 47.56 10.27 57.39 47.78 coo -6.81 22.81 34.74 -6.42 23.54 34.62 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 B 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -27.38 22.98 60.43 -27.77 23.26 61.11 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 7 hits 1rtf_c06 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 26 ILE~? 5.58 ZN ZN A 128 A 106 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 142 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -28.39 53.60 70.80 -27.04 53.79 70.32 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -30.72 49.15 73.99 -28.78 49.60 73.32 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE A 26 ILE~? 5.58 ZN ZN A 128 A 106 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 142 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -28.39 53.60 70.80 -27.04 53.79 70.32 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -26.02 47.31 76.45 -26.60 46.79 74.50 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE B 26 ILE~? 5.21 ZN ZN B 128 A 106 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 142 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -25.63 54.91 35.51 -26.14 53.70 35.96 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -20.72 56.25 32.46 -21.75 54.52 33.04 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 3 # 4 A 104 ILE B 26 ILE~? 5.21 ZN ZN B 128 A 106 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 142 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -25.63 54.91 35.51 -26.14 53.70 35.96 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -20.39 51.16 30.13 -19.69 51.56 32.06 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 5 3 # 5 A 104 ILE C 26 ILE~? 5.86 ZN ZN C 128 A 106 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 142 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -1.00 42.34 54.47 -1.79 42.45 55.68 coo -17.00 64.03 23.46 -18.21 65.65 22.90 0.61 46.90 50.78 -0.23 46.71 52.70 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 6 3 # 6 A 104 ILE C 26 ILE~? 5.86 ZN ZN C 128 A 106 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 142 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -1.00 42.34 54.47 -1.79 42.45 55.68 coo -17.00 64.03 23.46 -18.21 65.65 22.90 0.88 50.97 54.56 -1.00 50.36 53.86 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 7 3 # 7 A 104 ILE D 26 ILE~? 5.85 ZN ZN D 128 A 106 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 142 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -22.80 25.75 52.22 -22.58 26.49 51.00 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 8 3 # 8 A 104 ILE D 26 ILE~? 5.85 ZN ZN D 128 A 106 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 142 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo -15.54 60.72 29.56 -16.71 61.53 30.10 -22.80 25.75 52.22 -22.58 26.49 51.00 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -31.62 26.29 51.88 -30.63 27.88 52.82 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -29.32 31.61 55.53 -28.20 30.46 54.16 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 8 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 64 HIS A 10 HIS^? 15.73 ZN ZN A 128 221 SER C 13 SER^? 14.25 ZN ZN C 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 78.27 67.69 61.83 79.58 67.76 60.19 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 83.63 66.07 58.16 81.31 66.75 57.98 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 64 HIS C 10 HIS^? 15.40 ZN ZN C 128 221 SER C 13 SER^? 14.25 ZN ZN C 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 78.27 67.69 61.83 79.58 67.76 60.19 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 83.63 66.07 58.16 81.31 66.75 57.98 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 64 HIS B 10 HIS^? 15.59 ZN ZN B 128 221 SER D 13 SER^? 14.41 ZN ZN D 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 78.27 67.69 61.83 79.58 67.76 60.19 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 83.63 66.07 58.16 81.31 66.75 57.98 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 64 HIS D 10 HIS^? 15.91 ZN ZN D 128 221 SER D 13 SER^? 14.41 ZN ZN D 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 78.27 67.69 61.83 79.58 67.76 60.19 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 83.63 66.07 58.16 81.31 66.75 57.98 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 64 HIS A 10 HIS^? 15.73 ZN ZN A 128 221 SER A 13 SER^? 14.04 ZN ZN A 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 83.63 66.07 58.16 81.31 66.75 57.98 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 64 HIS C 10 HIS^? 15.40 ZN ZN C 128 221 SER A 13 SER^? 14.04 ZN ZN A 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 83.63 66.07 58.16 81.31 66.75 57.98 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 64 HIS B 10 HIS^? 15.59 ZN ZN B 128 221 SER B 13 SER^? 13.94 ZN ZN B 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 78.27 67.69 61.83 79.58 67.76 60.19 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 83.63 66.07 58.16 81.31 66.75 57.98 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 64 HIS D 10 HIS^? 15.91 ZN ZN D 128 221 SER B 13 SER^? 13.94 ZN ZN B 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 78.27 67.69 61.83 79.58 67.76 60.19 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 83.63 66.07 58.16 81.31 66.75 57.98 -22.32 47.02 46.39 -24.11 45.44 46.82 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 8 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 91 ASP.? 21.24 ZN ZN A 128 64 HIS A 47 HIS^? 20.92 ZN ZN A 128 155 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 78.27 67.69 61.83 79.58 67.76 60.19 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 80.34 61.88 52.75 81.25 63.19 54.35 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 91 ASP.? 21.34 ZN ZN B 128 64 HIS B 47 HIS^? 20.89 ZN ZN B 128 155 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 78.27 67.69 61.83 79.58 67.76 60.19 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 80.34 61.88 52.75 81.25 63.19 54.35 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP C 91 ASP.? 22.72 ZN ZN C 128 64 HIS C 47 HIS^? 21.11 ZN ZN C 128 155 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 78.27 67.69 61.83 79.58 67.76 60.19 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 80.34 61.88 52.75 81.25 63.19 54.35 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP D 91 ASP.? 22.90 ZN ZN D 128 64 HIS D 47 HIS^? 21.18 ZN ZN D 128 155 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo 80.16 73.25 62.48 80.01 71.25 61.82 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 78.27 67.69 61.83 79.58 67.76 60.19 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 80.34 61.88 52.75 81.25 63.19 54.35 -19.89 34.86 45.47 -21.06 36.60 45.16 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 4 hits 1sca_c01 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 37 SER A 60 SER.? 16.46 ZN ZN A 128 A 214 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 51.75 60.57 19.10 52.05 60.90 21.19 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 51.10 65.11 20.73 52.62 63.74 19.42 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 48.59 58.89 25.78 50.13 59.74 24.61 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 37 SER A 13 SER^? 14.04 ZN ZN A 128 A 214 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 51.75 60.57 19.10 52.05 60.90 21.19 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 51.10 65.11 20.73 52.62 63.74 19.42 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 48.59 58.89 25.78 50.13 59.74 24.61 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 37 SER B 13 SER^? 13.94 ZN ZN B 128 A 214 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 51.75 60.57 19.10 52.05 60.90 21.19 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 51.10 65.11 20.73 52.62 63.74 19.42 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 48.59 58.89 25.78 50.13 59.74 24.61 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 37 SER C 60 SER.? 15.14 ZN ZN C 128 A 214 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 51.75 60.57 19.10 52.05 60.90 21.19 8.18 57.58 47.56 10.27 57.39 47.78 coo 51.10 65.11 20.73 52.62 63.74 19.42 12.55 55.11 50.39 10.44 55.82 51.40 coo 48.59 58.89 25.78 50.13 59.74 24.61 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1sme_c04 PLASMEPSIN II user 5 3 # 5 A 34 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 37 SER C 13 SER^? 14.25 ZN ZN C 128 A 214 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 51.75 60.57 19.10 52.05 60.90 21.19 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 51.10 65.11 20.73 52.62 63.74 19.42 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 48.59 58.89 25.78 50.13 59.74 24.61 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1sme_c04 PLASMEPSIN II user 6 3 # 6 A 34 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 37 SER D 60 SER.? 15.90 ZN ZN D 128 A 214 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 51.75 60.57 19.10 52.05 60.90 21.19 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 51.10 65.11 20.73 52.62 63.74 19.42 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 48.59 58.89 25.78 50.13 59.74 24.61 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1sme_c04 PLASMEPSIN II user 7 3 # 7 A 34 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 37 SER D 13 SER^? 14.41 ZN ZN D 128 A 214 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 51.75 60.57 19.10 52.05 60.90 21.19 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 51.10 65.11 20.73 52.62 63.74 19.42 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 48.59 58.89 25.78 50.13 59.74 24.61 -21.74 43.31 43.14 -23.53 43.14 44.28 1sme_c04 source 1sme PLASMEPSIN II : 7 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 57 ASP.? 17.22 ZN ZN A 128 B 37 SER A 60 SER.? 16.46 ZN ZN A 128 B 214 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 20.67 100.44 55.84 20.21 98.51 54.45 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 12.41 98.71 58.47 14.37 98.17 58.05 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 37 SER A 13 SER^? 14.04 ZN ZN A 128 B 214 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 20.67 100.44 55.84 20.21 98.51 54.45 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 12.41 98.71 58.47 14.37 98.17 58.05 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP B 57 ASP.? 17.37 ZN ZN B 128 B 37 SER B 60 SER.? 16.61 ZN ZN B 128 B 214 ASP B 64 ASP.? 14.94 ZN ZN B 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 20.67 100.44 55.84 20.21 98.51 54.45 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 12.41 98.71 58.47 14.37 98.17 58.05 -18.76 47.29 19.05 -17.56 47.54 20.78 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 37 SER B 13 SER^? 13.94 ZN ZN B 128 B 214 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 20.67 100.44 55.84 20.21 98.51 54.45 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 12.41 98.71 58.47 14.37 98.17 58.05 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1sme_c05 PLASMEPSIN II user 5 3 # 5 B 34 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 37 SER C 60 SER.? 15.14 ZN ZN C 128 B 214 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 8.18 57.58 47.56 10.27 57.39 47.78 coo 20.67 100.44 55.84 20.21 98.51 54.45 12.55 55.11 50.39 10.44 55.82 51.40 coo 12.41 98.71 58.47 14.37 98.17 58.05 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 1sme_c05 PLASMEPSIN II user 6 3 # 6 B 34 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 37 SER C 13 SER^? 14.25 ZN ZN C 128 B 214 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 20.67 100.44 55.84 20.21 98.51 54.45 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 12.41 98.71 58.47 14.37 98.17 58.05 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 1sme_c05 PLASMEPSIN II user 7 3 # 7 B 34 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 37 SER D 60 SER.? 15.90 ZN ZN D 128 B 214 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 20.67 100.44 55.84 20.21 98.51 54.45 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 12.41 98.71 58.47 14.37 98.17 58.05 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 1sme_c05 PLASMEPSIN II user 8 3 # 8 B 34 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 37 SER D 13 SER^? 14.41 ZN ZN D 128 B 214 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 17.69 97.58 52.73 17.33 97.19 54.77 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 20.67 100.44 55.84 20.21 98.51 54.45 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 12.41 98.71 58.47 14.37 98.17 58.05 -21.74 43.31 43.14 -23.53 43.14 44.28 1sme_c05 source 1sme PLASMEPSIN II : 8 hits 1sme_c05 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 89 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 119 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 21.34 20.13 69.47 22.14 19.11 71.12 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 19.69 29.00 71.61 19.80 26.98 72.20 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG A 12 ARG^? 10.24 ZN ZN A 128 A 89 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 119 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 21.34 20.13 69.47 22.14 19.11 71.12 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 19.69 29.00 71.61 19.80 26.98 72.20 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG A 42 ARG^? 15.09 ZN ZN A 128 A 89 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 119 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 21.34 20.13 69.47 22.14 19.11 71.12 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 19.69 29.00 71.61 19.80 26.98 72.20 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 89 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 119 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 21.34 20.13 69.47 22.14 19.11 71.12 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 19.69 29.00 71.61 19.80 26.98 72.20 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 A 87 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 89 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 119 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 21.34 20.13 69.47 22.14 19.11 71.12 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 19.69 29.00 71.61 19.80 26.98 72.20 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 6 3 # 6 A 87 ARG B 42 ARG^? 15.17 ZN ZN B 128 A 89 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 119 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 21.34 20.13 69.47 22.14 19.11 71.12 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 19.69 29.00 71.61 19.80 26.98 72.20 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 7 3 # 7 A 87 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 89 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 119 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 21.34 20.13 69.47 22.14 19.11 71.12 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 19.69 29.00 71.61 19.80 26.98 72.20 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 8 3 # 8 A 87 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 89 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 119 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 21.34 20.13 69.47 22.14 19.11 71.12 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 19.69 29.00 71.61 19.80 26.98 72.20 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 9 3 # 9 A 87 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 89 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 119 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 21.34 20.13 69.47 22.14 19.11 71.12 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 19.69 29.00 71.61 19.80 26.98 72.20 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 10 3 # 10 A 87 ARG D 12 ARG^? 9.28 ZN ZN D 128 A 89 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 119 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo 28.44 23.52 73.95 30.13 24.84 76.11 -21.38 38.31 55.98 -23.17 35.84 55.80 coo 21.34 20.13 69.47 22.14 19.11 71.12 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 19.69 29.00 71.61 19.80 26.98 72.20 -19.89 34.86 45.47 -21.06 36.60 45.16 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 10 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 12 ARG^? 10.24 ZN ZN A 128 B 89 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 119 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -26.71 45.35 59.66 -27.06 47.43 61.87 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG A 12 ARG^? 10.24 ZN ZN A 128 B 89 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 119 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -26.71 45.35 59.66 -27.06 47.43 61.87 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG A 42 ARG^? 15.09 ZN ZN A 128 B 89 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 119 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 B 87 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 89 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 119 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 B 87 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 89 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 119 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 6 3 # 6 B 87 ARG B 42 ARG^? 15.17 ZN ZN B 128 B 89 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 119 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 7 3 # 7 B 87 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 89 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 119 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -12.88 45.85 50.29 -9.95 45.19 50.84 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 8 3 # 8 B 87 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 89 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 119 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 9 3 # 9 B 87 ARG D 12 ARG^? 9.28 ZN ZN D 128 B 89 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 119 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -21.38 38.31 55.98 -23.17 35.84 55.80 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -19.89 34.86 45.47 -21.06 36.60 45.16 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 9 hits 1smn_c01 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 102 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 193 GLY A 54 GLY^? 9.80 ZN ZN A 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 19.67 30.58 22.61 18.30 29.87 21.17 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 14.52 29.10 10.01 15.08 29.66 10.19 -23.94 47.04 81.44 -23.95 47.49 82.14 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 19.67 30.58 22.61 18.30 29.87 21.17 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 14.52 29.10 10.01 15.08 29.66 10.19 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 102 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 193 GLY B 54 GLY^? 9.98 ZN ZN B 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 19.67 30.58 22.61 18.30 29.87 21.17 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 14.52 29.10 10.01 15.08 29.66 10.19 -20.73 49.16 24.95 -21.20 49.33 24.28 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 19.67 30.58 22.61 18.30 29.87 21.17 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 14.52 29.10 10.01 15.08 29.66 10.19 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 19.67 30.58 22.61 18.30 29.87 21.17 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 14.52 29.10 10.01 15.08 29.66 10.19 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 102 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 193 GLY D 54 GLY^? 9.52 ZN ZN D 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 19.67 30.58 22.61 18.30 29.87 21.17 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 14.52 29.10 10.01 15.08 29.66 10.19 -35.39 23.38 49.70 -35.47 22.58 49.42 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 19.67 30.58 22.61 18.30 29.87 21.17 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 14.52 29.10 10.01 15.08 29.66 10.19 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 8 3 # 8 A 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 15.02 29.17 19.44 15.63 29.96 17.60 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 19.67 30.58 22.61 18.30 29.87 21.17 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 14.52 29.10 10.01 15.08 29.66 10.19 -27.38 22.98 60.43 -27.77 23.26 61.11 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 8 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 90 ASP.? 20.22 ZN ZN A 128 E 168 LYS A 19 LYS.? 16.70 ZN ZN A 128 E 201 THR A 92 THR.? 14.81 ZN ZN A 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 5.06 22.32 18.11 1.02 22.08 22.74 -25.66 62.13 69.69 -25.48 65.02 74.91 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 90 ASP.? 20.48 ZN ZN B 128 E 168 LYS B 19 LYS.? 16.80 ZN ZN B 128 E 201 THR B 92 THR.? 15.12 ZN ZN B 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 5.06 22.32 18.11 1.02 22.08 22.74 -34.93 54.65 36.44 -38.00 53.50 31.57 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP C 90 ASP.? 21.10 ZN ZN C 128 E 168 LYS C 19 LYS.? 17.60 ZN ZN C 128 E 201 THR C 92 THR.? 15.22 ZN ZN C 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 2.93 33.32 67.19 5.03 33.43 67.23 coo 5.06 22.32 18.11 1.02 22.08 22.74 0.64 35.92 60.53 5.63 36.47 64.53 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP D 90 ASP.? 20.62 ZN ZN D 128 E 168 LYS D 19 LYS.? 15.46 ZN ZN D 128 E 201 THR D 92 THR.? 15.38 ZN ZN D 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 5.06 22.32 18.11 1.02 22.08 22.74 -16.96 22.44 46.27 -19.09 18.04 45.40 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.23 25.46 39.42 -20.30 24.86 39.60 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c02 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 90 ASP.? 20.22 ZN ZN A 128 E 168 LYS A 19 LYS.? 16.70 ZN ZN A 128 E 171 ASN A 18 ASN.? 16.39 ZN ZN A 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 5.06 22.32 18.11 1.02 22.08 22.74 -25.66 62.13 69.69 -25.48 65.02 74.91 coo 6.68 21.78 22.39 5.28 20.74 23.60 -22.68 62.48 66.52 -24.06 63.34 65.13 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 90 ASP.? 20.48 ZN ZN B 128 E 168 LYS B 19 LYS.? 16.80 ZN ZN B 128 E 171 ASN B 18 ASN.? 16.24 ZN ZN B 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 5.06 22.32 18.11 1.02 22.08 22.74 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 6.68 21.78 22.39 5.28 20.74 23.60 -35.92 52.23 39.87 -36.26 53.93 41.12 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP C 90 ASP.? 21.10 ZN ZN C 128 E 168 LYS C 19 LYS.? 17.60 ZN ZN C 128 E 171 ASN C 18 ASN.? 16.75 ZN ZN C 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 2.93 33.32 67.19 5.03 33.43 67.23 coo 5.06 22.32 18.11 1.02 22.08 22.74 0.64 35.92 60.53 5.63 36.47 64.53 coo 6.68 21.78 22.39 5.28 20.74 23.60 -2.99 35.22 62.77 -3.32 33.34 61.83 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP D 90 ASP.? 20.62 ZN ZN D 128 E 168 LYS D 19 LYS.? 15.46 ZN ZN D 128 E 171 ASN D 18 ASN.? 16.75 ZN ZN D 128 coo 5.36 16.20 22.10 3.88 17.00 23.31 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 5.06 22.32 18.11 1.02 22.08 22.74 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 6.68 21.78 22.39 5.28 20.74 23.60 -15.23 25.74 43.96 -13.30 25.49 44.87 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c03 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 80 GLU A 28 GLU~? 12.19 ZN ZN A 128 B 223 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -30.72 49.15 73.99 -28.78 49.60 73.32 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -33.40 55.75 75.93 -32.70 57.39 77.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -19.64 50.95 45.34 -21.61 53.09 44.31 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 30 HIS.? -4.18 ZN ZN A 128s B 80 GLU A 28 GLU~? 12.19 ZN ZN A 128 B 223 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -30.72 49.15 73.99 -28.78 49.60 73.32 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -33.40 55.75 75.93 -32.70 57.39 77.09 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -12.88 45.85 50.29 -9.95 45.19 50.84 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 2 hits 1t0u_c01 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER A 13 SER^? 14.04 ZN ZN A 128 B 263 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 285 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1tah_c00 LIPASE user 2 3 # 2 B 87 SER B 13 SER^? 13.94 ZN ZN B 128 B 263 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 285 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1tah_c00 LIPASE user 3 3 # 3 B 87 SER C 13 SER^? 14.25 ZN ZN C 128 B 263 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 285 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1tah_c00 LIPASE user 4 3 # 4 B 87 SER D 13 SER^? 14.41 ZN ZN D 128 B 263 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 285 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -18.46 42.11 47.13 -20.09 43.42 47.28 1tah_c00 source 1tah LIPASE : 4 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER A 13 SER^? 14.04 ZN ZN A 128 A 263 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 285 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1tah_c01 LIPASE user 2 3 # 2 A 87 SER B 13 SER^? 13.94 ZN ZN B 128 A 263 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 285 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1tah_c01 LIPASE user 3 3 # 3 A 87 SER C 13 SER^? 14.25 ZN ZN C 128 A 263 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 285 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1tah_c01 LIPASE user 4 3 # 4 A 87 SER D 13 SER^? 14.41 ZN ZN D 128 A 263 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 285 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -18.46 42.11 47.13 -20.09 43.42 47.28 1tah_c01 source 1tah LIPASE : 4 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER A 13 SER^? 14.04 ZN ZN A 128 C 263 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 285 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1tah_c02 LIPASE user 2 3 # 2 C 87 SER B 13 SER^? 13.94 ZN ZN B 128 C 263 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 285 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1tah_c02 LIPASE user 3 3 # 3 C 87 SER C 13 SER^? 14.25 ZN ZN C 128 C 263 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 285 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1tah_c02 LIPASE user 4 3 # 4 C 87 SER D 13 SER^? 14.41 ZN ZN D 128 C 263 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 285 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -18.46 42.11 47.13 -20.09 43.42 47.28 1tah_c02 source 1tah LIPASE : 4 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER A 13 SER^? 14.04 ZN ZN A 128 D 263 ASP C 97 ASP^? 13.06 ZN ZN C 128 D 285 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1tah_c03 LIPASE user 2 3 # 2 D 87 SER B 13 SER^? 13.94 ZN ZN B 128 D 263 ASP D 97 ASP^? 13.24 ZN ZN D 128 D 285 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1tah_c03 LIPASE user 3 3 # 3 D 87 SER C 13 SER^? 14.25 ZN ZN C 128 D 263 ASP A 97 ASP^? 13.17 ZN ZN A 128 D 285 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1tah_c03 LIPASE user 4 3 # 4 D 87 SER D 13 SER^? 14.41 ZN ZN D 128 D 263 ASP B 97 ASP^? 13.03 ZN ZN B 128 D 285 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -18.46 42.11 47.13 -20.09 43.42 47.28 1tah_c03 source 1tah LIPASE : 4 hits 1tah_c03 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 60 SER.? 16.46 ZN ZN A 128 354 GLU A 58 GLU.? 14.95 ZN ZN A 128 463 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 48.87 13.74 2.81 48.49 11.54 3.93 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 39.95 14.43 3.01 41.55 14.10 1.63 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 43.90 10.50 2.81 45.63 11.48 3.27 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 60 SER.? 16.61 ZN ZN B 128 354 GLU B 58 GLU.? 14.99 ZN ZN B 128 463 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 48.87 13.74 2.81 48.49 11.54 3.93 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 39.95 14.43 3.01 41.55 14.10 1.63 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 43.90 10.50 2.81 45.63 11.48 3.27 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 3 3 # 3 217 SER C 60 SER.? 15.14 ZN ZN C 128 354 GLU C 58 GLU.? 14.59 ZN ZN C 128 463 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 48.87 13.74 2.81 48.49 11.54 3.93 12.55 55.11 50.39 10.44 55.82 51.40 coo 39.95 14.43 3.01 41.55 14.10 1.63 7.13 51.72 45.00 6.65 51.50 42.95 coo 43.90 10.50 2.81 45.63 11.48 3.27 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 4 3 # 4 217 SER D 60 SER.? 15.90 ZN ZN D 128 354 GLU D 58 GLU.? 14.54 ZN ZN D 128 463 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 48.87 13.74 2.81 48.49 11.54 3.93 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 39.95 14.43 3.01 41.55 14.10 1.63 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 43.90 10.50 2.81 45.63 11.48 3.27 -36.37 16.36 61.26 -35.21 16.95 62.91 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 4 hits 1thg_c00 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 174 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 404 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 174 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 404 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 174 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 404 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 174 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 404 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -34.83 43.92 51.78 -36.80 42.61 53.27 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 174 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 404 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 174 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 404 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 174 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 404 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS D 10 HIS^? 15.91 ZN ZN D 128 C 174 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 404 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -34.83 43.92 51.78 -36.80 42.61 53.27 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 10 HIS^? 15.73 ZN ZN A 128 E 174 ASP C 97 ASP^? 13.06 ZN ZN C 128 E 404 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS B 10 HIS^? 15.59 ZN ZN B 128 E 174 ASP D 97 ASP^? 13.24 ZN ZN D 128 E 404 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS C 10 HIS^? 15.40 ZN ZN C 128 E 174 ASP A 97 ASP^? 13.17 ZN ZN A 128 E 404 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS D 10 HIS^? 15.91 ZN ZN D 128 E 174 ASP B 97 ASP^? 13.03 ZN ZN B 128 E 404 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -34.83 43.92 51.78 -36.80 42.61 53.27 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 10 HIS^? 15.73 ZN ZN A 128 G 174 ASP C 97 ASP^? 13.06 ZN ZN C 128 G 404 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 60.48-101.16 45.95 60.56-101.20 43.85 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 58.10-108.15 40.62 59.57-106.86 41.51 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS B 10 HIS^? 15.59 ZN ZN B 128 G 174 ASP D 97 ASP^? 13.24 ZN ZN D 128 G 404 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 60.48-101.16 45.95 60.56-101.20 43.85 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 58.10-108.15 40.62 59.57-106.86 41.51 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS C 10 HIS^? 15.40 ZN ZN C 128 G 174 ASP A 97 ASP^? 13.17 ZN ZN A 128 G 404 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 60.48-101.16 45.95 60.56-101.20 43.85 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 58.10-108.15 40.62 59.57-106.86 41.51 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS D 10 HIS^? 15.91 ZN ZN D 128 G 174 ASP B 97 ASP^? 13.03 ZN ZN B 128 G 404 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 60.48-101.16 45.95 60.56-101.20 43.85 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 58.10-108.15 40.62 59.57-106.86 41.51 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -34.83 43.92 51.78 -36.80 42.61 53.27 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 10 HIS^? 15.73 ZN ZN A 128 I 174 ASP C 97 ASP^? 13.06 ZN ZN C 128 I 404 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS B 10 HIS^? 15.59 ZN ZN B 128 I 174 ASP D 97 ASP^? 13.24 ZN ZN D 128 I 404 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS C 10 HIS^? 15.40 ZN ZN C 128 I 174 ASP A 97 ASP^? 13.17 ZN ZN A 128 I 404 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS D 10 HIS^? 15.91 ZN ZN D 128 I 174 ASP B 97 ASP^? 13.03 ZN ZN B 128 I 404 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -24.77 44.27 50.01 -22.89 43.34 50.12 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -34.83 43.92 51.78 -36.80 42.61 53.27 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 10 HIS^? 15.73 ZN ZN A 128 K 174 ASP C 97 ASP^? 13.06 ZN ZN C 128 K 404 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 102.36 30.86 6.31 102.45 29.08 5.12 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS B 10 HIS^? 15.59 ZN ZN B 128 K 174 ASP D 97 ASP^? 13.24 ZN ZN D 128 K 404 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 102.36 30.86 6.31 102.45 29.08 5.12 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS C 10 HIS^? 15.40 ZN ZN C 128 K 174 ASP A 97 ASP^? 13.17 ZN ZN A 128 K 404 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 102.36 30.86 6.31 102.45 29.08 5.12 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS D 10 HIS^? 15.91 ZN ZN D 128 K 174 ASP B 97 ASP^? 13.03 ZN ZN B 128 K 404 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 102.36 30.86 6.31 102.45 29.08 5.12 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -34.83 43.92 51.78 -36.80 42.61 53.27 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c11 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 70 GLU^? 19.90 ZN ZN A 128 A 126 LYS A 51 LYS^? 15.98 ZN ZN A 128 A 171 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -19.26 55.16 77.77 -19.13 57.75 83.14 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 86 GLU^? 14.11 ZN ZN A 128 A 126 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 171 ALA A 87 ALA^? 12.75 ZN ZN A 128 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -23.80 59.27 78.25 -23.36 59.70 80.28 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -25.66 62.13 69.69 -25.48 65.02 74.91 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -21.53 60.02 74.19 -22.12 60.70 72.96 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU B 70 GLU^? 18.94 ZN ZN B 128 A 126 LYS B 51 LYS^? 16.33 ZN ZN B 128 A 171 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU C 70 GLU^? 19.15 ZN ZN C 128 A 126 LYS C 51 LYS^? 16.36 ZN ZN C 128 A 171 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -0.72 48.58 72.21 1.10 47.61 72.77 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 2.93 47.75 63.91 7.07 48.43 67.33 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU C 86 GLU^? 14.08 ZN ZN C 128 A 126 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 171 ALA C 87 ALA^? 13.17 ZN ZN C 128 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 6.41 43.35 62.15 8.10 44.52 62.72 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 0.64 35.92 60.53 5.63 36.47 64.53 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 2.48 41.23 63.72 1.86 39.89 63.37 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU D 70 GLU^? 19.86 ZN ZN D 128 A 126 LYS D 51 LYS^? 16.00 ZN ZN D 128 A 171 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -28.66 23.49 42.59 -29.87 18.31 40.35 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 A 46 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 126 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 171 ALA D 87 ALA^? 12.91 ZN ZN D 128 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -22.32 22.30 43.02 -20.89 22.62 43.40 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 7 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 70 GLU^? 19.90 ZN ZN A 128 B 126 LYS A 51 LYS^? 15.98 ZN ZN A 128 B 171 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo 20.47 87.42 16.54 20.16 87.17 14.45 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 24.73 94.37 14.59 21.08 89.84 11.98 -19.26 55.16 77.77 -19.13 57.75 83.14 coo 24.38 86.32 12.71 22.88 86.54 12.71 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 86 GLU^? 14.11 ZN ZN A 128 B 126 LYS A 19 LYS.? 16.70 ZN ZN A 128 B 171 ALA A 87 ALA^? 12.75 ZN ZN A 128 coo 20.47 87.42 16.54 20.16 87.17 14.45 -23.80 59.27 78.25 -23.36 59.70 80.28 coo 24.73 94.37 14.59 21.08 89.84 11.98 -25.66 62.13 69.69 -25.48 65.02 74.91 coo 24.38 86.32 12.71 22.88 86.54 12.71 -21.53 60.02 74.19 -22.12 60.70 72.96 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU B 70 GLU^? 18.94 ZN ZN B 128 B 126 LYS B 51 LYS^? 16.33 ZN ZN B 128 B 171 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo 20.47 87.42 16.54 20.16 87.17 14.45 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 24.73 94.37 14.59 21.08 89.84 11.98 -29.75 46.77 28.66 -32.67 46.99 23.53 coo 24.38 86.32 12.71 22.88 86.54 12.71 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU C 70 GLU^? 19.15 ZN ZN C 128 B 126 LYS C 51 LYS^? 16.36 ZN ZN C 128 B 171 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo 20.47 87.42 16.54 20.16 87.17 14.45 -0.72 48.58 72.21 1.10 47.61 72.77 coo 24.73 94.37 14.59 21.08 89.84 11.98 2.93 47.75 63.91 7.07 48.43 67.33 coo 24.38 86.32 12.71 22.88 86.54 12.71 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU C 86 GLU^? 14.08 ZN ZN C 128 B 126 LYS C 19 LYS.? 17.60 ZN ZN C 128 B 171 ALA C 87 ALA^? 13.17 ZN ZN C 128 coo 20.47 87.42 16.54 20.16 87.17 14.45 6.41 43.35 62.15 8.10 44.52 62.72 coo 24.73 94.37 14.59 21.08 89.84 11.98 0.64 35.92 60.53 5.63 36.47 64.53 coo 24.38 86.32 12.71 22.88 86.54 12.71 2.48 41.23 63.72 1.86 39.89 63.37 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU D 70 GLU^? 19.86 ZN ZN D 128 B 126 LYS D 51 LYS^? 16.00 ZN ZN D 128 B 171 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo 20.47 87.42 16.54 20.16 87.17 14.45 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 24.73 94.37 14.59 21.08 89.84 11.98 -28.66 23.49 42.59 -29.87 18.31 40.35 coo 24.38 86.32 12.71 22.88 86.54 12.71 -23.96 25.36 38.04 -24.83 24.52 37.10 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 49 ALA^? 15.93 ZN ZN A 128 A 224 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 252 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -15.43 59.12 73.84 -14.71 59.38 75.17 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 61 ALA.? 20.04 ZN ZN A 128 A 224 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 252 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -30.68 49.76 89.87 -30.90 49.96 91.37 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA A 71 ALA.? 18.90 ZN ZN A 128 A 224 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 252 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -10.85 57.79 70.32 -10.50 59.22 69.90 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA A 109 ALA.? 12.23 ZN ZN D 128 A 224 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 252 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -30.13 20.47 61.13 -30.71 19.50 60.10 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -36.37 16.36 61.26 -35.21 16.95 62.91 ULMN 3 1uk7_c00 3.07.01.0009 user 5 3 # 5 A 103 ALA B 49 ALA^? 16.22 ZN ZN B 128 A 224 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 252 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -34.75 44.14 32.50 -35.24 43.58 31.16 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 3 1uk7_c00 3.07.01.0009 user 6 3 # 6 A 103 ALA B 61 ALA.? 20.38 ZN ZN B 128 A 224 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 252 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -21.56 56.20 16.28 -21.70 56.37 14.76 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 1uk7_c00 3.07.01.0009 user 7 3 # 7 A 103 ALA B 71 ALA.? 18.94 ZN ZN B 128 A 224 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 252 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -34.70 39.55 36.03 -36.14 39.66 36.51 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 3 1uk7_c00 3.07.01.0009 user 8 3 # 8 A 103 ALA B 109 ALA.? 11.51 ZN ZN C 128 A 224 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 252 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 5.85 47.64 45.49 6.61 48.23 46.67 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 8.18 57.58 47.56 10.27 57.39 47.78 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1uk7_c00 3.07.01.0009 user 9 3 # 9 A 103 ALA C 49 ALA^? 16.41 ZN ZN C 128 A 224 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 252 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -0.09 43.99 68.78 1.05 44.60 69.61 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 3 1uk7_c00 3.07.01.0009 user 10 3 # 10 A 103 ALA C 61 ALA.? 19.20 ZN ZN C 128 A 224 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 252 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 14.70 52.81 52.57 16.23 52.88 52.61 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 8.18 57.58 47.56 10.27 57.39 47.78 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1uk7_c00 3.07.01.0009 user 11 3 # 11 A 103 ALA C 71 ALA.? 19.01 ZN ZN C 128 A 224 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 252 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 3 1uk7_c00 3.07.01.0009 user 12 3 # 12 A 103 ALA D 49 ALA^? 16.16 ZN ZN D 128 A 224 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 252 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -23.96 25.36 38.04 -24.83 24.52 37.10 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.20 28.58 35.23 -16.55 27.59 33.50 ULMN 3 1uk7_c00 3.07.01.0009 user 13 3 # 13 A 103 ALA D 61 ALA.? 19.60 ZN ZN D 128 A 224 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 252 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -37.19 13.11 53.70 -37.94 11.80 53.61 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -36.37 16.36 61.26 -35.21 16.95 62.91 ULMN 3 1uk7_c00 3.07.01.0009 user 14 3 # 14 A 103 ALA D 71 ALA.? 18.99 ZN ZN D 128 A 224 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 252 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.20 28.58 35.23 -16.55 27.59 33.50 1uk7_c00 source 1uk7 3.07.01.0009 : 14 hits 1uk7_c00 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 64 ASP.? 14.79 ZN ZN A 128 218 GLU A 107 GLU.? 11.70 ZN ZN D 128 329 ASP A 57 ASP.? 17.22 ZN ZN A 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 -31.66 41.62 85.16 -32.16 42.63 86.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 64 ASP.? 14.79 ZN ZN A 128 218 GLU D 103 GLU.? 16.17 ZN ZN A 128 329 ASP A 57 ASP.? 17.22 ZN ZN A 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 70.09 11.71 8.46 70.56 12.89 6.77 -31.28 51.42 58.86 -30.79 51.26 56.79 coo 59.16 37.82 13.95 57.63 37.03 15.12 -31.66 41.62 85.16 -32.16 42.63 86.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 64 ASP.? 14.94 ZN ZN B 128 218 GLU C 80 GLU.? 11.53 ZN ZN C 128 329 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 70.09 11.71 8.46 70.56 12.89 6.77 -4.16 58.03 47.91 -5.06 56.59 46.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.57 55.26 21.18 -14.41 55.74 19.31 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 32 ASP^? -2.40 ZN ZN C 128s 218 GLU C 107 GLU.? 20.28 ZN ZN B 128 329 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 70.09 11.71 8.46 70.56 12.89 6.77 -32.00 66.19 44.45 -32.39 64.60 45.80 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP C 64 ASP.? 14.22 ZN ZN C 128 218 GLU C 103 GLU.? 13.37 ZN ZN B 128 329 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.74 58.91 56.74 6.81 58.81 55.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP D 57 ASP.? 16.88 ZN ZN D 128 218 GLU B 70 GLU^? 18.94 ZN ZN B 128 329 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 70.09 11.71 8.46 70.56 12.89 6.77 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 59.16 37.82 13.95 57.63 37.03 15.12 -41.38 20.76 48.99 -40.62 22.36 50.18 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 6 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP C 32 ASP^? -2.40 ZN ZN C 128s 242 GLU C 62 GLU.? 18.47 ZN ZN C 128 329 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 30.42 34.74 5.00 29.09 35.09 3.38 15.69 53.46 57.19 15.40 51.47 57.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP D 32 ASP^? -2.55 ZN ZN D 128s 242 GLU D 62 GLU.? 21.02 ZN ZN D 128 329 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 30.42 34.74 5.00 29.09 35.09 3.38 -37.84 12.48 49.24 -39.17 11.41 48.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP D 97 ASP^? 13.24 ZN ZN D 128 242 GLU C 103 GLU.? 13.37 ZN ZN B 128 329 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.32 31.61 55.53 -28.20 30.46 54.16 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU C 103 GLU.? 13.37 ZN ZN B 128 A 596 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 647 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 69.13 32.20 28.58 68.39 32.96 30.44 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 70.89 37.31 29.70 69.54 36.29 32.39 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 66.09 40.54 34.70 66.92 37.69 35.49 -19.64 50.95 45.34 -21.61 53.09 44.31 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU C 103 GLU.? 13.37 ZN ZN B 128 B 596 ARG C 36 ARG.? 10.67 ZN ZN B 128 B 647 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 38.22 57.83 70.36 36.82 56.74 69.18 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 34.24 60.89 68.08 33.31 57.93 67.63 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 31.43 57.38 61.97 31.90 55.58 64.41 -19.64 50.95 45.34 -21.61 53.09 44.31 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU C 103 GLU.? 13.37 ZN ZN B 128 C 596 ARG C 36 ARG.? 10.67 ZN ZN B 128 C 647 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 11.31 31.26 27.00 13.31 30.71 26.58 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 13.44 32.78 22.07 15.56 30.91 23.37 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 21.00 33.35 22.82 19.83 30.82 24.09 -19.64 50.95 45.34 -21.61 53.09 44.31 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU C 103 GLU.? 13.37 ZN ZN B 128 D 596 ARG C 36 ARG.? 10.67 ZN ZN B 128 D 647 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -20.07 59.92 44.69 -19.74 61.53 43.36 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -19.64 50.95 45.34 -21.61 53.09 44.31 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU C 103 GLU.? 13.37 ZN ZN B 128 E 596 ARG C 36 ARG.? 10.67 ZN ZN B 128 E 647 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -19.64 50.95 45.34 -21.61 53.09 44.31 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU C 103 GLU.? 13.37 ZN ZN B 128 F 596 ARG C 36 ARG.? 10.67 ZN ZN B 128 F 647 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -20.07 59.92 44.69 -19.74 61.53 43.36 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -19.64 50.95 45.34 -21.61 53.09 44.31 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN D 84 ASN^? 8.98 ZN ZN D 128 457 GLY A 108 GLY.? 9.79 ZN ZN D 128 459 GLU D 58 GLU.? 14.54 ZN ZN D 128 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -28.44 21.48 51.55 -28.88 19.99 50.09 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -27.38 22.98 60.43 -27.77 23.26 61.11 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -34.12 20.46 61.00 -33.75 20.62 63.08 1vom_c00 source 1vom MYOSIN : 1 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 16 PHE.? 16.30 ZN ZN A 128 A 197 ASN C 7 ASN.? 21.77 ZN ZN C 128 A 198 PRO C 5 PRO.? 18.15 ZN ZN C 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -18.40 57.13 61.09 -15.92 55.92 60.55 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -12.90 62.63 56.56 -13.76 61.50 58.29 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE A 16 PHE.? 16.30 ZN ZN A 128 A 197 ASN C 7 ASN.? 21.77 ZN ZN C 128 A 198 PRO C 102 PRO.? 18.82 ZN ZN B 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -18.40 57.13 61.09 -15.92 55.92 60.55 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -19.80 61.50 51.61 -19.09 59.88 50.25 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE A 94 PHE^? 9.23 ZN ZN A 128 A 197 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 198 PRO A 15 PRO.? 13.64 ZN ZN A 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -20.26 55.80 68.38 -22.98 56.19 68.94 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -24.87 54.78 59.56 -22.97 53.66 59.93 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE A 99 PHE^? 14.45 ZN ZN A 128 A 197 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 198 PRO C 15 PRO.? 14.14 ZN ZN C 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -17.21 40.83 64.08 -15.57 42.86 63.04 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -11.94 37.21 55.80 -11.77 38.76 57.45 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 A 100 PHE B 16 PHE.? 16.34 ZN ZN B 128 A 197 ASN D 7 ASN.? 21.83 ZN ZN D 128 A 198 PRO D 5 PRO.? 18.10 ZN ZN D 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -38.86 42.71 49.47 -37.53 43.33 47.81 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 A 100 PHE B 16 PHE.? 16.34 ZN ZN B 128 A 197 ASN D 7 ASN.? 21.83 ZN ZN D 128 A 198 PRO D 102 PRO.? 19.10 ZN ZN A 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -36.45 49.00 55.10 -34.55 48.04 55.74 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 3 # 7 A 100 PHE B 94 PHE^? 9.33 ZN ZN B 128 A 197 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 198 PRO B 15 PRO.? 13.65 ZN ZN B 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -30.29 47.77 38.05 -29.70 50.41 37.36 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -28.05 52.14 46.91 -27.57 50.00 46.51 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 3 # 8 A 100 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 197 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 198 PRO D 15 PRO.? 14.03 ZN ZN D 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -16.73 40.99 42.20 -19.09 40.00 43.35 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -14.90 34.17 50.26 -16.35 35.36 49.04 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 9 3 # 9 A 100 PHE C 16 PHE.? 16.61 ZN ZN C 128 A 197 ASN A 7 ASN.? 18.20 ZN ZN D 128 A 198 PRO A 102 PRO~? 13.15 ZN ZN D 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -11.21 38.35 63.24 -13.14 39.96 64.53 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -13.63 30.96 63.21 -14.85 30.65 64.93 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -17.98 30.69 61.60 -20.13 30.89 62.19 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 10 3 # 10 A 100 PHE C 94 PHE^? 9.63 ZN ZN C 128 A 197 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 198 PRO C 15 PRO.? 14.14 ZN ZN C 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -4.76 42.24 62.13 -3.25 41.33 59.94 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -11.94 37.21 55.80 -11.77 38.76 57.45 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 11 3 # 11 A 100 PHE C 99 PHE^? 14.04 ZN ZN C 128 A 197 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 198 PRO A 15 PRO.? 13.64 ZN ZN A 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -14.56 53.53 56.74 -15.34 51.98 58.97 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -24.87 54.78 59.56 -22.97 53.66 59.93 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 12 3 # 12 A 100 PHE D 16 PHE.? 16.58 ZN ZN D 128 A 197 ASN B 7 ASN.? 18.27 ZN ZN C 128 A 198 PRO B 102 PRO~? 13.12 ZN ZN C 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -16.01 34.48 43.33 -17.02 36.72 41.96 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -8.30 34.59 43.15 -7.56 35.74 41.51 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -7.02 38.85 44.98 -6.60 40.97 44.39 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 13 3 # 13 A 100 PHE D 94 PHE^? 9.41 ZN ZN D 128 A 197 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 198 PRO D 15 PRO.? 14.03 ZN ZN D 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -21.52 29.39 44.56 -21.12 27.85 46.87 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -14.90 34.17 50.26 -16.35 35.36 49.04 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 14 3 # 14 A 100 PHE D 99 PHE^? 14.35 ZN ZN D 128 A 197 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 198 PRO B 15 PRO.? 13.65 ZN ZN B 128 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 -29.67 42.10 49.53 -27.93 42.65 47.39 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 -28.05 52.14 46.91 -27.57 50.00 46.51 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 14 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 16 PHE.? 16.30 ZN ZN A 128 B 197 ASN C 7 ASN.? 21.77 ZN ZN C 128 B 198 PRO C 5 PRO.? 18.15 ZN ZN C 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -18.40 57.13 61.09 -15.92 55.92 60.55 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -12.90 62.63 56.56 -13.76 61.50 58.29 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE A 16 PHE.? 16.30 ZN ZN A 128 B 197 ASN C 7 ASN.? 21.77 ZN ZN C 128 B 198 PRO C 102 PRO.? 18.82 ZN ZN B 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -18.40 57.13 61.09 -15.92 55.92 60.55 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -19.80 61.50 51.61 -19.09 59.88 50.25 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE A 94 PHE^? 9.23 ZN ZN A 128 B 197 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 198 PRO A 15 PRO.? 13.64 ZN ZN A 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -20.26 55.80 68.38 -22.98 56.19 68.94 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -24.87 54.78 59.56 -22.97 53.66 59.93 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE A 99 PHE^? 14.45 ZN ZN A 128 B 197 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 198 PRO C 15 PRO.? 14.14 ZN ZN C 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -17.21 40.83 64.08 -15.57 42.86 63.04 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -11.94 37.21 55.80 -11.77 38.76 57.45 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 B 100 PHE B 16 PHE.? 16.34 ZN ZN B 128 B 197 ASN D 7 ASN.? 21.83 ZN ZN D 128 B 198 PRO D 5 PRO.? 18.10 ZN ZN D 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -38.86 42.71 49.47 -37.53 43.33 47.81 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 B 100 PHE B 16 PHE.? 16.34 ZN ZN B 128 B 197 ASN D 7 ASN.? 21.83 ZN ZN D 128 B 198 PRO D 102 PRO.? 19.10 ZN ZN A 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -32.11 46.61 45.22 -31.70 43.89 45.83 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -36.45 49.00 55.10 -34.55 48.04 55.74 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 3 # 7 B 100 PHE B 94 PHE^? 9.33 ZN ZN B 128 B 197 ASN B 95 ASN^? 12.67 ZN ZN B 128 B 198 PRO B 15 PRO.? 13.65 ZN ZN B 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -30.29 47.77 38.05 -29.70 50.41 37.36 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -28.05 52.14 46.91 -27.57 50.00 46.51 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 3 # 8 B 100 PHE B 99 PHE^? 14.30 ZN ZN B 128 B 197 ASN D 95 ASN^? 12.80 ZN ZN D 128 B 198 PRO D 15 PRO.? 14.03 ZN ZN D 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -16.73 40.99 42.20 -19.09 40.00 43.35 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -14.90 34.17 50.26 -16.35 35.36 49.04 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 9 3 # 9 B 100 PHE C 16 PHE.? 16.61 ZN ZN C 128 B 197 ASN A 7 ASN.? 18.20 ZN ZN D 128 B 198 PRO A 102 PRO~? 13.15 ZN ZN D 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -11.21 38.35 63.24 -13.14 39.96 64.53 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -13.63 30.96 63.21 -14.85 30.65 64.93 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -17.98 30.69 61.60 -20.13 30.89 62.19 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 10 3 # 10 B 100 PHE C 94 PHE^? 9.63 ZN ZN C 128 B 197 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 198 PRO C 15 PRO.? 14.14 ZN ZN C 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -4.76 42.24 62.13 -3.25 41.33 59.94 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -11.94 37.21 55.80 -11.77 38.76 57.45 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 11 3 # 11 B 100 PHE C 99 PHE^? 14.04 ZN ZN C 128 B 197 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 198 PRO A 15 PRO.? 13.64 ZN ZN A 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -14.56 53.53 56.74 -15.34 51.98 58.97 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -24.87 54.78 59.56 -22.97 53.66 59.93 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 12 3 # 12 B 100 PHE D 16 PHE.? 16.58 ZN ZN D 128 B 197 ASN B 7 ASN.? 18.27 ZN ZN C 128 B 198 PRO B 5 PRO.? 18.70 ZN ZN B 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -16.01 34.48 43.33 -17.02 36.72 41.96 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -8.30 34.59 43.15 -7.56 35.74 41.51 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -10.61 36.49 36.76 -12.35 35.76 37.95 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 13 3 # 13 B 100 PHE D 16 PHE.? 16.58 ZN ZN D 128 B 197 ASN B 7 ASN.? 18.27 ZN ZN C 128 B 198 PRO B 102 PRO~? 13.12 ZN ZN C 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -16.01 34.48 43.33 -17.02 36.72 41.96 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -8.30 34.59 43.15 -7.56 35.74 41.51 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -7.02 38.85 44.98 -6.60 40.97 44.39 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 14 3 # 14 B 100 PHE D 94 PHE^? 9.41 ZN ZN D 128 B 197 ASN D 95 ASN^? 12.80 ZN ZN D 128 B 198 PRO D 15 PRO.? 14.03 ZN ZN D 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -21.52 29.39 44.56 -21.12 27.85 46.87 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -14.90 34.17 50.26 -16.35 35.36 49.04 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 15 3 # 15 B 100 PHE D 99 PHE^? 14.35 ZN ZN D 128 B 197 ASN B 95 ASN^? 12.67 ZN ZN B 128 B 198 PRO B 15 PRO.? 13.65 ZN ZN B 128 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -29.67 42.10 49.53 -27.93 42.65 47.39 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -28.05 52.14 46.91 -27.57 50.00 46.51 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 15 hits 1vq1_c01 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 52 TYR^? 7.20 ZN ZN A 128 A 40 ASP A 64 ASP.? 14.79 ZN ZN A 128 A 103 LEU A 53 LEU^? 11.36 ZN ZN A 128 coo 12.09 16.13 10.57 11.28 18.80 10.73 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 7.55 25.51 14.34 9.65 25.73 14.24 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 11.83 18.73 16.99 10.99 19.71 15.26 -23.73 51.71 81.77 -23.15 53.47 82.85 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 52 TYR^? 7.51 ZN ZN B 128 A 40 ASP B 64 ASP.? 14.94 ZN ZN B 128 A 103 LEU B 53 LEU^? 11.32 ZN ZN B 128 coo 12.09 16.13 10.57 11.28 18.80 10.73 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 7.55 25.51 14.34 9.65 25.73 14.24 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 11.83 18.73 16.99 10.99 19.71 15.26 -25.29 50.30 24.89 -27.13 50.14 23.79 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 52 TYR^? 7.59 ZN ZN C 128 A 40 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 103 LEU C 43 LEU^? 7.58 ZN ZN C 128 coo 12.09 16.13 10.57 11.28 18.80 10.73 1.13 52.00 59.76 1.13 53.77 57.61 coo 7.55 25.51 14.34 9.65 25.73 14.24 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 11.83 18.73 16.99 10.99 19.71 15.26 -5.40 48.02 60.83 -4.09 46.39 61.29 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR C 52 TYR^? 7.59 ZN ZN C 128 A 40 ASP C 64 ASP.? 14.22 ZN ZN C 128 A 103 LEU C 53 LEU^? 10.94 ZN ZN C 128 coo 12.09 16.13 10.57 11.28 18.80 10.73 1.13 52.00 59.76 1.13 53.77 57.61 coo 7.55 25.51 14.34 9.65 25.73 14.24 8.74 58.91 56.74 6.81 58.81 55.87 coo 11.83 18.73 16.99 10.99 19.71 15.26 6.33 50.19 58.65 7.63 49.46 60.23 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR D 52 TYR^? 7.54 ZN ZN D 128 A 40 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 103 LEU D 43 LEU^? 7.63 ZN ZN D 128 coo 12.09 16.13 10.57 11.28 18.80 10.73 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 7.55 25.51 14.34 9.65 25.73 14.24 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 11.83 18.73 16.99 10.99 19.71 15.26 -26.78 31.53 45.59 -25.55 29.84 45.01 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR D 52 TYR^? 7.54 ZN ZN D 128 A 40 ASP D 64 ASP.? 14.34 ZN ZN D 128 A 103 LEU D 53 LEU^? 10.68 ZN ZN D 128 coo 12.09 16.13 10.57 11.28 18.80 10.73 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 7.55 25.51 14.34 9.65 25.73 14.24 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 11.83 18.73 16.99 10.99 19.71 15.26 -32.04 20.62 47.67 -30.67 19.42 46.51 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 6 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 52 TYR^? 7.20 ZN ZN A 128 B 40 ASP A 64 ASP.? 14.79 ZN ZN A 128 B 103 LEU A 53 LEU^? 11.36 ZN ZN A 128 coo 14.25 20.09 37.35 13.48 17.40 37.38 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 9.39 10.77 34.53 11.50 10.63 34.41 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 12.89 17.60 31.13 12.34 16.51 32.90 -23.73 51.71 81.77 -23.15 53.47 82.85 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 52 TYR^? 7.51 ZN ZN B 128 B 40 ASP B 64 ASP.? 14.94 ZN ZN B 128 B 103 LEU B 53 LEU^? 11.32 ZN ZN B 128 coo 14.25 20.09 37.35 13.48 17.40 37.38 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 9.39 10.77 34.53 11.50 10.63 34.41 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 12.89 17.60 31.13 12.34 16.51 32.90 -25.29 50.30 24.89 -27.13 50.14 23.79 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 52 TYR^? 7.59 ZN ZN C 128 B 40 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 103 LEU C 43 LEU^? 7.58 ZN ZN C 128 coo 14.25 20.09 37.35 13.48 17.40 37.38 1.13 52.00 59.76 1.13 53.77 57.61 coo 9.39 10.77 34.53 11.50 10.63 34.41 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 12.89 17.60 31.13 12.34 16.51 32.90 -5.40 48.02 60.83 -4.09 46.39 61.29 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR C 52 TYR^? 7.59 ZN ZN C 128 B 40 ASP C 64 ASP.? 14.22 ZN ZN C 128 B 103 LEU C 53 LEU^? 10.94 ZN ZN C 128 coo 14.25 20.09 37.35 13.48 17.40 37.38 1.13 52.00 59.76 1.13 53.77 57.61 coo 9.39 10.77 34.53 11.50 10.63 34.41 8.74 58.91 56.74 6.81 58.81 55.87 coo 12.89 17.60 31.13 12.34 16.51 32.90 6.33 50.19 58.65 7.63 49.46 60.23 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR D 52 TYR^? 7.54 ZN ZN D 128 B 40 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 103 LEU D 43 LEU^? 7.63 ZN ZN D 128 coo 14.25 20.09 37.35 13.48 17.40 37.38 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 9.39 10.77 34.53 11.50 10.63 34.41 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 12.89 17.60 31.13 12.34 16.51 32.90 -26.78 31.53 45.59 -25.55 29.84 45.01 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR D 52 TYR^? 7.54 ZN ZN D 128 B 40 ASP D 64 ASP.? 14.34 ZN ZN D 128 B 103 LEU D 53 LEU^? 10.68 ZN ZN D 128 coo 14.25 20.09 37.35 13.48 17.40 37.38 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 9.39 10.77 34.53 11.50 10.63 34.41 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 12.89 17.60 31.13 12.34 16.51 32.90 -32.04 20.62 47.67 -30.67 19.42 46.51 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 6 hits 1vzz_c01 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 49 ALA^? 15.93 ZN ZN A 128 A 244 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 271 HIS A 47 HIS^? 20.92 ZN ZN A 128 coo 15.05 3.71 6.93 14.58 4.88 7.78 -15.43 59.12 73.84 -14.71 59.38 75.17 coo 9.85 8.15 0.76 10.61 7.04 2.39 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 10.61 7.65 6.01 12.39 6.55 6.23 -13.35 63.60 67.55 -12.78 65.45 68.34 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 109 ALA.? 12.23 ZN ZN D 128 A 244 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 271 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 15.05 3.71 6.93 14.58 4.88 7.78 -30.13 20.47 61.13 -30.71 19.50 60.10 coo 9.85 8.15 0.76 10.61 7.04 2.39 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 10.61 7.65 6.01 12.39 6.55 6.23 -36.37 16.36 61.26 -35.21 16.95 62.91 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA B 49 ALA^? 16.22 ZN ZN B 128 A 244 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 271 HIS B 47 HIS^? 20.89 ZN ZN B 128 coo 15.05 3.71 6.93 14.58 4.88 7.78 -34.75 44.14 32.50 -35.24 43.58 31.16 coo 9.85 8.15 0.76 10.61 7.04 2.39 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 10.61 7.65 6.01 12.39 6.55 6.23 -39.48 43.38 38.85 -41.38 43.59 37.99 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA B 109 ALA.? 11.51 ZN ZN C 128 A 244 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 271 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 15.05 3.71 6.93 14.58 4.88 7.78 5.85 47.64 45.49 6.61 48.23 46.67 coo 9.85 8.15 0.76 10.61 7.04 2.39 8.18 57.58 47.56 10.27 57.39 47.78 coo 10.61 7.65 6.01 12.39 6.55 6.23 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 105 ALA C 71 ALA.? 19.01 ZN ZN C 128 A 244 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 271 HIS C 47 HIS^? 21.11 ZN ZN C 128 coo 15.05 3.71 6.93 14.58 4.88 7.78 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 9.85 8.15 0.76 10.61 7.04 2.39 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 10.61 7.65 6.01 12.39 6.55 6.23 -4.93 38.23 71.51 -3.75 37.25 72.95 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 105 ALA D 49 ALA^? 16.16 ZN ZN D 128 A 244 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 271 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 15.05 3.71 6.93 14.58 4.88 7.78 -23.96 25.36 38.04 -24.83 24.52 37.10 coo 9.85 8.15 0.76 10.61 7.04 2.39 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 10.61 7.65 6.01 12.39 6.55 6.23 -17.20 28.58 35.23 -16.55 27.59 33.50 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 7 3 # 7 A 105 ALA D 71 ALA.? 18.99 ZN ZN D 128 A 244 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 271 HIS D 47 HIS^? 21.18 ZN ZN D 128 coo 15.05 3.71 6.93 14.58 4.88 7.78 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 9.85 8.15 0.76 10.61 7.04 2.39 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 10.61 7.65 6.01 12.39 6.55 6.23 -17.20 28.58 35.23 -16.55 27.59 33.50 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 7 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 71 ALA.? 18.90 ZN ZN A 128 B 126 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 138 GLU A 70 GLU^? 19.90 ZN ZN A 128 coo 2.11 4.00 19.31 3.14 4.86 19.99 -10.85 57.79 70.32 -10.50 59.22 69.90 coo 2.45 5.53 11.28 3.59 7.56 13.29 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 6.10 2.00 25.24 6.12 1.84 23.13 -10.78 57.16 76.11 -9.51 58.48 77.12 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 71 ALA.? 18.94 ZN ZN B 128 B 126 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 138 GLU B 70 GLU^? 18.94 ZN ZN B 128 coo 2.11 4.00 19.31 3.14 4.86 19.99 -34.70 39.55 36.03 -36.14 39.66 36.51 coo 2.45 5.53 11.28 3.59 7.56 13.29 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 6.10 2.00 25.24 6.12 1.84 23.13 -34.57 38.82 30.28 -36.03 40.31 29.90 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA C 71 ALA.? 19.01 ZN ZN C 128 B 126 ARG A 42 ARG^? 15.09 ZN ZN A 128 B 138 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo 2.11 4.00 19.31 3.14 4.86 19.99 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 2.45 5.53 11.28 3.59 7.56 13.29 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 6.10 2.00 25.24 6.12 1.84 23.13 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA D 71 ALA.? 18.99 ZN ZN D 128 B 126 ARG B 42 ARG^? 15.17 ZN ZN B 128 B 138 GLU D 70 GLU^? 19.86 ZN ZN D 128 coo 2.11 4.00 19.31 3.14 4.86 19.99 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 2.45 5.53 11.28 3.59 7.56 13.29 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 6.10 2.00 25.24 6.12 1.84 23.13 -27.83 26.66 34.57 -27.72 25.48 32.82 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 71 ALA.? 18.90 ZN ZN A 128 C 126 ARG C 42 ARG^? 15.11 ZN ZN C 128 C 138 GLU A 70 GLU^? 19.90 ZN ZN A 128 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -10.85 57.79 70.32 -10.50 59.22 69.90 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -10.78 57.16 76.11 -9.51 58.48 77.12 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 71 ALA.? 18.94 ZN ZN B 128 C 126 ARG D 42 ARG^? 14.89 ZN ZN D 128 C 138 GLU B 70 GLU^? 18.94 ZN ZN B 128 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -34.70 39.55 36.03 -36.14 39.66 36.51 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -29.08 38.55 44.25 -27.07 40.84 43.98 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -34.57 38.82 30.28 -36.03 40.31 29.90 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA C 71 ALA.? 19.01 ZN ZN C 128 C 126 ARG A 42 ARG^? 15.09 ZN ZN A 128 C 138 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -5.38 44.92 71.40 -5.39 43.57 72.14 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA D 71 ALA.? 18.99 ZN ZN D 128 C 126 ARG B 42 ARG^? 15.17 ZN ZN B 128 C 138 GLU D 70 GLU^? 19.86 ZN ZN D 128 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -23.67 30.79 35.16 -22.42 30.44 34.35 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -27.83 26.66 34.57 -27.72 25.48 32.82 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 71 ALA.? 18.90 ZN ZN A 128 D 126 ARG C 42 ARG^? 15.11 ZN ZN C 128 D 138 GLU A 70 GLU^? 19.90 ZN ZN A 128 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -10.85 57.79 70.32 -10.50 59.22 69.90 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 6.23 0.50 57.10 5.93 0.72 59.19 -10.78 57.16 76.11 -9.51 58.48 77.12 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 71 ALA.? 18.94 ZN ZN B 128 D 126 ARG D 42 ARG^? 14.89 ZN ZN D 128 D 138 GLU B 70 GLU^? 18.94 ZN ZN B 128 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -34.70 39.55 36.03 -36.14 39.66 36.51 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 6.23 0.50 57.10 5.93 0.72 59.19 -34.57 38.82 30.28 -36.03 40.31 29.90 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA C 71 ALA.? 19.01 ZN ZN C 128 D 126 ARG A 42 ARG^? 15.09 ZN ZN A 128 D 138 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -5.38 44.92 71.40 -5.39 43.57 72.14 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 6.23 0.50 57.10 5.93 0.72 59.19 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA D 71 ALA.? 18.99 ZN ZN D 128 D 126 ARG B 42 ARG^? 15.17 ZN ZN B 128 D 138 GLU D 70 GLU^? 19.86 ZN ZN D 128 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -23.67 30.79 35.16 -22.42 30.44 34.35 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 6.23 0.50 57.10 5.93 0.72 59.19 -27.83 26.66 34.57 -27.72 25.48 32.82 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 71 ALA.? 18.90 ZN ZN A 128 E 126 ARG C 42 ARG^? 15.11 ZN ZN C 128 E 138 GLU A 70 GLU^? 19.90 ZN ZN A 128 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -10.85 57.79 70.32 -10.50 59.22 69.90 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -10.78 57.16 76.11 -9.51 58.48 77.12 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 71 ALA.? 18.94 ZN ZN B 128 E 126 ARG D 42 ARG^? 14.89 ZN ZN D 128 E 138 GLU B 70 GLU^? 18.94 ZN ZN B 128 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -34.70 39.55 36.03 -36.14 39.66 36.51 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -29.08 38.55 44.25 -27.07 40.84 43.98 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -34.57 38.82 30.28 -36.03 40.31 29.90 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA C 71 ALA.? 19.01 ZN ZN C 128 E 126 ARG A 42 ARG^? 15.09 ZN ZN A 128 E 138 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -5.38 44.92 71.40 -5.39 43.57 72.14 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA D 71 ALA.? 18.99 ZN ZN D 128 E 126 ARG B 42 ARG^? 15.17 ZN ZN B 128 E 138 GLU D 70 GLU^? 19.86 ZN ZN D 128 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -23.67 30.79 35.16 -22.42 30.44 34.35 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -27.83 26.66 34.57 -27.72 25.48 32.82 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 71 ALA.? 18.90 ZN ZN A 128 F 126 ARG C 42 ARG^? 15.11 ZN ZN C 128 F 138 GLU A 70 GLU^? 19.90 ZN ZN A 128 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -10.85 57.79 70.32 -10.50 59.22 69.90 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -10.78 57.16 76.11 -9.51 58.48 77.12 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 71 ALA.? 18.94 ZN ZN B 128 F 126 ARG D 42 ARG^? 14.89 ZN ZN D 128 F 138 GLU B 70 GLU^? 18.94 ZN ZN B 128 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -34.70 39.55 36.03 -36.14 39.66 36.51 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -29.08 38.55 44.25 -27.07 40.84 43.98 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -34.57 38.82 30.28 -36.03 40.31 29.90 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA C 71 ALA.? 19.01 ZN ZN C 128 F 126 ARG A 42 ARG^? 15.09 ZN ZN A 128 F 138 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -5.38 44.92 71.40 -5.39 43.57 72.14 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA D 71 ALA.? 18.99 ZN ZN D 128 F 126 ARG B 42 ARG^? 15.17 ZN ZN B 128 F 138 GLU D 70 GLU^? 19.86 ZN ZN D 128 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -23.67 30.79 35.16 -22.42 30.44 34.35 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -27.83 26.66 34.57 -27.72 25.48 32.82 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c11 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 13 SER^? 14.04 ZN ZN A 128 338 ASP C 97 ASP^? 13.06 ZN ZN C 128 397 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 2 3 # 2 146 SER B 13 SER^? 13.94 ZN ZN B 128 338 ASP D 97 ASP^? 13.24 ZN ZN D 128 397 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 3 3 # 3 146 SER C 13 SER^? 14.25 ZN ZN C 128 338 ASP A 97 ASP^? 13.17 ZN ZN A 128 397 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 4 3 # 4 146 SER D 13 SER^? 14.41 ZN ZN D 128 338 ASP B 97 ASP^? 13.03 ZN ZN B 128 397 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -18.46 42.11 47.13 -20.09 43.42 47.28 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 4 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 13 SER^? 14.04 ZN ZN A 128 A 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 256 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 64.84 24.93 59.62 66.28 24.42 57.72 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 73.80 27.56 60.96 72.24 26.45 60.08 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 70.86 23.63 59.28 68.91 24.23 58.80 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1zoi_c00 ESTERASE user 2 3 # 2 A 97 SER A 13 SER^? 14.04 ZN ZN A 128 A 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 256 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 64.84 24.93 59.62 66.28 24.42 57.72 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 73.80 27.56 60.96 72.24 26.45 60.08 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 70.86 23.63 59.28 68.91 24.23 58.80 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1zoi_c00 ESTERASE user 3 3 # 3 A 97 SER B 13 SER^? 13.94 ZN ZN B 128 A 227 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 256 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 64.84 24.93 59.62 66.28 24.42 57.72 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 73.80 27.56 60.96 72.24 26.45 60.08 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 70.86 23.63 59.28 68.91 24.23 58.80 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1zoi_c00 ESTERASE user 4 3 # 4 A 97 SER C 13 SER^? 14.25 ZN ZN C 128 A 227 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 256 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 64.84 24.93 59.62 66.28 24.42 57.72 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 73.80 27.56 60.96 72.24 26.45 60.08 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 70.86 23.63 59.28 68.91 24.23 58.80 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1zoi_c00 ESTERASE user 5 3 # 5 A 97 SER D 13 SER^? 14.41 ZN ZN D 128 A 227 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 256 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 64.84 24.93 59.62 66.28 24.42 57.72 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 73.80 27.56 60.96 72.24 26.45 60.08 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 70.86 23.63 59.28 68.91 24.23 58.80 -18.46 42.11 47.13 -20.09 43.42 47.28 1zoi_c00 source 1zoi ESTERASE : 5 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 13 SER^? 14.04 ZN ZN A 128 B 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 256 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1zoi_c01 ESTERASE user 2 3 # 2 B 97 SER A 13 SER^? 14.04 ZN ZN A 128 B 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 256 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1zoi_c01 ESTERASE user 3 3 # 3 B 97 SER B 13 SER^? 13.94 ZN ZN B 128 B 227 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 256 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1zoi_c01 ESTERASE user 4 3 # 4 B 97 SER C 13 SER^? 14.25 ZN ZN C 128 B 227 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 256 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1zoi_c01 ESTERASE user 5 3 # 5 B 97 SER D 13 SER^? 14.41 ZN ZN D 128 B 227 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 256 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -18.46 42.11 47.13 -20.09 43.42 47.28 1zoi_c01 source 1zoi ESTERASE : 5 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 13 SER^? 14.04 ZN ZN A 128 C 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 256 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1zoi_c02 ESTERASE user 2 3 # 2 C 97 SER A 13 SER^? 14.04 ZN ZN A 128 C 227 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 256 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 1zoi_c02 ESTERASE user 3 3 # 3 C 97 SER B 13 SER^? 13.94 ZN ZN B 128 C 227 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 256 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 1zoi_c02 ESTERASE user 4 3 # 4 C 97 SER C 13 SER^? 14.25 ZN ZN C 128 C 227 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 256 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 1zoi_c02 ESTERASE user 5 3 # 5 C 97 SER D 13 SER^? 14.41 ZN ZN D 128 C 227 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 256 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -18.46 42.11 47.13 -20.09 43.42 47.28 1zoi_c02 source 1zoi ESTERASE : 5 hits 1zoi_c02 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 371 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 407 THR A 35 THR.? 8.83 ZN ZN A 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -28.11 44.25 70.85 -26.82 45.93 70.94 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -27.08 41.78 78.19 -22.69 42.64 82.54 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -28.69 39.43 70.39 -28.36 40.10 72.45 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 371 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 407 THR A 89 THR.? 18.72 ZN ZN A 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -25.66 62.13 69.69 -25.48 65.02 74.91 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -19.06 65.09 74.03 -16.96 64.91 73.52 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 371 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 407 THR A 92 THR.? 14.81 ZN ZN A 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -25.66 62.13 69.69 -25.48 65.02 74.91 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 371 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 407 THR B 35 THR.? 8.83 ZN ZN B 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -16.91 52.67 35.82 -18.80 51.89 35.31 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -14.88 50.71 28.23 -16.26 47.48 23.80 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -11.91 51.72 35.90 -12.77 51.64 33.90 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 371 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 407 THR B 89 THR.? 18.91 ZN ZN B 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -34.93 54.65 36.44 -38.00 53.50 31.57 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -39.38 49.52 32.40 -39.94 47.46 32.72 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 371 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 407 THR B 92 THR.? 15.12 ZN ZN B 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -34.93 54.65 36.44 -38.00 53.50 31.57 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 371 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 407 THR C 89 THR.? 19.23 ZN ZN C 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 2.93 33.32 67.19 5.03 33.43 67.23 coo -4.43 30.92 22.89 -6.61 31.91 19.71 0.64 35.92 60.53 5.63 36.47 64.53 coo -8.38 36.02 19.06 -8.83 34.10 19.89 3.40 37.97 68.34 2.23 38.61 70.05 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 8 3 # 8 A 369 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 371 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 407 THR C 92 THR.? 15.22 ZN ZN C 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 2.93 33.32 67.19 5.03 33.43 67.23 coo -4.43 30.92 22.89 -6.61 31.91 19.71 0.64 35.92 60.53 5.63 36.47 64.53 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 9 3 # 9 A 369 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 371 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 407 THR D 89 THR.? 18.97 ZN ZN D 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -16.96 22.44 46.27 -19.09 18.04 45.40 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -19.13 20.42 38.63 -19.24 21.85 36.98 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 10 3 # 10 A 369 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 371 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 407 THR D 92 THR.? 15.38 ZN ZN D 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -16.96 22.44 46.27 -19.09 18.04 45.40 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -18.23 25.46 39.42 -20.30 24.86 39.60 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 10 hits 1zrz_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 371 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 374 ASN A 18 ASN.? 16.39 ZN ZN A 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -25.66 62.13 69.69 -25.48 65.02 74.91 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -22.68 62.48 66.52 -24.06 63.34 65.13 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 371 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 374 ASN B 18 ASN.? 16.24 ZN ZN B 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -34.93 54.65 36.44 -38.00 53.50 31.57 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -35.92 52.23 39.87 -36.26 53.93 41.12 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 371 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 374 ASN C 18 ASN.? 16.75 ZN ZN C 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 2.93 33.32 67.19 5.03 33.43 67.23 coo -4.43 30.92 22.89 -6.61 31.91 19.71 0.64 35.92 60.53 5.63 36.47 64.53 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -2.99 35.22 62.77 -3.32 33.34 61.83 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 371 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 374 ASN D 18 ASN.? 16.75 ZN ZN D 128 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -16.96 22.44 46.27 -19.09 18.04 45.40 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -15.23 25.74 43.96 -13.30 25.49 44.87 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 4 hits 1zrz_c03 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 60 SER.? 16.46 ZN ZN A 128 327 GLU A 58 GLU.? 14.95 ZN ZN A 128 440 HIS A 59 HIS.? 17.66 ZN ZN A 128 coo 6.96 64.04 57.84 6.74 63.69 60.26 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 14.82 64.63 62.37 13.47 65.72 61.17 -35.58 45.32 81.43 -37.46 44.65 80.73 coo 9.52 66.51 63.07 8.75 65.02 61.81 -36.79 45.73 85.78 -38.28 45.69 84.31 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 60 SER.? 16.61 ZN ZN B 128 327 GLU B 58 GLU.? 14.99 ZN ZN B 128 440 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 6.96 64.04 57.84 6.74 63.69 60.26 -18.29 55.80 18.16 -16.70 54.11 18.90 coo 14.82 64.63 62.37 13.47 65.72 61.17 -16.19 59.88 24.88 -15.11 61.60 25.47 coo 9.52 66.51 63.07 8.75 65.02 61.81 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 3 3 # 3 200 SER C 60 SER.? 15.14 ZN ZN C 128 327 GLU C 58 GLU.? 14.59 ZN ZN C 128 440 HIS C 59 HIS.? 17.15 ZN ZN C 128 coo 6.96 64.04 57.84 6.74 63.69 60.26 12.55 55.11 50.39 10.44 55.82 51.40 coo 14.82 64.63 62.37 13.47 65.72 61.17 7.13 51.72 45.00 6.65 51.50 42.95 coo 9.52 66.51 63.07 8.75 65.02 61.81 11.45 52.92 44.80 10.43 52.05 43.19 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 4 3 # 4 200 SER D 60 SER.? 15.90 ZN ZN D 128 327 GLU D 58 GLU.? 14.54 ZN ZN D 128 440 HIS D 59 HIS.? 17.27 ZN ZN D 128 coo 6.96 64.04 57.84 6.74 63.69 60.26 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 14.82 64.63 62.37 13.47 65.72 61.17 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 9.52 66.51 63.07 8.75 65.02 61.81 -36.37 16.36 61.26 -35.21 16.95 62.91 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 4 hits 2ace_c00 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 48 HIS A 30 HIS.? -4.18 ZN ZN A 128s A 77 LYS A 81 LYS.? 12.55 ZN ZN A 128 coo 13.04 30.41 72.50 12.95 30.65 70.36 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 12.77 23.50 68.33 13.58 25.42 68.49 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 7.53 29.84 65.06 12.29 29.41 67.79 -27.08 41.78 78.19 -22.69 42.64 82.54 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 48 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 77 LYS B 81 LYS.? 12.71 ZN ZN B 128 coo 13.04 30.41 72.50 12.95 30.65 70.36 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 12.77 23.50 68.33 13.58 25.42 68.49 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 7.53 29.84 65.06 12.29 29.41 67.79 -14.88 50.71 28.23 -16.26 47.48 23.80 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 3 3 # 3 A 43 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 48 HIS C 30 HIS^? -3.56 ZN ZN C 128s A 77 LYS C 81 LYS.? 11.89 ZN ZN C 128 coo 13.04 30.41 72.50 12.95 30.65 70.36 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 12.77 23.50 68.33 13.58 25.42 68.49 0.61 46.90 50.78 -0.23 46.71 52.70 coo 7.53 29.84 65.06 12.29 29.41 67.79 0.65 56.08 51.29 4.22 57.96 54.91 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 4 3 # 4 A 43 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 48 HIS D 30 HIS^? -3.68 ZN ZN D 128s A 77 LYS D 81 LYS.? 12.28 ZN ZN D 128 coo 13.04 30.41 72.50 12.95 30.65 70.36 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 12.77 23.50 68.33 13.58 25.42 68.49 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 7.53 29.84 65.06 12.29 29.41 67.79 -36.76 27.60 54.86 -39.44 24.48 51.40 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 4 hits 2acu_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 7 ASN.? 18.20 ZN ZN D 128 A 106 PRO A 5 PRO.? 18.90 ZN ZN A 128 A 108 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -13.63 30.96 63.21 -14.85 30.65 64.93 coo 36.18 33.51 20.99 37.11 35.33 20.14 -14.60 33.63 69.44 -13.31 35.08 68.38 coo 33.01 33.46 15.68 31.96 34.97 17.80 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 A 105 ASN A 7 ASN.? 18.20 ZN ZN D 128 A 106 PRO A 102 PRO~? 13.15 ZN ZN D 128 A 108 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -13.63 30.96 63.21 -14.85 30.65 64.93 coo 36.18 33.51 20.99 37.11 35.33 20.14 -17.98 30.69 61.60 -20.13 30.89 62.19 coo 33.01 33.46 15.68 31.96 34.97 17.80 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 A 105 ASN B 7 ASN.? 18.27 ZN ZN C 128 A 106 PRO B 5 PRO.? 18.70 ZN ZN B 128 A 108 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -8.30 34.59 43.15 -7.56 35.74 41.51 coo 36.18 33.51 20.99 37.11 35.33 20.14 -10.61 36.49 36.76 -12.35 35.76 37.95 coo 33.01 33.46 15.68 31.96 34.97 17.80 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 A 105 ASN B 7 ASN.? 18.27 ZN ZN C 128 A 106 PRO B 102 PRO~? 13.12 ZN ZN C 128 A 108 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -8.30 34.59 43.15 -7.56 35.74 41.51 coo 36.18 33.51 20.99 37.11 35.33 20.14 -7.02 38.85 44.98 -6.60 40.97 44.39 coo 33.01 33.46 15.68 31.96 34.97 17.80 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 A 105 ASN C 7 ASN.? 21.77 ZN ZN C 128 A 106 PRO C 5 PRO.? 18.15 ZN ZN C 128 A 108 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 36.18 33.51 20.99 37.11 35.33 20.14 -12.90 62.63 56.56 -13.76 61.50 58.29 coo 33.01 33.46 15.68 31.96 34.97 17.80 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 A 105 ASN C 7 ASN.? 21.77 ZN ZN C 128 A 106 PRO C 102 PRO.? 18.82 ZN ZN B 128 A 108 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 36.18 33.51 20.99 37.11 35.33 20.14 -19.80 61.50 51.61 -19.09 59.88 50.25 coo 33.01 33.46 15.68 31.96 34.97 17.80 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 A 105 ASN D 7 ASN.? 21.83 ZN ZN D 128 A 106 PRO D 5 PRO.? 18.10 ZN ZN D 128 A 108 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 36.18 33.51 20.99 37.11 35.33 20.14 -38.86 42.71 49.47 -37.53 43.33 47.81 coo 33.01 33.46 15.68 31.96 34.97 17.80 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 8 3 # 8 A 105 ASN D 7 ASN.? 21.83 ZN ZN D 128 A 106 PRO D 102 PRO.? 19.10 ZN ZN A 128 A 108 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 34.91 38.94 20.48 33.53 38.20 19.00 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 36.18 33.51 20.99 37.11 35.33 20.14 -36.45 49.00 55.10 -34.55 48.04 55.74 coo 33.01 33.46 15.68 31.96 34.97 17.80 -34.83 43.92 51.78 -36.80 42.61 53.27 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 8 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 7 ASN.? 18.20 ZN ZN D 128 B 106 PRO A 5 PRO.? 18.90 ZN ZN A 128 B 108 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -13.63 30.96 63.21 -14.85 30.65 64.93 coo 4.66 43.53 47.47 3.74 41.73 46.59 -14.60 33.63 69.44 -13.31 35.08 68.38 coo 7.86 43.80 42.15 8.87 42.26 44.27 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 B 105 ASN A 7 ASN.? 18.20 ZN ZN D 128 B 106 PRO A 102 PRO~? 13.15 ZN ZN D 128 B 108 TYR A 8 TYR.? 17.33 ZN ZN A 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -13.63 30.96 63.21 -14.85 30.65 64.93 coo 4.66 43.53 47.47 3.74 41.73 46.59 -17.98 30.69 61.60 -20.13 30.89 62.19 coo 7.86 43.80 42.15 8.87 42.26 44.27 -17.14 34.95 65.78 -18.35 33.52 67.89 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 B 105 ASN B 7 ASN.? 18.27 ZN ZN C 128 B 106 PRO B 5 PRO.? 18.70 ZN ZN B 128 B 108 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -8.30 34.59 43.15 -7.56 35.74 41.51 coo 4.66 43.53 47.47 3.74 41.73 46.59 -10.61 36.49 36.76 -12.35 35.76 37.95 coo 7.86 43.80 42.15 8.87 42.26 44.27 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 B 105 ASN B 7 ASN.? 18.27 ZN ZN C 128 B 106 PRO B 102 PRO~? 13.12 ZN ZN C 128 B 108 TYR B 8 TYR.? 17.28 ZN ZN B 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -8.30 34.59 43.15 -7.56 35.74 41.51 coo 4.66 43.53 47.47 3.74 41.73 46.59 -7.02 38.85 44.98 -6.60 40.97 44.39 coo 7.86 43.80 42.15 8.87 42.26 44.27 -11.11 39.23 40.67 -9.41 39.91 38.53 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 B 105 ASN C 7 ASN.? 21.77 ZN ZN C 128 B 106 PRO C 5 PRO.? 18.15 ZN ZN C 128 B 108 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 4.66 43.53 47.47 3.74 41.73 46.59 -12.90 62.63 56.56 -13.76 61.50 58.29 coo 7.86 43.80 42.15 8.87 42.26 44.27 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 B 105 ASN C 7 ASN.? 21.77 ZN ZN C 128 B 106 PRO C 102 PRO.? 18.82 ZN ZN B 128 B 108 TYR C 8 TYR.? 16.68 ZN ZN C 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -19.63 62.63 55.75 -17.91 63.23 54.63 coo 4.66 43.53 47.47 3.74 41.73 46.59 -19.80 61.50 51.61 -19.09 59.88 50.25 coo 7.86 43.80 42.15 8.87 42.26 44.27 -14.96 59.08 54.51 -13.25 60.64 52.94 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 B 105 ASN D 7 ASN.? 21.83 ZN ZN D 128 B 106 PRO D 5 PRO.? 18.10 ZN ZN D 128 B 108 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 4.66 43.53 47.47 3.74 41.73 46.59 -38.86 42.71 49.47 -37.53 43.33 47.81 coo 7.86 43.80 42.15 8.87 42.26 44.27 -34.83 43.92 51.78 -36.80 42.61 53.27 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 8 3 # 8 B 105 ASN D 7 ASN.? 21.83 ZN ZN D 128 B 106 PRO D 102 PRO.? 19.10 ZN ZN A 128 B 108 TYR D 8 TYR.? 16.65 ZN ZN D 128 coo 5.98 38.14 46.94 7.30 38.92 45.46 -37.13 49.32 50.54 -38.26 47.82 51.54 coo 4.66 43.53 47.47 3.74 41.73 46.59 -36.45 49.00 55.10 -34.55 48.04 55.74 coo 7.86 43.80 42.15 8.87 42.26 44.27 -34.83 43.92 51.78 -36.80 42.61 53.27 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 8 hits 2adm_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 50 GLU A 70 GLU^? 19.90 ZN ZN A 128 B 113 GLN C 3 GLN.? 20.41 ZN ZN C 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -9.52 61.63 64.04 -10.81 62.63 65.44 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 50 GLU B 70 GLU^? 18.94 ZN ZN B 128 B 113 GLN D 3 GLN.? 20.28 ZN ZN D 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -38.65 39.10 42.12 -39.47 40.52 40.76 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 50 GLU C 70 GLU^? 19.15 ZN ZN C 128 B 113 GLN A 3 GLN.? 20.50 ZN ZN A 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -0.72 48.58 72.21 1.10 47.61 72.77 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -10.17 39.21 73.49 -8.12 38.64 73.27 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 50 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 113 GLN B 111 GLN.? 17.39 ZN ZN C 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 11.45 52.92 44.80 10.43 52.05 43.19 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 12.24 47.63 44.81 13.39 47.10 46.52 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS D 47 HIS^? 21.18 ZN ZN D 128 B 50 GLU D 70 GLU^? 19.86 ZN ZN D 128 B 113 GLN B 3 GLN.? 20.49 ZN ZN B 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -17.28 33.72 33.08 -17.35 31.60 33.39 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 50 GLU A 70 GLU^? 19.90 ZN ZN A 128 B 113 GLN C 3 GLN.? 20.41 ZN ZN C 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -9.52 61.63 64.04 -10.81 62.63 65.44 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 50 GLU B 70 GLU^? 18.94 ZN ZN B 128 B 113 GLN D 3 GLN.? 20.28 ZN ZN D 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -38.65 39.10 42.12 -39.47 40.52 40.76 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 50 GLU C 70 GLU^? 19.15 ZN ZN C 128 B 113 GLN A 3 GLN.? 20.50 ZN ZN A 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -0.72 48.58 72.21 1.10 47.61 72.77 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -10.17 39.21 73.49 -8.12 38.64 73.27 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 50 GLU B 107 GLU.? 12.06 ZN ZN C 128 B 113 GLN B 111 GLN.? 17.39 ZN ZN C 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 11.45 52.92 44.80 10.43 52.05 43.19 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 12.24 47.63 44.81 13.39 47.10 46.52 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS D 47 HIS^? 21.18 ZN ZN D 128 B 50 GLU D 70 GLU^? 19.86 ZN ZN D 128 B 113 GLN B 3 GLN.? 20.49 ZN ZN B 128 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -17.28 33.72 33.08 -17.35 31.60 33.39 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 50 GLU A 70 GLU^? 19.90 ZN ZN A 128 A 113 GLN C 3 GLN.? 20.41 ZN ZN C 128 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -9.52 61.63 64.04 -10.81 62.63 65.44 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 50 GLU B 70 GLU^? 18.94 ZN ZN B 128 A 113 GLN D 3 GLN.? 20.28 ZN ZN D 128 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -38.65 39.10 42.12 -39.47 40.52 40.76 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 50 GLU C 70 GLU^? 19.15 ZN ZN C 128 A 113 GLN A 3 GLN.? 20.50 ZN ZN A 128 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -0.72 48.58 72.21 1.10 47.61 72.77 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -10.17 39.21 73.49 -8.12 38.64 73.27 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 50 GLU B 107 GLU.? 12.06 ZN ZN C 128 A 113 GLN B 111 GLN.? 17.39 ZN ZN C 128 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 11.45 52.92 44.80 10.43 52.05 43.19 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 12.24 47.63 44.81 13.39 47.10 46.52 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 5 3 # 5 A 29 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 50 GLU D 70 GLU^? 19.86 ZN ZN D 128 A 113 GLN B 3 GLN.? 20.49 ZN ZN B 128 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -17.28 33.72 33.08 -17.35 31.60 33.39 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 47 HIS^? 20.92 ZN ZN A 128 C 50 GLU A 70 GLU^? 19.90 ZN ZN A 128 C 113 GLN C 3 GLN.? 20.41 ZN ZN C 128 coo 74.92 8.52 28.42 74.88 6.86 29.70 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 65.25 15.95 28.73 65.73 15.63 30.78 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 70.80 6.73 32.72 71.88 8.55 32.53 -9.52 61.63 64.04 -10.81 62.63 65.44 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS B 47 HIS^? 20.89 ZN ZN B 128 C 50 GLU B 70 GLU^? 18.94 ZN ZN B 128 C 113 GLN D 3 GLN.? 20.28 ZN ZN D 128 coo 74.92 8.52 28.42 74.88 6.86 29.70 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 65.25 15.95 28.73 65.73 15.63 30.78 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 70.80 6.73 32.72 71.88 8.55 32.53 -38.65 39.10 42.12 -39.47 40.52 40.76 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS C 47 HIS^? 21.11 ZN ZN C 128 C 50 GLU C 70 GLU^? 19.15 ZN ZN C 128 C 113 GLN A 3 GLN.? 20.50 ZN ZN A 128 coo 74.92 8.52 28.42 74.88 6.86 29.70 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 65.25 15.95 28.73 65.73 15.63 30.78 -0.72 48.58 72.21 1.10 47.61 72.77 coo 70.80 6.73 32.72 71.88 8.55 32.53 -10.17 39.21 73.49 -8.12 38.64 73.27 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 50 GLU B 107 GLU.? 12.06 ZN ZN C 128 C 113 GLN B 111 GLN.? 17.39 ZN ZN C 128 coo 74.92 8.52 28.42 74.88 6.86 29.70 11.45 52.92 44.80 10.43 52.05 43.19 coo 65.25 15.95 28.73 65.73 15.63 30.78 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 70.80 6.73 32.72 71.88 8.55 32.53 12.24 47.63 44.81 13.39 47.10 46.52 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 5 3 # 5 C 29 HIS D 47 HIS^? 21.18 ZN ZN D 128 C 50 GLU D 70 GLU^? 19.86 ZN ZN D 128 C 113 GLN B 3 GLN.? 20.49 ZN ZN B 128 coo 74.92 8.52 28.42 74.88 6.86 29.70 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 65.25 15.95 28.73 65.73 15.63 30.78 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 70.80 6.73 32.72 71.88 8.55 32.53 -17.28 33.72 33.08 -17.35 31.60 33.39 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 47 HIS^? 20.92 ZN ZN A 128 D 50 GLU A 70 GLU^? 19.90 ZN ZN A 128 D 113 GLN C 3 GLN.? 20.41 ZN ZN C 128 coo 38.66 11.31 27.15 38.67 12.13 25.22 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 48.72 12.85 33.83 48.36 14.77 32.95 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 42.85 14.77 24.15 41.85 15.11 26.02 -9.52 61.63 64.04 -10.81 62.63 65.44 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS B 47 HIS^? 20.89 ZN ZN B 128 D 50 GLU B 70 GLU^? 18.94 ZN ZN B 128 D 113 GLN D 3 GLN.? 20.28 ZN ZN D 128 coo 38.66 11.31 27.15 38.67 12.13 25.22 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 48.72 12.85 33.83 48.36 14.77 32.95 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 42.85 14.77 24.15 41.85 15.11 26.02 -38.65 39.10 42.12 -39.47 40.52 40.76 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS C 47 HIS^? 21.11 ZN ZN C 128 D 50 GLU C 70 GLU^? 19.15 ZN ZN C 128 D 113 GLN A 3 GLN.? 20.50 ZN ZN A 128 coo 38.66 11.31 27.15 38.67 12.13 25.22 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 48.72 12.85 33.83 48.36 14.77 32.95 -0.72 48.58 72.21 1.10 47.61 72.77 coo 42.85 14.77 24.15 41.85 15.11 26.02 -10.17 39.21 73.49 -8.12 38.64 73.27 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS C 59 HIS.? 17.15 ZN ZN C 128 D 50 GLU B 107 GLU.? 12.06 ZN ZN C 128 D 113 GLN B 111 GLN.? 17.39 ZN ZN C 128 coo 38.66 11.31 27.15 38.67 12.13 25.22 11.45 52.92 44.80 10.43 52.05 43.19 coo 48.72 12.85 33.83 48.36 14.77 32.95 -0.05 48.66 43.11 -0.32 50.61 42.31 coo 42.85 14.77 24.15 41.85 15.11 26.02 12.24 47.63 44.81 13.39 47.10 46.52 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 5 3 # 5 D 29 HIS D 47 HIS^? 21.18 ZN ZN D 128 D 50 GLU D 70 GLU^? 19.86 ZN ZN D 128 D 113 GLN B 3 GLN.? 20.49 ZN ZN B 128 coo 38.66 11.31 27.15 38.67 12.13 25.22 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 48.72 12.85 33.83 48.36 14.77 32.95 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 42.85 14.77 24.15 41.85 15.11 26.02 -17.28 33.72 33.08 -17.35 31.60 33.39 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 5 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 64 ASP.? 14.79 ZN ZN A 128 231 ASP A 97 ASP^? 13.17 ZN ZN A 128 294 ASP A 57 ASP.? 17.22 ZN ZN A 128 coo 27.89 102.52 14.98 29.35 101.92 13.57 -22.76 44.44 87.32 -23.27 43.38 85.56 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 33.16 106.80 7.72 33.34 104.87 6.92 -31.66 41.62 85.16 -32.16 42.63 86.92 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 64 ASP.? 14.94 ZN ZN B 128 231 ASP B 97 ASP^? 13.03 ZN ZN B 128 294 ASP B 57 ASP.? 17.37 ZN ZN B 128 coo 27.89 102.52 14.98 29.35 101.92 13.57 -18.76 47.29 19.05 -17.56 47.54 20.78 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.57 55.26 21.18 -14.41 55.74 19.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP C 32 ASP^? -2.40 ZN ZN C 128s 231 ASP C 90 ASP.? 21.10 ZN ZN C 128 294 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 27.89 102.52 14.98 29.35 101.92 13.57 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 14.74 93.05 -1.00 14.30 94.22 0.73 2.93 33.32 67.19 5.03 33.43 67.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP C 64 ASP.? 14.22 ZN ZN C 128 231 ASP C 97 ASP^? 13.06 ZN ZN C 128 294 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 27.89 102.52 14.98 29.35 101.92 13.57 8.74 58.91 56.74 6.81 58.81 55.87 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP C 97 ASP^? 13.06 ZN ZN C 128 231 ASP C 90 ASP.? 21.10 ZN ZN C 128 294 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 14.74 93.05 -1.00 14.30 94.22 0.73 2.93 33.32 67.19 5.03 33.43 67.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP C 97 ASP^? 13.06 ZN ZN C 128 231 ASP C 91 ASP.? 22.72 ZN ZN C 128 294 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP D 32 ASP^? -2.55 ZN ZN D 128s 231 ASP D 90 ASP.? 20.62 ZN ZN D 128 294 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.32 31.61 55.53 -28.20 30.46 54.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP D 64 ASP.? 14.34 ZN ZN D 128 231 ASP D 97 ASP^? 13.24 ZN ZN D 128 294 ASP D 57 ASP.? 16.88 ZN ZN D 128 coo 27.89 102.52 14.98 29.35 101.92 13.57 -41.38 20.76 48.99 -40.62 22.36 50.18 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.07 20.84 58.32 -40.41 18.78 58.10 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP D 97 ASP^? 13.24 ZN ZN D 128 231 ASP D 90 ASP.? 20.62 ZN ZN D 128 294 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 27.89 102.52 14.98 29.35 101.92 13.57 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP D 97 ASP^? 13.24 ZN ZN D 128 231 ASP D 91 ASP.? 22.90 ZN ZN D 128 294 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 27.89 102.52 14.98 29.35 101.92 13.57 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.32 31.61 55.53 -28.20 30.46 54.16 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 10 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 57 ASP.? 17.22 ZN ZN A 128 38 SER A 60 SER.? 16.46 ZN ZN A 128 218 ASP A 64 ASP.? 14.79 ZN ZN A 128 coo 41.14 58.72 105.19 42.39 59.85 103.92 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 46.04 57.35 103.96 44.97 58.52 105.78 -31.07 46.42 88.10 -29.75 44.46 87.48 coo 41.33 60.20 97.63 42.00 60.96 99.49 -22.76 44.44 87.32 -23.27 43.38 85.56 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP A 97 ASP^? 13.17 ZN ZN A 128 38 SER A 13 SER^? 14.04 ZN ZN A 128 218 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 41.14 58.72 105.19 42.39 59.85 103.92 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 46.04 57.35 103.96 44.97 58.52 105.78 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 41.33 60.20 97.63 42.00 60.96 99.49 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP B 97 ASP^? 13.03 ZN ZN B 128 38 SER B 13 SER^? 13.94 ZN ZN B 128 218 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 41.14 58.72 105.19 42.39 59.85 103.92 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 46.04 57.35 103.96 44.97 58.52 105.78 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 41.33 60.20 97.63 42.00 60.96 99.49 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP C 57 ASP.? 16.82 ZN ZN C 128 38 SER C 60 SER.? 15.14 ZN ZN C 128 218 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo 41.14 58.72 105.19 42.39 59.85 103.92 8.18 57.58 47.56 10.27 57.39 47.78 coo 46.04 57.35 103.96 44.97 58.52 105.78 12.55 55.11 50.39 10.44 55.82 51.40 coo 41.33 60.20 97.63 42.00 60.96 99.49 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 5 3 # 5 35 ASP C 97 ASP^? 13.06 ZN ZN C 128 38 SER C 13 SER^? 14.25 ZN ZN C 128 218 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 41.14 58.72 105.19 42.39 59.85 103.92 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 46.04 57.35 103.96 44.97 58.52 105.78 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 41.33 60.20 97.63 42.00 60.96 99.49 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 6 3 # 6 35 ASP D 57 ASP.? 16.88 ZN ZN D 128 38 SER D 60 SER.? 15.90 ZN ZN D 128 218 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo 41.14 58.72 105.19 42.39 59.85 103.92 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 46.04 57.35 103.96 44.97 58.52 105.78 -38.49 16.22 55.46 -39.72 18.27 55.05 coo 41.33 60.20 97.63 42.00 60.96 99.49 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 7 3 # 7 35 ASP D 97 ASP^? 13.24 ZN ZN D 128 38 SER D 13 SER^? 14.41 ZN ZN D 128 218 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 41.14 58.72 105.19 42.39 59.85 103.92 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 46.04 57.35 103.96 44.97 58.52 105.78 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 41.33 60.20 97.63 42.00 60.96 99.49 -21.74 43.31 43.14 -23.53 43.14 44.28 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 7 hits 2apr_c04 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 59 HIS.? 17.66 ZN ZN A 128 B 163 ALA A 61 ALA.? 20.04 ZN ZN A 128 B 182 SER A 60 SER.? 16.46 ZN ZN A 128 coo 30.42 1.98 4.36 29.07 0.41 4.68 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -30.68 49.76 89.87 -30.90 49.96 91.37 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -31.07 46.42 88.10 -29.75 44.46 87.48 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 59 HIS.? 17.68 ZN ZN B 128 B 163 ALA B 61 ALA.? 20.38 ZN ZN B 128 B 182 SER B 60 SER.? 16.61 ZN ZN B 128 coo 30.42 1.98 4.36 29.07 0.41 4.68 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -21.56 56.20 16.28 -21.70 56.37 14.76 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -18.29 55.80 18.16 -16.70 54.11 18.90 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 163 ALA C 56 ALA.? 16.16 ZN ZN C 128 B 182 SER C 60 SER.? 15.14 ZN ZN C 128 coo 30.42 1.98 4.36 29.07 0.41 4.68 11.45 52.92 44.80 10.43 52.05 43.19 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 7.75 58.58 51.94 9.07 59.36 51.88 coo 24.00 -0.17 2.07 24.51 1.00 0.04 12.55 55.11 50.39 10.44 55.82 51.40 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 163 ALA C 61 ALA.? 19.20 ZN ZN C 128 B 182 SER C 60 SER.? 15.14 ZN ZN C 128 coo 30.42 1.98 4.36 29.07 0.41 4.68 11.45 52.92 44.80 10.43 52.05 43.19 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 14.70 52.81 52.57 16.23 52.88 52.61 coo 24.00 -0.17 2.07 24.51 1.00 0.04 12.55 55.11 50.39 10.44 55.82 51.40 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 163 ALA D 61 ALA.? 19.60 ZN ZN D 128 B 182 SER D 60 SER.? 15.90 ZN ZN D 128 coo 30.42 1.98 4.36 29.07 0.41 4.68 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -37.19 13.11 53.70 -37.94 11.80 53.61 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -38.49 16.22 55.46 -39.72 18.27 55.05 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 5 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG C 112 ARG.? 13.24 ZN ZN B 128 A 161 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 174 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -33.64 60.73 36.36 -31.31 59.87 38.14 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -35.98 46.77 41.76 -37.33 44.77 43.20 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG C 112 ARG.? 13.24 ZN ZN B 128 B 161 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 174 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -33.64 60.73 36.36 -31.31 59.87 38.14 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -35.98 46.77 41.76 -37.33 44.77 43.20 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG C 112 ARG.? 13.24 ZN ZN B 128 C 161 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 174 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo 2.84 19.43 40.34 1.59 20.35 37.65 -33.64 60.73 36.36 -31.31 59.87 38.14 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 5.94 13.28 27.17 3.53 13.05 28.58 -35.98 46.77 41.76 -37.33 44.77 43.20 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG C 112 ARG.? 13.24 ZN ZN B 128 D 161 ASP B 91 ASP.? 21.34 ZN ZN B 128 D 174 TYR B 93 TYR^? 18.00 ZN ZN B 128 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -33.64 60.73 36.36 -31.31 59.87 38.14 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -35.98 46.77 41.76 -37.33 44.77 43.20 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 107 GLU.? 11.70 ZN ZN D 128 C 156 GLU D 80 GLU.? 11.79 ZN ZN D 128 C 194 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 41.23 29.31 13.28 43.03 29.85 12.29 -29.77 27.41 62.12 -31.06 28.03 63.69 coo 44.75 23.09 5.51 46.77 22.91 6.12 -37.55 31.59 59.30 -36.06 33.05 59.71 coo 49.75 21.00 18.12 50.45 23.02 18.26 -28.44 21.48 51.55 -28.88 19.99 50.09 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU D 58 GLU.? 14.54 ZN ZN D 128 C 156 GLU D 80 GLU.? 11.79 ZN ZN D 128 C 194 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 41.23 29.31 13.28 43.03 29.85 12.29 -34.12 20.46 61.00 -33.75 20.62 63.08 coo 44.75 23.09 5.51 46.77 22.91 6.12 -37.55 31.59 59.30 -36.06 33.05 59.71 coo 49.75 21.00 18.12 50.45 23.02 18.26 -28.44 21.48 51.55 -28.88 19.99 50.09 2dbt_c02 source 2dbt CHITINASE C : 2 hits 2dbt_c02 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 13 SER^? 14.04 ZN ZN A 128 B 158 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 208 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo 50.29 50.10 71.46 47.85 50.06 71.46 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 48.67 45.40 71.68 47.67 46.90 70.60 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 48.91 49.12 65.17 47.29 49.14 66.54 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER B 13 SER^? 13.94 ZN ZN B 128 B 158 HIS D 10 HIS^? 15.91 ZN ZN D 128 B 208 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo 50.29 50.10 71.46 47.85 50.06 71.46 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 48.67 45.40 71.68 47.67 46.90 70.60 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 48.91 49.12 65.17 47.29 49.14 66.54 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 3 3 # 3 B 137 SER C 13 SER^? 14.25 ZN ZN C 128 B 158 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 208 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo 50.29 50.10 71.46 47.85 50.06 71.46 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 48.67 45.40 71.68 47.67 46.90 70.60 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 48.91 49.12 65.17 47.29 49.14 66.54 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 4 3 # 4 B 137 SER D 13 SER^? 14.41 ZN ZN D 128 B 158 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 208 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo 50.29 50.10 71.46 47.85 50.06 71.46 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 48.67 45.40 71.68 47.67 46.90 70.60 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 48.91 49.12 65.17 47.29 49.14 66.54 -19.89 34.86 45.47 -21.06 36.60 45.16 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 4 hits 2hdh_c02 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 35 SER A 13 SER^? 14.04 ZN ZN A 128 A 215 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 35 SER B 13 SER^? 13.94 ZN ZN B 128 A 215 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 35 SER C 60 SER.? 15.14 ZN ZN C 128 A 215 ASP C 64 ASP.? 14.22 ZN ZN C 128 coo -14.00 61.45 43.99 -14.19 63.14 42.84 8.18 57.58 47.56 10.27 57.39 47.78 coo -13.21 66.21 45.84 -15.49 65.90 45.84 12.55 55.11 50.39 10.44 55.82 51.40 coo -10.72 64.19 37.77 -12.20 64.43 39.15 8.74 58.91 56.74 6.81 58.81 55.87 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 35 SER C 13 SER^? 14.25 ZN ZN C 128 A 215 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 2jxr_c04 LIGAND CP-081282 user 5 3 # 5 A 32 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 35 SER D 60 SER.? 15.90 ZN ZN D 128 A 215 ASP D 64 ASP.? 14.34 ZN ZN D 128 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -38.49 16.22 55.46 -39.72 18.27 55.05 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -41.38 20.76 48.99 -40.62 22.36 50.18 ULMN 3 2jxr_c04 LIGAND CP-081282 user 6 3 # 6 A 32 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 35 SER D 13 SER^? 14.41 ZN ZN D 128 A 215 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -21.74 43.31 43.14 -23.53 43.14 44.28 2jxr_c04 source 2jxr LIGAND CP-081282 : 6 hits 2jxr_c04 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 13 SER^? 14.04 ZN ZN A 128 264 ASP C 97 ASP^? 13.06 ZN ZN C 128 286 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 10.47 25.91 18.67 10.67 27.13 20.84 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 2.34 22.49 22.56 3.80 23.95 22.00 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 7.10 24.11 23.40 8.18 25.09 21.87 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 2lip_c00 LIPASE user 2 3 # 2 87 SER B 13 SER^? 13.94 ZN ZN B 128 264 ASP D 97 ASP^? 13.24 ZN ZN D 128 286 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 10.47 25.91 18.67 10.67 27.13 20.84 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 2.34 22.49 22.56 3.80 23.95 22.00 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 7.10 24.11 23.40 8.18 25.09 21.87 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 2lip_c00 LIPASE user 3 3 # 3 87 SER C 13 SER^? 14.25 ZN ZN C 128 264 ASP A 97 ASP^? 13.17 ZN ZN A 128 286 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 10.47 25.91 18.67 10.67 27.13 20.84 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 2.34 22.49 22.56 3.80 23.95 22.00 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 7.10 24.11 23.40 8.18 25.09 21.87 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 2lip_c00 LIPASE user 4 3 # 4 87 SER D 13 SER^? 14.41 ZN ZN D 128 264 ASP B 97 ASP^? 13.03 ZN ZN B 128 286 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 10.47 25.91 18.67 10.67 27.13 20.84 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 2.34 22.49 22.56 3.80 23.95 22.00 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 7.10 24.11 23.40 8.18 25.09 21.87 -18.46 42.11 47.13 -20.09 43.42 47.28 2lip_c00 source 2lip LIPASE : 4 hits 2lip_c00 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 102 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 193 GLY A 72 GLY.? 17.64 ZN ZN C 128 coo 14.96 29.22 19.55 15.62 29.93 17.67 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 19.64 30.69 22.61 18.18 29.94 21.25 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 14.54 28.99 9.76 15.06 29.59 10.02 -8.59 55.12 68.83 -9.23 54.89 69.30 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 30 HIS.? -4.20 ZN ZN B 128s A 102 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 193 GLY B 54 GLY^? 9.98 ZN ZN B 128 coo 14.96 29.22 19.55 15.62 29.93 17.67 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 19.64 30.69 22.61 18.18 29.94 21.25 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 14.54 28.99 9.76 15.06 29.59 10.02 -20.73 49.16 24.95 -21.20 49.33 24.28 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 102 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 193 GLY B 72 GLY.? 17.47 ZN ZN D 128 coo 14.96 29.22 19.55 15.62 29.93 17.67 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 19.64 30.69 22.61 18.18 29.94 21.25 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 14.54 28.99 9.76 15.06 29.59 10.02 -32.83 36.73 37.76 -32.46 37.24 37.22 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 102 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 193 GLY C 72 GLY.? 17.57 ZN ZN A 128 coo 14.96 29.22 19.55 15.62 29.93 17.67 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 19.64 30.69 22.61 18.18 29.94 21.25 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 14.54 28.99 9.76 15.06 29.59 10.02 -8.50 47.01 71.89 -7.91 47.25 71.32 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 102 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 193 GLY B 108 GLY.? 9.90 ZN ZN C 128 coo 14.96 29.22 19.55 15.62 29.93 17.67 11.45 52.92 44.80 10.43 52.05 43.19 coo 19.64 30.69 22.61 18.18 29.94 21.25 8.18 57.58 47.56 10.27 57.39 47.78 coo 14.54 28.99 9.76 15.06 29.59 10.02 2.73 45.52 45.80 2.60 46.11 45.24 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 6 3 # 6 A 57 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 102 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 193 GLY D 72 GLY.? 17.67 ZN ZN B 128 coo 14.96 29.22 19.55 15.62 29.93 17.67 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 19.64 30.69 22.61 18.18 29.94 21.25 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 14.54 28.99 9.76 15.06 29.59 10.02 -25.01 34.28 34.53 -25.35 33.80 35.13 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 7 3 # 7 A 57 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 102 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 193 GLY A 108 GLY.? 9.79 ZN ZN D 128 coo 14.96 29.22 19.55 15.62 29.93 17.67 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 19.64 30.69 22.61 18.18 29.94 21.25 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 14.54 28.99 9.76 15.06 29.59 10.02 -27.38 22.98 60.43 -27.77 23.26 61.11 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 7 hits 2lpr_c02 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 151 LYS A 81 LYS.? 12.55 ZN ZN A 128 A 186 THR A 35 THR.? 8.83 ZN ZN A 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 45.75 16.58 39.61 47.43 18.26 45.54 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 45.88 23.02 44.72 46.99 21.16 44.68 -28.69 39.43 70.39 -28.36 40.10 72.45 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 151 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 186 THR A 89 THR.? 18.72 ZN ZN A 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 45.75 16.58 39.61 47.43 18.26 45.54 -25.66 62.13 69.69 -25.48 65.02 74.91 coo 45.88 23.02 44.72 46.99 21.16 44.68 -19.06 65.09 74.03 -16.96 64.91 73.52 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 151 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 186 THR A 92 THR.? 14.81 ZN ZN A 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 45.75 16.58 39.61 47.43 18.26 45.54 -25.66 62.13 69.69 -25.48 65.02 74.91 coo 45.88 23.02 44.72 46.99 21.16 44.68 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 32 ASP.? -2.88 ZN ZN B 128s A 151 LYS B 81 LYS.? 12.71 ZN ZN B 128 A 186 THR B 35 THR.? 8.83 ZN ZN B 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 45.75 16.58 39.61 47.43 18.26 45.54 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 45.88 23.02 44.72 46.99 21.16 44.68 -11.91 51.72 35.90 -12.77 51.64 33.90 ULMN 3 2phk_c02 MC-PEPTIDE user 5 3 # 5 A 149 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 151 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 186 THR B 89 THR.? 18.91 ZN ZN B 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 45.75 16.58 39.61 47.43 18.26 45.54 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 45.88 23.02 44.72 46.99 21.16 44.68 -39.38 49.52 32.40 -39.94 47.46 32.72 ULMN 3 2phk_c02 MC-PEPTIDE user 6 3 # 6 A 149 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 151 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 186 THR B 92 THR.? 15.12 ZN ZN B 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 45.75 16.58 39.61 47.43 18.26 45.54 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 45.88 23.02 44.72 46.99 21.16 44.68 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 2phk_c02 MC-PEPTIDE user 7 3 # 7 A 149 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 151 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 186 THR C 89 THR.? 19.23 ZN ZN C 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 2.93 33.32 67.19 5.03 33.43 67.23 coo 45.75 16.58 39.61 47.43 18.26 45.54 0.64 35.92 60.53 5.63 36.47 64.53 coo 45.88 23.02 44.72 46.99 21.16 44.68 3.40 37.97 68.34 2.23 38.61 70.05 ULMN 3 2phk_c02 MC-PEPTIDE user 8 3 # 8 A 149 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 151 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 186 THR C 92 THR.? 15.22 ZN ZN C 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 2.93 33.32 67.19 5.03 33.43 67.23 coo 45.75 16.58 39.61 47.43 18.26 45.54 0.64 35.92 60.53 5.63 36.47 64.53 coo 45.88 23.02 44.72 46.99 21.16 44.68 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 2phk_c02 MC-PEPTIDE user 9 3 # 9 A 149 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 151 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 186 THR D 89 THR.? 18.97 ZN ZN D 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 45.75 16.58 39.61 47.43 18.26 45.54 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 45.88 23.02 44.72 46.99 21.16 44.68 -19.13 20.42 38.63 -19.24 21.85 36.98 ULMN 3 2phk_c02 MC-PEPTIDE user 10 3 # 10 A 149 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 151 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 186 THR D 92 THR.? 15.38 ZN ZN D 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 45.75 16.58 39.61 47.43 18.26 45.54 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 45.88 23.02 44.72 46.99 21.16 44.68 -18.23 25.46 39.42 -20.30 24.86 39.60 2phk_c02 source 2phk MC-PEPTIDE : 10 hits 2phk_c02 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 151 LYS A 19 LYS.? 16.70 ZN ZN A 128 A 154 ASN A 18 ASN.? 16.39 ZN ZN A 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 45.75 16.58 39.61 47.43 18.26 45.54 -25.66 62.13 69.69 -25.48 65.02 74.91 coo 44.77 13.10 43.25 45.01 14.21 45.03 -22.68 62.48 66.52 -24.06 63.34 65.13 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 151 LYS B 19 LYS.? 16.80 ZN ZN B 128 A 154 ASN B 18 ASN.? 16.24 ZN ZN B 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 45.75 16.58 39.61 47.43 18.26 45.54 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 44.77 13.10 43.25 45.01 14.21 45.03 -35.92 52.23 39.87 -36.26 53.93 41.12 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 151 LYS C 19 LYS.? 17.60 ZN ZN C 128 A 154 ASN C 18 ASN.? 16.75 ZN ZN C 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 2.93 33.32 67.19 5.03 33.43 67.23 coo 45.75 16.58 39.61 47.43 18.26 45.54 0.64 35.92 60.53 5.63 36.47 64.53 coo 44.77 13.10 43.25 45.01 14.21 45.03 -2.99 35.22 62.77 -3.32 33.34 61.83 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 151 LYS D 19 LYS.? 15.46 ZN ZN D 128 A 154 ASN D 18 ASN.? 16.75 ZN ZN D 128 coo 41.42 17.90 44.98 43.39 18.36 45.61 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 45.75 16.58 39.61 47.43 18.26 45.54 -16.96 22.44 46.27 -19.09 18.04 45.40 coo 44.77 13.10 43.25 45.01 14.21 45.03 -15.23 25.74 43.96 -13.30 25.49 44.87 2phk_c03 source 2phk MC-PEPTIDE : 4 hits 2phk_c03 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 84 ASN^? 8.90 ZN ZN A 128 20 HIS A 30 HIS.? -4.18 ZN ZN A 128s 93 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 -27.80 52.43 77.67 -27.36 52.78 79.72 coo 47.05 39.55 45.24 48.99 39.30 44.46 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 46.96 34.22 47.29 47.91 35.95 46.52 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN A 84 ASN^? 8.90 ZN ZN A 128 20 HIS A 83 HIS^? -3.82 ZN ZN A 128s 93 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 -27.80 52.43 77.67 -27.36 52.78 79.72 coo 47.05 39.55 45.24 48.99 39.30 44.46 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 46.96 34.22 47.29 47.91 35.95 46.52 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN B 84 ASN^? 9.22 ZN ZN B 128 20 HIS B 30 HIS.? -4.20 ZN ZN B 128s 93 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 -24.87 54.45 28.53 -25.79 53.87 26.69 coo 47.05 39.55 45.24 48.99 39.30 44.46 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 46.96 34.22 47.29 47.91 35.95 46.52 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 4 3 # 4 10 ASN B 84 ASN^? 9.22 ZN ZN B 128 20 HIS B 83 HIS^? -3.82 ZN ZN B 128s 93 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 -24.87 54.45 28.53 -25.79 53.87 26.69 coo 47.05 39.55 45.24 48.99 39.30 44.46 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 46.96 34.22 47.29 47.91 35.95 46.52 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 5 3 # 5 10 ASN C 84 ASN^? 8.97 ZN ZN C 128 20 HIS C 30 HIS^? -3.56 ZN ZN C 128s 93 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 4.63 46.66 55.03 6.28 47.10 56.31 coo 47.05 39.55 45.24 48.99 39.30 44.46 0.61 46.90 50.78 -0.23 46.71 52.70 coo 46.96 34.22 47.29 47.91 35.95 46.52 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 6 3 # 6 10 ASN C 84 ASN^? 8.97 ZN ZN C 128 20 HIS C 83 HIS^? -3.45 ZN ZN C 128s 93 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 4.63 46.66 55.03 6.28 47.10 56.31 coo 47.05 39.55 45.24 48.99 39.30 44.46 0.88 50.97 54.56 -1.00 50.36 53.86 coo 46.96 34.22 47.29 47.91 35.95 46.52 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 7 3 # 7 10 ASN D 84 ASN^? 8.98 ZN ZN D 128 20 HIS D 30 HIS^? -3.68 ZN ZN D 128s 93 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 -28.44 21.48 51.55 -28.88 19.99 50.09 coo 47.05 39.55 45.24 48.99 39.30 44.46 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 46.96 34.22 47.29 47.91 35.95 46.52 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 8 3 # 8 10 ASN D 84 ASN^? 8.98 ZN ZN D 128 20 HIS D 83 HIS^? -3.55 ZN ZN D 128s 93 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 45.21 45.27 48.24 46.79 44.92 46.88 -28.44 21.48 51.55 -28.88 19.99 50.09 coo 47.05 39.55 45.24 48.99 39.30 44.46 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 46.96 34.22 47.29 47.91 35.95 46.52 -29.32 31.61 55.53 -28.20 30.46 54.16 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 8 hits 2pth_c00 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 97 ASP^? 13.17 ZN ZN A 128 166 GLY C 34 GLY.? 11.55 ZN ZN C 128 169 GLU C 80 GLU.? 11.53 ZN ZN C 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.25 50.55 45.92 -9.76 50.87 45.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -4.16 58.03 47.91 -5.06 56.59 46.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP B 57 ASP.? 17.37 ZN ZN B 128 166 GLY B 25 GLY~? 8.72 ZN ZN B 128 169 GLU C 103 GLU.? 13.37 ZN ZN B 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -24.85 59.69 34.87 -25.34 59.12 35.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.07 59.92 44.69 -19.74 61.53 43.36 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 90 ASP.? 20.48 ZN ZN B 128 166 GLY B 25 GLY~? 8.72 ZN ZN B 128 169 GLU C 103 GLU.? 13.37 ZN ZN B 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -24.85 59.69 34.87 -25.34 59.12 35.01 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.07 59.92 44.69 -19.74 61.53 43.36 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 97 ASP^? 13.03 ZN ZN B 128 166 GLY B 54 GLY^? 9.98 ZN ZN B 128 169 GLU B 58 GLU.? 14.99 ZN ZN B 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -20.73 49.16 24.95 -21.20 49.33 24.28 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -16.19 59.88 24.88 -15.11 61.60 25.47 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 97 ASP^? 13.03 ZN ZN B 128 166 GLY D 34 GLY.? 11.12 ZN ZN D 128 169 GLU A 107 GLU.? 11.70 ZN ZN D 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.08 36.39 60.37 -28.54 35.99 60.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -29.77 27.41 62.12 -31.06 28.03 63.69 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 97 ASP^? 13.03 ZN ZN B 128 166 GLY D 34 GLY.? 11.12 ZN ZN D 128 169 GLU D 80 GLU.? 11.79 ZN ZN D 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.08 36.39 60.37 -28.54 35.99 60.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -37.55 31.59 59.30 -36.06 33.05 59.71 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP C 32 ASP^? -2.40 ZN ZN C 128s 166 GLY A 72 GLY.? 17.64 ZN ZN C 128 169 GLU A 70 GLU^? 19.90 ZN ZN A 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -8.59 55.12 68.83 -9.23 54.89 69.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -10.78 57.16 76.11 -9.51 58.48 77.12 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP C 64 ASP.? 14.22 ZN ZN C 128 166 GLY B 108 GLY.? 9.90 ZN ZN C 128 169 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 8.74 58.91 56.74 6.81 58.81 55.87 coo -8.58 13.22 3.21 -8.90 13.15 4.05 2.73 45.52 45.80 2.60 46.11 45.24 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP C 90 ASP.? 21.10 ZN ZN C 128 166 GLY C 25 GLY~? 8.98 ZN ZN C 128 169 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.93 33.32 67.19 5.03 33.43 67.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 1.59 40.69 50.63 1.30 40.60 51.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -2.48 40.28 42.03 -4.43 39.67 41.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP C 97 ASP^? 13.06 ZN ZN C 128 166 GLY A 38 GLY.? 15.25 ZN ZN A 128 169 GLU A 80 GLU.? 14.45 ZN ZN A 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.49 34.05 68.94 -22.88 34.72 69.19 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.62 36.67 74.75 -28.01 34.63 75.18 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 97 ASP^? 13.06 ZN ZN C 128 166 GLY A 38 GLY.? 15.25 ZN ZN A 128 169 GLU A 103 GLU~? 15.51 ZN ZN D 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.49 34.05 68.94 -22.88 34.72 69.19 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.80 26.87 64.77 -19.76 28.50 65.63 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 97 ASP^? 13.06 ZN ZN C 128 166 GLY D 34 GLY.? 11.12 ZN ZN D 128 169 GLU A 107 GLU.? 11.70 ZN ZN D 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.08 36.39 60.37 -28.54 35.99 60.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -29.77 27.41 62.12 -31.06 28.03 63.69 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP D 32 ASP^? -2.55 ZN ZN D 128s 166 GLY B 72 GLY.? 17.47 ZN ZN D 128 169 GLU B 70 GLU^? 18.94 ZN ZN B 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -32.83 36.73 37.76 -32.46 37.24 37.22 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.57 38.82 30.28 -36.03 40.31 29.90 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP D 64 ASP.? 14.34 ZN ZN D 128 166 GLY A 108 GLY.? 9.79 ZN ZN D 128 169 GLU A 103 GLU~? 15.51 ZN ZN D 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -41.38 20.76 48.99 -40.62 22.36 50.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -27.38 22.98 60.43 -27.77 23.26 61.11 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.80 26.87 64.77 -19.76 28.50 65.63 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP D 90 ASP.? 20.62 ZN ZN D 128 166 GLY D 25 GLY~? 8.97 ZN ZN D 128 169 GLU A 103 GLU~? 15.51 ZN ZN D 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.04 22.93 56.13 -21.85 23.17 55.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.80 26.87 64.77 -19.76 28.50 65.63 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP D 97 ASP^? 13.24 ZN ZN D 128 166 GLY B 38 GLY.? 15.25 ZN ZN B 128 169 GLU B 80 GLU.? 14.47 ZN ZN B 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -8.63 44.13 37.54 -9.13 44.63 37.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.61 50.34 31.62 -7.67 49.64 31.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP D 97 ASP^? 13.24 ZN ZN D 128 166 GLY B 38 GLY.? 15.25 ZN ZN B 128 169 GLU B 103 GLU~? 15.19 ZN ZN C 128 coo 8.28 6.87 1.62 10.08 5.77 1.34 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -8.63 44.13 37.54 -9.13 44.63 37.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -2.48 40.28 42.03 -4.43 39.67 41.46 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 17 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 52 TYR^? 7.20 ZN ZN A 128 A 172 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 267 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR A 55 TYR^? 11.76 ZN ZN A 128 A 172 HIS A 83 HIS^? -3.82 ZN ZN A 128s A 267 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 52 TYR^? 7.51 ZN ZN B 128 A 172 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 267 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR B 55 TYR.? 11.96 ZN ZN B 128 A 172 HIS B 83 HIS^? -3.82 ZN ZN B 128s A 267 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 A 169 TYR C 52 TYR^? 7.59 ZN ZN C 128 A 172 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 267 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 1.13 52.00 59.76 1.13 53.77 57.61 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 0.88 50.97 54.56 -1.00 50.36 53.86 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 A 169 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 172 HIS C 83 HIS^? -3.45 ZN ZN C 128s A 267 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 8.07 52.98 53.71 8.63 50.62 55.11 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 0.88 50.97 54.56 -1.00 50.36 53.86 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 7 3 # 7 A 169 TYR D 52 TYR^? 7.54 ZN ZN D 128 A 172 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 267 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 8 3 # 8 A 169 TYR D 55 TYR.? 11.30 ZN ZN D 128 A 172 HIS D 83 HIS^? -3.55 ZN ZN D 128s A 267 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 26.78 20.44 0.03 28.51 18.26 0.09 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -29.32 31.61 55.53 -28.20 30.46 54.16 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 8 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 52 TYR^? 7.20 ZN ZN A 128 B 172 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 267 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR A 55 TYR^? 11.76 ZN ZN A 128 B 172 HIS A 83 HIS^? -3.82 ZN ZN A 128s B 267 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 -27.79 47.98 83.72 -27.46 50.77 83.49 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR B 52 TYR^? 7.51 ZN ZN B 128 B 172 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 267 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR B 55 TYR.? 11.96 ZN ZN B 128 B 172 HIS B 83 HIS^? -3.82 ZN ZN B 128s B 267 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 -20.53 53.10 22.67 -23.31 53.51 22.82 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 5 3 # 5 B 169 TYR C 52 TYR^? 7.59 ZN ZN C 128 B 172 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 267 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 1.13 52.00 59.76 1.13 53.77 57.61 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 0.88 50.97 54.56 -1.00 50.36 53.86 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 6 3 # 6 B 169 TYR C 55 TYR.? 11.30 ZN ZN C 128 B 172 HIS C 83 HIS^? -3.45 ZN ZN C 128s B 267 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 8.07 52.98 53.71 8.63 50.62 55.11 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 0.88 50.97 54.56 -1.00 50.36 53.86 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 7 3 # 7 B 169 TYR D 52 TYR^? 7.54 ZN ZN D 128 B 172 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 267 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -29.32 31.61 55.53 -28.20 30.46 54.16 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 8 3 # 8 B 169 TYR D 55 TYR.? 11.30 ZN ZN D 128 B 172 HIS D 83 HIS^? -3.55 ZN ZN D 128s B 267 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 44.86 1.98 33.27 42.75 1.12 31.67 -35.27 19.83 52.49 -33.13 18.64 51.13 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -29.32 31.61 55.53 -28.20 30.46 54.16 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 8 hits 2tmd_c01 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR C 40 TYR^? 12.78 ZN ZN C 128 A 214 ASP C 32 ASP^? -2.40 ZN ZN C 128s A 256 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -9.42 57.42 55.22 -8.85 60.18 55.10 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR D 40 TYR^? 12.58 ZN ZN D 128 A 214 ASP D 32 ASP^? -2.55 ZN ZN D 128s A 256 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -34.73 38.00 51.16 -37.53 38.10 51.02 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -28.66 23.49 42.59 -29.87 18.31 40.35 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR C 40 TYR^? 12.78 ZN ZN C 128 B 214 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 256 LYS C 51 LYS^? 16.36 ZN ZN C 128 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -9.42 57.42 55.22 -8.85 60.18 55.10 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -16.04 12.06 11.09 -17.97 10.54 5.71 2.93 47.75 63.91 7.07 48.43 67.33 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR D 40 TYR^? 12.58 ZN ZN D 128 B 214 ASP D 32 ASP^? -2.55 ZN ZN D 128s B 256 LYS D 51 LYS^? 16.00 ZN ZN D 128 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -34.73 38.00 51.16 -37.53 38.10 51.02 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -28.66 23.49 42.59 -29.87 18.31 40.35 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 130 SER B 13 SER^? 13.94 ZN ZN B 128 A 159 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 18.35 45.84 20.99 16.20 47.83 21.89 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 15.14 43.67 10.77 15.61 44.43 13.04 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 11.57 48.49 22.18 13.51 49.99 17.21 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG D 36 ARG.? 10.17 ZN ZN A 128 A 130 SER A 13 SER^? 14.04 ZN ZN A 128 A 159 LYS A 33 LYS.? 11.45 ZN ZN A 128 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.18 43.37 61.68 -31.14 45.24 63.88 coo 15.14 43.67 10.77 15.61 44.43 13.04 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 11.57 48.49 22.18 13.51 49.99 17.21 -32.13 43.51 68.59 -35.31 47.47 65.43 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG C 36 ARG.? 10.67 ZN ZN B 128 B 130 SER B 13 SER^? 13.94 ZN ZN B 128 B 159 LYS B 33 LYS.? 11.38 ZN ZN B 128 coo 58.72 31.58 20.45 60.80 29.39 20.94 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 61.66 35.17 10.39 61.29 34.14 12.56 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 65.38 28.77 21.17 63.49 28.03 16.12 -14.69 55.97 38.01 -16.66 60.81 39.16 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG D 36 ARG.? 10.17 ZN ZN A 128 B 130 SER A 13 SER^? 14.04 ZN ZN A 128 B 159 LYS A 33 LYS.? 11.45 ZN ZN A 128 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.18 43.37 61.68 -31.14 45.24 63.88 coo 61.66 35.17 10.39 61.29 34.14 12.56 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 65.38 28.77 21.17 63.49 28.03 16.12 -32.13 43.51 68.59 -35.31 47.47 65.43 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c01 naa= 3 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 1 3 # 1 183 LYS A 81 LYS.? 12.55 ZN ZN A 128 220 HIS A 83 HIS^? -3.82 ZN ZN A 128s 255 ASP A 32 ASP.? -2.97 ZN ZN A 128s coo 11.94 40.77 50.56 7.67 36.15 49.76 -27.08 41.78 78.19 -22.69 42.64 82.54 coo 10.50 40.09 46.76 10.54 37.99 46.56 -26.02 47.31 76.45 -26.60 46.79 74.50 coo 4.47 38.05 47.65 5.63 36.87 46.50 -28.11 44.25 70.85 -26.82 45.93 70.94 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 2 3 # 2 183 LYS B 81 LYS.? 12.71 ZN ZN B 128 220 HIS B 83 HIS^? -3.82 ZN ZN B 128s 255 ASP B 32 ASP.? -2.88 ZN ZN B 128s coo 11.94 40.77 50.56 7.67 36.15 49.76 -14.88 50.71 28.23 -16.26 47.48 23.80 coo 10.50 40.09 46.76 10.54 37.99 46.56 -20.39 51.16 30.13 -19.69 51.56 32.06 coo 4.47 38.05 47.65 5.63 36.87 46.50 -16.91 52.67 35.82 -18.80 51.89 35.31 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 3 3 # 3 183 LYS C 81 LYS.? 11.89 ZN ZN C 128 220 HIS C 83 HIS^? -3.45 ZN ZN C 128s 255 ASP C 32 ASP^? -2.40 ZN ZN C 128s coo 11.94 40.77 50.56 7.67 36.15 49.76 0.65 56.08 51.29 4.22 57.96 54.91 coo 10.50 40.09 46.76 10.54 37.99 46.56 0.88 50.97 54.56 -1.00 50.36 53.86 coo 4.47 38.05 47.65 5.63 36.87 46.50 -4.92 50.07 51.06 -4.02 48.65 52.36 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 4 3 # 4 183 LYS D 81 LYS.? 12.28 ZN ZN D 128 220 HIS D 83 HIS^? -3.55 ZN ZN D 128s 255 ASP D 32 ASP^? -2.55 ZN ZN D 128s coo 11.94 40.77 50.56 7.67 36.15 49.76 -36.76 27.60 54.86 -39.44 24.48 51.40 coo 10.50 40.09 46.76 10.54 37.99 46.56 -31.62 26.29 51.88 -30.63 27.88 52.82 coo 4.47 38.05 47.65 5.63 36.87 46.50 -29.32 31.61 55.53 -28.20 30.46 54.16 2xis_c00 source 2xis XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH XY: 4 hits 2xis_c00 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 42 ARG^? 15.09 ZN ZN A 128 195 HIS A 10 HIS^? 15.73 ZN ZN A 128 199 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 21.96 2.03 15.24 19.33 1.86 13.55 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 42 ARG^? 15.17 ZN ZN B 128 195 HIS B 10 HIS^? 15.59 ZN ZN B 128 199 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 21.96 2.03 15.24 19.33 1.86 13.55 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 3 3 # 3 18 ARG C 29 ARG.? 13.36 ZN ZN C 128 195 HIS C 59 HIS.? 17.15 ZN ZN C 128 199 ASP C 57 ASP.? 16.82 ZN ZN C 128 coo 21.96 2.03 15.24 19.33 1.86 13.55 7.46 50.67 50.27 10.29 51.53 51.14 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 11.45 52.92 44.80 10.43 52.05 43.19 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 8.18 57.58 47.56 10.27 57.39 47.78 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 4 3 # 4 18 ARG C 42 ARG^? 15.11 ZN ZN C 128 195 HIS C 10 HIS^? 15.40 ZN ZN C 128 199 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo 21.96 2.03 15.24 19.33 1.86 13.55 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 5 3 # 5 18 ARG D 42 ARG^? 14.89 ZN ZN D 128 195 HIS D 10 HIS^? 15.91 ZN ZN D 128 199 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 21.96 2.03 15.24 19.33 1.86 13.55 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -25.08 39.18 47.70 -23.31 39.57 46.61 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 5 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 161 ARG A 42 ARG^? 15.09 ZN ZN A 128 A 186 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 18.62 26.83 58.17 18.48 28.64 57.08 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 23.76 27.69 57.88 24.05 29.81 55.69 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 16.67 31.22 54.64 18.74 31.15 54.14 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 161 ARG B 42 ARG^? 15.17 ZN ZN B 128 A 186 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 18.62 26.83 58.17 18.48 28.64 57.08 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 23.76 27.69 57.88 24.05 29.81 55.69 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 16.67 31.22 54.64 18.74 31.15 54.14 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 A 158 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 161 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 186 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 18.62 26.83 58.17 18.48 28.64 57.08 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 23.76 27.69 57.88 24.05 29.81 55.69 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 16.67 31.22 54.64 18.74 31.15 54.14 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 A 158 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 161 ARG D 42 ARG^? 14.89 ZN ZN D 128 A 186 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 18.62 26.83 58.17 18.48 28.64 57.08 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 23.76 27.69 57.88 24.05 29.81 55.69 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 16.67 31.22 54.64 18.74 31.15 54.14 -24.77 44.27 50.01 -22.89 43.34 50.12 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 4 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 161 ARG A 42 ARG^? 15.09 ZN ZN A 128 B 186 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 44.53 16.44 28.54 44.89 18.45 28.77 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 39.64 19.27 28.15 40.19 21.74 29.94 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 48.32 20.00 31.44 46.45 20.91 31.50 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP B 57 ASP.? 17.37 ZN ZN B 128 B 161 ARG B 29 ARG.? 13.89 ZN ZN B 128 B 186 HIS B 59 HIS.? 17.68 ZN ZN B 128 coo 44.53 16.44 28.54 44.89 18.45 28.77 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 39.64 19.27 28.15 40.19 21.74 29.94 -20.37 56.56 24.53 -21.49 56.80 21.70 coo 48.32 20.00 31.44 46.45 20.91 31.50 -16.45 61.27 20.51 -16.17 62.71 22.01 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 B 158 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 161 ARG B 42 ARG^? 15.17 ZN ZN B 128 B 186 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 44.53 16.44 28.54 44.89 18.45 28.77 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 39.64 19.27 28.15 40.19 21.74 29.94 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 48.32 20.00 31.44 46.45 20.91 31.50 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 B 158 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 161 ARG C 42 ARG^? 15.11 ZN ZN C 128 B 186 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 44.53 16.44 28.54 44.89 18.45 28.77 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 39.64 19.27 28.15 40.19 21.74 29.94 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 48.32 20.00 31.44 46.45 20.91 31.50 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 B 158 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 161 ARG D 42 ARG^? 14.89 ZN ZN D 128 B 186 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 44.53 16.44 28.54 44.89 18.45 28.77 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 39.64 19.27 28.15 40.19 21.74 29.94 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 48.32 20.00 31.44 46.45 20.91 31.50 -24.77 44.27 50.01 -22.89 43.34 50.12 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 5 hits 4mdh_c03 naa= 3 ULMN 3 5cox_c04 CYCLOOXYGENASE-2 user 1 3 # 1 A 203 GLN B 111 GLN.? 17.39 ZN ZN C 128 A 207 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 385 TYR C 55 TYR.? 11.30 ZN ZN C 128 coo 23.69 37.92 6.66 22.22 39.29 5.97 12.24 47.63 44.81 13.39 47.10 46.52 coo 27.49 36.78 4.86 25.87 35.83 3.93 11.45 52.92 44.80 10.43 52.05 43.19 coo 25.45 28.28 7.33 26.01 28.57 10.04 8.07 52.98 53.71 8.63 50.62 55.11 5cox_c04 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c04 naa= 3 ULMN 3 5cox_c05 CYCLOOXYGENASE-2 user 1 3 # 1 B 203 GLN B 111 GLN.? 17.39 ZN ZN C 128 B 207 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 385 TYR C 55 TYR.? 11.30 ZN ZN C 128 coo 71.73 24.29 -6.07 73.27 24.95 -7.36 12.24 47.63 44.81 13.39 47.10 46.52 coo 67.92 26.15 -5.01 69.53 27.05 -4.02 11.45 52.92 44.80 10.43 52.05 43.19 coo 69.83 23.77 3.61 69.22 21.05 3.32 8.07 52.98 53.71 8.63 50.62 55.11 5cox_c05 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c05 naa= 3 ULMN 3 5cox_c06 CYCLOOXYGENASE-2 user 1 3 # 1 C 203 GLN B 111 GLN.? 17.39 ZN ZN C 128 C 207 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 385 TYR C 55 TYR.? 11.30 ZN ZN C 128 coo 60.00 28.49 66.40 61.43 27.08 65.71 12.24 47.63 44.81 13.39 47.10 46.52 coo 56.23 29.81 64.65 57.85 30.66 63.63 11.45 52.92 44.80 10.43 52.05 43.19 coo 58.74 38.31 66.76 58.24 38.12 69.50 8.07 52.98 53.71 8.63 50.62 55.11 5cox_c06 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c06 naa= 3 ULMN 3 5cox_c07 CYCLOOXYGENASE-2 user 1 3 # 1 D 203 GLN B 111 GLN.? 17.39 ZN ZN C 128 D 207 HIS C 59 HIS.? 17.15 ZN ZN C 128 D 385 TYR C 55 TYR.? 11.30 ZN ZN C 128 coo 12.27 43.90 54.45 10.71 43.30 53.17 12.24 47.63 44.81 13.39 47.10 46.52 coo 16.03 41.92 55.47 14.38 41.13 56.50 11.45 52.92 44.80 10.43 52.05 43.19 coo 14.46 44.71 64.03 15.12 47.37 63.64 8.07 52.98 53.71 8.63 50.62 55.11 5cox_c07 source 5cox CYCLOOXYGENASE-2 : 1 hits 5cox_c07 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 65 GLN^? 12.20 ZN ZN A 128 94 HIS A 30 HIS.? -4.18 ZN ZN A 128s 96 HIS A 83 HIS^? -3.82 ZN ZN A 128s coo 12.06 13.83 19.61 9.96 13.82 20.00 -19.19 45.56 81.92 -19.17 43.71 80.84 coo 15.69 26.32 19.80 17.39 27.17 20.68 -30.72 49.15 73.99 -28.78 49.60 73.32 coo 14.38 20.59 22.16 12.49 20.21 21.35 -26.02 47.31 76.45 -26.60 46.79 74.50 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN B 65 GLN^? 12.25 ZN ZN B 128 94 HIS B 30 HIS.? -4.20 ZN ZN B 128s 96 HIS B 83 HIS^? -3.82 ZN ZN B 128s coo 12.06 13.83 19.61 9.96 13.82 20.00 -20.80 44.27 24.57 -18.98 43.74 25.56 coo 15.69 26.32 19.80 17.39 27.17 20.68 -20.72 56.25 32.46 -21.75 54.52 33.04 coo 14.38 20.59 22.16 12.49 20.21 21.35 -20.39 51.16 30.13 -19.69 51.56 32.06 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 3 3 # 3 83 GLN C 65 GLN^? 12.41 ZN ZN C 128 94 HIS C 30 HIS^? -3.56 ZN ZN C 128s 96 HIS C 83 HIS^? -3.45 ZN ZN C 128s coo 12.06 13.83 19.61 9.96 13.82 20.00 3.55 57.31 60.55 1.79 58.23 59.75 coo 15.69 26.32 19.80 17.39 27.17 20.68 0.61 46.90 50.78 -0.23 46.71 52.70 coo 14.38 20.59 22.16 12.49 20.21 21.35 0.88 50.97 54.56 -1.00 50.36 53.86 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 4 3 # 4 83 GLN D 65 GLN^? 12.29 ZN ZN D 128 94 HIS D 30 HIS^? -3.68 ZN ZN D 128s 96 HIS D 83 HIS^? -3.55 ZN ZN D 128s coo 12.06 13.83 19.61 9.96 13.82 20.00 -38.29 25.29 45.56 -38.57 27.22 46.45 coo 15.69 26.32 19.80 17.39 27.17 20.68 -27.59 25.34 55.74 -27.28 26.44 53.99 coo 14.38 20.59 22.16 12.49 20.21 21.35 -31.62 26.29 51.88 -30.63 27.88 52.82 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 4 hits 5fit_c00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 7 ASN.? 18.20 ZN ZN D 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.63 30.96 63.21 -14.85 30.65 64.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 18 ASN.? 16.39 ZN ZN A 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -22.68 62.48 66.52 -24.06 63.34 65.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 84 ASN^? 8.90 ZN ZN A 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -27.80 52.43 77.67 -27.36 52.78 79.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 7 ASN.? 18.27 ZN ZN C 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.30 34.59 43.15 -7.56 35.74 41.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 18 ASN.? 16.24 ZN ZN B 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -35.92 52.23 39.87 -36.26 53.93 41.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 84 ASN^? 9.22 ZN ZN B 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.87 54.45 28.53 -25.79 53.87 26.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN C 7 ASN.? 21.77 ZN ZN C 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.63 62.63 55.75 -17.91 63.23 54.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN C 18 ASN.? 16.75 ZN ZN C 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.99 35.22 62.77 -3.32 33.34 61.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN C 84 ASN^? 8.97 ZN ZN C 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 4.63 46.66 55.03 6.28 47.10 56.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN D 7 ASN.? 21.83 ZN ZN D 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.13 49.32 50.54 -38.26 47.82 51.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN D 18 ASN.? 16.75 ZN ZN D 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.23 25.74 43.96 -13.30 25.49 44.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN D 84 ASN^? 8.98 ZN ZN D 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -28.44 21.48 51.55 -28.88 19.99 50.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.89 34.86 45.47 -21.06 36.60 45.16 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 16 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 93 TYR^? 17.82 ZN ZN A 128 A 112 PHE A 94 PHE^? 9.23 ZN ZN A 128 A 140 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -17.49 60.90 64.70 -15.26 61.56 63.14 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -20.26 55.80 68.38 -22.98 56.19 68.94 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 93 TYR^? 18.00 ZN ZN B 128 A 112 PHE B 94 PHE^? 9.33 ZN ZN B 128 A 140 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -35.98 46.77 41.76 -37.33 44.77 43.20 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -30.29 47.77 38.05 -29.70 50.41 37.36 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -28.02 46.30 43.15 -27.06 44.43 43.46 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR D 93 TYR^? 18.01 ZN ZN D 128 A 112 PHE D 94 PHE^? 9.41 ZN ZN D 128 A 140 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -16.06 30.04 40.46 -15.16 31.88 38.54 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -21.52 29.39 44.56 -21.12 27.85 46.87 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -19.89 34.86 45.47 -21.06 36.60 45.16 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 3 hits 1o8s_p00 naa= 3 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 7 ASN.? 18.20 ZN ZN D 128 A 213 PRO A 102 PRO~? 13.15 ZN ZN D 128 A 219 ASN C 95 ASN^? 12.77 ZN ZN C 128 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -13.63 30.96 63.21 -14.85 30.65 64.93 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -17.98 30.69 61.60 -20.13 30.89 62.19 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -10.59 42.26 61.06 -11.87 43.93 61.32 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN B 7 ASN.? 18.27 ZN ZN C 128 A 213 PRO B 102 PRO~? 13.12 ZN ZN C 128 A 219 ASN D 18 ASN.? 16.75 ZN ZN D 128 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -8.30 34.59 43.15 -7.56 35.74 41.51 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -7.02 38.85 44.98 -6.60 40.97 44.39 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -15.23 25.74 43.96 -13.30 25.49 44.87 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 3 3 # 3 A 44 ASN B 7 ASN.? 18.27 ZN ZN C 128 A 213 PRO B 102 PRO~? 13.12 ZN ZN C 128 A 219 ASN D 95 ASN^? 12.80 ZN ZN D 128 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -8.30 34.59 43.15 -7.56 35.74 41.51 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -7.02 38.85 44.98 -6.60 40.97 44.39 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -19.89 34.86 45.47 -21.06 36.60 45.16 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 4 3 # 4 A 44 ASN C 7 ASN.? 21.77 ZN ZN C 128 A 213 PRO C 102 PRO.? 18.82 ZN ZN B 128 A 219 ASN A 18 ASN.? 16.39 ZN ZN A 128 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -19.63 62.63 55.75 -17.91 63.23 54.63 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -19.80 61.50 51.61 -19.09 59.88 50.25 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -22.68 62.48 66.52 -24.06 63.34 65.13 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 5 3 # 5 A 44 ASN C 7 ASN.? 21.77 ZN ZN C 128 A 213 PRO C 102 PRO.? 18.82 ZN ZN B 128 A 219 ASN A 95 ASN^? 12.70 ZN ZN A 128 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -19.63 62.63 55.75 -17.91 63.23 54.63 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -19.80 61.50 51.61 -19.09 59.88 50.25 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -19.15 53.27 63.15 -17.72 51.74 62.89 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 6 3 # 6 A 44 ASN D 7 ASN.? 21.83 ZN ZN D 128 A 213 PRO D 102 PRO.? 19.10 ZN ZN A 128 A 219 ASN B 18 ASN.? 16.24 ZN ZN B 128 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -37.13 49.32 50.54 -38.26 47.82 51.54 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -36.45 49.00 55.10 -34.55 48.04 55.74 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -35.92 52.23 39.87 -36.26 53.93 41.12 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 7 3 # 7 A 44 ASN D 7 ASN.? 21.83 ZN ZN D 128 A 213 PRO D 102 PRO.? 19.10 ZN ZN A 128 A 219 ASN B 95 ASN^? 12.67 ZN ZN B 128 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -37.13 49.32 50.54 -38.26 47.82 51.54 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -36.45 49.00 55.10 -34.55 48.04 55.74 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -28.02 46.30 43.15 -27.06 44.43 43.46 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 7 hits 1wbf_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 76 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 81 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo 4.09 43.69 67.89 2.45 42.40 68.10 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 4.75 48.17 75.81 4.99 47.30 77.74 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 0.57 50.41 73.18 0.46 48.28 73.56 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 76 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 81 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo 4.09 43.69 67.89 2.45 42.40 68.10 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 4.75 48.17 75.81 4.99 47.30 77.74 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 0.57 50.41 73.18 0.46 48.28 73.56 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 3 3 # 3 A 26 HIS D 10 HIS^? 15.91 ZN ZN D 128 A 76 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 81 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo 4.09 43.69 67.89 2.45 42.40 68.10 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 4.75 48.17 75.81 4.99 47.30 77.74 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 0.57 50.41 73.18 0.46 48.28 73.56 -21.74 43.31 43.14 -23.53 43.14 44.28 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 4 3 # 4 A 26 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 76 ASN D 18 ASN.? 16.75 ZN ZN D 128 A 81 ASP D 90 ASP.? 20.62 ZN ZN D 128 coo 4.09 43.69 67.89 2.45 42.40 68.10 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 4.75 48.17 75.81 4.99 47.30 77.74 -15.23 25.74 43.96 -13.30 25.49 44.87 coo 0.57 50.41 73.18 0.46 48.28 73.56 -14.45 19.85 39.76 -14.81 17.95 40.62 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 4 hits 2c3x_p00 naa= 3 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 42 ARG^? 15.09 ZN ZN A 128 A 148 SER C 44 SER^? 13.15 ZN ZN C 128 A 152 ALA C 75 ALA^? 11.02 ZN ZN C 128 A 194 GLU C 70 GLU^? 19.15 ZN ZN C 128 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -5.45 53.01 63.68 -3.95 52.79 63.75 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -0.72 48.58 72.21 1.10 47.61 72.77 ULMN 4 2cl8_p00 DECTIN-1 user 2 4 # 2 A 145 ARG B 42 ARG^? 15.17 ZN ZN B 128 A 148 SER D 44 SER^? 13.11 ZN ZN D 128 A 152 ALA D 75 ALA^? 10.80 ZN ZN D 128 A 194 GLU D 70 GLU^? 19.86 ZN ZN D 128 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -31.65 32.85 42.77 -31.81 31.34 42.74 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -27.83 26.66 34.57 -27.72 25.48 32.82 ULMN 4 2cl8_p00 DECTIN-1 user 3 4 # 3 A 145 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 148 SER A 44 SER^? 13.08 ZN ZN A 128 A 152 ALA A 75 ALA^? 11.02 ZN ZN A 128 A 194 GLU A 70 GLU^? 19.90 ZN ZN A 128 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -14.68 47.50 72.94 -15.20 48.23 74.17 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -10.78 57.16 76.11 -9.51 58.48 77.12 2cl8_p00 source 2cl8 DECTIN-1 : 3 hits 2cl8_p00 naa= 4 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 1 4 # 1 A 87 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 184 TYR C 8 TYR.? 16.68 ZN ZN C 128 A 400 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 416 ASP C 97 ASP^? 13.06 ZN ZN C 128 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -14.96 59.08 54.51 -13.25 60.64 52.94 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -13.22 48.33 58.62 -13.88 46.78 59.86 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 2 4 # 2 A 87 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 184 TYR D 8 TYR.? 16.65 ZN ZN D 128 A 400 ARG D 42 ARG^? 14.89 ZN ZN D 128 A 416 ASP D 97 ASP^? 13.24 ZN ZN D 128 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -34.83 43.92 51.78 -36.80 42.61 53.27 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -29.08 38.55 44.25 -27.07 40.84 43.98 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -25.08 39.18 47.70 -23.31 39.57 46.61 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 3 4 # 3 A 87 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 184 TYR A 8 TYR.? 17.33 ZN ZN A 128 A 400 ARG A 42 ARG^? 15.09 ZN ZN A 128 A 416 ASP A 97 ASP^? 13.17 ZN ZN A 128 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -17.14 34.95 65.78 -18.35 33.52 67.89 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -14.23 45.62 66.89 -13.61 45.68 63.87 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -18.00 46.34 63.27 -17.25 47.97 62.16 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 4 4 # 4 A 87 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 184 TYR B 8 TYR.? 17.28 ZN ZN B 128 A 400 ARG B 42 ARG^? 15.17 ZN ZN B 128 A 416 ASP B 97 ASP^? 13.03 ZN ZN B 128 coo -0.32 21.89 76.95 -2.29 21.43 77.55 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -13.84 24.02 81.30 -13.39 23.42 78.61 -11.11 39.23 40.67 -9.41 39.91 38.53 coo -2.45 25.99 82.19 -2.93 24.57 79.52 -22.13 39.38 39.45 -22.11 38.65 42.43 coo -5.39 20.15 83.91 -5.94 21.73 82.59 -21.74 43.31 43.14 -23.53 43.14 44.28 2g3n_p00 source 2g3n ALPHA-GLUCOSIDASE : 4 hits 2g3n_p00 naa= 4 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 12 ARG^? 10.24 ZN ZN A 128 B 6 THR D 35 THR.? 11.51 ZN ZN A 128 B 8 THR A 35 THR.? 8.83 ZN ZN A 128 coo 40.52 16.08 100.90 37.97 16.41 102.60 -26.71 45.35 59.66 -27.06 47.43 61.87 coo 36.11 13.64 95.03 34.54 14.86 95.91 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 32.72 8.05 92.39 31.25 9.11 91.35 -28.69 39.43 70.39 -28.36 40.10 72.45 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 36 ARG.? 14.54 ZN ZN D 128 B 6 THR D 35 THR.? 11.51 ZN ZN A 128 B 8 THR A 11 THR^? 14.69 ZN ZN D 128 coo 40.52 16.08 100.90 37.97 16.41 102.60 -29.05 33.74 68.19 -28.81 35.05 65.43 coo 36.11 13.64 95.03 34.54 14.86 95.91 -28.60 38.86 63.25 -27.28 40.41 64.00 coo 32.72 8.05 92.39 31.25 9.11 91.35 -21.95 40.72 59.07 -22.88 39.66 60.69 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 12 ARG^? 9.84 ZN ZN B 128 B 6 THR C 35 THR.? 11.32 ZN ZN B 128 B 8 THR B 35 THR.? 8.83 ZN ZN B 128 coo 40.52 16.08 100.90 37.97 16.41 102.60 -19.64 50.95 45.34 -21.61 53.09 44.31 coo 36.11 13.64 95.03 34.54 14.86 95.91 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 32.72 8.05 92.39 31.25 9.11 91.35 -11.91 51.72 35.90 -12.77 51.64 33.90 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 36 ARG.? 14.53 ZN ZN C 128 B 6 THR C 35 THR.? 11.32 ZN ZN B 128 B 8 THR B 11 THR^? 14.42 ZN ZN C 128 coo 40.52 16.08 100.90 37.97 16.41 102.60 -7.28 49.73 38.22 -8.28 50.76 40.96 coo 36.11 13.64 95.03 34.54 14.86 95.91 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 32.72 8.05 92.39 31.25 9.11 91.35 -15.35 45.63 47.22 -13.97 46.20 45.66 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG C 12 ARG^? 8.72 ZN ZN C 128 B 6 THR C 35 THR.? 11.32 ZN ZN B 128 B 8 THR B 35 THR.? 8.83 ZN ZN B 128 coo 40.52 16.08 100.90 37.97 16.41 102.60 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 36.11 13.64 95.03 34.54 14.86 95.91 -12.31 51.29 42.82 -14.33 50.63 43.21 coo 32.72 8.05 92.39 31.25 9.11 91.35 -11.91 51.72 35.90 -12.77 51.64 33.90 1b01_d00 source 1b01 GENE REGULATION/DNA : 5 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 6 GLN.? 18.48 ZN ZN C 128 A 11 ASN C 95 ASN^? 12.77 ZN ZN C 128 A 13 ARG A 42 ARG^? 15.09 ZN ZN A 128 coo 33.45 2.10 7.21 34.51 1.09 5.67 -8.32 34.40 65.59 -6.40 33.78 64.92 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -10.59 42.26 61.06 -11.87 43.93 61.32 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -14.23 45.62 66.89 -13.61 45.68 63.87 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN B 6 GLN.? 18.19 ZN ZN D 128 A 11 ASN D 95 ASN^? 12.80 ZN ZN D 128 A 13 ARG B 42 ARG^? 15.17 ZN ZN B 128 coo 33.45 2.10 7.21 34.51 1.09 5.67 -13.04 30.88 42.47 -12.86 28.78 42.24 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -19.89 34.86 45.47 -21.06 36.60 45.16 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -22.13 39.38 39.45 -22.11 38.65 42.43 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN C 6 GLN.? 17.65 ZN ZN A 128 A 11 ASN A 95 ASN^? 12.70 ZN ZN A 128 A 13 ARG C 42 ARG^? 15.11 ZN ZN C 128 coo 33.45 2.10 7.21 34.51 1.09 5.67 -19.61 61.65 61.56 -20.27 62.79 63.23 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -19.15 53.27 63.15 -17.72 51.74 62.89 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -11.57 52.04 62.13 -14.42 50.97 62.50 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN D 6 GLN.? 17.69 ZN ZN B 128 A 11 ASN B 95 ASN^? 12.67 ZN ZN B 128 A 13 ARG D 42 ARG^? 14.89 ZN ZN D 128 coo 33.45 2.10 7.21 34.51 1.09 5.67 -36.12 49.22 44.83 -37.00 50.18 43.14 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -28.02 46.30 43.15 -27.06 44.43 43.46 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -29.08 38.55 44.25 -27.07 40.84 43.98 1bdv_d00 source 1bdv GENE REGULATION/DNA : 4 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 8 TYR.? 17.33 ZN ZN A 128 I 306 VAL A 39 VAL^? 11.69 ZN ZN A 128 I 308 VAL A 104 VAL~? 13.08 ZN ZN D 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -17.14 34.95 65.78 -18.35 33.52 67.89 coo 23.55 29.53 9.81 23.15 27.39 10.24 -23.40 37.65 68.10 -25.35 38.06 67.19 coo 16.43 30.18 9.35 15.05 30.67 11.01 -25.23 30.59 64.05 -24.48 31.72 65.74 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 40 TYR^? 13.15 ZN ZN A 128 I 306 VAL A 100 VAL^? 15.06 ZN ZN A 128 I 308 VAL A 104 VAL~? 13.08 ZN ZN D 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -19.24 38.51 70.38 -18.99 36.30 72.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -21.17 36.36 64.38 -22.91 36.83 63.17 coo 16.43 30.18 9.35 15.05 30.67 11.01 -25.23 30.59 64.05 -24.48 31.72 65.74 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 52 TYR^? 7.20 ZN ZN A 128 I 306 VAL A 50 VAL^? 10.61 ZN ZN A 128 I 308 VAL A 45 VAL^? 13.42 ZN ZN A 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -20.95 49.22 77.42 -22.18 46.73 77.85 coo 23.55 29.53 9.81 23.15 27.39 10.24 -18.31 56.74 74.47 -19.58 55.92 72.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 -14.95 55.65 68.68 -14.87 55.99 70.85 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 93 TYR^? 17.82 ZN ZN A 128 I 306 VAL A 45 VAL^? 13.42 ZN ZN A 128 I 308 VAL A 50 VAL^? 10.61 ZN ZN A 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -17.49 60.90 64.70 -15.26 61.56 63.14 coo 23.55 29.53 9.81 23.15 27.39 10.24 -14.95 55.65 68.68 -14.87 55.99 70.85 coo 16.43 30.18 9.35 15.05 30.67 11.01 -18.31 56.74 74.47 -19.58 55.92 72.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 40 TYR^? 13.12 ZN ZN B 128 I 306 VAL B 100 VAL^? 14.78 ZN ZN B 128 I 308 VAL B 104 VAL~? 12.95 ZN ZN C 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -13.98 42.26 35.98 -11.85 41.33 34.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 -11.40 43.64 42.18 -10.91 45.70 42.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 -4.99 45.64 42.47 -6.12 46.23 40.69 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 52 TYR^? 7.51 ZN ZN B 128 I 306 VAL B 50 VAL^? 10.92 ZN ZN B 128 I 308 VAL B 45 VAL^? 13.72 ZN ZN B 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.54 46.80 28.87 -20.82 47.32 28.41 coo 23.55 29.53 9.81 23.15 27.39 10.24 -31.68 46.25 31.86 -30.63 47.18 33.52 coo 16.43 30.18 9.35 15.05 30.67 11.01 -31.49 42.50 37.64 -32.37 43.25 35.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 93 TYR^? 18.00 ZN ZN B 128 I 306 VAL B 45 VAL^? 13.72 ZN ZN B 128 I 308 VAL B 50 VAL^? 10.92 ZN ZN B 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -35.98 46.77 41.76 -37.33 44.77 43.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -31.49 42.50 37.64 -32.37 43.25 35.80 coo 16.43 30.18 9.35 15.05 30.67 11.01 -31.68 46.25 31.86 -30.63 47.18 33.52 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR C 52 TYR^? 7.59 ZN ZN C 128 I 306 VAL C 50 VAL^? 11.09 ZN ZN C 128 I 308 VAL C 45 VAL^? 14.04 ZN ZN C 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 1.13 52.00 59.76 1.13 53.77 57.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.39 45.23 65.20 -1.02 44.73 63.58 coo 16.43 30.18 9.35 15.05 30.67 11.01 -6.16 44.59 66.61 -4.46 45.02 67.90 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR C 93 TYR^? 17.98 ZN ZN C 128 I 306 VAL C 45 VAL^? 14.04 ZN ZN C 128 I 308 VAL C 50 VAL^? 11.09 ZN ZN C 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.81 37.29 66.15 -8.85 36.99 68.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 -6.16 44.59 66.61 -4.46 45.02 67.90 coo 16.43 30.18 9.35 15.05 30.67 11.01 0.39 45.23 65.20 -1.02 44.73 63.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR D 52 TYR^? 7.54 ZN ZN D 128 I 306 VAL D 50 VAL^? 10.84 ZN ZN D 128 I 308 VAL D 45 VAL^? 13.71 ZN ZN D 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -32.42 26.30 46.60 -34.28 26.82 48.63 coo 23.55 29.53 9.81 23.15 27.39 10.24 -25.46 25.18 41.52 -24.72 26.31 43.21 coo 16.43 30.18 9.35 15.05 30.67 11.01 -23.29 31.37 39.73 -23.83 29.32 39.37 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR D 93 TYR^? 18.01 ZN ZN D 128 I 306 VAL D 45 VAL^? 13.71 ZN ZN D 128 I 308 VAL D 50 VAL^? 10.84 ZN ZN D 128 coo 26.18 35.24 6.87 24.33 35.18 8.97 -16.06 30.04 40.46 -15.16 31.88 38.54 coo 23.55 29.53 9.81 23.15 27.39 10.24 -23.29 31.37 39.73 -23.83 29.32 39.37 coo 16.43 30.18 9.35 15.05 30.67 11.01 -25.46 25.18 41.52 -24.72 26.31 43.21 1cqt_d00 source 1cqt GENE REGULATION/DNA : 11 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 78 PRO.? 9.63 ZN ZN A 128 A 272 LEU A 2 LEU.? 13.32 ZN ZN A 128 A 276 ARG A 42 ARG^? 15.09 ZN ZN A 128 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -21.46 42.06 77.90 -21.00 41.48 75.80 coo 10.97 0.43 16.73 11.31 2.11 18.06 -15.57 40.98 75.17 -16.63 40.33 76.94 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -14.23 45.62 66.89 -13.61 45.68 63.87 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 102 PRO~? 13.15 ZN ZN D 128 A 272 LEU A 105 LEU~? 10.03 ZN ZN D 128 A 276 ARG A 36 ARG.? 14.54 ZN ZN D 128 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -17.98 30.69 61.60 -20.13 30.89 62.19 coo 10.97 0.43 16.73 11.31 2.11 18.06 -23.68 32.88 60.16 -23.32 34.83 59.33 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -29.05 33.74 68.19 -28.81 35.05 65.43 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO B 78 PRO.? 9.69 ZN ZN B 128 A 272 LEU B 2 LEU.? 13.10 ZN ZN B 128 A 276 ARG B 42 ARG^? 15.17 ZN ZN B 128 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -16.66 45.38 28.50 -16.27 44.79 30.63 coo 10.97 0.43 16.73 11.31 2.11 18.06 -17.23 39.30 31.08 -16.79 40.87 29.68 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -22.13 39.38 39.45 -22.11 38.65 42.43 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 79 PRO.? 10.46 ZN ZN B 128 A 272 LEU B 2 LEU.? 13.10 ZN ZN B 128 A 276 ARG B 42 ARG^? 15.17 ZN ZN B 128 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -12.37 45.32 33.25 -13.51 46.78 31.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 -17.23 39.30 31.08 -16.79 40.87 29.68 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -22.13 39.38 39.45 -22.11 38.65 42.43 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO B 102 PRO~? 13.12 ZN ZN C 128 A 272 LEU B 105 LEU~? 10.01 ZN ZN C 128 A 276 ARG B 36 ARG.? 14.53 ZN ZN C 128 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -7.02 38.85 44.98 -6.60 40.97 44.39 coo 10.97 0.43 16.73 11.31 2.11 18.06 -7.52 45.21 46.61 -9.66 45.33 46.69 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -7.28 49.73 38.22 -8.28 50.76 40.96 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO B 102 PRO~? 13.12 ZN ZN C 128 A 272 LEU B 105 LEU~? 10.01 ZN ZN C 128 A 276 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -7.02 38.85 44.98 -6.60 40.97 44.39 coo 10.97 0.43 16.73 11.31 2.11 18.06 -7.52 45.21 46.61 -9.66 45.33 46.69 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -12.88 45.85 50.29 -9.95 45.19 50.84 1emh_d00 source 1emh HYDROLASE/DNA : 6 hits 1emh_d00 naa= 3 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN B 20 GLN.? 18.32 ZN ZN B 128 C 44 LYS B 19 LYS.? 16.80 ZN ZN B 128 C 75 ARG C 112 ARG.? 13.24 ZN ZN B 128 coo 34.33 34.01 1.06 32.24 34.35 1.22 -37.90 57.59 38.67 -38.03 59.21 37.29 coo 36.27 30.15 5.40 32.93 24.83 5.96 -34.93 54.65 36.44 -38.00 53.50 31.57 coo 30.88 29.31 6.12 29.39 29.02 3.47 -33.64 60.73 36.36 -31.31 59.87 38.14 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 2 3 # 2 C 43 GLN B 20 GLN.? 18.32 ZN ZN B 128 C 44 LYS C 113 LYS.? 25.09 ZN ZN B 128 C 75 ARG C 112 ARG.? 13.24 ZN ZN B 128 coo 34.33 34.01 1.06 32.24 34.35 1.22 -37.90 57.59 38.67 -38.03 59.21 37.29 coo 36.27 30.15 5.40 32.93 24.83 5.96 -39.27 61.49 31.97 -43.88 61.90 29.42 coo 30.88 29.31 6.12 29.39 29.02 3.47 -33.64 60.73 36.36 -31.31 59.87 38.14 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 3 3 # 3 C 43 GLN C 111 GLN.? 22.04 ZN ZN B 128 C 44 LYS C 113 LYS.? 25.09 ZN ZN B 128 C 75 ARG C 112 ARG.? 13.24 ZN ZN B 128 coo 34.33 34.01 1.06 32.24 34.35 1.22 -40.03 61.86 39.48 -41.25 60.14 39.70 coo 36.27 30.15 5.40 32.93 24.83 5.96 -39.27 61.49 31.97 -43.88 61.90 29.42 coo 30.88 29.31 6.12 29.39 29.02 3.47 -33.64 60.73 36.36 -31.31 59.87 38.14 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 3 hits 2er8_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 32 LYS B 33 LYS.? 11.38 ZN ZN B 128 A 46 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -15.69 56.10 43.84 -17.06 58.00 41.84 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -14.69 55.97 38.01 -16.66 60.81 39.16 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -12.88 45.85 50.29 -9.95 45.19 50.84 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 1 hits 2ky8_d00 naa= 3 ULMN 4 2q2t_d00 LIGASE/DNA user 1 4 # 1 A 48 ARG C 42 ARG^? 15.11 ZN ZN C 128 A 249 THR B 35 THR.? 8.83 ZN ZN B 128 A 285 ARG B 12 ARG^? 9.84 ZN ZN B 128 A 286 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -81.95 4.55 64.73 -81.11 4.84 61.78 -11.57 52.04 62.13 -14.42 50.97 62.50 coo -64.79 -0.51 43.10 -64.46 -1.42 45.04 -11.91 51.72 35.90 -12.77 51.64 33.90 coo -72.24 -8.41 51.99 -72.03 -9.47 54.89 -19.64 50.95 45.34 -21.61 53.09 44.31 coo -68.50 -7.10 50.68 -69.42 -6.74 53.31 -18.19 48.06 41.51 -19.79 50.06 40.34 2q2t_d00 source 2q2t LIGASE/DNA : 1 hits 2q2t_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 44 SER^? 13.08 ZN ZN A 128 B 37 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 45 THR A 11 THR^? 14.69 ZN ZN D 128 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -19.15 53.27 63.15 -17.72 51.74 62.89 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -21.95 40.72 59.07 -22.88 39.66 60.69 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 44 SER^? 13.08 ZN ZN A 128 B 37 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 45 THR A 89 THR.? 18.72 ZN ZN A 128 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -19.15 53.27 63.15 -17.72 51.74 62.89 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -19.06 65.09 74.03 -16.96 64.91 73.52 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 44 SER^? 13.08 ZN ZN A 128 B 37 ASN A 95 ASN^? 12.70 ZN ZN A 128 B 45 THR C 14 THR.? 9.55 ZN ZN C 128 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -19.15 53.27 63.15 -17.72 51.74 62.89 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -11.64 41.49 55.94 -9.73 42.48 56.15 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER C 44 SER^? 13.15 ZN ZN C 128 B 37 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 45 THR A 14 THR.? 9.34 ZN ZN A 128 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -10.59 42.26 61.06 -11.87 43.93 61.32 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -23.51 50.82 61.06 -23.73 50.87 63.22 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER C 44 SER^? 13.15 ZN ZN C 128 B 37 ASN C 95 ASN^? 12.77 ZN ZN C 128 B 45 THR C 11 THR^? 14.35 ZN ZN C 128 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -10.59 42.26 61.06 -11.87 43.93 61.32 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -17.36 49.55 51.91 -16.04 50.82 50.77 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 5 hits 2z3x_d00 naa= 3 ULMN 4 3cbb_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 69 ASP A 32 ASP.? -2.97 ZN ZN A 128s A 72 LYS A 33 LYS.? 11.45 ZN ZN A 128 A 76 ARG D 36 ARG.? 10.17 ZN ZN A 128 A 77 ARG A 12 ARG^? 10.24 ZN ZN A 128 coo 9.42 -0.85 -10.61 7.95 -0.24 -12.03 -28.11 44.25 70.85 -26.82 45.93 70.94 coo 14.81 -2.90 -13.11 11.72 2.11 -15.49 -32.13 43.51 68.59 -35.31 47.47 65.43 coo 19.33 3.10 -14.10 17.43 4.12 -11.91 -32.18 43.37 61.68 -31.14 45.24 63.88 coo 20.27 2.02 -7.55 17.74 0.41 -6.90 -26.71 45.35 59.66 -27.06 47.43 61.87 3cbb_d00 source 3cbb TRANSCRIPTION/DNA : 1 hits 3cbb_d00 naa= 4 ULMN 4 3jxy_d00 HYDROLASE/DNA user 1 4 # 1 A 27 TYR C 55 TYR.? 11.30 ZN ZN C 128 A 109 TRP C 82 TRP.? 10.56 ZN ZN C 128 A 183 LYS C 33 LYS.? 11.91 ZN ZN C 128 A 215 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 8.07 52.98 53.71 8.63 50.62 55.11 coo 4.70 1.38 14.78 1.19 -0.08 15.75 4.18 54.49 47.85 3.69 51.13 45.87 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 -12.88 45.85 50.29 -9.95 45.19 50.84 3jxy_d00 source 3jxy HYDROLASE/DNA : 1 hits 3jxy_d00 naa= 4 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG A 29 ARG.? 13.64 ZN ZN A 128 G 387 HIS A 59 HIS.? 17.66 ZN ZN A 128 G 390 SER A 60 SER.? 16.46 ZN ZN A 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -31.22 50.95 82.45 -31.20 48.79 84.59 coo 95.60 53.07 40.31 97.10 52.52 41.67 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 93.25 46.91 38.79 94.12 47.43 36.62 -31.07 46.42 88.10 -29.75 44.46 87.48 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 G 386 ARG A 42 ARG^? 15.09 ZN ZN A 128 G 387 HIS A 10 HIS^? 15.73 ZN ZN A 128 G 390 SER A 13 SER^? 14.04 ZN ZN A 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -14.23 45.62 66.89 -13.61 45.68 63.87 coo 95.60 53.07 40.31 97.10 52.52 41.67 -17.72 42.81 59.27 -18.61 44.71 59.17 coo 93.25 46.91 38.79 94.12 47.43 36.62 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 G 386 ARG B 42 ARG^? 15.17 ZN ZN B 128 G 387 HIS B 10 HIS^? 15.59 ZN ZN B 128 G 390 SER B 13 SER^? 13.94 ZN ZN B 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -22.13 39.38 39.45 -22.11 38.65 42.43 coo 95.60 53.07 40.31 97.10 52.52 41.67 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 93.25 46.91 38.79 94.12 47.43 36.62 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 G 386 ARG C 12 ARG^? 8.72 ZN ZN C 128 G 387 HIS B 10 HIS^? 15.59 ZN ZN B 128 G 390 SER B 13 SER^? 13.94 ZN ZN B 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 95.60 53.07 40.31 97.10 52.52 41.67 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 93.25 46.91 38.79 94.12 47.43 36.62 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 G 386 ARG C 12 ARG^? 8.72 ZN ZN C 128 G 387 HIS B 10 HIS^? 15.59 ZN ZN B 128 G 390 SER D 13 SER^? 14.41 ZN ZN D 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 95.60 53.07 40.31 97.10 52.52 41.67 -18.46 42.11 47.13 -20.09 43.42 47.28 coo 93.25 46.91 38.79 94.12 47.43 36.62 -20.94 39.05 50.60 -21.28 40.97 49.13 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 G 386 ARG C 42 ARG^? 15.11 ZN ZN C 128 G 387 HIS C 10 HIS^? 15.40 ZN ZN C 128 G 390 SER A 13 SER^? 14.04 ZN ZN A 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 95.60 53.07 40.31 97.10 52.52 41.67 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 93.25 46.91 38.79 94.12 47.43 36.62 -21.49 47.80 59.94 -19.64 49.31 59.49 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 G 386 ARG C 42 ARG^? 15.11 ZN ZN C 128 G 387 HIS C 10 HIS^? 15.40 ZN ZN C 128 G 390 SER C 13 SER^? 14.25 ZN ZN C 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -11.57 52.04 62.13 -14.42 50.97 62.50 coo 95.60 53.07 40.31 97.10 52.52 41.67 -17.83 49.51 56.44 -17.15 47.54 56.54 coo 93.25 46.91 38.79 94.12 47.43 36.62 -14.19 44.26 55.72 -15.84 45.12 57.33 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 G 386 ARG D 42 ARG^? 14.89 ZN ZN D 128 G 387 HIS D 10 HIS^? 15.91 ZN ZN D 128 G 390 SER B 13 SER^? 13.94 ZN ZN B 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 95.60 53.07 40.31 97.10 52.52 41.67 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 93.25 46.91 38.79 94.12 47.43 36.62 -22.32 47.02 46.39 -24.11 45.44 46.82 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 G 386 ARG D 42 ARG^? 14.89 ZN ZN D 128 G 387 HIS D 10 HIS^? 15.91 ZN ZN D 128 G 390 SER D 13 SER^? 14.41 ZN ZN D 128 coo 93.17 52.97 31.81 95.66 54.71 32.14 -29.08 38.55 44.25 -27.07 40.84 43.98 coo 95.60 53.07 40.31 97.10 52.52 41.67 -24.77 44.27 50.01 -22.89 43.34 50.12 coo 93.25 46.91 38.79 94.12 47.43 36.62 -20.94 39.05 50.60 -21.28 40.97 49.13 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 9 hits 3qrf_d00 naa= 3 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG C 12 ARG^? 8.72 ZN ZN C 128 A 82 LYS C 33 LYS.? 11.91 ZN ZN C 128 A 97 ARG B 12 ARG^? 9.84 ZN ZN B 128 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -12.88 45.85 50.29 -9.95 45.19 50.84 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -6.57 50.97 46.70 -3.25 53.30 43.27 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -19.64 50.95 45.34 -21.61 53.09 44.31 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG C 36 ARG.? 10.67 ZN ZN B 128 A 82 LYS B 33 LYS.? 11.38 ZN ZN B 128 A 97 ARG C 12 ARG^? 8.72 ZN ZN C 128 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -15.69 56.10 43.84 -17.06 58.00 41.84 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 -14.69 55.97 38.01 -16.66 60.81 39.16 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 -12.88 45.85 50.29 -9.95 45.19 50.84 4er8_d00 source 4er8 DNA BINDING PROTEIN/DNA : 2 hits 4er8_d00 naa= 3 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 A 75 SER A 13 SER^? 14.04 ZN ZN A 128 A 138 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 165 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 A 75 SER A 13 SER^? 14.04 ZN ZN A 128 A 138 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 165 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 3 3 # 3 A 75 SER B 13 SER^? 13.94 ZN ZN B 128 A 138 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 165 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 4 3 # 4 A 75 SER B 13 SER^? 13.94 ZN ZN B 128 A 138 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 165 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 5 3 # 5 A 75 SER C 13 SER^? 14.25 ZN ZN C 128 A 138 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 165 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 6 3 # 6 A 75 SER D 13 SER^? 14.41 ZN ZN D 128 A 138 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 165 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -18.46 42.11 47.13 -20.09 43.42 47.28 2qs9_o00 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 6 hits 2qs9_o00 naa= 3 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 B 75 SER A 13 SER^? 14.04 ZN ZN A 128 B 138 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 165 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 6.59 48.30 3.28 6.43 48.98 5.63 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 13.13 55.06 6.15 11.38 53.90 6.43 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 7.83 53.78 5.96 7.73 51.68 6.00 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 B 75 SER A 13 SER^? 14.04 ZN ZN A 128 B 138 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 165 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 6.59 48.30 3.28 6.43 48.98 5.63 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 13.13 55.06 6.15 11.38 53.90 6.43 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 7.83 53.78 5.96 7.73 51.68 6.00 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 3 3 # 3 B 75 SER B 13 SER^? 13.94 ZN ZN B 128 B 138 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 165 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 6.59 48.30 3.28 6.43 48.98 5.63 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 13.13 55.06 6.15 11.38 53.90 6.43 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 7.83 53.78 5.96 7.73 51.68 6.00 -18.46 42.11 47.13 -20.09 43.42 47.28 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 4 3 # 4 B 75 SER B 13 SER^? 13.94 ZN ZN B 128 B 138 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 165 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 6.59 48.30 3.28 6.43 48.98 5.63 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 13.13 55.06 6.15 11.38 53.90 6.43 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 7.83 53.78 5.96 7.73 51.68 6.00 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 5 3 # 5 B 75 SER C 13 SER^? 14.25 ZN ZN C 128 B 138 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 165 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 6.59 48.30 3.28 6.43 48.98 5.63 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 13.13 55.06 6.15 11.38 53.90 6.43 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 7.83 53.78 5.96 7.73 51.68 6.00 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 6 3 # 6 B 75 SER D 13 SER^? 14.41 ZN ZN D 128 B 138 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 165 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 6.59 48.30 3.28 6.43 48.98 5.63 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 13.13 55.06 6.15 11.38 53.90 6.43 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 7.83 53.78 5.96 7.73 51.68 6.00 -18.46 42.11 47.13 -20.09 43.42 47.28 2qs9_o01 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 6 hits 2qs9_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 13 SER^? 14.04 ZN ZN A 128 A 166 PHE A 16 PHE.? 16.30 ZN ZN A 128 A 182 PHE A 94 PHE^? 9.23 ZN ZN A 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -20.26 55.80 68.38 -22.98 56.19 68.94 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 13 SER^? 14.04 ZN ZN A 128 A 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 A 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 13 SER^? 14.04 ZN ZN A 128 A 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 A 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 44 SER^? 13.08 ZN ZN A 128 A 166 PHE A 16 PHE.? 16.30 ZN ZN A 128 A 182 PHE C 99 PHE^? 14.04 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -14.56 53.53 56.74 -15.34 51.98 58.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 44 SER^? 13.08 ZN ZN A 128 A 166 PHE A 77 PHE.? 6.06 ZN ZN A 128 A 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -20.65 46.43 74.00 -19.92 49.13 73.70 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER A 44 SER^? 13.08 ZN ZN A 128 A 166 PHE A 98 PHE^? 7.66 ZN ZN A 128 A 182 PHE A 99 PHE^? 14.45 ZN ZN A 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -23.46 44.22 64.74 -24.90 46.32 65.93 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -17.21 40.83 64.08 -15.57 42.86 63.04 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER A 44 SER^? 13.08 ZN ZN A 128 A 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 A 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER A 44 SER^? 13.08 ZN ZN A 128 A 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 A 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER B 13 SER^? 13.94 ZN ZN B 128 A 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 A 182 PHE B 94 PHE^? 9.33 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -30.29 47.77 38.05 -29.70 50.41 37.36 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER B 13 SER^? 13.94 ZN ZN B 128 A 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 182 PHE B 74 PHE^? 15.25 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -24.88 37.89 37.15 -23.16 35.68 37.15 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER B 13 SER^? 13.94 ZN ZN B 128 A 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER B 13 SER^? 13.94 ZN ZN B 128 A 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 A 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER B 44 SER^? 13.00 ZN ZN B 128 A 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 A 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER B 44 SER^? 13.00 ZN ZN B 128 A 166 PHE B 77 PHE.? 6.21 ZN ZN B 128 A 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -21.11 45.75 32.44 -23.89 45.86 32.80 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 15 3 # 15 A 130 SER B 44 SER^? 13.00 ZN ZN B 128 A 166 PHE B 98 PHE^? 7.32 ZN ZN B 128 A 182 PHE B 99 PHE^? 14.30 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -18.19 48.06 41.51 -19.79 50.06 40.34 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -16.73 40.99 42.20 -19.09 40.00 43.35 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 16 3 # 16 A 130 SER B 44 SER^? 13.00 ZN ZN B 128 A 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 17 3 # 17 A 130 SER B 44 SER^? 13.00 ZN ZN B 128 A 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 18 3 # 18 A 130 SER C 13 SER^? 14.25 ZN ZN C 128 A 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 A 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 19 3 # 19 A 130 SER C 13 SER^? 14.25 ZN ZN C 128 A 166 PHE C 16 PHE.? 16.61 ZN ZN C 128 A 182 PHE C 94 PHE^? 9.63 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -11.21 38.35 63.24 -13.14 39.96 64.53 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -4.76 42.24 62.13 -3.25 41.33 59.94 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 20 3 # 20 A 130 SER C 13 SER^? 14.25 ZN ZN C 128 A 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 A 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 21 3 # 21 A 130 SER C 44 SER^? 13.15 ZN ZN C 128 A 166 PHE C 77 PHE.? 5.68 ZN ZN C 128 A 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -3.10 52.12 57.92 -2.59 49.92 59.60 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 22 3 # 22 A 130 SER C 44 SER^? 13.15 ZN ZN C 128 A 166 PHE C 98 PHE^? 7.17 ZN ZN C 128 A 182 PHE C 99 PHE^? 14.04 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -10.58 48.79 53.26 -8.33 47.13 53.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -14.56 53.53 56.74 -15.34 51.98 58.97 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 23 3 # 23 A 130 SER C 44 SER^? 13.15 ZN ZN C 128 A 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 A 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 24 3 # 24 A 130 SER C 44 SER^? 13.15 ZN ZN C 128 A 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 A 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 25 3 # 25 A 130 SER D 13 SER^? 14.41 ZN ZN D 128 A 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 182 PHE B 74 PHE^? 15.25 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -24.88 37.89 37.15 -23.16 35.68 37.15 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 26 3 # 26 A 130 SER D 13 SER^? 14.41 ZN ZN D 128 A 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 A 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 27 3 # 27 A 130 SER D 13 SER^? 14.41 ZN ZN D 128 A 166 PHE D 16 PHE.? 16.58 ZN ZN D 128 A 182 PHE D 94 PHE^? 9.41 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.01 34.48 43.33 -17.02 36.72 41.96 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -21.52 29.39 44.56 -21.12 27.85 46.87 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 28 3 # 28 A 130 SER D 13 SER^? 14.41 ZN ZN D 128 A 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 A 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 29 3 # 29 A 130 SER D 44 SER^? 13.11 ZN ZN D 128 A 166 PHE D 77 PHE.? 5.25 ZN ZN D 128 A 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -31.30 30.46 48.64 -29.26 29.22 47.17 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 30 3 # 30 A 130 SER D 44 SER^? 13.11 ZN ZN D 128 A 166 PHE D 98 PHE^? 7.40 ZN ZN D 128 A 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -26.13 36.91 53.13 -25.06 34.30 52.99 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 31 3 # 31 A 130 SER D 44 SER^? 13.11 ZN ZN D 128 A 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 A 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 32 3 # 32 A 130 SER D 44 SER^? 13.11 ZN ZN D 128 A 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 A 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -26.13 36.91 53.13 -25.06 34.30 52.99 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 32 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 13 SER^? 14.04 ZN ZN A 128 B 166 PHE A 16 PHE.? 16.30 ZN ZN A 128 B 182 PHE A 94 PHE^? 9.23 ZN ZN A 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -20.26 55.80 68.38 -22.98 56.19 68.94 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 13 SER^? 14.04 ZN ZN A 128 B 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 B 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 13 SER^? 14.04 ZN ZN A 128 B 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 B 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 44 SER^? 13.08 ZN ZN A 128 B 166 PHE A 77 PHE.? 6.06 ZN ZN A 128 B 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -20.65 46.43 74.00 -19.92 49.13 73.70 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 44 SER^? 13.08 ZN ZN A 128 B 166 PHE A 98 PHE^? 7.66 ZN ZN A 128 B 182 PHE A 99 PHE^? 14.45 ZN ZN A 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -23.46 44.22 64.74 -24.90 46.32 65.93 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -17.21 40.83 64.08 -15.57 42.86 63.04 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 44 SER^? 13.08 ZN ZN A 128 B 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 B 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 44 SER^? 13.08 ZN ZN A 128 B 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 B 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER B 13 SER^? 13.94 ZN ZN B 128 B 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 B 182 PHE B 94 PHE^? 9.33 ZN ZN B 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -30.29 47.77 38.05 -29.70 50.41 37.36 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER B 13 SER^? 13.94 ZN ZN B 128 B 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 B 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER B 13 SER^? 13.94 ZN ZN B 128 B 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 B 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER B 44 SER^? 13.00 ZN ZN B 128 B 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 B 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER B 44 SER^? 13.00 ZN ZN B 128 B 166 PHE B 77 PHE.? 6.21 ZN ZN B 128 B 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -21.11 45.75 32.44 -23.89 45.86 32.80 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER B 44 SER^? 13.00 ZN ZN B 128 B 166 PHE B 98 PHE^? 7.32 ZN ZN B 128 B 182 PHE B 99 PHE^? 14.30 ZN ZN B 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -18.19 48.06 41.51 -19.79 50.06 40.34 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -16.73 40.99 42.20 -19.09 40.00 43.35 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 14 3 # 14 B 130 SER B 44 SER^? 13.00 ZN ZN B 128 B 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 B 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 15 3 # 15 B 130 SER B 44 SER^? 13.00 ZN ZN B 128 B 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 B 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 16 3 # 16 B 130 SER C 13 SER^? 14.25 ZN ZN C 128 B 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 B 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 17 3 # 17 B 130 SER C 13 SER^? 14.25 ZN ZN C 128 B 166 PHE C 16 PHE.? 16.61 ZN ZN C 128 B 182 PHE C 94 PHE^? 9.63 ZN ZN C 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -11.21 38.35 63.24 -13.14 39.96 64.53 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -4.76 42.24 62.13 -3.25 41.33 59.94 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 18 3 # 18 B 130 SER C 13 SER^? 14.25 ZN ZN C 128 B 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 B 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 19 3 # 19 B 130 SER C 44 SER^? 13.15 ZN ZN C 128 B 166 PHE C 77 PHE.? 5.68 ZN ZN C 128 B 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -3.10 52.12 57.92 -2.59 49.92 59.60 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 20 3 # 20 B 130 SER C 44 SER^? 13.15 ZN ZN C 128 B 166 PHE C 98 PHE^? 7.17 ZN ZN C 128 B 182 PHE C 99 PHE^? 14.04 ZN ZN C 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -10.58 48.79 53.26 -8.33 47.13 53.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -14.56 53.53 56.74 -15.34 51.98 58.97 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 21 3 # 21 B 130 SER C 44 SER^? 13.15 ZN ZN C 128 B 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 B 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 22 3 # 22 B 130 SER C 44 SER^? 13.15 ZN ZN C 128 B 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 B 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 23 3 # 23 B 130 SER D 13 SER^? 14.41 ZN ZN D 128 B 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 B 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 24 3 # 24 B 130 SER D 13 SER^? 14.41 ZN ZN D 128 B 166 PHE D 16 PHE.? 16.58 ZN ZN D 128 B 182 PHE D 94 PHE^? 9.41 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -16.01 34.48 43.33 -17.02 36.72 41.96 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -21.52 29.39 44.56 -21.12 27.85 46.87 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 25 3 # 25 B 130 SER D 13 SER^? 14.41 ZN ZN D 128 B 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 B 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 26 3 # 26 B 130 SER D 44 SER^? 13.11 ZN ZN D 128 B 166 PHE D 77 PHE.? 5.25 ZN ZN D 128 B 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -31.30 30.46 48.64 -29.26 29.22 47.17 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 27 3 # 27 B 130 SER D 44 SER^? 13.11 ZN ZN D 128 B 166 PHE D 98 PHE^? 7.40 ZN ZN D 128 B 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -26.13 36.91 53.13 -25.06 34.30 52.99 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 28 3 # 28 B 130 SER D 44 SER^? 13.11 ZN ZN D 128 B 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 B 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 29 3 # 29 B 130 SER D 44 SER^? 13.11 ZN ZN D 128 B 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 B 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -26.13 36.91 53.13 -25.06 34.30 52.99 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 29 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 13 SER^? 14.04 ZN ZN A 128 C 166 PHE A 16 PHE.? 16.30 ZN ZN A 128 C 182 PHE A 94 PHE^? 9.23 ZN ZN A 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -20.26 55.80 68.38 -22.98 56.19 68.94 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 13 SER^? 14.04 ZN ZN A 128 C 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 C 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 13 SER^? 14.04 ZN ZN A 128 C 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 C 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 44 SER^? 13.08 ZN ZN A 128 C 166 PHE A 16 PHE.? 16.30 ZN ZN A 128 C 182 PHE C 99 PHE^? 14.04 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -14.56 53.53 56.74 -15.34 51.98 58.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 44 SER^? 13.08 ZN ZN A 128 C 166 PHE A 77 PHE.? 6.06 ZN ZN A 128 C 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -20.65 46.43 74.00 -19.92 49.13 73.70 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER A 44 SER^? 13.08 ZN ZN A 128 C 166 PHE A 98 PHE^? 7.66 ZN ZN A 128 C 182 PHE A 99 PHE^? 14.45 ZN ZN A 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -23.46 44.22 64.74 -24.90 46.32 65.93 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -17.21 40.83 64.08 -15.57 42.86 63.04 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER A 44 SER^? 13.08 ZN ZN A 128 C 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 C 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER A 44 SER^? 13.08 ZN ZN A 128 C 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 C 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER B 13 SER^? 13.94 ZN ZN B 128 C 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 C 182 PHE B 94 PHE^? 9.33 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -30.29 47.77 38.05 -29.70 50.41 37.36 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER B 13 SER^? 13.94 ZN ZN B 128 C 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 C 182 PHE B 74 PHE^? 15.25 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -24.88 37.89 37.15 -23.16 35.68 37.15 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER B 13 SER^? 13.94 ZN ZN B 128 C 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 C 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER B 13 SER^? 13.94 ZN ZN B 128 C 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 C 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 13 3 # 13 C 130 SER B 44 SER^? 13.00 ZN ZN B 128 C 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 C 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 14 3 # 14 C 130 SER B 44 SER^? 13.00 ZN ZN B 128 C 166 PHE B 77 PHE.? 6.21 ZN ZN B 128 C 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -21.11 45.75 32.44 -23.89 45.86 32.80 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 15 3 # 15 C 130 SER B 44 SER^? 13.00 ZN ZN B 128 C 166 PHE B 98 PHE^? 7.32 ZN ZN B 128 C 182 PHE B 99 PHE^? 14.30 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -18.19 48.06 41.51 -19.79 50.06 40.34 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -16.73 40.99 42.20 -19.09 40.00 43.35 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 16 3 # 16 C 130 SER B 44 SER^? 13.00 ZN ZN B 128 C 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 C 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 17 3 # 17 C 130 SER B 44 SER^? 13.00 ZN ZN B 128 C 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 C 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 18 3 # 18 C 130 SER C 13 SER^? 14.25 ZN ZN C 128 C 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 C 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 19 3 # 19 C 130 SER C 13 SER^? 14.25 ZN ZN C 128 C 166 PHE C 16 PHE.? 16.61 ZN ZN C 128 C 182 PHE C 94 PHE^? 9.63 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -11.21 38.35 63.24 -13.14 39.96 64.53 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -4.76 42.24 62.13 -3.25 41.33 59.94 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 20 3 # 20 C 130 SER C 13 SER^? 14.25 ZN ZN C 128 C 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 C 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 21 3 # 21 C 130 SER C 44 SER^? 13.15 ZN ZN C 128 C 166 PHE C 77 PHE.? 5.68 ZN ZN C 128 C 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -3.10 52.12 57.92 -2.59 49.92 59.60 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 22 3 # 22 C 130 SER C 44 SER^? 13.15 ZN ZN C 128 C 166 PHE C 98 PHE^? 7.17 ZN ZN C 128 C 182 PHE C 99 PHE^? 14.04 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -10.58 48.79 53.26 -8.33 47.13 53.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -14.56 53.53 56.74 -15.34 51.98 58.97 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 23 3 # 23 C 130 SER C 44 SER^? 13.15 ZN ZN C 128 C 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 C 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 24 3 # 24 C 130 SER C 44 SER^? 13.15 ZN ZN C 128 C 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 C 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 25 3 # 25 C 130 SER D 13 SER^? 14.41 ZN ZN D 128 C 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 C 182 PHE B 74 PHE^? 15.25 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -24.88 37.89 37.15 -23.16 35.68 37.15 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 26 3 # 26 C 130 SER D 13 SER^? 14.41 ZN ZN D 128 C 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 C 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 27 3 # 27 C 130 SER D 13 SER^? 14.41 ZN ZN D 128 C 166 PHE D 16 PHE.? 16.58 ZN ZN D 128 C 182 PHE D 94 PHE^? 9.41 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.01 34.48 43.33 -17.02 36.72 41.96 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -21.52 29.39 44.56 -21.12 27.85 46.87 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 28 3 # 28 C 130 SER D 13 SER^? 14.41 ZN ZN D 128 C 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 C 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 29 3 # 29 C 130 SER D 44 SER^? 13.11 ZN ZN D 128 C 166 PHE D 77 PHE.? 5.25 ZN ZN D 128 C 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -31.30 30.46 48.64 -29.26 29.22 47.17 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 30 3 # 30 C 130 SER D 44 SER^? 13.11 ZN ZN D 128 C 166 PHE D 98 PHE^? 7.40 ZN ZN D 128 C 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -26.13 36.91 53.13 -25.06 34.30 52.99 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 31 3 # 31 C 130 SER D 44 SER^? 13.11 ZN ZN D 128 C 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 C 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 32 3 # 32 C 130 SER D 44 SER^? 13.11 ZN ZN D 128 C 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 C 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -26.13 36.91 53.13 -25.06 34.30 52.99 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 32 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 13 SER^? 14.04 ZN ZN A 128 D 166 PHE A 16 PHE.? 16.30 ZN ZN A 128 D 182 PHE A 94 PHE^? 9.23 ZN ZN A 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -18.40 57.13 61.09 -15.92 55.92 60.55 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -20.26 55.80 68.38 -22.98 56.19 68.94 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 13 SER^? 14.04 ZN ZN A 128 D 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 D 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 13 SER^? 14.04 ZN ZN A 128 D 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 D 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 44 SER^? 13.08 ZN ZN A 128 D 166 PHE A 98 PHE^? 7.66 ZN ZN A 128 D 182 PHE A 99 PHE^? 14.45 ZN ZN A 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -23.46 44.22 64.74 -24.90 46.32 65.93 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -17.21 40.83 64.08 -15.57 42.86 63.04 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 44 SER^? 13.08 ZN ZN A 128 D 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 D 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 44 SER^? 13.08 ZN ZN A 128 D 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 D 182 PHE C 16 PHE.? 16.61 ZN ZN C 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -15.06 51.94 67.95 -14.23 50.17 66.49 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -11.21 38.35 63.24 -13.14 39.96 64.53 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER B 13 SER^? 13.94 ZN ZN B 128 D 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 D 182 PHE B 94 PHE^? 9.33 ZN ZN B 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -30.29 47.77 38.05 -29.70 50.41 37.36 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER B 13 SER^? 13.94 ZN ZN B 128 D 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 D 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER B 13 SER^? 13.94 ZN ZN B 128 D 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 D 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER B 44 SER^? 13.00 ZN ZN B 128 D 166 PHE B 16 PHE.? 16.34 ZN ZN B 128 D 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -32.11 46.61 45.22 -31.70 43.89 45.83 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER B 44 SER^? 13.00 ZN ZN B 128 D 166 PHE B 77 PHE.? 6.21 ZN ZN B 128 D 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -21.11 45.75 32.44 -23.89 45.86 32.80 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER B 44 SER^? 13.00 ZN ZN B 128 D 166 PHE B 98 PHE^? 7.32 ZN ZN B 128 D 182 PHE B 99 PHE^? 14.30 ZN ZN B 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -18.19 48.06 41.51 -19.79 50.06 40.34 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -16.73 40.99 42.20 -19.09 40.00 43.35 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER B 44 SER^? 13.00 ZN ZN B 128 D 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 D 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER B 44 SER^? 13.00 ZN ZN B 128 D 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 D 182 PHE D 16 PHE.? 16.58 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -27.80 41.88 38.27 -27.32 41.64 40.63 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -16.01 34.48 43.33 -17.02 36.72 41.96 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER C 13 SER^? 14.25 ZN ZN C 128 D 166 PHE A 99 PHE^? 14.45 ZN ZN A 128 D 182 PHE A 98 PHE^? 7.66 ZN ZN A 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -17.21 40.83 64.08 -15.57 42.86 63.04 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -23.46 44.22 64.74 -24.90 46.32 65.93 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 16 3 # 16 D 130 SER C 13 SER^? 14.25 ZN ZN C 128 D 166 PHE C 16 PHE.? 16.61 ZN ZN C 128 D 182 PHE C 94 PHE^? 9.63 ZN ZN C 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -11.21 38.35 63.24 -13.14 39.96 64.53 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -4.76 42.24 62.13 -3.25 41.33 59.94 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 17 3 # 17 D 130 SER C 13 SER^? 14.25 ZN ZN C 128 D 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 D 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 18 3 # 18 D 130 SER C 44 SER^? 13.15 ZN ZN C 128 D 166 PHE C 77 PHE.? 5.68 ZN ZN C 128 D 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -3.10 52.12 57.92 -2.59 49.92 59.60 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 19 3 # 19 D 130 SER C 44 SER^? 13.15 ZN ZN C 128 D 166 PHE C 98 PHE^? 7.17 ZN ZN C 128 D 182 PHE C 99 PHE^? 14.04 ZN ZN C 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -10.58 48.79 53.26 -8.33 47.13 53.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -14.56 53.53 56.74 -15.34 51.98 58.97 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 20 3 # 20 D 130 SER C 44 SER^? 13.15 ZN ZN C 128 D 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 D 182 PHE A 16 PHE.? 16.30 ZN ZN A 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.40 57.13 61.09 -15.92 55.92 60.55 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 21 3 # 21 D 130 SER C 44 SER^? 13.15 ZN ZN C 128 D 166 PHE C 99 PHE^? 14.04 ZN ZN C 128 D 182 PHE C 98 PHE^? 7.17 ZN ZN C 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -8.23 46.92 64.43 -10.34 48.09 64.36 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.56 53.53 56.74 -15.34 51.98 58.97 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -10.58 48.79 53.26 -8.33 47.13 53.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 22 3 # 22 D 130 SER D 13 SER^? 14.41 ZN ZN D 128 D 166 PHE B 99 PHE^? 14.30 ZN ZN B 128 D 182 PHE B 98 PHE^? 7.32 ZN ZN B 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -16.73 40.99 42.20 -19.09 40.00 43.35 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -18.19 48.06 41.51 -19.79 50.06 40.34 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 23 3 # 23 D 130 SER D 13 SER^? 14.41 ZN ZN D 128 D 166 PHE D 16 PHE.? 16.58 ZN ZN D 128 D 182 PHE D 94 PHE^? 9.41 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -16.01 34.48 43.33 -17.02 36.72 41.96 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -21.52 29.39 44.56 -21.12 27.85 46.87 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 24 3 # 24 D 130 SER D 13 SER^? 14.41 ZN ZN D 128 D 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 D 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 25 3 # 25 D 130 SER D 44 SER^? 13.11 ZN ZN D 128 D 166 PHE D 77 PHE.? 5.25 ZN ZN D 128 D 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -31.30 30.46 48.64 -29.26 29.22 47.17 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -26.13 36.91 53.13 -25.06 34.30 52.99 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 26 3 # 26 D 130 SER D 44 SER^? 13.11 ZN ZN D 128 D 166 PHE D 98 PHE^? 7.40 ZN ZN D 128 D 182 PHE D 99 PHE^? 14.35 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -26.13 36.91 53.13 -25.06 34.30 52.99 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -29.67 42.10 49.53 -27.93 42.65 47.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 27 3 # 27 D 130 SER D 44 SER^? 13.11 ZN ZN D 128 D 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 D 182 PHE B 16 PHE.? 16.34 ZN ZN B 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -32.11 46.61 45.22 -31.70 43.89 45.83 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 28 3 # 28 D 130 SER D 44 SER^? 13.11 ZN ZN D 128 D 166 PHE D 99 PHE^? 14.35 ZN ZN D 128 D 182 PHE D 98 PHE^? 7.40 ZN ZN D 128 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -25.20 33.87 41.85 -23.76 35.78 42.26 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -29.67 42.10 49.53 -27.93 42.65 47.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -26.13 36.91 53.13 -25.06 34.30 52.99 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 28 hits 2r11_o03 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 57 ASP.? 17.22 ZN ZN A 128 A 86 HIS A 59 HIS.? 17.66 ZN ZN A 128 A 250 ALA A 61 ALA.? 20.04 ZN ZN A 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -30.68 49.76 89.87 -30.90 49.96 91.37 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 250 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 A 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 A 250 ALA A 71 ALA.? 18.90 ZN ZN A 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -10.85 57.79 70.32 -10.50 59.22 69.90 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 57 ASP.? 17.37 ZN ZN B 128 A 86 HIS B 59 HIS.? 17.68 ZN ZN B 128 A 250 ALA B 61 ALA.? 20.38 ZN ZN B 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -21.56 56.20 16.28 -21.70 56.37 14.76 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 250 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 A 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 A 250 ALA B 71 ALA.? 18.94 ZN ZN B 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -34.70 39.55 36.03 -36.14 39.66 36.51 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 8.18 57.58 47.56 10.27 57.39 47.78 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 11.45 52.92 44.80 10.43 52.05 43.19 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 A 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 A 250 ALA C 61 ALA.? 19.20 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 8.18 57.58 47.56 10.27 57.39 47.78 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 11.45 52.92 44.80 10.43 52.05 43.19 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 14.70 52.81 52.57 16.23 52.88 52.61 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 A 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 250 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 A 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 A 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 A 250 ALA C 71 ALA.? 19.01 ZN ZN C 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -5.38 44.92 71.40 -5.39 43.57 72.14 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 A 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 A 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 A 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 A 250 ALA D 61 ALA.? 19.60 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -37.19 13.11 53.70 -37.94 11.80 53.61 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 A 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 250 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 A 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 A 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 A 250 ALA D 71 ALA.? 18.99 ZN ZN D 128 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -23.67 30.79 35.16 -22.42 30.44 34.35 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 14 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 57 ASP.? 17.22 ZN ZN A 128 B 86 HIS A 59 HIS.? 17.66 ZN ZN A 128 B 250 ALA A 61 ALA.? 20.04 ZN ZN A 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -36.79 45.73 85.78 -38.28 45.69 84.31 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -30.68 49.76 89.87 -30.90 49.96 91.37 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 250 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 B 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 B 250 ALA A 71 ALA.? 18.90 ZN ZN A 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -10.85 57.79 70.32 -10.50 59.22 69.90 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP B 57 ASP.? 17.37 ZN ZN B 128 B 86 HIS B 59 HIS.? 17.68 ZN ZN B 128 B 250 ALA B 61 ALA.? 20.38 ZN ZN B 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -16.45 61.27 20.51 -16.17 62.71 22.01 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -21.56 56.20 16.28 -21.70 56.37 14.76 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 B 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 250 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 B 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 B 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 B 250 ALA B 71 ALA.? 18.94 ZN ZN B 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -34.70 39.55 36.03 -36.14 39.66 36.51 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 B 49 ASP C 32 ASP^? -2.40 ZN ZN C 128s B 86 HIS C 30 HIS^? -3.56 ZN ZN C 128s B 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 0.61 46.90 50.78 -0.23 46.71 52.70 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 B 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 8.18 57.58 47.56 10.27 57.39 47.78 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 11.45 52.92 44.80 10.43 52.05 43.19 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 B 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 B 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 B 250 ALA C 61 ALA.? 19.20 ZN ZN C 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 8.18 57.58 47.56 10.27 57.39 47.78 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 11.45 52.92 44.80 10.43 52.05 43.19 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 14.70 52.81 52.57 16.23 52.88 52.61 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 B 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 250 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 B 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 B 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 B 250 ALA C 71 ALA.? 19.01 ZN ZN C 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -5.38 44.92 71.40 -5.39 43.57 72.14 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 B 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 B 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 B 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 B 250 ALA D 61 ALA.? 19.60 ZN ZN D 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -37.19 13.11 53.70 -37.94 11.80 53.61 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 B 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 B 250 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 B 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 B 250 ALA D 71 ALA.? 18.99 ZN ZN D 128 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -23.67 30.79 35.16 -22.42 30.44 34.35 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 15 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 57 ASP.? 17.22 ZN ZN A 128 C 86 HIS A 59 HIS.? 17.66 ZN ZN A 128 C 250 ALA A 61 ALA.? 20.04 ZN ZN A 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -30.68 49.76 89.87 -30.90 49.96 91.37 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 C 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 C 250 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 C 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 C 250 ALA A 71 ALA.? 18.90 ZN ZN A 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -10.85 57.79 70.32 -10.50 59.22 69.90 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 C 49 ASP B 57 ASP.? 17.37 ZN ZN B 128 C 86 HIS B 59 HIS.? 17.68 ZN ZN B 128 C 250 ALA B 61 ALA.? 20.38 ZN ZN B 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -21.56 56.20 16.28 -21.70 56.37 14.76 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 C 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 C 250 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 C 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 C 250 ALA B 71 ALA.? 18.94 ZN ZN B 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -34.70 39.55 36.03 -36.14 39.66 36.51 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 C 49 ASP C 32 ASP^? -2.40 ZN ZN C 128s C 86 HIS C 30 HIS^? -3.56 ZN ZN C 128s C 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -4.92 50.07 51.06 -4.02 48.65 52.36 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 0.61 46.90 50.78 -0.23 46.71 52.70 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 C 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 C 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 8.18 57.58 47.56 10.27 57.39 47.78 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 11.45 52.92 44.80 10.43 52.05 43.19 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 C 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 C 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 C 250 ALA C 61 ALA.? 19.20 ZN ZN C 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 8.18 57.58 47.56 10.27 57.39 47.78 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 11.45 52.92 44.80 10.43 52.05 43.19 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 14.70 52.81 52.57 16.23 52.88 52.61 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 C 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 C 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 C 250 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 C 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 C 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 C 250 ALA C 71 ALA.? 19.01 ZN ZN C 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -5.38 44.92 71.40 -5.39 43.57 72.14 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 C 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 C 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 C 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 C 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 C 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 C 250 ALA D 61 ALA.? 19.60 ZN ZN D 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -37.19 13.11 53.70 -37.94 11.80 53.61 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 C 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 C 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 C 250 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 C 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 C 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 C 250 ALA D 71 ALA.? 18.99 ZN ZN D 128 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -23.67 30.79 35.16 -22.42 30.44 34.35 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 15 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 57 ASP.? 17.22 ZN ZN A 128 D 86 HIS A 59 HIS.? 17.66 ZN ZN A 128 D 250 ALA A 61 ALA.? 20.04 ZN ZN A 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -31.66 41.62 85.16 -32.16 42.63 86.92 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -36.79 45.73 85.78 -38.28 45.69 84.31 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -30.68 49.76 89.87 -30.90 49.96 91.37 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 D 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 D 250 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 D 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 D 250 ALA A 71 ALA.? 18.90 ZN ZN A 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -13.35 63.60 67.55 -12.78 65.45 68.34 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -10.85 57.79 70.32 -10.50 59.22 69.90 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP B 57 ASP.? 17.37 ZN ZN B 128 D 86 HIS B 59 HIS.? 17.68 ZN ZN B 128 D 250 ALA B 61 ALA.? 20.38 ZN ZN B 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -13.57 55.26 21.18 -14.41 55.74 19.31 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -16.45 61.27 20.51 -16.17 62.71 22.01 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -21.56 56.20 16.28 -21.70 56.37 14.76 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 D 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 D 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 D 250 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 D 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 D 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 D 250 ALA B 71 ALA.? 18.94 ZN ZN B 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -39.48 43.38 38.85 -41.38 43.59 37.99 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -34.70 39.55 36.03 -36.14 39.66 36.51 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 D 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 D 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 D 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 8.18 57.58 47.56 10.27 57.39 47.78 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 11.45 52.92 44.80 10.43 52.05 43.19 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 D 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 D 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 D 250 ALA C 61 ALA.? 19.20 ZN ZN C 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 8.18 57.58 47.56 10.27 57.39 47.78 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 11.45 52.92 44.80 10.43 52.05 43.19 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 14.70 52.81 52.57 16.23 52.88 52.61 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 D 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 D 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 D 250 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 D 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 D 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 D 250 ALA C 71 ALA.? 19.01 ZN ZN C 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -4.93 38.23 71.51 -3.75 37.25 72.95 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -5.38 44.92 71.40 -5.39 43.57 72.14 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 D 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 D 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 D 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 D 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 D 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 D 250 ALA D 61 ALA.? 19.60 ZN ZN D 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -40.07 20.84 58.32 -40.41 18.78 58.10 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -36.37 16.36 61.26 -35.21 16.95 62.91 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -37.19 13.11 53.70 -37.94 11.80 53.61 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 D 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 D 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 D 250 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 D 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 D 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 D 250 ALA D 71 ALA.? 18.99 ZN ZN D 128 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -17.20 28.58 35.23 -16.55 27.59 33.50 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -23.67 30.79 35.16 -22.42 30.44 34.35 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 14 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 57 ASP.? 17.22 ZN ZN A 128 E 86 HIS A 59 HIS.? 17.66 ZN ZN A 128 E 250 ALA A 61 ALA.? 20.04 ZN ZN A 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -36.79 45.73 85.78 -38.28 45.69 84.31 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -30.68 49.76 89.87 -30.90 49.96 91.37 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 E 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 E 250 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 E 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 E 250 ALA A 71 ALA.? 18.90 ZN ZN A 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -10.85 57.79 70.32 -10.50 59.22 69.90 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP B 57 ASP.? 17.37 ZN ZN B 128 E 86 HIS B 59 HIS.? 17.68 ZN ZN B 128 E 250 ALA B 61 ALA.? 20.38 ZN ZN B 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -16.45 61.27 20.51 -16.17 62.71 22.01 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -21.56 56.20 16.28 -21.70 56.37 14.76 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 E 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 E 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 E 250 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 E 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 E 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 E 250 ALA B 71 ALA.? 18.94 ZN ZN B 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -34.70 39.55 36.03 -36.14 39.66 36.51 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 E 49 ASP C 32 ASP^? -2.40 ZN ZN C 128s E 86 HIS C 30 HIS^? -3.56 ZN ZN C 128s E 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -36.85 29.32 15.06 -38.90 29.14 15.48 0.61 46.90 50.78 -0.23 46.71 52.70 coo -44.49 29.68 13.98 -43.47 28.67 13.52 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 E 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 E 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 E 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 8.18 57.58 47.56 10.27 57.39 47.78 coo -36.85 29.32 15.06 -38.90 29.14 15.48 11.45 52.92 44.80 10.43 52.05 43.19 coo -44.49 29.68 13.98 -43.47 28.67 13.52 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 E 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 E 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 E 250 ALA C 61 ALA.? 19.20 ZN ZN C 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 8.18 57.58 47.56 10.27 57.39 47.78 coo -36.85 29.32 15.06 -38.90 29.14 15.48 11.45 52.92 44.80 10.43 52.05 43.19 coo -44.49 29.68 13.98 -43.47 28.67 13.52 14.70 52.81 52.57 16.23 52.88 52.61 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 E 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 E 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 E 250 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 E 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 E 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 E 250 ALA C 71 ALA.? 19.01 ZN ZN C 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -5.38 44.92 71.40 -5.39 43.57 72.14 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 E 49 ASP D 32 ASP^? -2.55 ZN ZN D 128s E 86 HIS D 30 HIS^? -3.68 ZN ZN D 128s E 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 E 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 E 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 E 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 E 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 E 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 E 250 ALA D 61 ALA.? 19.60 ZN ZN D 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -37.19 13.11 53.70 -37.94 11.80 53.61 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 E 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 E 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 E 250 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 E 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 E 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 E 250 ALA D 71 ALA.? 18.99 ZN ZN D 128 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -23.67 30.79 35.16 -22.42 30.44 34.35 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 57 ASP.? 17.22 ZN ZN A 128 F 86 HIS A 59 HIS.? 17.66 ZN ZN A 128 F 250 ALA A 61 ALA.? 20.04 ZN ZN A 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -31.66 41.62 85.16 -32.16 42.63 86.92 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -36.79 45.73 85.78 -38.28 45.69 84.31 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -30.68 49.76 89.87 -30.90 49.96 91.37 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 F 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 F 250 ALA A 49 ALA^? 15.93 ZN ZN A 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -15.43 59.12 73.84 -14.71 59.38 75.17 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP A 91 ASP.? 21.24 ZN ZN A 128 F 86 HIS A 47 HIS^? 20.92 ZN ZN A 128 F 250 ALA A 71 ALA.? 18.90 ZN ZN A 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -17.26 66.98 68.26 -15.96 67.19 69.91 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -13.35 63.60 67.55 -12.78 65.45 68.34 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -10.85 57.79 70.32 -10.50 59.22 69.90 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP B 57 ASP.? 17.37 ZN ZN B 128 F 86 HIS B 59 HIS.? 17.68 ZN ZN B 128 F 250 ALA B 61 ALA.? 20.38 ZN ZN B 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -13.57 55.26 21.18 -14.41 55.74 19.31 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -16.45 61.27 20.51 -16.17 62.71 22.01 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -21.56 56.20 16.28 -21.70 56.37 14.76 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 F 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 F 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 F 250 ALA B 49 ALA^? 16.22 ZN ZN B 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -34.75 44.14 32.50 -35.24 43.58 31.16 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 F 49 ASP B 91 ASP.? 21.34 ZN ZN B 128 F 86 HIS B 47 HIS^? 20.89 ZN ZN B 128 F 250 ALA B 71 ALA.? 18.94 ZN ZN B 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -42.02 48.13 37.63 -42.45 47.31 35.73 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -39.48 43.38 38.85 -41.38 43.59 37.99 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -34.70 39.55 36.03 -36.14 39.66 36.51 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 F 49 ASP C 32 ASP^? -2.40 ZN ZN C 128s F 86 HIS C 30 HIS^? -3.56 ZN ZN C 128s F 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -4.92 50.07 51.06 -4.02 48.65 52.36 coo -84.21 11.81 39.90 -82.43 12.70 39.26 0.61 46.90 50.78 -0.23 46.71 52.70 coo -78.49 17.13 41.31 -79.25 15.85 41.61 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 F 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 F 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 F 250 ALA B 109 ALA.? 11.51 ZN ZN C 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 8.18 57.58 47.56 10.27 57.39 47.78 coo -84.21 11.81 39.90 -82.43 12.70 39.26 11.45 52.92 44.80 10.43 52.05 43.19 coo -78.49 17.13 41.31 -79.25 15.85 41.61 5.85 47.64 45.49 6.61 48.23 46.67 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 F 49 ASP C 57 ASP.? 16.82 ZN ZN C 128 F 86 HIS C 59 HIS.? 17.15 ZN ZN C 128 F 250 ALA C 61 ALA.? 19.20 ZN ZN C 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 8.18 57.58 47.56 10.27 57.39 47.78 coo -84.21 11.81 39.90 -82.43 12.70 39.26 11.45 52.92 44.80 10.43 52.05 43.19 coo -78.49 17.13 41.31 -79.25 15.85 41.61 14.70 52.81 52.57 16.23 52.88 52.61 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 F 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 F 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 F 250 ALA C 49 ALA^? 16.41 ZN ZN C 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -0.09 43.99 68.78 1.05 44.60 69.61 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 F 49 ASP C 91 ASP.? 22.72 ZN ZN C 128 F 86 HIS C 47 HIS^? 21.11 ZN ZN C 128 F 250 ALA C 71 ALA.? 19.01 ZN ZN C 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -1.22 34.88 70.14 -0.71 32.98 70.85 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -4.93 38.23 71.51 -3.75 37.25 72.95 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -5.38 44.92 71.40 -5.39 43.57 72.14 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 12 3 # 12 F 49 ASP D 32 ASP^? -2.55 ZN ZN D 128s F 86 HIS D 30 HIS^? -3.68 ZN ZN D 128s F 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -29.32 31.61 55.53 -28.20 30.46 54.16 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -27.59 25.34 55.74 -27.28 26.44 53.99 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 13 3 # 13 F 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 F 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 F 250 ALA A 109 ALA.? 12.23 ZN ZN D 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -30.13 20.47 61.13 -30.71 19.50 60.10 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 14 3 # 14 F 49 ASP D 57 ASP.? 16.88 ZN ZN D 128 F 86 HIS D 59 HIS.? 17.27 ZN ZN D 128 F 250 ALA D 61 ALA.? 19.60 ZN ZN D 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -40.07 20.84 58.32 -40.41 18.78 58.10 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -36.37 16.36 61.26 -35.21 16.95 62.91 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -37.19 13.11 53.70 -37.94 11.80 53.61 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 15 3 # 15 F 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 F 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 F 250 ALA D 49 ALA^? 16.16 ZN ZN D 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -23.96 25.36 38.04 -24.83 24.52 37.10 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 16 3 # 16 F 49 ASP D 91 ASP.? 22.90 ZN ZN D 128 F 86 HIS D 47 HIS^? 21.18 ZN ZN D 128 F 250 ALA D 71 ALA.? 18.99 ZN ZN D 128 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -17.20 28.58 35.23 -16.55 27.59 33.50 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -23.67 30.79 35.16 -22.42 30.44 34.35 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 16 hits 2wwt_o05 naa= 3 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 1 3 # 1 A 89 SER C 13 SER^? 14.25 ZN ZN C 128 A 216 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 243 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 11.52 10.39 18.97 12.10 9.11 20.95 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 20.60 4.89 19.19 18.56 4.62 19.55 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 16.75 7.77 21.42 14.85 7.46 20.58 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 2 3 # 2 A 89 SER D 13 SER^? 14.41 ZN ZN D 128 A 216 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 243 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 11.52 10.39 18.97 12.10 9.11 20.95 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 20.60 4.89 19.19 18.56 4.62 19.55 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 16.75 7.77 21.42 14.85 7.46 20.58 -18.46 42.11 47.13 -20.09 43.42 47.28 2xmz_o00 source 2XMZ HYDROLASE, ALPHA/BETA HYDROLASE FOLD FAMILY : 2 hits 2xmz_o00 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 86 GLU^? 14.11 ZN ZN A 128 A 44 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 50 THR A 89 THR.? 18.72 ZN ZN A 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -23.80 59.27 78.25 -23.36 59.70 80.28 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -19.06 65.09 74.03 -16.96 64.91 73.52 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 86 GLU^? 14.11 ZN ZN A 128 A 44 ASP A 90 ASP.? 20.22 ZN ZN A 128 A 50 THR A 92 THR.? 14.81 ZN ZN A 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -23.80 59.27 78.25 -23.36 59.70 80.28 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 86 GLU^? 14.21 ZN ZN B 128 A 44 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 50 THR B 89 THR.? 18.91 ZN ZN B 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -32.66 52.13 28.08 -32.88 52.09 25.98 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -39.38 49.52 32.40 -39.94 47.46 32.72 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU B 86 GLU^? 14.21 ZN ZN B 128 A 44 ASP B 90 ASP.? 20.48 ZN ZN B 128 A 50 THR B 92 THR.? 15.12 ZN ZN B 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -32.66 52.13 28.08 -32.88 52.09 25.98 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 3hde_o00 LYSOZYME user 5 3 # 5 A 35 GLU C 86 GLU^? 14.08 ZN ZN C 128 A 44 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 50 THR C 89 THR.? 19.23 ZN ZN C 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 6.41 43.35 62.15 8.10 44.52 62.72 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 2.93 33.32 67.19 5.03 33.43 67.23 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 3.40 37.97 68.34 2.23 38.61 70.05 ULMN 3 3hde_o00 LYSOZYME user 6 3 # 6 A 35 GLU C 86 GLU^? 14.08 ZN ZN C 128 A 44 ASP C 90 ASP.? 21.10 ZN ZN C 128 A 50 THR C 92 THR.? 15.22 ZN ZN C 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 6.41 43.35 62.15 8.10 44.52 62.72 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 2.93 33.32 67.19 5.03 33.43 67.23 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 3hde_o00 LYSOZYME user 7 3 # 7 A 35 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 44 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 50 THR D 89 THR.? 18.97 ZN ZN D 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -25.28 18.69 44.67 -26.61 17.28 43.81 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -19.13 20.42 38.63 -19.24 21.85 36.98 ULMN 3 3hde_o00 LYSOZYME user 8 3 # 8 A 35 GLU D 86 GLU^? 14.30 ZN ZN D 128 A 44 ASP D 90 ASP.? 20.62 ZN ZN D 128 A 50 THR D 92 THR.? 15.38 ZN ZN D 128 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -25.28 18.69 44.67 -26.61 17.28 43.81 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -18.23 25.46 39.42 -20.30 24.86 39.60 3hde_o00 source 3HDE LYSOZYME : 8 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 86 GLU^? 14.11 ZN ZN A 128 B 44 ASP A 90 ASP.? 20.22 ZN ZN A 128 B 50 THR A 92 THR.? 14.81 ZN ZN A 128 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -23.80 59.27 78.25 -23.36 59.70 80.28 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -21.48 68.18 71.21 -23.15 68.60 72.44 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU B 86 GLU^? 14.21 ZN ZN B 128 B 44 ASP B 90 ASP.? 20.48 ZN ZN B 128 B 50 THR B 92 THR.? 15.12 ZN ZN B 128 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -32.66 52.13 28.08 -32.88 52.09 25.98 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -41.70 52.65 35.26 -41.90 54.02 33.70 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU C 86 GLU^? 14.08 ZN ZN C 128 B 44 ASP C 90 ASP.? 21.10 ZN ZN C 128 B 50 THR C 92 THR.? 15.22 ZN ZN C 128 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 6.41 43.35 62.15 8.10 44.52 62.72 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 2.93 33.32 67.19 5.03 33.43 67.23 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU D 70 GLU^? 19.86 ZN ZN D 128 B 44 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 50 THR D 89 THR.? 18.97 ZN ZN D 128 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -27.83 26.66 34.57 -27.72 25.48 32.82 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -19.13 20.42 38.63 -19.24 21.85 36.98 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU D 70 GLU^? 19.86 ZN ZN D 128 B 44 ASP D 91 ASP.? 22.90 ZN ZN D 128 B 50 THR D 92 THR.? 15.38 ZN ZN D 128 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -27.83 26.66 34.57 -27.72 25.48 32.82 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -15.13 23.89 36.32 -13.65 22.60 35.55 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -18.23 25.46 39.42 -20.30 24.86 39.60 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU D 86 GLU^? 14.30 ZN ZN D 128 B 44 ASP D 90 ASP.? 20.62 ZN ZN D 128 B 50 THR D 92 THR.? 15.38 ZN ZN D 128 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -25.28 18.69 44.67 -26.61 17.28 43.81 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -14.45 19.85 39.76 -14.81 17.95 40.62 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -18.23 25.46 39.42 -20.30 24.86 39.60 3hde_o01 source 3HDE LYSOZYME : 6 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 70 GLU^? 19.90 ZN ZN A 128 C 44 ASP A 91 ASP.? 21.24 ZN ZN A 128 C 50 THR A 89 THR.? 18.72 ZN ZN A 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 25.48 4.87 1.60 23.90 4.95 0.15 -19.06 65.09 74.03 -16.96 64.91 73.52 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 70 GLU^? 19.90 ZN ZN A 128 C 44 ASP A 91 ASP.? 21.24 ZN ZN A 128 C 50 THR A 92 THR.? 14.81 ZN ZN A 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -10.78 57.16 76.11 -9.51 58.48 77.12 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -17.26 66.98 68.26 -15.96 67.19 69.91 coo 25.48 4.87 1.60 23.90 4.95 0.15 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU A 86 GLU^? 14.11 ZN ZN A 128 C 44 ASP A 90 ASP.? 20.22 ZN ZN A 128 C 50 THR A 92 THR.? 14.81 ZN ZN A 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -23.80 59.27 78.25 -23.36 59.70 80.28 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -21.48 68.18 71.21 -23.15 68.60 72.44 coo 25.48 4.87 1.60 23.90 4.95 0.15 -18.17 62.44 69.62 -18.23 61.18 71.41 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 70 GLU^? 18.94 ZN ZN B 128 C 44 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 50 THR B 89 THR.? 18.91 ZN ZN B 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 25.48 4.87 1.60 23.90 4.95 0.15 -39.38 49.52 32.40 -39.94 47.46 32.72 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 70 GLU^? 18.94 ZN ZN B 128 C 44 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 50 THR B 92 THR.? 15.12 ZN ZN B 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -34.57 38.82 30.28 -36.03 40.31 29.90 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 3hde_o02 LYSOZYME user 6 3 # 6 C 35 GLU B 86 GLU^? 14.21 ZN ZN B 128 C 44 ASP B 90 ASP.? 20.48 ZN ZN B 128 C 50 THR B 92 THR.? 15.12 ZN ZN B 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -32.66 52.13 28.08 -32.88 52.09 25.98 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -41.70 52.65 35.26 -41.90 54.02 33.70 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 3hde_o02 LYSOZYME user 7 3 # 7 C 35 GLU B 86 GLU^? 14.21 ZN ZN B 128 C 44 ASP B 91 ASP.? 21.34 ZN ZN B 128 C 50 THR B 92 THR.? 15.12 ZN ZN B 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -32.66 52.13 28.08 -32.88 52.09 25.98 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -42.02 48.13 37.63 -42.45 47.31 35.73 coo 25.48 4.87 1.60 23.90 4.95 0.15 -37.24 47.79 36.87 -36.06 47.31 35.09 ULMN 3 3hde_o02 LYSOZYME user 8 3 # 8 C 35 GLU C 70 GLU^? 19.15 ZN ZN C 128 C 44 ASP C 91 ASP.? 22.72 ZN ZN C 128 C 50 THR C 89 THR.? 19.23 ZN ZN C 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -0.72 48.58 72.21 1.10 47.61 72.77 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 25.48 4.87 1.60 23.90 4.95 0.15 3.40 37.97 68.34 2.23 38.61 70.05 ULMN 3 3hde_o02 LYSOZYME user 9 3 # 9 C 35 GLU C 70 GLU^? 19.15 ZN ZN C 128 C 44 ASP C 91 ASP.? 22.72 ZN ZN C 128 C 50 THR C 92 THR.? 15.22 ZN ZN C 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -0.72 48.58 72.21 1.10 47.61 72.77 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 25.48 4.87 1.60 23.90 4.95 0.15 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 3hde_o02 LYSOZYME user 10 3 # 10 C 35 GLU C 86 GLU^? 14.08 ZN ZN C 128 C 44 ASP C 90 ASP.? 21.10 ZN ZN C 128 C 50 THR C 92 THR.? 15.22 ZN ZN C 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 6.41 43.35 62.15 8.10 44.52 62.72 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 2.93 33.32 67.19 5.03 33.43 67.23 coo 25.48 4.87 1.60 23.90 4.95 0.15 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 3hde_o02 LYSOZYME user 11 3 # 11 C 35 GLU C 86 GLU^? 14.08 ZN ZN C 128 C 44 ASP C 91 ASP.? 22.72 ZN ZN C 128 C 50 THR C 92 THR.? 15.22 ZN ZN C 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 6.41 43.35 62.15 8.10 44.52 62.72 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -1.22 34.88 70.14 -0.71 32.98 70.85 coo 25.48 4.87 1.60 23.90 4.95 0.15 -1.81 38.46 67.24 -0.75 40.31 66.94 ULMN 3 3hde_o02 LYSOZYME user 12 3 # 12 C 35 GLU C 103 GLU.? 13.37 ZN ZN B 128 C 44 ASP B 32 ASP.? -2.88 ZN ZN B 128s C 50 THR C 35 THR.? 11.32 ZN ZN B 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -20.07 59.92 44.69 -19.74 61.53 43.36 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -16.91 52.67 35.82 -18.80 51.89 35.31 coo 25.48 4.87 1.60 23.90 4.95 0.15 -12.31 51.29 42.82 -14.33 50.63 43.21 ULMN 3 3hde_o02 LYSOZYME user 13 3 # 13 C 35 GLU D 70 GLU^? 19.86 ZN ZN D 128 C 44 ASP D 91 ASP.? 22.90 ZN ZN D 128 C 50 THR D 89 THR.? 18.97 ZN ZN D 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 25.48 4.87 1.60 23.90 4.95 0.15 -19.13 20.42 38.63 -19.24 21.85 36.98 ULMN 3 3hde_o02 LYSOZYME user 14 3 # 14 C 35 GLU D 70 GLU^? 19.86 ZN ZN D 128 C 44 ASP D 91 ASP.? 22.90 ZN ZN D 128 C 50 THR D 92 THR.? 15.38 ZN ZN D 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -27.83 26.66 34.57 -27.72 25.48 32.82 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 25.48 4.87 1.60 23.90 4.95 0.15 -18.23 25.46 39.42 -20.30 24.86 39.60 ULMN 3 3hde_o02 LYSOZYME user 15 3 # 15 C 35 GLU D 86 GLU^? 14.30 ZN ZN D 128 C 44 ASP D 90 ASP.? 20.62 ZN ZN D 128 C 50 THR D 92 THR.? 15.38 ZN ZN D 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -14.45 19.85 39.76 -14.81 17.95 40.62 coo 25.48 4.87 1.60 23.90 4.95 0.15 -18.23 25.46 39.42 -20.30 24.86 39.60 ULMN 3 3hde_o02 LYSOZYME user 16 3 # 16 C 35 GLU D 86 GLU^? 14.30 ZN ZN D 128 C 44 ASP D 91 ASP.? 22.90 ZN ZN D 128 C 50 THR D 92 THR.? 15.38 ZN ZN D 128 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -25.28 18.69 44.67 -26.61 17.28 43.81 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -15.13 23.89 36.32 -13.65 22.60 35.55 coo 25.48 4.87 1.60 23.90 4.95 0.15 -18.23 25.46 39.42 -20.30 24.86 39.60 3hde_o02 source 3HDE LYSOZYME : 16 hits 3hde_o02 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS A 10 HIS^? 15.73 ZN ZN A 128 A 250 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 328 SER C 44 SER^? 13.15 ZN ZN C 128 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -8.23 46.92 64.43 -10.34 48.09 64.36 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 2 3 # 2 A 220 HIS B 10 HIS^? 15.59 ZN ZN B 128 A 250 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 328 SER D 44 SER^? 13.11 ZN ZN D 128 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -25.20 33.87 41.85 -23.76 35.78 42.26 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 3 3 # 3 A 220 HIS C 10 HIS^? 15.40 ZN ZN C 128 A 250 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 328 SER A 44 SER^? 13.08 ZN ZN A 128 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -15.06 51.94 67.95 -14.23 50.17 66.49 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 3 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS A 10 HIS^? 15.73 ZN ZN A 128 B 250 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 328 SER C 44 SER^? 13.15 ZN ZN C 128 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -8.23 46.92 64.43 -10.34 48.09 64.36 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 2 3 # 2 B 220 HIS B 10 HIS^? 15.59 ZN ZN B 128 B 250 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 328 SER D 44 SER^? 13.11 ZN ZN D 128 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -25.20 33.87 41.85 -23.76 35.78 42.26 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 3 3 # 3 B 220 HIS C 10 HIS^? 15.40 ZN ZN C 128 B 250 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 328 SER A 44 SER^? 13.08 ZN ZN A 128 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -15.06 51.94 67.95 -14.23 50.17 66.49 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 3 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS A 10 HIS^? 15.73 ZN ZN A 128 C 250 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 328 SER C 44 SER^? 13.15 ZN ZN C 128 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -17.72 42.81 59.27 -18.61 44.71 59.17 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -8.23 46.92 64.43 -10.34 48.09 64.36 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 2 3 # 2 C 220 HIS B 10 HIS^? 15.59 ZN ZN B 128 C 250 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 328 SER D 44 SER^? 13.11 ZN ZN D 128 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -18.46 42.11 47.13 -20.09 43.42 47.28 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -25.20 33.87 41.85 -23.76 35.78 42.26 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 3 3 # 3 C 220 HIS C 10 HIS^? 15.40 ZN ZN C 128 C 250 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 328 SER A 44 SER^? 13.08 ZN ZN A 128 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -17.83 49.51 56.44 -17.15 47.54 56.54 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -15.06 51.94 67.95 -14.23 50.17 66.49 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 3 hits 3nwu_o02 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 13 SER^? 14.04 ZN ZN A 128 A 524 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 556 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -21.49 47.80 59.94 -19.64 49.31 59.49 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -13.22 48.33 58.62 -13.88 46.78 59.86 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER B 13 SER^? 13.94 ZN ZN B 128 A 524 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 556 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -22.32 47.02 46.39 -24.11 45.44 46.82 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -25.08 39.18 47.70 -23.31 39.57 46.61 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER C 13 SER^? 14.25 ZN ZN C 128 A 524 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 556 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -14.19 44.26 55.72 -15.84 45.12 57.33 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -18.00 46.34 63.27 -17.25 47.97 62.16 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER D 13 SER^? 14.41 ZN ZN D 128 A 524 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 556 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -20.94 39.05 50.60 -21.28 40.97 49.13 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -21.74 43.31 43.14 -23.53 43.14 44.28 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -18.46 42.11 47.13 -20.09 43.42 47.28 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o00 naa= 3 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 C 445 SER A 13 SER^? 14.04 ZN ZN A 128 C 524 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 556 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 C 445 SER A 13 SER^? 14.04 ZN ZN A 128 C 524 ASP C 97 ASP^? 13.06 ZN ZN C 128 C 556 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 C 445 SER B 13 SER^? 13.94 ZN ZN B 128 C 524 ASP D 97 ASP^? 13.24 ZN ZN D 128 C 556 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 C 445 SER C 13 SER^? 14.25 ZN ZN C 128 C 524 ASP A 97 ASP^? 13.17 ZN ZN A 128 C 556 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 5 3 # 5 C 445 SER D 13 SER^? 14.41 ZN ZN D 128 C 524 ASP B 97 ASP^? 13.03 ZN ZN B 128 C 556 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -18.46 42.11 47.13 -20.09 43.42 47.28 3o4g_o02 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 5 hits 3o4g_o02 naa= 3 ULMN 3 3zwq_o00 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 1 3 # 1 A 157 SER A 13 SER^? 14.04 ZN ZN A 128 A 254 ASP C 97 ASP^? 13.06 ZN ZN C 128 A 284 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo -20.09 -13.76 4.99 -18.56 -11.94 4.87 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -21.52 -7.55 12.04 -21.23 -8.42 10.14 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -18.29 -9.68 9.15 -18.87 -10.69 7.41 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 3zwq_o00 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 2 3 # 2 A 157 SER B 13 SER^? 13.94 ZN ZN B 128 A 254 ASP D 97 ASP^? 13.24 ZN ZN D 128 A 284 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo -20.09 -13.76 4.99 -18.56 -11.94 4.87 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -21.52 -7.55 12.04 -21.23 -8.42 10.14 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -18.29 -9.68 9.15 -18.87 -10.69 7.41 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 3zwq_o00 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 3 3 # 3 A 157 SER C 13 SER^? 14.25 ZN ZN C 128 A 254 ASP A 97 ASP^? 13.17 ZN ZN A 128 A 284 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -20.09 -13.76 4.99 -18.56 -11.94 4.87 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -21.52 -7.55 12.04 -21.23 -8.42 10.14 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -18.29 -9.68 9.15 -18.87 -10.69 7.41 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 3zwq_o00 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 4 3 # 4 A 157 SER D 13 SER^? 14.41 ZN ZN D 128 A 254 ASP B 97 ASP^? 13.03 ZN ZN B 128 A 284 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -20.09 -13.76 4.99 -18.56 -11.94 4.87 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -21.52 -7.55 12.04 -21.23 -8.42 10.14 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -18.29 -9.68 9.15 -18.87 -10.69 7.41 -18.46 42.11 47.13 -20.09 43.42 47.28 3zwq_o00 source 3ZWQ ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN : 4 hits 3zwq_o00 naa= 3 ULMN 3 3zwq_o01 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 1 3 # 1 B 157 SER A 13 SER^? 14.04 ZN ZN A 128 B 254 ASP C 97 ASP^? 13.06 ZN ZN C 128 B 284 HIS C 10 HIS^? 15.40 ZN ZN C 128 coo -37.32 -16.63 33.25 -39.45 -15.48 33.60 -21.49 47.80 59.94 -19.64 49.31 59.49 coo -37.64 -10.09 26.32 -37.69 -11.02 28.21 -13.22 48.33 58.62 -13.88 46.78 59.86 coo -40.12 -13.34 29.11 -39.19 -14.07 30.85 -17.83 49.51 56.44 -17.15 47.54 56.54 ULMN 3 3zwq_o01 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 2 3 # 2 B 157 SER B 13 SER^? 13.94 ZN ZN B 128 B 254 ASP D 97 ASP^? 13.24 ZN ZN D 128 B 284 HIS D 10 HIS^? 15.91 ZN ZN D 128 coo -37.32 -16.63 33.25 -39.45 -15.48 33.60 -22.32 47.02 46.39 -24.11 45.44 46.82 coo -37.64 -10.09 26.32 -37.69 -11.02 28.21 -25.08 39.18 47.70 -23.31 39.57 46.61 coo -40.12 -13.34 29.11 -39.19 -14.07 30.85 -24.77 44.27 50.01 -22.89 43.34 50.12 ULMN 3 3zwq_o01 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 3 3 # 3 B 157 SER C 13 SER^? 14.25 ZN ZN C 128 B 254 ASP A 97 ASP^? 13.17 ZN ZN A 128 B 284 HIS A 10 HIS^? 15.73 ZN ZN A 128 coo -37.32 -16.63 33.25 -39.45 -15.48 33.60 -14.19 44.26 55.72 -15.84 45.12 57.33 coo -37.64 -10.09 26.32 -37.69 -11.02 28.21 -18.00 46.34 63.27 -17.25 47.97 62.16 coo -40.12 -13.34 29.11 -39.19 -14.07 30.85 -17.72 42.81 59.27 -18.61 44.71 59.17 ULMN 3 3zwq_o01 ALPHA/BETA HYDROLASE FOLD-3 DOMAIN Puser 4 3 # 4 B 157 SER D 13 SER^? 14.41 ZN ZN D 128 B 254 ASP B 97 ASP^? 13.03 ZN ZN B 128 B 284 HIS B 10 HIS^? 15.59 ZN ZN B 128 coo -37.32 -16.63 33.25 -39.45 -15.48 33.60 -20.94 39.05 50.60 -21.28 40.97 49.13 coo -37.64 -10.09 26.32 -37.69 -11.02 28.21 -21.74 43.31 43.14 -23.53 43.14 44.28 coo -40.12 -13.34 29.11 -39.19 -14.07 30.85 -18.46 42.11 47.13 -20.09 43.42 47.28 3zwq_o01 source 3ZWQ ALPHA/BETA HYDROLASE FOLD-3 DOMAIN PROTEIN : 4 hits 3zwq_o01 naa= 3